Term,NES,FDR q-val,Perturbation
RRNA_PROCESSING,2.596329058,0,sparfosic-acid
TRANSLATION,2.576304133,0,sparfosic-acid
NONSENSE_MEDIATED_DECAY_NMD,2.403552092,0.001026609,sparfosic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.323283482,0.004619741,sparfosic-acid
SELENOAMINO_ACID_METABOLISM,2.28615861,0.004927723,sparfosic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.261692873,0.005133045,sparfosic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.225630045,0.005279704,sparfosic-acid
EUKARYOTIC_TRANSLATION_INITIATION,2.067409697,0.011164373,sparfosic-acid
INFLUENZA_INFECTION,2.025637,0.013345918,sparfosic-acid
DNA_REPLICATION,1.916617447,0.025562565,sparfosic-acid
SELENOAMINO_ACID_METABOLISM,-2.796723279,0,zileuton
SARS_COV_1_HOST_INTERACTIONS,-2.371969057,0,zileuton
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.391811682,0,zileuton
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.440504057,0,zileuton
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.454948914,0,zileuton
RRNA_PROCESSING,-2.480815975,0,zileuton
TRANSLATION,-2.489656728,0,zileuton
CELLULAR_RESPONSE_TO_STARVATION,-2.534742453,0,zileuton
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.386417746,0,zileuton
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.599194776,0,zileuton
EUKARYOTIC_TRANSLATION_ELONGATION,3.730336822,0,sodium-butyrate
SARS_COV_2_HOST_INTERACTIONS,2.748889959,0,sodium-butyrate
VIRAL_INFECTION_PATHWAYS,2.871952464,0,sodium-butyrate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.92185917,0,sodium-butyrate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.00384061,0,sodium-butyrate
METABOLISM_OF_RNA,3.072927962,0,sodium-butyrate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.118297177,0,sodium-butyrate
SARS_COV_1_INFECTION,3.189334224,0,sodium-butyrate
RRNA_PROCESSING,3.193659159,0,sodium-butyrate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.195947737,0,sodium-butyrate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.777436746,0,tamoxifen
SELENOAMINO_ACID_METABOLISM,-2.745447105,0,tamoxifen
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.727112627,0,tamoxifen
NONSENSE_MEDIATED_DECAY_NMD,-2.7040001,0,tamoxifen
CELLULAR_RESPONSE_TO_STARVATION,-2.671496163,0,tamoxifen
EUKARYOTIC_TRANSLATION_INITIATION,-2.658529058,0,tamoxifen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.64394806,0,tamoxifen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.642531935,0,tamoxifen
INFLUENZA_INFECTION,-2.612737458,0,tamoxifen
SIGNALING_BY_ROBO_RECEPTORS,-2.546872842,0,tamoxifen
EUKARYOTIC_TRANSLATION_ELONGATION,2.798443108,0,BRD-K76188144
SELENOAMINO_ACID_METABOLISM,2.787665237,0,BRD-K76188144
RRNA_PROCESSING,2.763270541,0,BRD-K76188144
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.681808988,0,BRD-K76188144
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.306045687,0.002155572,BRD-K76188144
NONSENSE_MEDIATED_DECAY_NMD,2.351777141,0.005287808,BRD-K76188144
TRANSLATION,2.408255651,0.006345369,BRD-K76188144
EUKARYOTIC_TRANSLATION_INITIATION,2.317711708,0.005539608,BRD-K76188144
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.259121578,0.006107453,BRD-K76188144
CELLULAR_RESPONSE_TO_STARVATION,2.12491239,0.010575616,BRD-K76188144
CELL_CYCLE_CHECKPOINTS,2.777626796,0.002052836,7-nitroindazole
CELL_CYCLE_MITOTIC,2.514105238,0.007184926,7-nitroindazole
DNA_REPLICATION,2.436079552,0.006842787,7-nitroindazole
TRANSLATION,2.361600681,0.008211344,7-nitroindazole
SEPARATION_OF_SISTER_CHROMATIDS,2.327173419,0.006979643,7-nitroindazole
RESPIRATORY_ELECTRON_TRANSPORT,2.299028456,0.006500648,7-nitroindazole
RRNA_PROCESSING,2.177974097,0.014956377,7-nitroindazole
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.169672618,0.013343435,7-nitroindazole
SYNTHESIS_OF_DNA,2.133536624,0.016194596,7-nitroindazole
CELL_CYCLE,2.100971733,0.01703854,7-nitroindazole
CELL_CYCLE_CHECKPOINTS,2.852794083,0,promethazine
SELENOAMINO_ACID_METABOLISM,2.751142488,0.001867929,promethazine
RRNA_PROCESSING,2.70108522,0.001245286,promethazine
SEPARATION_OF_SISTER_CHROMATIDS,2.616660085,0.000933965,promethazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.591516757,0.000747172,promethazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.522859378,0.001245286,promethazine
EUKARYOTIC_TRANSLATION_INITIATION,2.410328915,0.002668471,promethazine
MITOTIC_METAPHASE_AND_ANAPHASE,2.267261803,0.002988687,promethazine
MITOTIC_SPINDLE_CHECKPOINT,2.285151705,0.003320764,promethazine
TRANSLATION,2.332923627,0.003735859,promethazine
METABOLISM_OF_RNA,3.533399452,0,losartan
INFLUENZA_INFECTION,3.451809362,0,losartan
TRANSLATION,3.440250178,0,losartan
RRNA_PROCESSING,3.226506663,0,losartan
SELENOAMINO_ACID_METABOLISM,3.173339659,0,losartan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.61660639,0.000856943,losartan
MRNA_SPLICING,2.570681138,0.000734523,losartan
HIV_INFECTION,2.474312941,0.000642707,losartan
HIV_LIFE_CYCLE,2.243231263,0.003427772,losartan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.986797043,0.017481637,losartan
RESPIRATORY_ELECTRON_TRANSPORT,2.415149677,0.003348281,sildenafil
TRANSLATION,2.163992731,0.016741405,sildenafil
INFLUENZA_INFECTION,2.089028769,0.025670154,sildenafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.089818635,0.031958606,sildenafil
NEDDYLATION,1.93226487,0.053572496,sildenafil
GPCR_LIGAND_BINDING,-2.049915821,0.025490793,sildenafil
SIGNALING_BY_INTERLEUKINS,1.782124308,0.112502242,sildenafil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.763368057,0.108819133,sildenafil
RRNA_PROCESSING,1.738294203,0.105710015,sildenafil
TRANSCRIPTION_OF_THE_HIV_GENOME,1.691165759,0.118445441,sildenafil
HCMV_EARLY_EVENTS,2.16010277,0.100245165,curcumin
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.950873567,0.228893126,curcumin
REGULATION_OF_PTEN_GENE_TRANSCRIPTION,1.881136771,0.242816066,curcumin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.899931081,0.473766458,curcumin
PTEN_REGULATION,1.788980765,0.314101516,curcumin
SIGNALING_BY_HEDGEHOG,1.513265571,1,curcumin
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.48883631,0.984073368,curcumin
HOST_INTERACTIONS_OF_HIV_FACTORS,1.483419044,0.865927281,curcumin
ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,-1.69028668,1,curcumin
VISUAL_PHOTOTRANSDUCTION,-1.687697369,0.88884563,curcumin
METABOLISM_OF_RNA,-3.093093598,0,vorinostat
RRNA_PROCESSING,-2.894627825,0,vorinostat
INTEGRATION_OF_ENERGY_METABOLISM,2.767187945,0,vorinostat
CILIUM_ASSEMBLY,2.747680285,0,vorinostat
NEURONAL_SYSTEM,2.705024781,0.000314942,vorinostat
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.505155995,0.000346275,vorinostat
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.555485335,0.001889652,vorinostat
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.440774694,0.001038824,vorinostat
SIGNALING_BY_GPCR,2.541902927,0.001889652,vorinostat
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.508600805,0.002204594,vorinostat
RRNA_PROCESSING,2.926644964,0,rosiglitazone
FATTY_ACID_METABOLISM,2.212532701,0.021455458,rosiglitazone
NONSENSE_MEDIATED_DECAY_NMD,2.17198762,0.021455458,rosiglitazone
METABOLISM_OF_RNA,2.160922304,0.017283563,rosiglitazone
EUKARYOTIC_TRANSLATION_INITIATION,2.140070342,0.015257215,rosiglitazone
EUKARYOTIC_TRANSLATION_ELONGATION,2.08236495,0.017879548,rosiglitazone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.044925766,0.018730955,rosiglitazone
SELENOAMINO_ACID_METABOLISM,1.998215742,0.025031368,rosiglitazone
MRNA_SPLICING,1.969386168,0.027547749,rosiglitazone
STIMULI_SENSING_CHANNELS,-2.061237837,0.073599809,rosiglitazone
TRANSLATION,2.480552324,0,gossypol
SELENOAMINO_ACID_METABOLISM,2.366026646,0.003519631,gossypol
RRNA_PROCESSING,2.371008445,0.005279447,gossypol
EUKARYOTIC_TRANSLATION_ELONGATION,2.310081445,0.003299654,gossypol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.188467489,0.003959585,gossypol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.216425598,0.004751502,gossypol
NONSENSE_MEDIATED_DECAY_NMD,2.149175496,0.006033653,gossypol
EUKARYOTIC_TRANSLATION_INITIATION,2.001407703,0.017818132,gossypol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.161096593,0.063516606,gossypol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.880879394,0.034316403,gossypol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.013374892,0.16713413,capsaicin
TRANSLATION,-1.863520724,0.339043521,capsaicin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.803324991,0.368331787,capsaicin
CELL_JUNCTION_ORGANIZATION,1.501607485,1,capsaicin
REGULATION_OF_TP53_ACTIVITY,-1.765829537,0.36960519,capsaicin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.760765574,0.310391956,capsaicin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.737450083,0.317236496,capsaicin
METABOLISM_OF_STEROIDS,1.419723337,1,capsaicin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.413443545,0.834421989,capsaicin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.682208044,0.408898765,capsaicin
RESPIRATORY_ELECTRON_TRANSPORT,2.334510784,0.047662433,ASN-05257430
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.293467161,0.033156475,ASN-05257430
RRNA_PROCESSING,2.054656688,0.122955261,ASN-05257430
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.965825455,0.240556887,ASN-05257430
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.957902043,0.130048961,ASN-05257430
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.910861528,0.212408668,ASN-05257430
CLEC7A_DECTIN_1_SIGNALING,1.892494497,0.185261804,ASN-05257430
KERATINIZATION,-1.932987865,0.083217859,ASN-05257430
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.932987865,0.083217859,ASN-05257430
SIGNALING_BY_WNT,1.803353949,0.250400462,ASN-05257430
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.022217954,0.301357545,carbamazepine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.898980444,0.25271738,carbamazepine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.898980444,0.25271738,carbamazepine
GLUCOSE_METABOLISM,-1.880209929,0.214518989,carbamazepine
METABOLISM_OF_STEROIDS,-1.817562374,0.258533052,carbamazepine
UNFOLDED_PROTEIN_RESPONSE_UPR,-1.811402035,0.223903369,carbamazepine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-1.799643931,0.207098343,carbamazepine
PROGRAMMED_CELL_DEATH,-1.756170292,0.241086036,carbamazepine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,-1.749126956,0.224167718,carbamazepine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.729955143,0.226811205,carbamazepine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.714363702,0,olaparib
GPCR_LIGAND_BINDING,2.691623508,0,olaparib
SARS_COV_1_HOST_INTERACTIONS,-2.733540938,0,olaparib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.781697778,0,olaparib
METABOLISM_OF_RNA,-3.019205472,0,olaparib
RRNA_PROCESSING,-3.15805677,0,olaparib
TRANSLATION,-3.234958699,0,olaparib
SIGNALING_BY_ROBO_RECEPTORS,-3.320069749,0,olaparib
VIRAL_INFECTION_PATHWAYS,-2.705795952,0,olaparib
NONSENSE_MEDIATED_DECAY_NMD,-3.483389536,0,olaparib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.646497188,0,AR-C133057XX
RRNA_PROCESSING,2.753013266,0,AR-C133057XX
EUKARYOTIC_TRANSLATION_INITIATION,2.756410208,0,AR-C133057XX
SELENOAMINO_ACID_METABOLISM,2.784416332,0,AR-C133057XX
TRANSLATION,2.949542541,0,AR-C133057XX
EUKARYOTIC_TRANSLATION_ELONGATION,2.799895617,0,AR-C133057XX
NONSENSE_MEDIATED_DECAY_NMD,2.796497818,0,AR-C133057XX
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.312750988,0.005520085,AR-C133057XX
CELLULAR_RESPONSE_TO_STARVATION,2.283774792,0.005315638,AR-C133057XX
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.263335606,0.015775854,AR-C133057XX
EUKARYOTIC_TRANSLATION_ELONGATION,-2.199156022,0.016719715,BRD-K31342827
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.269157473,0.025538799,BRD-K31342827
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.126414565,0.020435207,BRD-K31342827
EUKARYOTIC_TRANSLATION_INITIATION,-2.077019949,0.025698821,BRD-K31342827
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.035241429,0.0267051,BRD-K31342827
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.029796659,0.022850277,BRD-K31342827
RRNA_PROCESSING,-2.026012015,0.019506334,BRD-K31342827
SELENOAMINO_ACID_METABOLISM,-2.004643147,0.019904422,BRD-K31342827
SIGNALING_BY_ROBO_RECEPTORS,-1.998180018,0.018113024,BRD-K31342827
MRNA_SPLICING,1.753625907,0.209221702,BRD-K31342827
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.408075246,0.008876459,tosedostat
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.342415644,0.009986017,tosedostat
CELLULAR_RESPONSE_TO_STARVATION,2.128859848,0.026629377,tosedostat
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.119529272,0.043932237,tosedostat
TOLL_LIKE_RECEPTOR_CASCADES,2.07275061,0.029403271,tosedostat
MYD88_INDEPENDENT_TLR4_CASCADE,1.919938467,0.059472276,tosedostat
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.867939883,0.067683001,tosedostat
KEAP1_NFE2L2_PATHWAY,1.849104666,0.067524493,tosedostat
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.760808284,0.099582776,tosedostat
EUKARYOTIC_TRANSLATION_INITIATION,1.716068587,0.116873379,tosedostat
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.805228582,0,PX-12
INFLUENZA_INFECTION,2.626063622,0.001856405,PX-12
METABOLISM_OF_RNA,2.491857931,0.003712809,PX-12
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.228767045,0.01206663,PX-12
HIV_LIFE_CYCLE,2.135840424,0.02004917,PX-12
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.124344854,0.017945244,PX-12
TRANSLATION,2.086288953,0.020685651,PX-12
TRNA_PROCESSING,2.015383413,0.022276855,PX-12
FATTY_ACID_METABOLISM,2.022648787,0.024597361,PX-12
CELL_CYCLE_CHECKPOINTS,1.865849729,0.049751643,PX-12
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.320825567,0,AZD-7545
RESPIRATORY_ELECTRON_TRANSPORT,3.238525618,0,AZD-7545
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.486958669,0.001666667,AZD-7545
MITOCHONDRIAL_BIOGENESIS,2.418285793,0.00125,AZD-7545
RRNA_PROCESSING,2.38155388,0.0025,AZD-7545
C_TYPE_LECTIN_RECEPTORS_CLRS,2.099482162,0.03125,AZD-7545
METABOLISM_OF_RNA,2.029814179,0.039285714,AZD-7545
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.87620893,0.0871875,AZD-7545
NEURONAL_SYSTEM,-1.960828832,0.224421053,AZD-7545
GPCR_LIGAND_BINDING,-1.948612127,0.125894737,AZD-7545
TRANSLATION,3.252003736,0,lenalidomide
NONSENSE_MEDIATED_DECAY_NMD,2.512551214,0,lenalidomide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.544542662,0,lenalidomide
EUKARYOTIC_TRANSLATION_INITIATION,2.590890685,0,lenalidomide
S_PHASE,2.602870782,0,lenalidomide
METABOLISM_OF_RNA,2.603501996,0,lenalidomide
SELENOAMINO_ACID_METABOLISM,2.823187107,0,lenalidomide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.725978722,0,lenalidomide
RRNA_PROCESSING,2.848160506,0,lenalidomide
EUKARYOTIC_TRANSLATION_ELONGATION,2.835510416,0,lenalidomide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.263209888,0,flutamide
SARS_COV_1_INFECTION,-2.585975278,0,flutamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.699133202,0,flutamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.714014534,0,flutamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.752540544,0,flutamide
SIGNALING_BY_ROBO_RECEPTORS,-2.807807726,0,flutamide
INFLUENZA_INFECTION,-2.86384543,0,flutamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.913785043,0,flutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.915897543,0,flutamide
SARS_COV_1_HOST_INTERACTIONS,-2.606130968,0,flutamide
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.781093132,0,batimastat
KEAP1_NFE2L2_PATHWAY,2.556528655,0,batimastat
RRNA_PROCESSING,2.380455279,0.003666361,batimastat
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.295108172,0.002749771,batimastat
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.201465701,0.010999083,batimastat
METABOLISM_OF_RNA,2.155212569,0.013443324,batimastat
HOST_INTERACTIONS_OF_HIV_FACTORS,2.052708338,0.023045699,batimastat
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2.043974159,0.020164986,batimastat
CELL_CYCLE_CHECKPOINTS,2.030053674,0.02118342,batimastat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.954907137,0.031897342,batimastat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.596764061,0,valdecoxib
GPCR_LIGAND_BINDING,-2.512971793,0.000442117,valdecoxib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.489610059,0.001669805,valdecoxib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.413451298,0.000294744,valdecoxib
SIGNALING_BY_GPCR,-2.254111379,0.002431641,valdecoxib
G_ALPHA_I_SIGNALLING_EVENTS,-2.106925134,0.009549717,valdecoxib
G_ALPHA_S_SIGNALLING_EVENTS,-2.105797107,0.008105469,valdecoxib
KEAP1_NFE2L2_PATHWAY,1.984864329,0.098518492,valdecoxib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.950634991,0.03802202,valdecoxib
NEURONAL_SYSTEM,-1.944155622,0.035921966,valdecoxib
MUSCLE_CONTRACTION,2.617382758,0,trifluoperazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.194208666,0.025044042,trifluoperazine
NONSENSE_MEDIATED_DECAY_NMD,-2.190766202,0.012522021,trifluoperazine
KERATINIZATION,-2.166719995,0.010888714,trifluoperazine
SIGNALING_BY_ROBO_RECEPTORS,-2.148827002,0.010888714,trifluoperazine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.137568315,0.010017617,trifluoperazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.098753578,0.014518285,trifluoperazine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.095721318,0.01275535,trifluoperazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.042547084,0.018510813,trifluoperazine
CELLULAR_RESPONSE_TO_STARVATION,-2.02967834,0.018631799,trifluoperazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.186903767,0,lonidamine
EUKARYOTIC_TRANSLATION_ELONGATION,4.160527952,0,lonidamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.980493918,0,lonidamine
SELENOAMINO_ACID_METABOLISM,3.904094194,0,lonidamine
INFLUENZA_INFECTION,3.838089843,0,lonidamine
CELLULAR_RESPONSE_TO_STARVATION,3.343741109,0,lonidamine
EUKARYOTIC_TRANSLATION_INITIATION,3.007264789,0,lonidamine
NONSENSE_MEDIATED_DECAY_NMD,2.744473669,0,lonidamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.486091052,0.000505633,lonidamine
TRANSLATION,2.435880782,0.000455069,lonidamine
CELL_CYCLE_MITOTIC,-3.469272935,0,selumetinib
MITOTIC_PROMETAPHASE,-2.567191422,0,selumetinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.570464677,0,selumetinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.58483206,0,selumetinib
METABOLISM_OF_NUCLEOTIDES,-2.597150265,0,selumetinib
ORC1_REMOVAL_FROM_CHROMATIN,-2.633376873,0,selumetinib
CHROMOSOME_MAINTENANCE,-2.660489758,0,selumetinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.666971199,0,selumetinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.772624255,0,selumetinib
RRNA_PROCESSING,-2.796652053,0,selumetinib
GPCR_LIGAND_BINDING,-2.458552631,0,swainsonine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.351606179,0.000456828,swainsonine
SIGNALING_BY_GPCR,-2.336926695,0.000304552,swainsonine
G_ALPHA_I_SIGNALLING_EVENTS,-2.154139463,0.003654624,swainsonine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.133900609,0.003837355,swainsonine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.98079763,0.018729948,swainsonine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.78360572,0.402590194,swainsonine
METABOLISM_OF_STEROIDS,1.72759236,0.277567068,swainsonine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.874548208,0.049728992,swainsonine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.866070506,0.046939078,swainsonine
METABOLISM_OF_RNA,-3.024390408,0,TG-101348
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.523215303,0,TG-101348
RRNA_PROCESSING,-2.579073049,0,TG-101348
CELL_CYCLE_CHECKPOINTS,-2.583086024,0,TG-101348
MITOCHONDRIAL_TRANSLATION,-2.604897224,0,TG-101348
SYNTHESIS_OF_DNA,-2.622411951,0,TG-101348
HOMOLOGY_DIRECTED_REPAIR,-2.602012103,0,TG-101348
CELL_CYCLE_MITOTIC,-2.750358398,0,TG-101348
DNA_REPLICATION,-2.768876701,0,TG-101348
CELL_CYCLE,-2.785274773,0,TG-101348
EUKARYOTIC_TRANSLATION_ELONGATION,3.724812261,0,dacarbazine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.764082565,0,dacarbazine
SARS_COV_1_INFECTION,2.768123744,0,dacarbazine
SARS_COV_1_HOST_INTERACTIONS,2.889817167,0,dacarbazine
SIGNALING_BY_ROBO_RECEPTORS,2.973573335,0,dacarbazine
TRANSLATION,3.030586054,0,dacarbazine
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.080866504,0,dacarbazine
RRNA_PROCESSING,3.205311068,0,dacarbazine
INFLUENZA_INFECTION,3.236183593,0,dacarbazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.874252783,0,dacarbazine
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2.336577692,0.026231361,alisertib
SIGNALING_BY_VEGF,2.22573144,0.037329244,alisertib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.028836009,0.090128265,alisertib
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1.913236261,0.140236889,alisertib
CELLULAR_RESPONSES_TO_STIMULI,1.741744981,0.309126496,alisertib
KEAP1_NFE2L2_PATHWAY,1.736295713,0.2660129,alisertib
LEISHMANIA_INFECTION,1.719240882,0.249630311,alisertib
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.698078936,0.246927904,alisertib
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.693116049,0.225769061,alisertib
DISEASES_OF_GLYCOSYLATION,1.691897579,0.205209952,alisertib
METABOLISM_OF_RNA,4.027106353,0,troglitazone
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.544741052,0,troglitazone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.557283347,0,troglitazone
PROTEASOME_ASSEMBLY,2.575845767,0,troglitazone
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.598550143,0,troglitazone
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.609401294,0,troglitazone
UCH_PROTEINASES,2.6475611,0,troglitazone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.650736683,0,troglitazone
KEAP1_NFE2L2_PATHWAY,2.711695888,0,troglitazone
SARS_COV_1_HOST_INTERACTIONS,2.741717734,0,troglitazone
METABOLISM_OF_RNA,-3.385155071,0,mitoxantrone
RRNA_PROCESSING,-2.633747883,0,mitoxantrone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.563532874,0,mitoxantrone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.543628919,0.001873695,mitoxantrone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.529406481,0.000936847,mitoxantrone
TRNA_PROCESSING,-2.476672878,0.000519784,mitoxantrone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.452761751,0.000936847,mitoxantrone
CELL_CYCLE_CHECKPOINTS,-2.424917108,0.000831654,mitoxantrone
COLLAGEN_FORMATION,2.421577228,0.001171059,mitoxantrone
CELL_CYCLE,-2.384842996,0.00138609,mitoxantrone
METABOLISM_OF_RNA,-3.770664747,0,alvocidib
MRNA_SPLICING,-2.732411909,0,alvocidib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.740460206,0,alvocidib
SIGNALING_BY_GPCR,2.773042518,0,alvocidib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.803240606,0,alvocidib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.827283898,0,alvocidib
G2_M_CHECKPOINTS,-2.840930864,0,alvocidib
RRNA_PROCESSING,-2.850014486,0,alvocidib
HOMOLOGY_DIRECTED_REPAIR,-2.887170922,0,alvocidib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.88753377,0,alvocidib
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.840461647,0.225281891,BRD-K59333713
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.771477519,0.26446135,BRD-K59333713
G2_M_CHECKPOINTS,-3.703761218,0.321364851,BRD-K59333713
RAC2_GTPASE_CYCLE,1.932555793,0.434302001,BRD-K59333713
GPCR_LIGAND_BINDING,1.916799606,0.249457835,BRD-K59333713
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.65825971,0.335823937,BRD-K59333713
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.646063346,0.289088439,BRD-K59333713
SIGNALING_BY_GPCR,1.834868292,0.314889398,BRD-K59333713
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.414356554,0.530321967,BRD-K59333713
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-3.389624493,0.466555398,BRD-K59333713
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.324730231,0,fluspirilene
SELENOAMINO_ACID_METABOLISM,4.186851493,0,fluspirilene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.164564248,0,fluspirilene
EUKARYOTIC_TRANSLATION_ELONGATION,4.059341883,0,fluspirilene
TRANSLATION,4.048389284,0,fluspirilene
EUKARYOTIC_TRANSLATION_INITIATION,3.838581553,0,fluspirilene
CELLULAR_RESPONSE_TO_STARVATION,3.781823858,0,fluspirilene
SARS_COV_1_INFECTION,2.769026212,0,fluspirilene
SARS_COV_1_HOST_INTERACTIONS,2.722749513,0,fluspirilene
METABOLISM_OF_RNA,2.2895385,0.002874859,fluspirilene
METABOLISM_OF_RNA,-3.051054185,0,afatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.962718018,0,afatinib
GPCR_LIGAND_BINDING,2.955747222,0,afatinib
TRANSLATION,-2.533515466,0.001280666,afatinib
RRNA_PROCESSING,-2.52685013,0.000853777,afatinib
SIGNALING_BY_GPCR,2.395631959,0.004074326,afatinib
NUCLEOTIDE_EXCISION_REPAIR,-2.399887251,0.004162163,afatinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.34630047,0.004583617,afatinib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-2.353860705,0.005378795,afatinib
INFLUENZA_INFECTION,-2.349271008,0.00448233,afatinib
METABOLISM_OF_RNA,-5.586400069,0,dasatinib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-3.251773936,0,dasatinib
SEPARATION_OF_SISTER_CHROMATIDS,-3.180698621,0,dasatinib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-3.143169572,0,dasatinib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-3.139017019,0,dasatinib
G2_M_DNA_DAMAGE_CHECKPOINT,-3.0943976,0,dasatinib
EXTENSION_OF_TELOMERES,-3.0348909,0,dasatinib
TELOMERE_MAINTENANCE,-3.011027313,0,dasatinib
CHROMOSOME_MAINTENANCE,-3.31596828,0,dasatinib
MRNA_SPLICING,-2.975610546,0,dasatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.893636773,0,pazopanib
EXTRACELLULAR_MATRIX_ORGANIZATION,2.412551615,0.036245899,pazopanib
BIOLOGICAL_OXIDATIONS,2.257064498,0.067864662,pazopanib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.040081332,0.062458594,pazopanib
KERATINIZATION,-2.040081332,0.062458594,pazopanib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.091279581,0.144983597,pazopanib
KEAP1_NFE2L2_PATHWAY,1.975132198,0.204519414,pazopanib
SARS_COV_1_INFECTION,1.96496076,0.178144739,pazopanib
SELENOAMINO_ACID_METABOLISM,1.96130752,0.154017529,pazopanib
CELLULAR_RESPONSE_TO_STARVATION,1.947549607,0.144598002,pazopanib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.068545791,0,tanespimycin
RESPIRATORY_ELECTRON_TRANSPORT,2.703711464,0,tanespimycin
KEAP1_NFE2L2_PATHWAY,2.676308637,0,tanespimycin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.671375452,0,tanespimycin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.552691313,0,tanespimycin
GPCR_LIGAND_BINDING,-2.488905231,0,tanespimycin
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,2.397540481,0.002259054,tanespimycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.286000357,0.003544483,tanespimycin
KERATINIZATION,-2.266426614,0.002577806,tanespimycin
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.247918835,0.002577806,tanespimycin
EUKARYOTIC_TRANSLATION_ELONGATION,3.017785198,0,amiloride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.902528935,0,amiloride
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.628619666,0.000862871,amiloride
SELENOAMINO_ACID_METABOLISM,2.610654526,0.00097073,amiloride
INFLUENZA_INFECTION,2.579799112,0.000776584,amiloride
DEVELOPMENTAL_CELL_LINEAGES,2.396250332,0.001510025,amiloride
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.237043453,0.009799752,amiloride
EUKARYOTIC_TRANSLATION_INITIATION,2.146771206,0.015208106,amiloride
CELLULAR_RESPONSE_TO_STARVATION,2.006822214,0.034946286,amiloride
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.00307141,0.194301312,amiloride
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.04232226,0,indometacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.828359179,0,indometacin
RESPIRATORY_ELECTRON_TRANSPORT,2.788028116,0,indometacin
EUKARYOTIC_TRANSLATION_ELONGATION,2.775083898,0,indometacin
TRANSLATION,2.73444576,0,indometacin
NONSENSE_MEDIATED_DECAY_NMD,2.725942981,0,indometacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.688726918,0,indometacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.649917767,0,indometacin
EUKARYOTIC_TRANSLATION_INITIATION,2.466085586,0.000147357,indometacin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.557154384,0.000168408,indometacin
TRANSLATION,2.317864347,0.020768929,naftifine
CELLULAR_RESPONSE_TO_STARVATION,2.012181475,0.0588453,naftifine
INFLUENZA_INFECTION,1.940595895,0.066922106,naftifine
MRNA_SPLICING,1.934244282,0.053076153,naftifine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.799507382,0.097383202,naftifine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.680105321,0.160382288,naftifine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.586352859,0.224831902,naftifine
NONSENSE_MEDIATED_DECAY_NMD,1.497884637,0.321053033,naftifine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.751961173,1,naftifine
SIGNALING_BY_NTRKS,1.443448208,0.384866209,naftifine
NONSENSE_MEDIATED_DECAY_NMD,-2.778971304,0,zardaverine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.766153384,0,zardaverine
SELENOAMINO_ACID_METABOLISM,-2.744466372,0,zardaverine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.671903162,0,zardaverine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.634535678,0,zardaverine
EUKARYOTIC_TRANSLATION_INITIATION,-2.625783148,0,zardaverine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.60449393,0,zardaverine
CELLULAR_RESPONSE_TO_STARVATION,-2.571788419,0,zardaverine
SIGNALING_BY_ROBO_RECEPTORS,-2.568099477,0,zardaverine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.530664111,0,zardaverine
CARDIAC_CONDUCTION,2.29771218,0.021927137,phenoxybenzamine
SIGNALING_BY_GPCR,2.294079908,0.011916922,phenoxybenzamine
GPCR_LIGAND_BINDING,2.250740707,0.012393599,phenoxybenzamine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.405007797,0.082009454,phenoxybenzamine
MUSCLE_CONTRACTION,2.164949487,0.020258767,phenoxybenzamine
PEROXISOMAL_PROTEIN_IMPORT,-2.32464415,0.075780888,phenoxybenzamine
GLYCOSAMINOGLYCAN_METABOLISM,-2.283525426,0.06920629,phenoxybenzamine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.262442962,0.058392807,phenoxybenzamine
G_ALPHA_Q_SIGNALLING_EVENTS,1.904374408,0.104487572,phenoxybenzamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.815263812,0.147134264,phenoxybenzamine
EUKARYOTIC_TRANSLATION_ELONGATION,-4.113230902,0,BRD-K59946561
METABOLISM_OF_RNA,-3.089884317,0,BRD-K59946561
SARS_COV_1_HOST_INTERACTIONS,-3.182162204,0,BRD-K59946561
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.449717595,0,BRD-K59946561
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.469983003,0,BRD-K59946561
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.511108785,0,BRD-K59946561
SIGNALING_BY_ROBO_RECEPTORS,-3.713532148,0,BRD-K59946561
TRANSLATION,-3.730522309,0,BRD-K59946561
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.874987446,0,BRD-K59946561
RRNA_PROCESSING,-3.833198308,0,BRD-K59946561
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.357580631,0.005145834,lansoprazole
GPCR_LIGAND_BINDING,2.356074957,0.002572917,lansoprazole
SLC_TRANSPORTER_DISORDERS,-2.703833916,0.108610593,lansoprazole
SIGNALING_BY_GPCR,2.192329128,0.0087908,lansoprazole
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-2.573843812,0.134030094,lansoprazole
PHASE_II_CONJUGATION_OF_COMPOUNDS,-2.489838097,0.142503261,lansoprazole
DISEASES_OF_GLYCOSYLATION,-2.440546057,0.133452378,lansoprazole
GLYCOSAMINOGLYCAN_METABOLISM,-2.425497111,0.113232321,lansoprazole
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.38219454,0.128252935,lansoprazole
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.373125495,0.116863678,lansoprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.253898356,0.028356706,zolpidem
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.215637489,0.019978588,zolpidem
GPCR_LIGAND_BINDING,-2.067568394,0.065735999,zolpidem
EUKARYOTIC_TRANSLATION_INITIATION,-2.015360215,0.086036823,zolpidem
GLUCOSE_METABOLISM,-2.001087325,0.081461082,zolpidem
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.993745847,0.073469646,zolpidem
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.947205583,0.090962419,zolpidem
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.927129605,0.084497254,zolpidem
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.927396682,0.094737176,zolpidem
NONSENSE_MEDIATED_DECAY_NMD,-1.896465297,0.097959529,zolpidem
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.354012399,0.013955985,moracizine
MRNA_SPLICING,2.167350404,0.017444981,moracizine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.772678634,0.133744856,moracizine
SELENOAMINO_ACID_METABOLISM,-1.85980499,0.336634439,moracizine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.84459019,0.202595922,moracizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.842990057,0.136235869,moracizine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.839435891,0.106351872,moracizine
NONSENSE_MEDIATED_DECAY_NMD,-1.825913537,0.09773825,moracizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.822504955,0.083938874,moracizine
EUKARYOTIC_TRANSLATION_INITIATION,-1.808451194,0.082369337,moracizine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.847873627,0,pergolide
GPCR_LIGAND_BINDING,2.742830688,0,pergolide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.620695995,0,pergolide
SIGNALING_BY_GPCR,2.368573301,0.001716103,pergolide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.523482316,0.009132678,pergolide
G_ALPHA_I_SIGNALLING_EVENTS,2.091964111,0.019122288,pergolide
SENSORY_PERCEPTION,2.042738869,0.024270597,pergolide
GLYCOSAMINOGLYCAN_METABOLISM,-2.150865812,0.102996307,pergolide
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.952924714,0.246582293,pergolide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.951945609,0.198483525,pergolide
MUSCLE_CONTRACTION,2.944050859,0,glibenclamide
RRNA_PROCESSING,2.219587261,0.022933241,glibenclamide
CARDIAC_CONDUCTION,2.125045801,0.027825665,glibenclamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.079934975,0.029125215,glibenclamide
CILIUM_ASSEMBLY,-2.041463887,0.213981174,glibenclamide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.981465754,0.045866481,glibenclamide
MEMBRANE_TRAFFICKING,-2.010620063,0.148655191,glibenclamide
GPCR_LIGAND_BINDING,1.841187489,0.091121409,glibenclamide
VESICLE_MEDIATED_TRANSPORT,-1.907165837,0.25033054,glibenclamide
INFLUENZA_INFECTION,1.684407758,0.185693725,glibenclamide
GPCR_LIGAND_BINDING,2.490864527,0.00248097,alprostadil
MUSCLE_CONTRACTION,2.213327303,0.008683394,alprostadil
APOPTOSIS,1.968391879,0.052100367,alprostadil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.156251407,0.137246913,alprostadil
INFLUENZA_INFECTION,-2.135192657,0.083294678,alprostadil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.126877669,0.059000397,alprostadil
NEURONAL_SYSTEM,1.880834766,0.070397519,alprostadil
SIGNALING_BY_GPCR,1.874488953,0.0575585,alprostadil
CELLULAR_RESPONSE_TO_STARVATION,-2.070586902,0.072646211,alprostadil
EUKARYOTIC_TRANSLATION_INITIATION,-2.069827583,0.058306275,alprostadil
GPCR_LIGAND_BINDING,2.663738599,0,clemastine
SIGNALING_BY_GPCR,2.449319534,0.002046189,clemastine
MUSCLE_CONTRACTION,2.395776057,0.001909776,clemastine
SENSORY_PERCEPTION,2.387778226,0.00184157,clemastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.385709205,0.001473256,clemastine
STRIATED_MUSCLE_CONTRACTION,2.247075332,0.005183678,clemastine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.430215064,0.12862155,clemastine
VISUAL_PHOTOTRANSDUCTION,2.087971699,0.015784883,clemastine
G_ALPHA_Q_SIGNALLING_EVENTS,2.036264487,0.020257267,clemastine
CARDIAC_CONDUCTION,1.914948434,0.046198391,clemastine
MITF_M_DEPENDENT_GENE_EXPRESSION,2.669250666,0,doxapram
GPCR_LIGAND_BINDING,-2.19298428,0.010830708,doxapram
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.230132805,0.03317885,doxapram
SIGNALING_BY_GPCR,-2.090774096,0.015608962,doxapram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.089636901,0.010618341,doxapram
G_ALPHA_I_SIGNALLING_EVENTS,-2.035338122,0.014494036,doxapram
M_PHASE,1.913366805,0.152728039,doxapram
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.905782579,0.12086581,doxapram
METABOLISM_OF_RNA,1.826854259,0.153570676,doxapram
UB_SPECIFIC_PROCESSING_PROTEASES,1.785664686,0.167474194,doxapram
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.266287788,0.064445835,naloxone
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.154439478,0.080766534,naloxone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.10016051,0.082858931,naloxone
DNA_REPLICATION,2.020852844,0.30078925,naloxone
SYNTHESIS_OF_DNA,2.01024806,0.162053123,naloxone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.997211722,0.122025613,naloxone
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.906483445,0.187118894,naloxone
ORC1_REMOVAL_FROM_CHROMATIN,1.890238119,0.173012111,naloxone
TCR_SIGNALING,-1.934440935,0.206938088,naloxone
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.85372118,0.18750751,naloxone
RESPIRATORY_ELECTRON_TRANSPORT,2.995398236,0,profenamine
PCP_CE_PATHWAY,2.574063428,0.002199726,profenamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.5256919,0.002199726,profenamine
EUKARYOTIC_TRANSLATION_INITIATION,2.189698078,0.022547193,profenamine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.186010401,0.01935759,profenamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.165876268,0.020164156,profenamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.16473962,0.017283563,profenamine
TRANSLATION,2.155991297,0.015948015,profenamine
KEAP1_NFE2L2_PATHWAY,2.133713028,0.016131325,profenamine
INTERLEUKIN_1_SIGNALING,2.1267763,0.014958138,profenamine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.680263897,0.003687225,purvalanol-a
CILIUM_ASSEMBLY,-2.259393107,0.007287086,purvalanol-a
KEAP1_NFE2L2_PATHWAY,2.435428806,0.010139869,purvalanol-a
EUKARYOTIC_TRANSLATION_INITIATION,2.418279515,0.006759912,purvalanol-a
MUSCLE_CONTRACTION,2.313452873,0.009218062,purvalanol-a
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-2.081267679,0.033196724,purvalanol-a
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,2.116834304,0.026179297,purvalanol-a
CYTOPROTECTION_BY_HMOX1,2.063321009,0.031034144,purvalanol-a
AURKA_ACTIVATION_BY_TPX2,-2.051758137,0.030767695,purvalanol-a
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-2.035903098,0.027731409,purvalanol-a
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.204954886,0.024363455,melperone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.187695902,0.015662221,melperone
ECM_PROTEOGLYCANS,-2.175126001,0.011311604,melperone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.109126326,0.017619999,melperone
COLLAGEN_FORMATION,-2.097875529,0.015662221,melperone
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.901632694,0.53089826,melperone
BIOLOGICAL_OXIDATIONS,1.899142231,0.270591002,melperone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.858197806,0.233098187,melperone
MUSCLE_CONTRACTION,1.840340035,0.194105659,melperone
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.696101489,0.344248315,melperone
DNA_REPAIR,-2.223333514,0.030215441,bisoprolol
CHROMATIN_ORGANIZATION,-2.104372237,0.057525552,bisoprolol
POTASSIUM_CHANNELS,1.918559317,0.310374981,bisoprolol
TRANSLATION,-1.909495474,0.220030394,bisoprolol
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-1.827067383,0.302154415,bisoprolol
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.815423273,0.258458238,bisoprolol
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.784170052,0.263804047,bisoprolol
RRNA_PROCESSING,-1.754363273,0.28156807,bisoprolol
GPCR_LIGAND_BINDING,1.662095029,0.7158068,bisoprolol
NEURONAL_SYSTEM,1.646256382,0.518011762,bisoprolol
TRANSLATION,2.165878567,0.056530214,oxymetazoline
EUKARYOTIC_TRANSLATION_INITIATION,2.159312929,0.028265107,oxymetazoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.130573729,0.022432625,oxymetazoline
EUKARYOTIC_TRANSLATION_ELONGATION,1.993973394,0.033648937,oxymetazoline
DNA_REPLICATION,1.955774846,0.031764597,oxymetazoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.941616482,0.027367802,oxymetazoline
SELENOAMINO_ACID_METABOLISM,1.851307139,0.035764013,oxymetazoline
ION_CHANNEL_TRANSPORT,-2.01248224,0.187496305,oxymetazoline
NONSENSE_MEDIATED_DECAY_NMD,1.69359257,0.078065534,oxymetazoline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.584189653,0.121734377,oxymetazoline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.330906061,0.00078322,nicergoline
COLLAGEN_FORMATION,-2.326163582,0.00039161,nicergoline
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.325300685,0.000261073,nicergoline
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.508112703,0.007531929,nicergoline
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.28971982,0.00078322,nicergoline
GPCR_LIGAND_BINDING,-2.17057522,0.002662949,nicergoline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.165510193,0.002480198,nicergoline
COLLAGEN_DEGRADATION,-2.149639977,0.002237772,nicergoline
TOLL_LIKE_RECEPTOR_CASCADES,2.128797775,0.037659644,nicergoline
ECM_PROTEOGLYCANS,-2.093753982,0.004993029,nicergoline
GPCR_LIGAND_BINDING,2.686292622,0,beclomethasone-dipropionate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.530982133,0.001120443,beclomethasone-dipropionate
PROTEIN_LOCALIZATION,-2.698735266,0.005516021,beclomethasone-dipropionate
SIGNALING_BY_GPCR,2.481955056,0.001244937,beclomethasone-dipropionate
COPII_MEDIATED_VESICLE_TRANSPORT,-2.314838042,0.03378563,beclomethasone-dipropionate
DEUBIQUITINATION,-2.27643785,0.031717122,beclomethasone-dipropionate
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.220912147,0.035854138,beclomethasone-dipropionate
G_ALPHA_I_SIGNALLING_EVENTS,2.12143401,0.019981239,beclomethasone-dipropionate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.104499782,0.061779437,beclomethasone-dipropionate
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.10308306,0.051942533,beclomethasone-dipropionate
NEUTROPHIL_DEGRANULATION,-2.271112869,0.053030979,anagrelide
MUSCLE_CONTRACTION,2.058805755,0.088472791,anagrelide
INNATE_IMMUNE_SYSTEM,-2.159180667,0.05892331,anagrelide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.897761985,0.228229622,anagrelide
GLUCOSE_METABOLISM,-1.819538054,0.272520311,anagrelide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.799926118,0.243235425,anagrelide
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.758604845,0.482578861,anagrelide
RNA_POLYMERASE_II_TRANSCRIPTION,1.746468406,0.350614394,anagrelide
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.733261886,0.290664397,anagrelide
NEDDYLATION,1.713850303,0.26398851,anagrelide
TRANSLATION,2.926452032,0,bumetanide
RESPIRATORY_ELECTRON_TRANSPORT,2.493836227,0.002289331,bumetanide
METABOLISM_OF_RNA,2.440883381,0.002034961,bumetanide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.293778595,0.010058864,bumetanide
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.234029538,0.005867671,bumetanide
ECM_PROTEOGLYCANS,-2.239672779,0.008801506,bumetanide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.175663956,0.007334589,bumetanide
NONSENSE_MEDIATED_DECAY_NMD,2.252860091,0.013735984,bumetanide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.25146346,0.010988787,bumetanide
EUKARYOTIC_TRANSLATION_INITIATION,2.195265925,0.011955394,bumetanide
RRNA_PROCESSING,3.144452269,0,chloroquine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.917800329,0,chloroquine
EUKARYOTIC_TRANSLATION_ELONGATION,2.906041367,0,chloroquine
SELENOAMINO_ACID_METABOLISM,2.78249833,0,chloroquine
CELLULAR_RESPONSE_TO_STARVATION,2.749205617,0,chloroquine
TRANSLATION,2.637792637,0.000945916,chloroquine
EUKARYOTIC_TRANSLATION_INITIATION,2.585187352,0.000810785,chloroquine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.51987855,0.001064155,chloroquine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.123476427,0.008197938,chloroquine
INFLUENZA_INFECTION,2.05832113,0.010783441,chloroquine
METABOLISM_OF_RNA,-5.375336188,0,AT-7519
HIV_INFECTION,-2.726232155,0,AT-7519
MITOTIC_METAPHASE_AND_ANAPHASE,-2.760585674,0,AT-7519
MITOCHONDRIAL_BIOGENESIS,-2.802647157,0,AT-7519
DNA_REPAIR,-2.811250267,0,AT-7519
TELOMERE_MAINTENANCE,-2.819032166,0,AT-7519
CHROMATIN_ORGANIZATION,-2.840358863,0,AT-7519
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.856723283,0,AT-7519
TRNA_PROCESSING,-2.920235735,0,AT-7519
G2_M_CHECKPOINTS,-2.987957798,0,AT-7519
NEUTROPHIL_DEGRANULATION,2.135732286,0.040062998,quinidine
ECM_PROTEOGLYCANS,-1.992099394,0.220194192,quinidine
TRANSLATION,1.855015225,0.138054927,quinidine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.923617611,0.217231938,quinidine
DNA_REPLICATION,1.730232155,0.182268596,quinidine
COLLAGEN_DEGRADATION,-1.877210254,0.232372346,quinidine
GPCR_LIGAND_BINDING,-1.874227566,0.177735222,quinidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.827702276,0.209727562,quinidine
INTERFERON_ALPHA_BETA_SIGNALING,1.602191837,0.275839157,quinidine
SIGNALING_BY_GPCR,-1.818424448,0.190242516,quinidine
METABOLISM_OF_RNA,-2.370168106,0.020332829,terbinafine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.316905907,0.015249622,terbinafine
CELL_CYCLE,-1.911663404,0.169440242,terbinafine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.909444744,0.128986384,terbinafine
CELL_CYCLE_MITOTIC,-1.894354403,0.117930408,terbinafine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.838110725,0.135552194,terbinafine
M_PHASE,-1.811181428,0.130711044,terbinafine
NEURONAL_SYSTEM,1.924401273,0.28022524,terbinafine
MRNA_SPLICING,-1.731026084,0.179500756,terbinafine
CELL_CYCLE_CHECKPOINTS,-1.720803594,0.168593041,terbinafine
COLLAGEN_FORMATION,-2.497187934,0.002776661,lomerizine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.416359982,0.004164992,lomerizine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.391824171,0.002776661,lomerizine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.225598193,0.024256616,lomerizine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.159647931,0.032166382,lomerizine
ADAPTIVE_IMMUNE_SYSTEM,2.080684937,0.04288851,lomerizine
ECM_PROTEOGLYCANS,-1.972122226,0.073581528,lomerizine
BIOLOGICAL_OXIDATIONS,1.957396429,0.080943273,lomerizine
DEATH_RECEPTOR_SIGNALING,1.955833021,0.066020181,lomerizine
CILIUM_ASSEMBLY,1.945686214,0.059762677,lomerizine
GPCR_LIGAND_BINDING,2.701812586,0,disopyramide
SIGNALING_BY_GPCR,2.573548847,0,disopyramide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.564578196,0,disopyramide
G_ALPHA_Q_SIGNALLING_EVENTS,2.477715235,0.000200093,disopyramide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.755197362,0.017712244,disopyramide
MUSCLE_CONTRACTION,2.170266186,0.006082839,disopyramide
NEUTROPHIL_DEGRANULATION,-2.659468133,0.032699528,disopyramide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.394870437,0.182572363,disopyramide
SENSORY_PERCEPTION,1.930737378,0.064563463,disopyramide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.883947162,0.078779621,disopyramide
SELENOAMINO_ACID_METABOLISM,2.091720817,0.133627107,theophylline
NONSENSE_MEDIATED_DECAY_NMD,2.07893375,0.071398797,theophylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.020980424,0.075547351,theophylline
INFLUENZA_INFECTION,2.002267185,0.065831001,theophylline
EUKARYOTIC_TRANSLATION_ELONGATION,1.951130047,0.07126779,theophylline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.946863712,0.060699895,theophylline
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.927244273,0.059888899,theophylline
TRANSLATION,1.709684758,0.20551718,theophylline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.798036552,1,theophylline
AUTOPHAGY,1.664803079,0.233046838,theophylline
SELENOAMINO_ACID_METABOLISM,-2.625458022,0,celecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.593720254,0,celecoxib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.551470538,0,celecoxib
NONSENSE_MEDIATED_DECAY_NMD,-2.545810206,0,celecoxib
EUKARYOTIC_TRANSLATION_INITIATION,-2.545045152,0,celecoxib
VIRAL_INFECTION_PATHWAYS,-2.520443972,0,celecoxib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.495866976,0.000204036,celecoxib
RRNA_PROCESSING,-2.483984422,0.000178532,celecoxib
METABOLISM_OF_RNA,-2.468349638,0.00031739,celecoxib
INFLUENZA_INFECTION,-2.466659981,0.000285651,celecoxib
SELENOAMINO_ACID_METABOLISM,-3.592004784,0,piretanide
NERVOUS_SYSTEM_DEVELOPMENT,-2.782847276,0,piretanide
SARS_COV_1_INFECTION,-2.864939796,0,piretanide
SARS_COV_1_HOST_INTERACTIONS,-3.01313645,0,piretanide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.018087269,0,piretanide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.040684007,0,piretanide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.072389977,0,piretanide
SIGNALING_BY_ROBO_RECEPTORS,-3.102737624,0,piretanide
INFLUENZA_INFECTION,-3.10443588,0,piretanide
SARS_COV_2_HOST_INTERACTIONS,-2.481977579,0,piretanide
DNA_REPAIR,-2.803322334,0,linifanib
GPCR_LIGAND_BINDING,2.704809632,0,linifanib
CHROMATIN_ORGANIZATION,-2.703868345,0,linifanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.629948105,0,linifanib
SIGNALING_BY_GPCR,2.424390126,0.000219525,linifanib
CELL_CYCLE,-2.518667335,0.002459332,linifanib
DNA_REPLICATION,-2.511149167,0.001844499,linifanib
CELL_CYCLE_MITOTIC,-2.377488767,0.004918664,linifanib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.339581499,0.004918664,linifanib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.152897815,0.007408961,linifanib
METABOLISM_OF_RNA,-3.07252766,0,erlotinib
M_PHASE,-2.752512487,0,erlotinib
CHROMOSOME_MAINTENANCE,-2.666986231,0,erlotinib
CELL_CYCLE,-2.64290155,0.000472119,erlotinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.583717794,0.00075539,erlotinib
GPCR_LIGAND_BINDING,2.39162175,0.001954191,erlotinib
RRNA_PROCESSING,-2.562618327,0.001258984,erlotinib
CELL_CYCLE_MITOTIC,-2.547472666,0.001079129,erlotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.208598167,0.011725143,erlotinib
SIGNALING_BY_GPCR,2.189821056,0.009770953,erlotinib
CELL_CYCLE,-2.734353208,0,bortezomib
CELL_CYCLE_MITOTIC,-2.590088605,0,bortezomib
DNA_REPAIR,-2.487267302,0,bortezomib
MITOTIC_PROMETAPHASE,-2.42803887,0,bortezomib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.587265813,0.001576873,bortezomib
MITOTIC_SPINDLE_CHECKPOINT,-2.377662402,0.000615304,bortezomib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.336021152,0.000659254,bortezomib
CHROMOSOME_MAINTENANCE,-2.335487103,0.000576847,bortezomib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.336749252,0.00076913,bortezomib
METABOLISM_OF_NUCLEOTIDES,-2.326188264,0.00076913,bortezomib
MRNA_SPLICING,2.930299925,0,rufinamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.909050488,0,rufinamide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.467644692,0.638697088,rufinamide
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.384642884,0.70755779,rufinamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.87299061,1,rufinamide
G_ALPHA_Q_SIGNALLING_EVENTS,-1.819730852,1,rufinamide
NUCLEOTIDE_EXCISION_REPAIR,1.214018232,1,rufinamide
SENSORY_PERCEPTION,-1.769846987,1,rufinamide
SIGNALING_BY_GPCR,-1.757901217,1,rufinamide
GPCR_LIGAND_BINDING,-1.755138674,0.992309087,rufinamide
GPCR_LIGAND_BINDING,-3.049955463,0,levetiracetam
SIGNALING_BY_GPCR,-2.618693988,0.000299339,levetiracetam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.509371259,0.000598677,levetiracetam
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.498311534,0.000449008,levetiracetam
NEURONAL_SYSTEM,-2.278208877,0.002993387,levetiracetam
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.241044322,0.003292725,levetiracetam
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.230808706,0.003164437,levetiracetam
G_ALPHA_S_SIGNALLING_EVENTS,-2.213683529,0.003592064,levetiracetam
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.164991811,0.108763716,levetiracetam
G_ALPHA_I_SIGNALLING_EVENTS,-2.167891938,0.005454616,levetiracetam
METABOLISM_OF_RNA,-2.506393554,0.004187545,valrubicin
TRANSLATION,-2.063761811,0.166803865,valrubicin
RRNA_PROCESSING,-2.032450537,0.132605583,valrubicin
MRNA_SPLICING,-1.948169738,0.174481031,valrubicin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.912851483,0.178110236,valrubicin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-1.868236948,0.201700072,valrubicin
DEATH_RECEPTOR_SIGNALING,1.843771439,0.582438779,valrubicin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.769129499,0.494066588,valrubicin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.757371099,0.3413846,valrubicin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.744062547,0.385566924,valrubicin
INTERFERON_ALPHA_BETA_SIGNALING,2.17828363,0.076200994,naproxen
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.000537297,0.144119271,naproxen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.978645899,0.215423118,naproxen
MRNA_SPLICING,1.926259995,0.1783545,naproxen
RESPIRATORY_ELECTRON_TRANSPORT,1.919658034,0.139149641,naproxen
TRANSPORT_OF_SMALL_MOLECULES,-1.934688462,0.160654529,naproxen
CELL_CYCLE_CHECKPOINTS,1.865319861,0.147763666,naproxen
ECM_PROTEOGLYCANS,-1.911004038,0.128523623,naproxen
MITOTIC_PROPHASE,1.844076878,0.140806184,naproxen
G2_M_CHECKPOINTS,1.831049237,0.130630275,naproxen
METABOLISM_OF_RNA,-2.741875225,0.001998427,aripiprazole
RRNA_PROCESSING,-2.364443774,0.010991347,aripiprazole
DNA_REPLICATION,-2.062947859,0.060618945,aripiprazole
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.109096878,0.066199076,aripiprazole
MRNA_SPLICING,-2.011656168,0.06794651,aripiprazole
SYNTHESIS_OF_DNA,-1.954517391,0.079537385,aripiprazole
TELOMERE_MAINTENANCE,-1.940311021,0.072276435,aripiprazole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.017616317,0.082214981,aripiprazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.869424053,0.096780954,aripiprazole
TCR_SIGNALING,1.956715261,0.093959979,aripiprazole
RESPIRATORY_ELECTRON_TRANSPORT,2.170604413,0.055031179,mepacrine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.053368062,0.065513309,mepacrine
BIOLOGICAL_OXIDATIONS,2.002644993,0.064639798,mepacrine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.981376714,0.055031179,mepacrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.903130144,0.068920001,mepacrine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.882327804,0.067697086,mepacrine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.806281868,0.085916025,mepacrine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.829530689,0.709771495,mepacrine
L1CAM_INTERACTIONS,-1.774016682,0.561788249,mepacrine
MUSCLE_CONTRACTION,1.585107418,0.247312741,mepacrine
EUKARYOTIC_TRANSLATION_ELONGATION,4.045788571,0,ivacaftor
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.96478937,0,ivacaftor
CELLULAR_RESPONSE_TO_STARVATION,3.908855701,0,ivacaftor
SELENOAMINO_ACID_METABOLISM,3.881583794,0,ivacaftor
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.830381007,0,ivacaftor
NONSENSE_MEDIATED_DECAY_NMD,3.713942035,0,ivacaftor
INFLUENZA_INFECTION,3.663488904,0,ivacaftor
EUKARYOTIC_TRANSLATION_INITIATION,3.529595744,0,ivacaftor
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.184558804,0,ivacaftor
TRANSLATION,3.091389697,0,ivacaftor
GPCR_LIGAND_BINDING,-2.789731973,0,ARRY-334543
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.439208161,0.000324746,ARRY-334543
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.33743338,0.001515483,ARRY-334543
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.321621904,0.001298986,ARRY-334543
INTERFERON_ALPHA_BETA_SIGNALING,2.267785266,0.037994491,ARRY-334543
SIGNALING_BY_GPCR,-2.158678412,0.007014522,ARRY-334543
ADAPTIVE_IMMUNE_SYSTEM,2.122116832,0.065133413,ARRY-334543
NEURONAL_SYSTEM,-2.082461759,0.012881606,ARRY-334543
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.06593888,0.012989855,ARRY-334543
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.04329631,0.085638376,ARRY-334543
TRANSLATION,3.680729654,0,dabigatran-etexilate
COLLAGEN_DEGRADATION,-2.547274459,0,dabigatran-etexilate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.197143873,0,dabigatran-etexilate
SELENOAMINO_ACID_METABOLISM,3.223015383,0,dabigatran-etexilate
CELLULAR_RESPONSE_TO_STARVATION,3.424283677,0,dabigatran-etexilate
INFLUENZA_INFECTION,2.743866962,0,dabigatran-etexilate
EUKARYOTIC_TRANSLATION_INITIATION,3.455377994,0,dabigatran-etexilate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.499970893,0,dabigatran-etexilate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.671197278,0,dabigatran-etexilate
EUKARYOTIC_TRANSLATION_ELONGATION,3.680149653,0,dabigatran-etexilate
CELLULAR_RESPONSE_TO_STARVATION,2.730402944,0,tiapride
TRANSLATION,2.543504968,0,tiapride
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.427621401,0,tiapride
SIGNALING_BY_GPCR,-2.366089807,0.000464051,tiapride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.358234723,0.000309367,tiapride
NEUTROPHIL_DEGRANULATION,2.430890071,0.001397836,tiapride
ECM_PROTEOGLYCANS,-2.325017496,0.000928102,tiapride
GPCR_LIGAND_BINDING,-2.320860523,0.000742482,tiapride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.2932808,0.005591346,tiapride
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.172476328,0.003093674,tiapride
SELENOAMINO_ACID_METABOLISM,3.42110902,0,topiroxostat
INFLUENZA_INFECTION,3.411496156,0,topiroxostat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.374207424,0,topiroxostat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.346165505,0,topiroxostat
EUKARYOTIC_TRANSLATION_ELONGATION,3.061141187,0,topiroxostat
ECM_PROTEOGLYCANS,-2.339595655,0,topiroxostat
CELLULAR_RESPONSE_TO_STARVATION,2.971006605,0.00032424,topiroxostat
NONSENSE_MEDIATED_DECAY_NMD,2.550455284,0.001389598,topiroxostat
EUKARYOTIC_TRANSLATION_INITIATION,2.387921216,0.001459078,topiroxostat
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.138347434,0.00770311,topiroxostat
CELLULAR_RESPONSE_TO_STARVATION,1.991549919,0.142309651,PH-797804
INFLUENZA_INFECTION,1.961174969,0.093466084,PH-797804
FATTY_ACID_METABOLISM,1.960762603,0.062310723,PH-797804
SELENOAMINO_ACID_METABOLISM,1.841127332,0.100099161,PH-797804
SIGNALING_BY_GPCR,-1.915983111,0.476590206,PH-797804
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.893903945,0.288361145,PH-797804
GPCR_LIGAND_BINDING,-1.887227655,0.207324763,PH-797804
PROTEIN_LOCALIZATION,1.633506384,0.235655134,PH-797804
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.837394579,0.246719678,PH-797804
TP53_REGULATES_METABOLIC_GENES,1.562547942,0.282207274,PH-797804
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.444323167,0.002303477,quetiapine
GPCR_LIGAND_BINDING,2.333608342,0.002879346,quetiapine
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.269129902,0.073190336,quetiapine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.045810431,0.151463334,quetiapine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.052276704,0.039351058,quetiapine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.986404108,0.15112449,quetiapine
CHROMATIN_ORGANIZATION,-1.959463767,0.138756678,quetiapine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.95612027,0.113038408,quetiapine
SYNTHESIS_OF_DNA,-1.946723221,0.103008621,quetiapine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-1.912376365,0.109785504,quetiapine
METABOLISM_OF_RNA,-2.147079746,0.466454174,aclidinium
PROTEIN_FOLDING,-2.113661922,0.291795324,aclidinium
NUCLEOTIDE_EXCISION_REPAIR,-1.981902691,0.421830755,aclidinium
APOPTOSIS,-1.964870897,0.343042532,aclidinium
MITOTIC_METAPHASE_AND_ANAPHASE,-1.89699738,0.394917256,aclidinium
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.88348897,0.352455284,aclidinium
GLUCOSE_METABOLISM,-1.87067551,0.326607567,aclidinium
CELL_CYCLE,-1.861773473,0.299377819,aclidinium
KEAP1_NFE2L2_PATHWAY,-1.83123411,0.313525999,aclidinium
GASTRULATION,-1.828093619,0.284683467,aclidinium
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.409680041,0.003080454,agomelatine
GPCR_LIGAND_BINDING,-2.287325768,0.009241361,agomelatine
CELLULAR_RESPONSE_TO_STARVATION,2.241120528,0.040333236,agomelatine
EUKARYOTIC_TRANSLATION_INITIATION,2.145810886,0.044886988,agomelatine
SELENOAMINO_ACID_METABOLISM,2.126089584,0.039032164,agomelatine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.106964752,0.033502607,agomelatine
EUKARYOTIC_TRANSLATION_ELONGATION,2.084269581,0.032787018,agomelatine
TRANSLATION,2.015844278,0.044670143,agomelatine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.008424365,0.040333236,agomelatine
SENSORY_PERCEPTION,-2.013498059,0.092156908,agomelatine
INTERFERON_ALPHA_BETA_SIGNALING,2.52967568,0.003586389,cediranib
GPCR_LIGAND_BINDING,-2.331246162,0.002531215,cediranib
ADAPTIVE_IMMUNE_SYSTEM,2.313719031,0.018828544,cediranib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.289214048,0.014345557,cediranib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.180089797,0.011390467,cediranib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.155653877,0.01012486,cediranib
NEURONAL_SYSTEM,-2.014123727,0.035911612,cediranib
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.965660516,0.129558316,cediranib
INNATE_IMMUNE_SYSTEM,1.963335337,0.104722569,cediranib
G_ALPHA_S_SIGNALLING_EVENTS,-1.973549579,0.041005682,cediranib
SIGNALING_BY_GPCR,2.628877183,0,GW-501516
GPCR_LIGAND_BINDING,2.717125602,0,GW-501516
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.383302695,0.000875163,GW-501516
NEURONAL_SYSTEM,2.326261433,0.001706569,GW-501516
POTASSIUM_CHANNELS,2.203903101,0.004515843,GW-501516
G_ALPHA_I_SIGNALLING_EVENTS,2.126597886,0.008226536,GW-501516
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.070775041,0.011777199,GW-501516
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.934516452,0.028683481,GW-501516
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.515599501,0.932088062,GW-501516
G_ALPHA_Q_SIGNALLING_EVENTS,1.8342928,0.05437682,GW-501516
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.139598672,0,mirtazapine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.036692778,0,mirtazapine
ECM_PROTEOGLYCANS,-2.425357866,0.004255196,mirtazapine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.173163884,0.056179924,mirtazapine
CILIUM_ASSEMBLY,2.014019216,0.118602062,mirtazapine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.610290598,0.548008452,mirtazapine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.694386314,0.949510077,mirtazapine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.661045181,0.884313622,mirtazapine
KERATINIZATION,1.649393065,0.638092966,mirtazapine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.649393065,0.638092966,mirtazapine
RRNA_PROCESSING,3.571486239,0,mesoridazine
SELENOAMINO_ACID_METABOLISM,3.521049251,0,mesoridazine
EUKARYOTIC_TRANSLATION_ELONGATION,3.478461285,0,mesoridazine
EUKARYOTIC_TRANSLATION_INITIATION,3.4308966,0,mesoridazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.36468025,0,mesoridazine
TRANSLATION,3.301170333,0,mesoridazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.960194739,0,mesoridazine
NONSENSE_MEDIATED_DECAY_NMD,2.828406662,0,mesoridazine
INFLUENZA_INFECTION,2.583154536,0.000285022,mesoridazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.608528459,0.000310933,mesoridazine
GPCR_LIGAND_BINDING,2.159620222,0.042114514,ketoconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.015797248,0.077579368,ketoconazole
SIGNALING_BY_GPCR,1.847440004,0.212050273,ketoconazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.003422994,1,ketoconazole
DEATH_RECEPTOR_SIGNALING,-2.815942663,1,ketoconazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.681175442,0.515718086,ketoconazole
DEUBIQUITINATION,-2.749374498,1,ketoconazole
SENSORY_PERCEPTION,1.667100172,0.449664795,ketoconazole
INNATE_IMMUNE_SYSTEM,-1.91827299,1,ketoconazole
GLYCOSAMINOGLYCAN_METABOLISM,-1.884626536,1,ketoconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.045863378,0,dexamethasone
GPCR_LIGAND_BINDING,3.0366385,0,dexamethasone
SIGNALING_BY_GPCR,2.871159249,0,dexamethasone
G_ALPHA_Q_SIGNALLING_EVENTS,2.64368612,0,dexamethasone
NEUTROPHIL_DEGRANULATION,-2.663673623,0.004030387,dexamethasone
NEURONAL_SYSTEM,2.291614504,0.002547225,dexamethasone
G_ALPHA_I_SIGNALLING_EVENTS,2.228249215,0.004120512,dexamethasone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.190475386,0.00460213,dexamethasone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.300005771,0.045677716,dexamethasone
SENSORY_PERCEPTION,2.12603879,0.006929951,dexamethasone
KERATINIZATION,-2.359226697,0.022842063,navitoclax
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.214250823,0.039157823,navitoclax
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.150180341,0.082942997,navitoclax
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.117308013,0.045684127,navitoclax
RNA_POLYMERASE_II_TRANSCRIPTION,1.968922016,0.183856976,navitoclax
RESPIRATORY_ELECTRON_TRANSPORT,1.915785518,0.173258704,navitoclax
GPCR_LIGAND_BINDING,-1.88263995,0.182736508,navitoclax
MITOCHONDRIAL_BIOGENESIS,1.874051372,0.17441069,navitoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.815287126,0.229725895,navitoclax
DRUG_ADME,-1.808483618,0.199777412,navitoclax
RESPIRATORY_ELECTRON_TRANSPORT,2.882266639,0,purvalanol-b
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.78782718,0,purvalanol-b
TRANSLATION,2.74256527,0,purvalanol-b
EUKARYOTIC_TRANSLATION_INITIATION,2.510873418,0.00157086,purvalanol-b
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.23231641,0.014661363,purvalanol-b
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,2.076910656,0.039096968,purvalanol-b
G1_S_DNA_DAMAGE_CHECKPOINTS,2.056042661,0.037102225,purvalanol-b
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,2.048190795,0.033773497,purvalanol-b
INTERLEUKIN_1_FAMILY_SIGNALING,2.030058625,0.034675287,purvalanol-b
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.016094234,0.033092791,purvalanol-b
TRANSLATION,2.048327682,0.162388454,nicardipine
CELL_CYCLE_CHECKPOINTS,1.962740524,0.141786934,nicardipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.05592906,0.240047477,nicardipine
SEPARATION_OF_SISTER_CHROMATIDS,1.794076997,0.269031618,nicardipine
MITOTIC_METAPHASE_AND_ANAPHASE,1.790869097,0.203591495,nicardipine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.996556606,0.208770933,nicardipine
GPCR_LIGAND_BINDING,-1.973643923,0.167068874,nicardipine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.968471792,0.131752443,nicardipine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.631647136,0.364525724,nicardipine
RRNA_PROCESSING,1.61525584,0.32800852,nicardipine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.481815153,0.021282295,sulfinpyrazone
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.415484237,0.018969002,sulfinpyrazone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.391823414,0.014805075,sulfinpyrazone
INNATE_IMMUNE_SYSTEM,-2.157123181,0.094845009,sulfinpyrazone
NEUTROPHIL_DEGRANULATION,-1.986195042,0.223001437,sulfinpyrazone
GLYCOSAMINOGLYCAN_METABOLISM,-1.944123338,0.237960731,sulfinpyrazone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1.774085926,1,sulfinpyrazone
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.772445161,0.869172884,sulfinpyrazone
SYNTHESIS_OF_DNA,1.759027751,0.633094657,sulfinpyrazone
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-1.884729173,0.28116423,sulfinpyrazone
G_ALPHA_Q_SIGNALLING_EVENTS,2.328243206,0.013270295,megestrol-acetate
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.109895672,0.049508408,megestrol-acetate
SIGNALING_BY_GPCR,2.065038807,0.05137986,megestrol-acetate
RESPIRATORY_ELECTRON_TRANSPORT,2.024878003,0.055377962,megestrol-acetate
GPCR_LIGAND_BINDING,2.023770321,0.044506528,megestrol-acetate
SYNTHESIS_OF_DNA,1.966039009,0.061587779,megestrol-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.965198467,0.053372835,megestrol-acetate
GLYCOSAMINOGLYCAN_METABOLISM,-2.076884188,0.645018143,megestrol-acetate
DNA_REPLICATION,1.901904084,0.076559394,megestrol-acetate
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.824804158,0.112740796,megestrol-acetate
MUSCLE_CONTRACTION,2.840494006,0,cinacalcet
STRIATED_MUSCLE_CONTRACTION,2.391836396,0.004180058,cinacalcet
CARDIAC_CONDUCTION,2.186196938,0.014630204,cinacalcet
PI3K_AKT_SIGNALING_IN_CANCER,1.768749863,0.250280993,cinacalcet
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.068562991,1,cinacalcet
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.705107007,0.299988853,cinacalcet
ADIPOGENESIS,1.696029545,0.263227562,cinacalcet
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.635741142,0.323158319,cinacalcet
SENSORY_PERCEPTION,1.624558877,0.301312538,cinacalcet
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.911574227,1,cinacalcet
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.352878299,0.00652665,acepromazine
EUKARYOTIC_TRANSLATION_INITIATION,2.340632382,0.003263325,acepromazine
TRANSLATION,2.301471622,0.005438875,acepromazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.281730328,0.003263325,acepromazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.281730328,0.003263325,acepromazine
DNA_REPLICATION_PRE_INITIATION,2.230296368,0.0043511,acepromazine
SYNTHESIS_OF_DNA,2.222414172,0.003729515,acepromazine
NONSENSE_MEDIATED_DECAY_NMD,2.22023815,0.003263325,acepromazine
S_PHASE,2.181450293,0.003625917,acepromazine
SELENOAMINO_ACID_METABOLISM,2.141606364,0.00522132,acepromazine
STRIATED_MUSCLE_CONTRACTION,3.173462223,0,simvastatin
MUSCLE_CONTRACTION,2.739240252,0,simvastatin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.34272926,0.0099995,simvastatin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.264430906,0.014582604,simvastatin
CHROMATIN_ORGANIZATION,-2.096828854,0.081492743,simvastatin
KEAP1_NFE2L2_PATHWAY,2.082214408,0.04299785,simvastatin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.008503428,0.054719486,simvastatin
ORC1_REMOVAL_FROM_CHROMATIN,1.979829724,0.0528545,simvastatin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.975745755,0.047497625,simvastatin
G2_M_CHECKPOINTS,1.972911004,0.042590463,simvastatin
MRNA_SPLICING,2.927213304,0,pimozide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.808018263,0,pimozide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.233455785,0.014816866,pimozide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.182920037,0.011112649,pimozide
NONSENSE_MEDIATED_DECAY_NMD,-2.174992857,0.008334487,pimozide
EUKARYOTIC_TRANSLATION_INITIATION,-2.167652452,0.007176919,pimozide
SELENOAMINO_ACID_METABOLISM,-2.163062338,0.005741535,pimozide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.156316759,0.005401982,pimozide
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,2.002178728,0.044110552,pimozide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.025461021,0.018521082,pimozide
DNA_REPLICATION,2.651898019,0,CCT-018159
S_PHASE,2.256170987,0.023369565,CCT-018159
SELENOAMINO_ACID_METABOLISM,2.233730169,0.016778149,CCT-018159
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.096505262,0.03145903,CCT-018159
G2_M_CHECKPOINTS,1.987651201,0.042424749,CCT-018159
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.956466953,0.039548495,CCT-018159
EUKARYOTIC_TRANSLATION_INITIATION,1.955373072,0.03389871,CCT-018159
EUKARYOTIC_TRANSLATION_ELONGATION,1.939111882,0.03145903,CCT-018159
CELL_CYCLE_CHECKPOINTS,1.931434862,0.028762542,CCT-018159
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.832067798,0.046020067,CCT-018159
DNA_REPLICATION,2.924884653,0,dobutamine
SYNTHESIS_OF_DNA,2.798282869,0,dobutamine
DNA_REPLICATION_PRE_INITIATION,2.756513724,0,dobutamine
S_PHASE,2.496123125,0.00110424,dobutamine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.276975118,0.005300353,dobutamine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.25676847,0.004416961,dobutamine
MITOCHONDRIAL_TRANSLATION,2.103966393,0.016405856,dobutamine
CELL_CYCLE_CHECKPOINTS,2.06506056,0.018219965,dobutamine
G2_M_CHECKPOINTS,2.019409683,0.017667845,dobutamine
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.982132441,0.019434629,dobutamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.820827637,0,warfarin
MRNA_SPLICING,2.347245775,0.004784689,warfarin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.140379015,0.013588456,warfarin
EUKARYOTIC_TRANSLATION_INITIATION,-2.089475829,0.014073758,warfarin
SELENOAMINO_ACID_METABOLISM,-2.083926388,0.010029574,warfarin
TRANSLATION,-2.034135619,0.012617852,warfarin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.032540534,0.010094281,warfarin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.009282885,0.011809015,warfarin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.004907794,0.011231275,warfarin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.987815702,0.011404597,warfarin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.070276461,0,pirlindole
G2_M_CHECKPOINTS,2.880934361,0,pirlindole
G1_S_DNA_DAMAGE_CHECKPOINTS,2.824192699,0,pirlindole
RESPIRATORY_ELECTRON_TRANSPORT,2.762848819,0,pirlindole
CELL_CYCLE_CHECKPOINTS,2.667521716,0,pirlindole
REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,2.636740011,0,pirlindole
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.609237263,0,pirlindole
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.606917909,0,pirlindole
DNA_REPLICATION,2.591764459,0,pirlindole
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.574236196,0,pirlindole
SYNTHESIS_OF_DNA,2.175738937,0.057306016,estropipate
DNA_REPLICATION,2.164338336,0.030857086,estropipate
DEUBIQUITINATION,-3.651198086,0.114799327,estropipate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.088103934,0.043346858,estropipate
DEATH_RECEPTOR_SIGNALING,-3.603579573,0.127906337,estropipate
GASTRULATION,1.953356838,0.110754897,estropipate
MAPK6_MAPK4_SIGNALING,1.936006976,0.106897761,estropipate
RESPIRATORY_ELECTRON_TRANSPORT,1.930759232,0.092387584,estropipate
DNA_REPLICATION_PRE_INITIATION,1.926526116,0.081078567,estropipate
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.832969465,0.137754846,estropipate
ORC1_REMOVAL_FROM_CHROMATIN,2.941062123,0,diphemanil
UCH_PROTEINASES,3.020420386,0,diphemanil
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.967699995,0,diphemanil
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.962583012,0,diphemanil
PROTEASOME_ASSEMBLY,2.913475784,0,diphemanil
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,2.74341689,0.000138386,diphemanil
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,2.742535042,0.000131103,diphemanil
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,2.735708535,0.000124548,diphemanil
PCP_CE_PATHWAY,2.732046559,0.000118617,diphemanil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.716528257,0.000113225,diphemanil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.521799578,0,dosulepin
SELENOAMINO_ACID_METABOLISM,-2.414694105,0,dosulepin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.385051663,0,dosulepin
NONSENSE_MEDIATED_DECAY_NMD,-2.362793139,0,dosulepin
EUKARYOTIC_TRANSLATION_INITIATION,-2.357529196,0,dosulepin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.350984613,0.000169118,dosulepin
CELLULAR_RESPONSE_TO_STARVATION,-2.260158469,0.000144958,dosulepin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.25204463,0.000126838,dosulepin
RRNA_PROCESSING,-2.24916763,0.00022549,dosulepin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.349164548,0.006834825,dosulepin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.504084434,0.000824212,doxylamine
GPCR_LIGAND_BINDING,2.469246037,0.000824212,doxylamine
INNATE_IMMUNE_SYSTEM,-2.645306058,0.022528107,doxylamine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.498229631,0.037105117,doxylamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.037076562,0.0442327,doxylamine
GLYCOSAMINOGLYCAN_METABOLISM,-2.300834652,0.090554154,doxylamine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.170396518,0.142788441,doxylamine
NEUTROPHIL_DEGRANULATION,-2.168312873,0.116881118,doxylamine
SIGNALING_BY_GPCR,1.928806858,0.084275656,doxylamine
SLC_TRANSPORTER_DISORDERS,-2.143793642,0.114407444,doxylamine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.609594156,0.000669836,bendroflumethiazide
BIOLOGICAL_OXIDATIONS,2.238934997,0.019760172,bendroflumethiazide
COLLAGEN_FORMATION,-1.884049718,0.857652219,bendroflumethiazide
ECM_PROTEOGLYCANS,-1.869488675,0.482287189,bendroflumethiazide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.777982133,0.245383383,bendroflumethiazide
GPCR_LIGAND_BINDING,1.748983282,0.217361896,bendroflumethiazide
SIGNALING_BY_ROBO_RECEPTORS,-1.787083296,0.628262478,bendroflumethiazide
CHROMATIN_ORGANIZATION,-1.78097991,0.493093152,bendroflumethiazide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.774973238,0.415403966,bendroflumethiazide
FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,-1.758453062,0.390720871,bendroflumethiazide
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.245363041,0.033437681,cladribine
RRNA_PROCESSING,-2.201569353,0.048642552,cladribine
AURKA_ACTIVATION_BY_TPX2,-1.996665287,0.136739617,cladribine
TRANSLATION,-1.966854517,0.117102439,cladribine
EUKARYOTIC_TRANSLATION_INITIATION,-1.919945952,0.121876616,cladribine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.888268877,0.121714474,cladribine
SUMOYLATION,-1.882365117,0.106292983,cladribine
AUTOPHAGY,1.894015375,0.281509121,cladribine
SIGNALING_BY_NTRKS,1.869934614,0.228942677,cladribine
DEVELOPMENTAL_CELL_LINEAGES,1.845967552,0.208533643,cladribine
GPCR_LIGAND_BINDING,2.635936674,0,guanaben-acetate
SENSORY_PERCEPTION,2.545857589,0.000393401,guanaben-acetate
SIGNALING_BY_GPCR,2.481846741,0.000262267,guanaben-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.447281518,0.0001967,guanaben-acetate
VISUAL_PHOTOTRANSDUCTION,2.27361072,0.002675125,guanaben-acetate
POTASSIUM_CHANNELS,2.238007629,0.002622672,guanaben-acetate
NEUTROPHIL_DEGRANULATION,-2.351456858,0.065590672,guanaben-acetate
NEURONAL_SYSTEM,2.179426771,0.00494561,guanaben-acetate
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.302778815,0.054658893,guanaben-acetate
G_ALPHA_Q_SIGNALLING_EVENTS,2.135814924,0.006589463,guanaben-acetate
GPCR_LIGAND_BINDING,2.861911918,0,benzbromarone
SIGNALING_BY_GPCR,2.721452655,0,benzbromarone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.684702392,0,benzbromarone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.444664271,0.000649304,benzbromarone
NEUTROPHIL_DEGRANULATION,-2.493200265,0.008850689,benzbromarone
MUSCLE_CONTRACTION,2.214924651,0.007618498,benzbromarone
G_ALPHA_Q_SIGNALLING_EVENTS,2.174623787,0.009667412,benzbromarone
POTASSIUM_CHANNELS,2.109179194,0.014346522,benzbromarone
NCAM1_INTERACTIONS,2.073333386,0.01763942,benzbromarone
G_ALPHA_I_SIGNALLING_EVENTS,2.012529869,0.024048289,benzbromarone
GPCR_LIGAND_BINDING,2.517160651,0.000976297,etoposide
G_ALPHA_S_SIGNALLING_EVENTS,2.464203031,0.000732223,etoposide
RHO_GTPASE_EFFECTORS,-2.693609015,0.007260536,etoposide
S_PHASE,-2.467239859,0.01694125,etoposide
CELL_CYCLE_MITOTIC,-2.428146799,0.012907619,etoposide
M_PHASE,-2.402952397,0.010285759,etoposide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.379713338,0.008712643,etoposide
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.376140662,0.007260536,etoposide
DNA_REPLICATION,-2.328875059,0.008643495,etoposide
METABOLISM_OF_RNA,-2.235037922,0.012100893,etoposide
ORC1_REMOVAL_FROM_CHROMATIN,2.554356937,0.002957874,rutin
KERATINIZATION,2.241345535,0.01528235,rutin
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.241345535,0.01528235,rutin
PEROXISOMAL_PROTEIN_IMPORT,-2.194785216,0.051713985,rutin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.049129018,0.053981203,rutin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,2.021875377,0.053537522,rutin
G2_M_CHECKPOINTS,2.016118843,0.046833007,rutin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.057951871,0.098502828,rutin
SYNTHESIS_OF_DNA,1.993206973,0.046480879,rutin
DNA_REPLICATION,1.980809272,0.044552979,rutin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.323138492,0.020694527,BRD-K34685430
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.323138492,0.020694527,BRD-K34685430
TRANSLATION,2.236816253,0.034819363,BRD-K34685430
DEATH_RECEPTOR_SIGNALING,-3.270241741,0.048752708,BRD-K34685430
RRNA_PROCESSING,2.200997448,0.033012698,BRD-K34685430
SYNTHESIS_OF_DNA,2.138525251,0.034293787,BRD-K34685430
NEDDYLATION,2.096873252,0.03679027,BRD-K34685430
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.004809357,0.063069034,BRD-K34685430
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.98889322,0.060112673,BRD-K34685430
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.975074276,0.057594292,BRD-K34685430
GPCR_LIGAND_BINDING,-2.465022136,0,phenazone
CELL_CYCLE_CHECKPOINTS,2.627353122,0.009229958,phenazone
MITOTIC_SPINDLE_CHECKPOINT,2.493851962,0.004614979,phenazone
M_PHASE,2.469811947,0.004102203,phenazone
METABOLISM_OF_RNA,2.446945258,0.003076653,phenazone
SIGNALING_BY_GPCR,-2.259338082,0.00130985,phenazone
RESPIRATORY_ELECTRON_TRANSPORT,2.304934173,0.007178856,phenazone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.31161135,0.008614627,phenazone
CELL_CYCLE_MITOTIC,2.295760539,0.006592827,phenazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.188640115,0.00314364,phenazone
METABOLISM_OF_RNA,-3.209639027,0,trazodone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.842095489,0,trazodone
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.737772448,0,trazodone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.46125001,0.003289695,trazodone
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.409232051,0.003289695,trazodone
MRNA_SPLICING,-2.256864338,0.006579389,trazodone
S_PHASE,-2.240084873,0.006109433,trazodone
SEPARATION_OF_SISTER_CHROMATIDS,-2.200862406,0.006990601,trazodone
NEUTROPHIL_DEGRANULATION,-2.176145867,0.006944911,trazodone
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.109614641,0.008882175,trazodone
METABOLISM_OF_RNA,-4.145033441,0,epirubicin
M_PHASE,-2.717027723,0,epirubicin
MRNA_SPLICING,-2.744875794,0,epirubicin
SIGNALING_BY_GPCR,2.747804678,0,epirubicin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.771210293,0,epirubicin
CELL_CYCLE,-2.79124419,0,epirubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.671360941,0,epirubicin
RRNA_PROCESSING,-2.810966196,0,epirubicin
CELL_CYCLE_MITOTIC,-2.892345911,0,epirubicin
GPCR_LIGAND_BINDING,3.189428645,0,epirubicin
MUSCLE_CONTRACTION,3.553096868,0,prochlorperazine
STRIATED_MUSCLE_CONTRACTION,2.794732474,0,prochlorperazine
CARDIAC_CONDUCTION,2.814791351,0,prochlorperazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.988273252,0,prochlorperazine
INFLUENZA_INFECTION,-2.999171721,0,prochlorperazine
TRANSLATION,-3.030567798,0,prochlorperazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.015015744,0,prochlorperazine
NONSENSE_MEDIATED_DECAY_NMD,-3.147302575,0,prochlorperazine
CELLULAR_RESPONSE_TO_STARVATION,-3.225885035,0,prochlorperazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.231614458,0,prochlorperazine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.250006502,0,rolipram
ESR_MEDIATED_SIGNALING,-2.540390629,0,rolipram
SARS_COV_2_HOST_INTERACTIONS,-2.573497888,0,rolipram
SARS_COV_1_INFECTION,-2.740415906,0,rolipram
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.769563771,0,rolipram
SARS_COV_1_HOST_INTERACTIONS,-2.786527144,0,rolipram
INFLUENZA_INFECTION,-2.83440694,0,rolipram
TRANSLATION,-2.88100392,0,rolipram
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.899379167,0,rolipram
RRNA_PROCESSING,-2.902536435,0,rolipram
INNATE_IMMUNE_SYSTEM,-2.836805981,0.002757932,tibolone
GPCR_LIGAND_BINDING,2.513312133,0.001514438,tibolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.474417252,0.000757219,tibolone
SIGNALING_BY_GPCR,2.393806551,0.001262031,tibolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.246735672,0.004543313,tibolone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.385300223,0.039990019,tibolone
G_ALPHA_I_SIGNALLING_EVENTS,2.140340151,0.01044962,tibolone
NEUTROPHIL_DEGRANULATION,-2.223497997,0.091931078,tibolone
TCR_SIGNALING,-2.157326767,0.104801429,tibolone
DEATH_RECEPTOR_SIGNALING,-2.072865749,0.144239861,tibolone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.313148797,0,fluphenazine
RRNA_PROCESSING,3.149848491,0,fluphenazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.221757317,0,fluphenazine
INFLUENZA_INFECTION,3.373359943,0,fluphenazine
TRANSLATION,3.688057903,0,fluphenazine
NONSENSE_MEDIATED_DECAY_NMD,3.813796183,0,fluphenazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.517766059,0,fluphenazine
SELENOAMINO_ACID_METABOLISM,4.14352226,0,fluphenazine
EUKARYOTIC_TRANSLATION_ELONGATION,4.194110983,0,fluphenazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.236559586,0,fluphenazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.964721208,0,rofecoxib
INFLUENZA_INFECTION,2.770078789,0,rofecoxib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.734307895,0,rofecoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.690484945,0,rofecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,2.676876155,0,rofecoxib
TRANSLATION,2.66272939,0,rofecoxib
CELLULAR_RESPONSE_TO_STARVATION,2.64639418,0,rofecoxib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.614579778,0,rofecoxib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.559939876,0,rofecoxib
HIV_INFECTION,2.546040313,0,rofecoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.710192582,0,resveratrol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.093050544,0.093576344,resveratrol
G2_M_CHECKPOINTS,1.901121758,0.23034177,resveratrol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.928267302,0.368528786,resveratrol
MUSCLE_CONTRACTION,1.814425883,0.313120843,resveratrol
TNF_SIGNALING,-1.890958278,0.250050834,resveratrol
SIGNALING_BY_GPCR,1.759438495,0.348032018,resveratrol
HOST_INTERACTIONS_OF_HIV_FACTORS,1.721155463,0.363808029,resveratrol
GPCR_LIGAND_BINDING,1.714989517,0.320576101,resveratrol
SYNTHESIS_OF_DNA,1.694153837,0.310871412,resveratrol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-4.046526463,0,flupirtine
INFECTIOUS_DISEASE,-2.949686874,0,flupirtine
SARS_COV_1_HOST_INTERACTIONS,-3.023359991,0,flupirtine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.098450114,0,flupirtine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.171015443,0,flupirtine
METABOLISM_OF_RNA,-3.180171029,0,flupirtine
CELLULAR_RESPONSES_TO_STIMULI,-3.195772781,0,flupirtine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.321638319,0,flupirtine
SIGNALING_BY_ROBO_RECEPTORS,-3.359101043,0,flupirtine
TRANSLATION,-3.561389118,0,flupirtine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.769399613,0.784784574,dantrolene
EUKARYOTIC_TRANSLATION_INITIATION,1.809042788,1,dantrolene
G_ALPHA_S_SIGNALLING_EVENTS,-1.579504502,1,dantrolene
RNA_POLYMERASE_II_TRANSCRIPTION,1.665222891,1,dantrolene
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.661193229,1,dantrolene
CELLULAR_RESPONSE_TO_STARVATION,1.638461786,0.950772215,dantrolene
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.635729523,0.773506075,dantrolene
SENSORY_PERCEPTION,-1.524975076,1,dantrolene
NONSENSE_MEDIATED_DECAY_NMD,1.632524522,0.659659396,dantrolene
METABOLISM_OF_STEROIDS,-1.499142453,0.918492016,dantrolene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.87554681,0,loratadine
EUKARYOTIC_TRANSLATION_ELONGATION,2.766521261,0,loratadine
CELLULAR_RESPONSE_TO_STARVATION,2.713858398,0,loratadine
EUKARYOTIC_TRANSLATION_INITIATION,2.661645396,0,loratadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.651220202,0,loratadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.57251552,0,loratadine
SELENOAMINO_ACID_METABOLISM,2.567791965,0,loratadine
GPCR_LIGAND_BINDING,-2.412044451,0.003247534,loratadine
NONSENSE_MEDIATED_DECAY_NMD,2.375214409,0.001649729,loratadine
INFLUENZA_INFECTION,2.373981925,0.001443513,loratadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.794290898,0,gliquidone
COLLAGEN_FORMATION,-2.537991184,0.001428571,gliquidone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.372885594,0.004444444,gliquidone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.260922122,0.031911765,gliquidone
CILIUM_ASSEMBLY,2.258204114,0.015955882,gliquidone
GPCR_LIGAND_BINDING,-2.27704022,0.008333333,gliquidone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.273186723,0.006857143,gliquidone
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.168540386,0.026078431,gliquidone
ADAPTIVE_IMMUNE_SYSTEM,1.963210932,0.100882353,gliquidone
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.917888813,0.114882353,gliquidone
GPCR_LIGAND_BINDING,3.26694045,0,aminoglutethimide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.047272508,0,aminoglutethimide
SIGNALING_BY_GPCR,2.864885396,0,aminoglutethimide
G_ALPHA_Q_SIGNALLING_EVENTS,2.540293771,0.000427952,aminoglutethimide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.487504782,0.000855904,aminoglutethimide
G_ALPHA_I_SIGNALLING_EVENTS,2.387260201,0.001711808,aminoglutethimide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.01685761,0.684818194,aminoglutethimide
PEROXISOMAL_PROTEIN_IMPORT,-2.015454279,0.344106994,aminoglutethimide
NEUTROPHIL_DEGRANULATION,-2.007970801,0.236950868,aminoglutethimide
ADAPTIVE_IMMUNE_SYSTEM,-1.989039144,0.202898614,aminoglutethimide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.060423064,0,lofexidine
SARS_COV_1_HOST_INTERACTIONS,-2.403285735,0,lofexidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.562219277,0,lofexidine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.636557288,0,lofexidine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.663535737,0,lofexidine
SIGNALING_BY_ROBO_RECEPTORS,-2.670037623,0,lofexidine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.69333028,0,lofexidine
RRNA_PROCESSING,-2.714713482,0,lofexidine
CELLULAR_RESPONSE_TO_STARVATION,-2.81013224,0,lofexidine
INFLUENZA_INFECTION,-2.845065609,0,lofexidine
MUSCLE_CONTRACTION,2.825148421,0,diflunisal
GPCR_LIGAND_BINDING,2.665215903,0,diflunisal
STRIATED_MUSCLE_CONTRACTION,2.656345829,0,diflunisal
NEURONAL_SYSTEM,2.625745076,0,diflunisal
SIGNALING_BY_GPCR,2.438490576,0.000251084,diflunisal
SELENOAMINO_ACID_METABOLISM,-2.410028573,0.020939548,diflunisal
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.352458525,0.015355669,diflunisal
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.291493831,0.014425022,diflunisal
EUKARYOTIC_TRANSLATION_ELONGATION,-2.273272845,0.011516752,diflunisal
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.178780233,0.006067869,diflunisal
TCR_SIGNALING,-2.187048957,0.042094255,amiodarone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.130387069,0.046399349,amiodarone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.024740409,0.087377468,amiodarone
PEROXISOMAL_PROTEIN_IMPORT,-2.011660485,0.072469086,amiodarone
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.006021391,0.061228007,amiodarone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.766753695,0.350307111,amiodarone
CILIUM_ASSEMBLY,-1.766738094,0.300263238,amiodarone
SENSORY_PERCEPTION,1.538484387,1,amiodarone
RESPIRATORY_ELECTRON_TRANSPORT,1.535658983,1,amiodarone
PTEN_REGULATION,1.517895818,0.929885586,amiodarone
EUKARYOTIC_TRANSLATION_ELONGATION,-3.604829382,0,bicalutamide
NERVOUS_SYSTEM_DEVELOPMENT,-2.775086367,0,bicalutamide
SARS_COV_1_INFECTION,-2.778096263,0,bicalutamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.856961328,0,bicalutamide
SARS_COV_1_HOST_INTERACTIONS,-2.929476833,0,bicalutamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.955741956,0,bicalutamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.054568601,0,bicalutamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.088600573,0,bicalutamide
INFLUENZA_INFECTION,-3.155390457,0,bicalutamide
TRANSLATION,-3.21100729,0,bicalutamide
GPCR_LIGAND_BINDING,3.072050262,0,nadolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.979247611,0,nadolol
SIGNALING_BY_GPCR,2.860799919,0,nadolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.334790621,0.002846328,nadolol
G_ALPHA_Q_SIGNALLING_EVENTS,2.32861133,0.002428867,nadolol
PEROXISOMAL_PROTEIN_IMPORT,-2.374448842,0.111876937,nadolol
NEUTROPHIL_DEGRANULATION,-2.316560114,0.079193787,nadolol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.297201555,0.061176153,nadolol
G_ALPHA_I_SIGNALLING_EVENTS,2.029814841,0.031625869,nadolol
MEMBRANE_TRAFFICKING,-2.153686779,0.126961468,nadolol
EUKARYOTIC_TRANSLATION_INITIATION,-3.171233826,0,anastrozole
SARS_COV_1_HOST_INTERACTIONS,-2.598728169,0,anastrozole
RRNA_PROCESSING,-2.606955777,0,anastrozole
CELLULAR_RESPONSE_TO_STARVATION,-2.624156329,0,anastrozole
VIRAL_INFECTION_PATHWAYS,-2.674385153,0,anastrozole
SELENOAMINO_ACID_METABOLISM,-2.740089185,0,anastrozole
SARS_COV_1_INFECTION,-2.74157915,0,anastrozole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.781707902,0,anastrozole
TRANSLATION,-2.663600936,0,anastrozole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.793888003,0,anastrozole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.529932065,0,raloxifene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.495767584,0,raloxifene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.480529698,0,raloxifene
SIGNALING_BY_ROBO_RECEPTORS,-2.450927503,0,raloxifene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.420057991,0,raloxifene
EUKARYOTIC_TRANSLATION_INITIATION,-2.414335169,0,raloxifene
SELENOAMINO_ACID_METABOLISM,-2.407888911,0,raloxifene
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.407722578,0,raloxifene
CELLULAR_RESPONSE_TO_STARVATION,-2.372973684,0,raloxifene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.371408536,0,raloxifene
COLLAGEN_FORMATION,-2.712306093,0,aminolevulinic-acid
COLLAGEN_DEGRADATION,-2.435833621,0.000956382,aminolevulinic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.678801969,0.004375808,aminolevulinic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.670712844,0.002187904,aminolevulinic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.602831275,0.001823253,aminolevulinic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.587693256,0.00136744,aminolevulinic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.34972178,0.001275176,aminolevulinic-acid
TRANSLATION,2.551777727,0.001531533,aminolevulinic-acid
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.343445075,0.001195478,aminolevulinic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.33928223,0.000956382,aminolevulinic-acid
DNA_REPLICATION,-3.157967378,0,foretinib
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.507255996,0,foretinib
ORC1_REMOVAL_FROM_CHROMATIN,-2.516362081,0,foretinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.53239058,0,foretinib
DNA_STRAND_ELONGATION,-2.584437077,0,foretinib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.585354979,0,foretinib
METABOLISM_OF_RNA,-2.765253015,0,foretinib
DNA_REPLICATION_PRE_INITIATION,-2.819171851,0,foretinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.862416236,0,foretinib
SYNTHESIS_OF_DNA,-2.956264929,0,foretinib
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.696483022,0,geldanamycin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.621567242,0,geldanamycin
DNA_REPLICATION,-2.570780217,0,geldanamycin
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.500839887,0,geldanamycin
DNA_REPLICATION_PRE_INITIATION,-2.439721783,0.000646861,geldanamycin
S_PHASE,-2.433237616,0.00053905,geldanamycin
G2_M_CHECKPOINTS,-2.36518713,0.001078101,geldanamycin
CELL_CYCLE,-2.341544494,0.000943338,geldanamycin
SYNTHESIS_OF_DNA,-2.323910965,0.001437468,geldanamycin
CELL_CYCLE_CHECKPOINTS,-2.296869766,0.001832772,geldanamycin
CELL_CYCLE,-3.436200107,0,AZD-8330
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.57547914,0,AZD-8330
MITOTIC_METAPHASE_AND_ANAPHASE,-2.564234418,0,AZD-8330
M_PHASE,-2.550669632,0,AZD-8330
HOMOLOGY_DIRECTED_REPAIR,-2.518438557,0,AZD-8330
SEPARATION_OF_SISTER_CHROMATIDS,-2.476056497,0,AZD-8330
TELOMERE_MAINTENANCE,-2.460477553,0,AZD-8330
ORC1_REMOVAL_FROM_CHROMATIN,-2.583012238,0,AZD-8330
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.452862675,0,AZD-8330
MITOTIC_SPINDLE_CHECKPOINT,-2.438299229,0,AZD-8330
GPCR_LIGAND_BINDING,-2.201899955,0.013242784,risperidone
SIGNALING_BY_GPCR,-2.105561727,0.023837012,risperidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.090644438,0.020305603,risperidone
RAB_REGULATION_OF_TRAFFICKING,1.908711226,0.451357702,risperidone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.870010773,0.142139219,risperidone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.867178912,0.116889643,risperidone
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.850881548,0.108590832,risperidone
EUKARYOTIC_TRANSLATION_INITIATION,1.703341497,0.663172324,risperidone
SIGNALING_BY_ROBO_RECEPTORS,1.688103722,0.483194082,risperidone
G_ALPHA_Q_SIGNALLING_EVENTS,-1.77233087,0.183002668,risperidone
EUKARYOTIC_TRANSLATION_INITIATION,2.765804572,0,neratinib
CELLULAR_RESPONSE_TO_STARVATION,2.654956557,0,neratinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.607176423,0,neratinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.606684714,0,neratinib
SELENOAMINO_ACID_METABOLISM,2.467962528,0.001041043,neratinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.41635941,0.001518188,neratinib
DNA_REPAIR,-2.37174814,0.007580707,neratinib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.334676256,0.002974409,neratinib
CELLULAR_RESPONSES_TO_STIMULI,2.29187668,0.003741249,neratinib
NONSENSE_MEDIATED_DECAY_NMD,2.26664378,0.003759322,neratinib
TRANSLATION,3.341429279,0,menadione
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.60491201,0,menadione
CELLULAR_RESPONSE_TO_STARVATION,2.741823854,0,menadione
METABOLISM_OF_RNA,2.829805645,0,menadione
EUKARYOTIC_TRANSLATION_INITIATION,2.832281151,0,menadione
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.738426839,0,menadione
SELENOAMINO_ACID_METABOLISM,2.976122323,0,menadione
RRNA_PROCESSING,3.027580438,0,menadione
EUKARYOTIC_TRANSLATION_ELONGATION,3.057824237,0,menadione
INFLUENZA_INFECTION,3.215425998,0,menadione
METABOLISM_OF_RNA,-2.610103988,0.00437225,fexofenadine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.153853255,0.044815563,fexofenadine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.000899972,0.077243084,fexofenadine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.914780525,0.101654814,fexofenadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.873865138,0.104934001,fexofenadine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.833969326,0.109670605,fexofenadine
RHOA_GTPASE_CYCLE,-1.822310375,0.099312537,fexofenadine
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-1.785979109,0.109579517,fexofenadine
ECM_PROTEOGLYCANS,-1.765939109,0.110520765,fexofenadine
MRNA_SPLICING,-1.735146158,0.119581039,fexofenadine
CELL_CYCLE_MITOTIC,-3.155336147,0,vemurafenib
CELL_CYCLE,-3.150198454,0,vemurafenib
DNA_REPLICATION,-2.912107341,0,vemurafenib
METABOLISM_OF_RNA,-2.873987779,0,vemurafenib
S_PHASE,-2.828069636,0,vemurafenib
SYNTHESIS_OF_DNA,-2.826860505,0,vemurafenib
CELL_CYCLE_CHECKPOINTS,-2.744086283,0,vemurafenib
M_PHASE,-2.626648351,0,vemurafenib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.558328024,0,vemurafenib
CHROMOSOME_MAINTENANCE,-2.553732422,0,vemurafenib
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.852634113,1,BRD-K72166146
FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,-1.814059984,0.967128576,BRD-K72166146
FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,-1.812934893,0.650231866,BRD-K72166146
PHOSPHOLIPID_METABOLISM,-1.809014811,0.498632864,BRD-K72166146
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-1.79553222,0.428860793,BRD-K72166146
RNA_POLYMERASE_II_TRANSCRIPTION,1.816103578,0.579449806,BRD-K72166146
METABOLISM_OF_STEROIDS,-1.722310851,0.529378846,BRD-K72166146
MITF_M_DEPENDENT_GENE_EXPRESSION,1.768423928,0.399458504,BRD-K72166146
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.692904238,0.530466045,BRD-K72166146
APOPTOSIS,-1.687751055,0.478313118,BRD-K72166146
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.389766602,0.001709241,carbachol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.243131143,0.002991171,carbachol
ECM_PROTEOGLYCANS,-2.23012235,0.001994114,carbachol
MYD88_INDEPENDENT_TLR4_CASCADE,2.272142941,0.023718009,carbachol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.070334487,0.013246614,carbachol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.030907144,0.017263329,carbachol
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.922815842,0.114277679,carbachol
COLLAGEN_DEGRADATION,-2.027902575,0.014955854,carbachol
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.009607183,0.015016899,carbachol
GPCR_LIGAND_BINDING,-1.989128597,0.016558267,carbachol
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.325513109,0.290781744,tamibarotene
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.287675192,0.18582502,tamibarotene
STRIATED_MUSCLE_CONTRACTION,2.009482931,0.189552495,tamibarotene
SENSORY_PERCEPTION,-2.225121333,0.179516146,tamibarotene
ECM_PROTEOGLYCANS,-2.14550625,0.206902395,tamibarotene
SIGNALING_BY_WNT,-2.134148714,0.176533769,tamibarotene
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.129912171,0.150552678,tamibarotene
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-1.930791313,0.367717235,tamibarotene
DISEASES_OF_GLYCOSYLATION,-1.918593648,0.34218473,tamibarotene
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.909346836,0.317929021,tamibarotene
SELENOAMINO_ACID_METABOLISM,3.288588606,0,methimazole
CELLULAR_RESPONSE_TO_STARVATION,2.845239338,0,methimazole
EUKARYOTIC_TRANSLATION_INITIATION,2.6038145,0.00090938,methimazole
NONSENSE_MEDIATED_DECAY_NMD,2.569783604,0.000682035,methimazole
INFLUENZA_INFECTION,2.535683006,0.001091256,methimazole
GPCR_LIGAND_BINDING,-2.219969376,0.012969754,methimazole
TRANSLATION,2.275120086,0.004319556,methimazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.175712117,0.00926411,methimazole
SIGNALING_BY_GPCR,-2.174147251,0.007102484,methimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.145654964,0.007642891,methimazole
MUSCLE_CONTRACTION,3.480547996,0,nitrendipine
SELENOAMINO_ACID_METABOLISM,1.952194675,0.133919975,nitrendipine
EUKARYOTIC_TRANSLATION_INITIATION,1.945360458,0.089279984,nitrendipine
EUKARYOTIC_TRANSLATION_ELONGATION,1.91375986,0.083230639,nitrendipine
TRANSLATION,1.832327564,0.103631532,nitrendipine
CELLULAR_RESPONSE_TO_STARVATION,1.747234801,0.143932684,nitrendipine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.743244673,0.127304436,nitrendipine
DNA_REPLICATION,1.741211711,0.11264297,nitrendipine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.73967038,0.100961477,nitrendipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.694247719,0.122155043,nitrendipine
SIGNALING_BY_GPCR,2.927653288,0,piperine
GPCR_LIGAND_BINDING,2.669229114,0,piperine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.586309281,0,piperine
MUSCLE_CONTRACTION,2.376742344,0.000595488,piperine
G_ALPHA_Q_SIGNALLING_EVENTS,2.207151795,0.004922703,piperine
G_ALPHA_I_SIGNALLING_EVENTS,2.006703921,0.031494715,piperine
COLLAGEN_DEGRADATION,1.928600172,0.047185359,piperine
STRIATED_MUSCLE_CONTRACTION,1.882913973,0.06004507,piperine
SENSORY_PERCEPTION,1.859031529,0.064400957,piperine
DEVELOPMENTAL_CELL_LINEAGES,1.832385788,0.070585213,piperine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.574652781,1,clonidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.559918541,1,clonidine
INTERFERON_ALPHA_BETA_SIGNALING,1.515742513,0.86400818,clonidine
ONCOGENIC_MAPK_SIGNALING,-1.809089453,0.827527762,clonidine
RRNA_PROCESSING,1.458880092,0.845858896,clonidine
SARS_COV_2_HOST_INTERACTIONS,1.44811337,0.710429448,clonidine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.435380557,0.632924335,clonidine
TRANSLATION,1.41201025,0.60035057,clonidine
SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,-1.751850177,0.66362906,clonidine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.315673569,0.828220859,clonidine
GPCR_LIGAND_BINDING,2.654961553,0.000851265,oxaprozin
SIGNALING_BY_GPCR,2.623405173,0.000425633,oxaprozin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.376912504,0.002270041,oxaprozin
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.213309309,0.171553145,oxaprozin
NEUTROPHIL_DEGRANULATION,-2.198055811,0.097562667,oxaprozin
G_ALPHA_Q_SIGNALLING_EVENTS,2.012750091,0.051075925,oxaprozin
COPII_MEDIATED_VESICLE_TRANSPORT,-2.100574798,0.116551374,oxaprozin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.946595666,0.071506296,oxaprozin
INNATE_IMMUNE_SYSTEM,-1.966755043,0.189232286,oxaprozin
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.892531521,0.089808502,oxaprozin
GPCR_LIGAND_BINDING,2.821620959,0,procarbazine
SIGNALING_BY_GPCR,2.677885148,0,procarbazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.573298751,0,procarbazine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.520964197,0.001510464,procarbazine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.342190518,0.010573245,procarbazine
KERATINIZATION,-2.293082344,0.009818013,procarbazine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.293082344,0.009818013,procarbazine
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.177576761,0.023865325,procarbazine
G_ALPHA_Q_SIGNALLING_EVENTS,2.109414068,0.017161224,procarbazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.088592955,0.014883753,procarbazine
G2_M_CHECKPOINTS,2.74918296,0,methocarbamol
DNA_REPLICATION_PRE_INITIATION,2.553320074,0,methocarbamol
DNA_REPLICATION,2.488592087,0,methocarbamol
SYNTHESIS_OF_DNA,2.413454352,0.001538928,methocarbamol
ORC1_REMOVAL_FROM_CHROMATIN,2.393292793,0.001231142,methocarbamol
CELL_CYCLE,2.305475715,0.004787776,methocarbamol
REGULATION_OF_RAS_BY_GAPS,2.29573149,0.004103808,methocarbamol
HOMOLOGY_DIRECTED_REPAIR,2.289156256,0.003590832,methocarbamol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.266113682,0.005471744,methocarbamol
S_PHASE,2.23555532,0.005596102,methocarbamol
GPCR_LIGAND_BINDING,2.624112216,0.002058871,practolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.42889226,0.006176613,practolol
G_ALPHA_I_SIGNALLING_EVENTS,2.118235368,0.032598788,practolol
SIGNALING_BY_GPCR,2.087658507,0.031655139,practolol
GASTRULATION,2.062788971,0.029853627,practolol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.162625684,0.230154175,practolol
INNATE_IMMUNE_SYSTEM,-2.097387714,0.201014483,practolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.90260389,0.068972173,practolol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.056916704,0.175825936,practolol
MUSCLE_CONTRACTION,1.805276643,0.109120154,practolol
METABOLISM_OF_RNA,-3.34263437,0,salbutamol
MRNA_SPLICING,-2.681414151,0,salbutamol
GPCR_LIGAND_BINDING,2.591204752,0,salbutamol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.652440244,0.001229962,salbutamol
SIGNALING_BY_GPCR,2.507294212,0.000701624,salbutamol
POTASSIUM_CHANNELS,2.503078515,0.000467749,salbutamol
NEURONAL_SYSTEM,2.407561106,0.000350812,salbutamol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.374841562,0.000561299,salbutamol
G_ALPHA_Q_SIGNALLING_EVENTS,2.2440459,0.002455683,salbutamol
SENSORY_PERCEPTION,2.208591217,0.002706263,salbutamol
CELL_CYCLE_CHECKPOINTS,1.981208442,0.445305372,vecuronium
METABOLISM_OF_RNA,1.736389078,1,vecuronium
MITOTIC_SPINDLE_CHECKPOINT,1.723214828,0.968868803,vecuronium
SEPARATION_OF_SISTER_CHROMATIDS,1.706193764,0.820433679,vecuronium
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.910066029,1,vecuronium
G2_M_CHECKPOINTS,1.684582529,0.749491047,vecuronium
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.677116377,0.650945436,vecuronium
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.638952828,0.706327595,vecuronium
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.767799148,1,vecuronium
DNA_REPLICATION,1.625844389,0.666363124,vecuronium
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.841489732,0.670096067,glimepiride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.846554097,1,glimepiride
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.646179232,0.947268057,glimepiride
NEUTROPHIL_DEGRANULATION,-3.07868084,1,glimepiride
HEMOSTASIS,-2.710919239,0.833098518,glimepiride
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.155706848,0.753654605,glimepiride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.763077116,1,glimepiride
MITOCHONDRIAL_BIOGENESIS,1.760906965,0.834355905,glimepiride
INNATE_IMMUNE_SYSTEM,-1.963013726,0.687278017,glimepiride
DEGRADATION_OF_AXIN,1.756471256,0.644901951,glimepiride
METABOLISM_OF_RNA,-3.686129761,0,gefitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.269749637,0,gefitinib
MRNA_SPLICING,-2.854432592,0,gefitinib
S_PHASE,-2.519717296,0.002435519,gefitinib
G2_M_CHECKPOINTS,-2.368848675,0.002922622,gefitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.229841085,0.004059198,gefitinib
DNA_REPLICATION,-2.218412562,0.0055669,gefitinib
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.967964919,0.029226224,gefitinib
GPCR_LIGAND_BINDING,2.06396872,0.035300393,gefitinib
CELL_CYCLE_MITOTIC,-1.933012206,0.034097261,gefitinib
METABOLISM_OF_RNA,-5.836641005,0,mocetinostat
CHROMATIN_ORGANIZATION,-2.701215058,0,mocetinostat
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.703034529,0,mocetinostat
VIRAL_INFECTION_PATHWAYS,-2.715798046,0,mocetinostat
DNA_REPAIR,-2.803531747,0,mocetinostat
SEPARATION_OF_SISTER_CHROMATIDS,-2.902026828,0,mocetinostat
HIV_LIFE_CYCLE,-2.9303899,0,mocetinostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.934986235,0,mocetinostat
CELL_CYCLE_CHECKPOINTS,-2.967480696,0,mocetinostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.018350797,0,mocetinostat
MUSCLE_CONTRACTION,2.541022881,0.004309845,cetirizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.564125422,0.003880694,cetirizine
EUKARYOTIC_TRANSLATION_INITIATION,-2.478312313,0.004204085,cetirizine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.478312313,0.004204085,cetirizine
GPCR_LIGAND_BINDING,2.351353726,0.007542228,cetirizine
CELLULAR_RESPONSE_TO_STARVATION,-2.463973846,0.004123238,cetirizine
NONSENSE_MEDIATED_DECAY_NMD,-2.430447472,0.004268764,cetirizine
SELENOAMINO_ACID_METABOLISM,-2.408166416,0.00404239,cetirizine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.35790344,0.007068407,cetirizine
TRANSLATION,-2.305445542,0.010793181,cetirizine
GPCR_LIGAND_BINDING,2.597669554,0,BRD-K89997465
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.579759665,0,BRD-K89997465
SIGNALING_BY_GPCR,2.261361423,0.002496246,BRD-K89997465
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.16657847,0.007488738,BRD-K89997465
ADIPOGENESIS,2.121806557,0.00966728,BRD-K89997465
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-2.168277474,0.191712689,BRD-K89997465
NEURONAL_SYSTEM,2.084728943,0.012140833,BRD-K89997465
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2.043180079,0.015755527,BRD-K89997465
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.033474312,0.015062575,BRD-K89997465
MUSCLE_CONTRACTION,2.027455479,0.014145394,BRD-K89997465
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.120408449,0.031593886,triamcinolone
TCR_SIGNALING,-1.869931933,0.210625908,triamcinolone
PTEN_REGULATION,1.523075599,0.928119609,triamcinolone
PEROXISOMAL_PROTEIN_IMPORT,-1.790761808,0.283068455,triamcinolone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.386167974,0.900517539,triamcinolone
COPII_MEDIATED_VESICLE_TRANSPORT,-1.699459043,0.449255488,triamcinolone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.698169943,0.363233952,triamcinolone
INTERFERON_GAMMA_SIGNALING,1.237953082,1,triamcinolone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.17214867,1,triamcinolone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.653931928,0.429868331,triamcinolone
SIGNALING_BY_INTERLEUKINS,2.287579146,0.025570177,cyproheptadine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.008534265,0.158291575,cyproheptadine
INTERLEUKIN_1_FAMILY_SIGNALING,1.956558817,0.162350333,cyproheptadine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.912355436,0.170163443,cyproheptadine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.850039727,0.219416475,cyproheptadine
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.846254417,0.187717573,cyproheptadine
INTERLEUKIN_1_SIGNALING,1.839435691,0.170641797,cyproheptadine
C_TYPE_LECTIN_RECEPTORS_CLRS,1.798179855,0.198168876,cyproheptadine
RRNA_PROCESSING,1.777831927,0.200908537,cyproheptadine
METABOLISM_OF_RNA,1.741020092,0.231958039,cyproheptadine
MRNA_SPLICING,2.803085438,0,nalbuphine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.637947775,0,nalbuphine
GPCR_LIGAND_BINDING,-2.380121518,0,nalbuphine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.258492557,0.001062531,nalbuphine
SIGNALING_BY_GPCR,-2.166589147,0.002597297,nalbuphine
SENSORY_PERCEPTION,-2.095951987,0.005135564,nalbuphine
G2_M_CHECKPOINTS,2.096776426,0.039196311,nalbuphine
G_ALPHA_I_SIGNALLING_EVENTS,-2.026269931,0.010341964,nalbuphine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.969098612,0.059634387,nalbuphine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.913897078,0.071225296,nalbuphine
NEURONAL_SYSTEM,2.466220359,0.001075982,diclofenac
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.716945997,0.00467937,diclofenac
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.629946253,0.003899475,diclofenac
MUSCLE_CONTRACTION,2.460727766,0.001075982,diclofenac
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.548713654,0.00467937,diclofenac
GPCR_LIGAND_BINDING,2.402567356,0.001434642,diclofenac
INNATE_IMMUNE_SYSTEM,-2.488003999,0.00623916,diclofenac
NEUTROPHIL_DEGRANULATION,-2.38885044,0.010294614,diclofenac
CARDIAC_CONDUCTION,2.192439958,0.007397373,diclofenac
ADAPTIVE_IMMUNE_SYSTEM,-2.211378773,0.03171573,diclofenac
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-2.313808975,0.078650647,escitalopram
NEUTROPHIL_DEGRANULATION,-2.282771451,0.048890943,escitalopram
RRNA_PROCESSING,-2.212265554,0.048182378,escitalopram
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.143236894,0.052610906,escitalopram
RHOA_GTPASE_CYCLE,-2.06617674,0.068872458,escitalopram
DUAL_INCISION_IN_TC_NER,-2.031066283,0.075816389,escitalopram
NUCLEOTIDE_EXCISION_REPAIR,-2.029288029,0.065896488,escitalopram
APOPTOSIS,-1.875036334,0.133121534,escitalopram
METABOLISM_OF_RNA,-1.802931336,0.179975354,escitalopram
NEURONAL_SYSTEM,1.89388501,0.447328814,escitalopram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.130692064,0,DR-2313
MUSCLE_CONTRACTION,2.765848314,0,DR-2313
GPCR_LIGAND_BINDING,2.855883986,0,DR-2313
SIGNALING_BY_GPCR,2.807026579,0,DR-2313
EXTRACELLULAR_MATRIX_ORGANIZATION,2.797808525,0,DR-2313
COLLAGEN_DEGRADATION,2.564857537,0.000450732,DR-2313
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.511414833,0.000482927,DR-2313
KERATINIZATION,2.479236133,0.000676097,DR-2313
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.479236133,0.000676097,DR-2313
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.354071583,0.001555024,DR-2313
NEUTROPHIL_DEGRANULATION,1.960009612,0.214362528,reserpine
METABOLISM_OF_STEROIDS,1.748132262,0.310550842,reserpine
INNATE_IMMUNE_SYSTEM,1.679411244,0.293756057,reserpine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.562640797,0.409945434,reserpine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.798436416,0.781112686,reserpine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.519264415,0.423961445,reserpine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.518747919,0.354828003,reserpine
SIGNALING_BY_NOTCH,-1.759189163,0.555525264,reserpine
ECM_PROTEOGLYCANS,-1.753619791,0.3922883,reserpine
ADAPTIVE_IMMUNE_SYSTEM,1.452918381,0.426107688,reserpine
MRNA_SPLICING,2.284310688,0.010182435,olanzapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.195942962,0.00201265,olanzapine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.186912669,0.00201265,olanzapine
EUKARYOTIC_TRANSLATION_INITIATION,-2.145607199,0.003018975,olanzapine
SELENOAMINO_ACID_METABOLISM,-2.129514228,0.002767394,olanzapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.125933937,0.002213915,olanzapine
NONSENSE_MEDIATED_DECAY_NMD,-2.099073595,0.002515812,olanzapine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.093343068,0.002443932,olanzapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.080128355,0.002515812,olanzapine
GPCR_LIGAND_BINDING,-2.037865092,0.0040253,olanzapine
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.072601135,0.126206654,promazine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.817753476,0.299011532,promazine
MUSCLE_CONTRACTION,1.749473908,0.214744646,promazine
TCR_SIGNALING,-1.948745922,0.19737582,promazine
TRANSLATION,1.663849538,0.232866557,promazine
SELENOAMINO_ACID_METABOLISM,1.605651026,0.236490939,promazine
PEROXISOMAL_PROTEIN_IMPORT,-1.852136223,0.285625586,promazine
KEAP1_NFE2L2_PATHWAY,1.562989451,0.242742998,promazine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.508204234,0.268657331,promazine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.790135762,0.357269213,promazine
RESPIRATORY_ELECTRON_TRANSPORT,2.696887726,0,bosentan
TRANSLATION,2.179865863,0.042033164,bosentan
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.261497531,0.049230805,bosentan
COLLAGEN_DEGRADATION,-2.128506764,0.089865755,bosentan
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.125517766,0.060952425,bosentan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.111060828,0.051379769,bosentan
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.087211503,0.050012246,bosentan
ECM_PROTEOGLYCANS,-2.047015202,0.0579569,bosentan
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.027166024,0.057380122,bosentan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.021708012,0.052454251,bosentan
RESPIRATORY_ELECTRON_TRANSPORT,2.545438645,0.001354183,amisulpride
CELL_CYCLE_CHECKPOINTS,2.445423508,0.002708366,amisulpride
DNA_REPLICATION,2.413097289,0.003611155,amisulpride
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.350483669,0.004739641,amisulpride
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.308417537,0.004875059,amisulpride
SYNTHESIS_OF_DNA,2.301515394,0.004513944,amisulpride
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.297849489,0.003869095,amisulpride
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.280986958,0.004062549,amisulpride
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.273966879,0.003611155,amisulpride
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.251665457,0.004197968,amisulpride
MUSCLE_CONTRACTION,3.033731414,0,levocetirizine
STRIATED_MUSCLE_CONTRACTION,2.602511199,0,levocetirizine
GPCR_LIGAND_BINDING,2.465467856,0.000659867,levocetirizine
CARDIAC_CONDUCTION,2.369467516,0.001814633,levocetirizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.319917314,0.019201017,levocetirizine
SELENOAMINO_ACID_METABOLISM,-2.280656984,0.016640881,levocetirizine
CHROMATIN_ORGANIZATION,-2.274851385,0.01152061,levocetirizine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.213137971,0.014080746,levocetirizine
CELL_CYCLE,-2.174549735,0.016640881,levocetirizine
NEURONAL_SYSTEM,2.162542311,0.009766027,levocetirizine
RNA_POLYMERASE_II_TRANSCRIPTION,2.385741849,0.012712284,tretinoin
MITOCHONDRIAL_BIOGENESIS,2.181274954,0.03178071,tretinoin
CHROMOSOME_MAINTENANCE,2.119788574,0.033899424,tretinoin
TRANSLATION,2.050631806,0.043915163,tretinoin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.016080993,0.048537812,tretinoin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.035574036,0.185263458,tretinoin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.032824443,0.094379498,tretinoin
METABOLISM_OF_LIPIDS,-1.907070697,0.163707647,tretinoin
METABOLISM_OF_RNA,1.870803562,0.112291843,tretinoin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.841128453,0.115070936,tretinoin
METABOLISM_OF_RNA,-3.227714694,0,decitabine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.907025987,0,decitabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.892289996,0,decitabine
GPCR_LIGAND_BINDING,2.864324316,0,decitabine
CELL_CYCLE_MITOTIC,-2.754446925,0,decitabine
TRANSLATION,-2.753208119,0,decitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.725079968,0,decitabine
CELL_CYCLE,-2.690063142,0,decitabine
SYNTHESIS_OF_DNA,-2.679503222,0,decitabine
DNA_REPLICATION,-2.661488243,0,decitabine
METABOLISM_OF_RNA,-3.260788044,0,BMS-387032
CELL_CYCLE_MITOTIC,-2.631530447,0,BMS-387032
DNA_REPLICATION,-2.657150095,0,BMS-387032
MRNA_SPLICING,-2.665702768,0,BMS-387032
SEPARATION_OF_SISTER_CHROMATIDS,-2.753379989,0,BMS-387032
GPCR_LIGAND_BINDING,2.770028201,0,BMS-387032
M_PHASE,-2.777315017,0,BMS-387032
G2_M_CHECKPOINTS,-2.782923034,0,BMS-387032
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.832497233,0,BMS-387032
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.881588011,0,BMS-387032
COLLAGEN_DEGRADATION,-2.718855891,0,tiagabine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.683962948,0,tiagabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.551981073,0,tiagabine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.444286331,0,tiagabine
ECM_PROTEOGLYCANS,-2.427591276,0,tiagabine
COLLAGEN_FORMATION,-2.383376775,0,tiagabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.330521254,0,tiagabine
CELLULAR_RESPONSE_TO_STARVATION,2.502632755,0.002593143,tiagabine
TRANSLATION,2.38535789,0.004321904,tiagabine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.173424457,0.003489807,tiagabine
GPCR_LIGAND_BINDING,-2.615035719,0,tetracaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.471944342,0,tetracaine
REGULATION_OF_TP53_ACTIVITY,2.330632465,0.017485429,tetracaine
SIGNALING_BY_GPCR,-2.25071136,0.001661027,tetracaine
INNATE_IMMUNE_SYSTEM,2.286017776,0.017485429,tetracaine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.176985738,0.003270146,tetracaine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.219200551,0.024146545,tetracaine
M_PHASE,2.160400971,0.026852623,tetracaine
ECM_PROTEOGLYCANS,-2.105382912,0.005605965,tetracaine
ADAPTIVE_IMMUNE_SYSTEM,2.138708085,0.022980849,tetracaine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.241565423,0.006560254,tazarotene
ADAPTIVE_IMMUNE_SYSTEM,2.079540935,0.115118769,tazarotene
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.062544797,0.027471064,tazarotene
COLLAGEN_DEGRADATION,-2.053542184,0.019134074,tazarotene
INNATE_IMMUNE_SYSTEM,1.997482648,0.097717095,tazarotene
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.032020266,0.018655722,tazarotene
MITF_M_DEPENDENT_GENE_EXPRESSION,1.95294452,0.083884995,tazarotene
TCR_SIGNALING,1.895409211,0.075630354,tazarotene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.003348131,0.019024737,tazarotene
GPCR_LIGAND_BINDING,-1.996229828,0.016810651,tazarotene
HOMOLOGY_DIRECTED_REPAIR,-2.005601491,0.112589064,crizotinib
HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,-1.969647603,0.083057506,crizotinib
AUTOPHAGY,1.846316537,0.329889747,crizotinib
SIGNALING_BY_WNT,1.779374937,0.22844865,crizotinib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-1.896406237,0.12550912,crizotinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.69407581,0.241919148,crizotinib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.878869249,0.10982048,crizotinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.846798823,0.121817676,crizotinib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-1.802284828,0.153810196,crizotinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.534878208,0.411125098,crizotinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-4.034837403,0,sorafenib
SARS_COV_2_INFECTION,-2.824973302,0,sorafenib
SARS_COV_INFECTIONS,-2.824099616,0,sorafenib
S_PHASE,-2.820860799,0,sorafenib
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.730932976,0,sorafenib
DNA_REPLICATION_PRE_INITIATION,-2.720741971,0,sorafenib
DNA_REPLICATION,-2.667515327,0,sorafenib
CELL_CYCLE_MITOTIC,-2.64806101,0,sorafenib
SYNTHESIS_OF_DNA,-2.629318146,0,sorafenib
CELL_CYCLE,-2.618862966,0,sorafenib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.235851893,0.011950167,metformin
INFLUENZA_INFECTION,2.134150028,0.090213783,metformin
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.029138491,0.101752755,metformin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.956450115,0.119128226,metformin
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.804812086,0.274138007,metformin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.794674442,0.212946488,metformin
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.790973127,0.172874784,metformin
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.765099858,0.170986589,metformin
GPCR_LIGAND_BINDING,-1.891077459,0.150621894,metformin
PROTEIN_LOCALIZATION,1.729651405,0.178629285,metformin
INFLUENZA_INFECTION,2.045161597,0.168135802,quercetin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.035659698,0.088917972,quercetin
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1.708493451,0.441895377,quercetin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.87892596,0.322367379,quercetin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.860753762,0.197723212,quercetin
GPCR_LIGAND_BINDING,-1.855913086,0.13796231,quercetin
SYNTHESIS_OF_DNA,1.642482565,0.486623812,quercetin
UNFOLDED_PROTEIN_RESPONSE_UPR,1.632665921,0.413872743,quercetin
DNA_REPLICATION,1.585926542,0.442434274,quercetin
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.552470324,0.450363755,quercetin
CELLULAR_RESPONSE_TO_STARVATION,2.994139138,0,lidocaine
INFLUENZA_INFECTION,2.49341176,0.002460557,lidocaine
GPCR_LIGAND_BINDING,-2.155771177,0.019545802,lidocaine
ECM_PROTEOGLYCANS,-2.109778677,0.018213133,lidocaine
EUKARYOTIC_TRANSLATION_INITIATION,2.149819505,0.03280742,lidocaine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.080347724,0.019249653,lidocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.058059828,0.01932369,lidocaine
SIGNALING_BY_GPCR,-2.009110555,0.02594261,lidocaine
TRANSLATION,1.954891431,0.076687345,lidocaine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.91959153,0.076113215,lidocaine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.323619999,0.035617917,moxisylyte
GASTRULATION,-2.296993522,0.020237453,moxisylyte
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.238673903,0.024284943,moxisylyte
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.147114152,0.035617917,moxisylyte
RRNA_PROCESSING,-2.033087427,0.058607663,moxisylyte
SIGNALING_BY_MET,-2.006814965,0.0569347,moxisylyte
METABOLISM_OF_RNA,-1.941734835,0.076786678,moxisylyte
SIGNALING_BY_NOTCH4,-1.937426695,0.068807339,moxisylyte
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.941550367,0.321550453,moxisylyte
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.875698607,0.087605684,moxisylyte
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.086675488,0,lorcaserin
EUKARYOTIC_TRANSLATION_ELONGATION,4.073960201,0,lorcaserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.805127977,0,lorcaserin
CELLULAR_RESPONSE_TO_STARVATION,3.792265901,0,lorcaserin
SELENOAMINO_ACID_METABOLISM,3.768940029,0,lorcaserin
NONSENSE_MEDIATED_DECAY_NMD,3.544405843,0,lorcaserin
EUKARYOTIC_TRANSLATION_INITIATION,3.480634095,0,lorcaserin
INFLUENZA_INFECTION,3.270962748,0,lorcaserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.144709576,0,lorcaserin
TRANSLATION,3.103632486,0,lorcaserin
TRANSLATION,3.295237374,0,nimodipine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.32907706,0,nimodipine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.481138042,0.006702118,nimodipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.209470808,0.005288775,nimodipine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.162090459,0.005424385,nimodipine
S_PHASE,2.208676809,0.031276552,nimodipine
RRNA_PROCESSING,2.186421599,0.02546805,nimodipine
DNA_REPLICATION_PRE_INITIATION,2.172391685,0.021446779,nimodipine
G2_M_CHECKPOINTS,2.13866416,0.023680818,nimodipine
GPCR_LIGAND_BINDING,-2.058833587,0.017290227,nimodipine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.472702458,0,bezafibrate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.369621612,0,bezafibrate
GPCR_LIGAND_BINDING,-2.366719703,0,bezafibrate
RESPIRATORY_ELECTRON_TRANSPORT,2.328726904,0.028796562,bezafibrate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.181315866,0.03743553,bezafibrate
SARS_COV_2_HOST_INTERACTIONS,2.167471025,0.027516714,bezafibrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.102033009,0.007578071,bezafibrate
SIGNALING_BY_GPCR,-2.071822983,0.008083276,bezafibrate
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.035980343,0.036475645,bezafibrate
G_ALPHA_S_SIGNALLING_EVENTS,-2.042400075,0.009585936,bezafibrate
GLYCOSAMINOGLYCAN_METABOLISM,-2.603571664,0.00150932,primidone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.35647263,0.00981058,primidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.205197628,0.051876385,primidone
GPCR_LIGAND_BINDING,2.176422336,0.033674144,primidone
DISEASES_OF_GLYCOSYLATION,-1.987799927,0.088546776,primidone
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.981620267,0.069806052,primidone
SIGNALING_BY_GPCR,1.977258284,0.138337026,primidone
SENSORY_PROCESSING_OF_SOUND,-1.79954937,0.150932005,primidone
ESR_MEDIATED_SIGNALING,-1.76440913,0.149674238,primidone
DISEASES_OF_METABOLISM,-1.670369635,0.214970299,primidone
GPCR_LIGAND_BINDING,3.737937982,0,DNQX
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.666076384,0,DNQX
SIGNALING_BY_GPCR,3.649205484,0,DNQX
MUSCLE_CONTRACTION,3.125758075,0,DNQX
EXTRACELLULAR_MATRIX_ORGANIZATION,2.556772276,0.000223386,DNQX
POTASSIUM_CHANNELS,2.571486899,0.000255298,DNQX
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.69791608,0.000148924,DNQX
G_ALPHA_I_SIGNALLING_EVENTS,2.700567643,0.000178709,DNQX
CARDIAC_CONDUCTION,2.49436959,0.000297848,DNQX
G_ALPHA_S_SIGNALLING_EVENTS,2.388929971,0.000893543,DNQX
GPCR_LIGAND_BINDING,2.888372171,0,BRD-K82216340
SIGNALING_BY_GPCR,2.621574033,0,BRD-K82216340
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.594487018,0,BRD-K82216340
SENSORY_PERCEPTION,2.318871788,0.002081103,BRD-K82216340
G_ALPHA_Q_SIGNALLING_EVENTS,2.032383277,0.028302996,BRD-K82216340
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.815115076,0.135618525,BRD-K82216340
G_ALPHA_S_SIGNALLING_EVENTS,1.791196025,0.136758176,BRD-K82216340
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.093478948,1,BRD-K82216340
PEROXISOMAL_PROTEIN_IMPORT,-1.946896271,1,BRD-K82216340
TCR_SIGNALING,-1.912929682,1,BRD-K82216340
MUSCLE_CONTRACTION,2.57334058,0.00058033,midodrine
CARDIAC_CONDUCTION,2.389060653,0.004642639,midodrine
GPCR_LIGAND_BINDING,2.23518872,0.013347587,midodrine
NEURONAL_SYSTEM,2.184142733,0.01291234,midodrine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.116232828,0.017642028,midodrine
POTASSIUM_CHANNELS,1.97751663,0.037818163,midodrine
DEVELOPMENTAL_CELL_LINEAGES,1.967059543,0.034902697,midodrine
DNA_REPAIR,-1.932848506,0.617041296,midodrine
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.922219127,0.040623091,midodrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.907972275,0.377156299,midodrine
GPCR_LIGAND_BINDING,2.720791956,0,BRD-K19136521
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.344349929,0.001748172,BRD-K19136521
SIGNALING_BY_GPCR,2.171049671,0.01515082,BRD-K19136521
MAPK1_MAPK3_SIGNALING,2.075036276,0.030593002,BRD-K19136521
G_ALPHA_Q_SIGNALLING_EVENTS,2.053373705,0.032166356,BRD-K19136521
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,2.026752852,0.033992224,BRD-K19136521
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,-2.115982219,0.247771551,BRD-K19136521
GASTRULATION,1.972629424,0.050280743,BRD-K19136521
CELL_CELL_COMMUNICATION,1.90933668,0.076482505,BRD-K19136521
REGULATION_OF_INSULIN_SECRETION,1.906362581,0.06927939,BRD-K19136521
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.896371645,0,genistein
RRNA_PROCESSING,-2.432877811,0,genistein
NERVOUS_SYSTEM_DEVELOPMENT,-2.446439828,0,genistein
INFLUENZA_INFECTION,-2.537710674,0,genistein
SARS_COV_1_INFECTION,-2.666457954,0,genistein
SIGNALING_BY_ROBO_RECEPTORS,-2.687693913,0,genistein
CELLULAR_RESPONSE_TO_STARVATION,-2.751528934,0,genistein
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.752108437,0,genistein
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.778513581,0,genistein
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.637327369,0,genistein
STRIATED_MUSCLE_CONTRACTION,3.230400173,0,chlortalidone
SELENOAMINO_ACID_METABOLISM,-2.558780189,0,chlortalidone
NONSENSE_MEDIATED_DECAY_NMD,-2.620380192,0,chlortalidone
CELLULAR_RESPONSE_TO_STARVATION,-2.722500979,0,chlortalidone
TRANSLATION,-2.782125059,0,chlortalidone
INFLUENZA_INFECTION,-2.539810226,0,chlortalidone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.886081341,0,chlortalidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.887268581,0,chlortalidone
EUKARYOTIC_TRANSLATION_INITIATION,-2.930175271,0,chlortalidone
MUSCLE_CONTRACTION,3.183341283,0,chlortalidone
RESPIRATORY_ELECTRON_TRANSPORT,3.152873199,0,quinethazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.832625186,0.002324959,quinethazone
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.802968919,0.001549973,quinethazone
DNA_REPLICATION,2.721635938,0.00116248,quinethazone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.663624515,0.000929984,quinethazone
ORC1_REMOVAL_FROM_CHROMATIN,2.637515543,0.00116248,quinethazone
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.633579039,0.001328548,quinethazone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.614548618,0.00116248,quinethazone
SYNTHESIS_OF_DNA,2.532883631,0.002536319,quinethazone
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.533878886,0.002789951,quinethazone
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.019877577,0,rosuvastatin
EUKARYOTIC_TRANSLATION_ELONGATION,2.612456628,0,rosuvastatin
SELENOAMINO_ACID_METABOLISM,2.600730591,0,rosuvastatin
EUKARYOTIC_TRANSLATION_INITIATION,2.545077901,0,rosuvastatin
CILIUM_ASSEMBLY,2.542044078,0,rosuvastatin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.715036621,0.000301873,rosuvastatin
GPCR_LIGAND_BINDING,-2.707852921,0.000201248,rosuvastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.526727822,0.000251671,rosuvastatin
INFLUENZA_INFECTION,2.518981051,0.000209726,rosuvastatin
ECM_PROTEOGLYCANS,-2.52662767,0.000301873,rosuvastatin
GPCR_LIGAND_BINDING,2.832437286,0,pravastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.496980289,0.002836953,pravastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.407855957,0.011740002,pravastatin
NEUTROPHIL_DEGRANULATION,-2.380318973,0.006457001,pravastatin
INNATE_IMMUNE_SYSTEM,-2.370103392,0.005087334,pravastatin
INFLUENZA_INFECTION,-2.322574554,0.007044001,pravastatin
SIGNALING_BY_GPCR,2.250917651,0.009186324,pravastatin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.250991358,0.010800802,pravastatin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.249278176,0.009196335,pravastatin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.234010942,0.008721144,pravastatin
GPCR_LIGAND_BINDING,3.168147907,0,carvedilol
METABOLISM_OF_RNA,-3.068509818,0,carvedilol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.028992141,0,carvedilol
NEUTROPHIL_DEGRANULATION,-2.700471654,0,carvedilol
SIGNALING_BY_GPCR,2.734168274,0.000175899,carvedilol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.569445464,0.001104432,carvedilol
CELLULAR_RESPONSE_TO_STARVATION,-2.554977443,0.000828324,carvedilol
MUSCLE_CONTRACTION,2.553688158,0.000395772,carvedilol
TRNA_PROCESSING,-2.461604556,0.001104432,carvedilol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.497640331,0.000527696,carvedilol
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.387350031,0.024463027,levonorgestrel
METABOLISM_OF_RNA,-2.350716824,0.016599911,levonorgestrel
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.296457009,0.015726232,levonorgestrel
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.259509168,0.016163072,levonorgestrel
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-2.192883412,0.022366197,levonorgestrel
UCH_PROTEINASES,-2.120677806,0.03261737,levonorgestrel
NUCLEOTIDE_EXCISION_REPAIR,-2.09543557,0.033449446,levonorgestrel
METABOLISM_OF_STEROIDS,-2.012229587,0.050891834,levonorgestrel
CELL_CYCLE_MITOTIC,-1.99997256,0.0479553,levonorgestrel
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.999548741,0.043334506,levonorgestrel
TRANSLATION,-3.426208633,0,imatinib
EUKARYOTIC_TRANSLATION_INITIATION,-3.180551085,0,imatinib
EUKARYOTIC_TRANSLATION_ELONGATION,-3.037618393,0,imatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.99322953,0,imatinib
METABOLISM_OF_RNA,-2.827345055,0.000603188,imatinib
SELENOAMINO_ACID_METABOLISM,-2.763222863,0.000502657,imatinib
NEURONAL_SYSTEM,2.290285633,0.000717586,imatinib
RRNA_PROCESSING,-2.699933323,0.000861698,imatinib
INFLUENZA_INFECTION,-2.501692811,0.001507971,imatinib
NONSENSE_MEDIATED_DECAY_NMD,-2.359402815,0.001340418,imatinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.411183933,0.007916528,phenolphthalein
CELL_CYCLE_CHECKPOINTS,2.016939755,0.14645577,phenolphthalein
SYNTHESIS_OF_DNA,1.90692765,0.2063575,phenolphthalein
DNA_REPLICATION,1.878919849,0.183267626,phenolphthalein
S_PHASE,1.76326165,0.296711474,phenolphthalein
SEPARATION_OF_SISTER_CHROMATIDS,1.761655997,0.250162289,phenolphthalein
REGULATION_OF_INSULIN_SECRETION,1.744326223,0.234781606,phenolphthalein
MITOTIC_METAPHASE_AND_ANAPHASE,1.742586268,0.207808863,phenolphthalein
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.722408458,0.208116728,phenolphthalein
CELL_CYCLE_MITOTIC,1.66984841,0.25047895,phenolphthalein
GPCR_LIGAND_BINDING,2.645838812,0.001063785,propafenone
SIGNALING_BY_GPCR,2.317665682,0.011169747,propafenone
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.165232895,0.02694923,propafenone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.361471229,0.100112609,propafenone
GASTRULATION,2.119746503,0.028988152,propafenone
PEROXISOMAL_PROTEIN_IMPORT,-2.243505224,0.123251844,propafenone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.238908868,0.086890189,propafenone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.001652717,0.052976513,propafenone
MUSCLE_CONTRACTION,1.992569469,0.047338451,propafenone
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.935972193,0.063371216,propafenone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.53113103,0.008684837,brimonidine
MUSCLE_CONTRACTION,2.142932875,0.099792432,brimonidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.301483791,0.041687217,brimonidine
NEURONAL_SYSTEM,2.072583245,0.095357213,brimonidine
CARDIAC_CONDUCTION,1.991951123,0.114946097,brimonidine
SIGNALING_BY_GPCR,1.987073556,0.089535987,brimonidine
G_ALPHA_Q_SIGNALLING_EVENTS,1.884887164,0.153902106,brimonidine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.861005042,0.148949444,brimonidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.813328608,0.182160788,brimonidine
DEVELOPMENTAL_CELL_LINEAGES,1.773862729,0.206653494,brimonidine
GPCR_LIGAND_BINDING,2.988869328,0,idarubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.920419342,0,idarubicin
SIGNALING_BY_GPCR,2.467742749,0.000745861,idarubicin
SENSORY_PERCEPTION,2.317772978,0.003356376,idarubicin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.252856358,0.004176824,idarubicin
G_ALPHA_S_SIGNALLING_EVENTS,2.242636913,0.003729307,idarubicin
G_ALPHA_I_SIGNALLING_EVENTS,2.232656926,0.003516204,idarubicin
NEURONAL_SYSTEM,2.212468264,0.003729307,idarubicin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.150625166,0.005370202,idarubicin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.151268635,0.005966891,idarubicin
STRIATED_MUSCLE_CONTRACTION,2.794707476,0,ondansetron
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.459035533,0.002354096,ondansetron
MUSCLE_CONTRACTION,2.440952294,0.001569397,ondansetron
GPCR_LIGAND_BINDING,2.301793329,0.003362994,ondansetron
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.232201163,0.061724315,ondansetron
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.162319214,0.010088983,ondansetron
CHROMATIN_ORGANIZATION,-2.113662366,0.10374938,ondansetron
DEVELOPMENTAL_CELL_LINEAGES,2.05816423,0.021186864,ondansetron
TNF_SIGNALING,-1.966084028,0.199619061,ondansetron
BIOLOGICAL_OXIDATIONS,1.934077571,0.044487611,ondansetron
PROGRAMMED_CELL_DEATH,-1.905610075,0.44742096,quinapril
NEURONAL_SYSTEM,1.959540806,0.264048739,quinapril
APOPTOSIS,-1.84116685,0.347671266,quinapril
METABOLISM_OF_NUCLEOTIDES,-1.802482748,0.282139913,quinapril
SYNTHESIS_OF_DNA,-1.747599801,0.288596204,quinapril
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.885882671,0.262852143,quinapril
G2_M_CHECKPOINTS,-1.683770896,0.320361155,quinapril
RHOA_GTPASE_CYCLE,-1.668534974,0.286013687,quinapril
METABOLISM_OF_RNA,-1.63921947,0.282508844,quinapril
DNA_REPLICATION,-1.621471989,0.270679996,quinapril
GPCR_LIGAND_BINDING,2.904972105,0,desipramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.702917955,0,desipramine
SIGNALING_BY_GPCR,2.531295011,0.000533891,desipramine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.998064572,0.063666456,desipramine
G_ALPHA_Q_SIGNALLING_EVENTS,1.917429843,0.090334292,desipramine
TCR_SIGNALING,-2.15879174,1,desipramine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.929762091,1,desipramine
G_ALPHA_I_SIGNALLING_EVENTS,1.714003372,0.312993372,desipramine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.900682177,1,desipramine
NEUTROPHIL_DEGRANULATION,-1.854176648,1,desipramine
GPCR_LIGAND_BINDING,2.218668825,0.01980379,MDL-29951
REGULATION_OF_INSULIN_SECRETION,2.147438936,0.019011639,MDL-29951
SIGNALING_BY_GPCR,2.077620096,0.030629862,MDL-29951
G_ALPHA_I_SIGNALLING_EVENTS,1.93907783,0.075650478,MDL-29951
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.927418407,0.067016026,MDL-29951
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.90471067,0.067596937,MDL-29951
G_ALPHA_S_SIGNALLING_EVENTS,1.893767434,0.063824787,MDL-29951
NEURONAL_SYSTEM,1.887680753,0.058421181,MDL-29951
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.823682313,0.087752795,MDL-29951
INTEGRATION_OF_ENERGY_METABOLISM,1.822347831,0.079769667,MDL-29951
EUKARYOTIC_TRANSLATION_ELONGATION,-3.127299405,0,clomipramine
NERVOUS_SYSTEM_DEVELOPMENT,-2.40125391,0,clomipramine
SARS_COV_2_HOST_INTERACTIONS,-2.438345647,0,clomipramine
SARS_COV_1_INFECTION,-2.514653307,0,clomipramine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.53215532,0,clomipramine
TRANSLATION,-2.628412499,0,clomipramine
SIGNALING_BY_ROBO_RECEPTORS,-2.664571594,0,clomipramine
SARS_COV_1_HOST_INTERACTIONS,-2.66518514,0,clomipramine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.693605979,0,clomipramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.770532683,0,clomipramine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.284407914,0.009742693,staurosporine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.141218704,0.030556628,staurosporine
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.835499299,0.434108527,staurosporine
HCMV_EARLY_EVENTS,1.717981194,0.378833839,staurosporine
DEADENYLATION_DEPENDENT_MRNA_DECAY,1.689742157,0.301988541,staurosporine
SARS_COV_1_HOST_INTERACTIONS,-1.97887717,0.114550451,staurosporine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.94135187,0.122226512,staurosporine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.909375632,0.129134967,staurosporine
MITOCHONDRIAL_TRANSLATION,1.502269102,0.552746882,staurosporine
NONSENSE_MEDIATED_DECAY_NMD,-1.876267932,0.140973815,staurosporine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.356431944,0.008405648,milrinone
ADAPTIVE_IMMUNE_SYSTEM,1.959278979,0.215394718,milrinone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.893823743,0.217145895,milrinone
DRUG_ADME,-1.855190311,0.838588388,milrinone
REGULATION_OF_TP53_ACTIVITY,1.832940309,0.248754632,milrinone
CELL_CYCLE_CHECKPOINTS,1.600859446,0.802108917,milrinone
TRANSPORT_OF_SMALL_MOLECULES,-1.595473333,1,milrinone
PHOSPHOLIPID_METABOLISM,-1.541542509,1,milrinone
GPCR_LIGAND_BINDING,-1.531362654,1,milrinone
G2_M_CHECKPOINTS,1.502535507,1,milrinone
CELL_CYCLE_CHECKPOINTS,3.04820172,0,omeprazole
G2_M_CHECKPOINTS,2.78067772,0,omeprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.611292067,0.000727396,omeprazole
RESPIRATORY_ELECTRON_TRANSPORT,2.534311347,0.001091094,omeprazole
METABOLISM_OF_RNA,2.511754968,0.001309313,omeprazole
TRANSLATION,2.467564122,0.001454792,omeprazole
ECM_PROTEOGLYCANS,-2.287754841,0.00492847,omeprazole
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.409466266,0.00249393,omeprazole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.225843014,0.004576437,omeprazole
INFLUENZA_INFECTION,2.239907713,0.006546565,omeprazole
GPCR_LIGAND_BINDING,2.654231692,0,riboflavin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.521679425,0.00083208,riboflavin
SIGNALING_BY_GPCR,2.45938709,0.001109441,riboflavin
MUSCLE_CONTRACTION,2.287413834,0.004784463,riboflavin
CARDIAC_CONDUCTION,2.259618354,0.004493235,riboflavin
G_ALPHA_Q_SIGNALLING_EVENTS,2.052406992,0.025378455,riboflavin
STRIATED_MUSCLE_CONTRACTION,2.006737855,0.030311503,riboflavin
SENSORY_PERCEPTION,1.990402047,0.029746877,riboflavin
GLYCOSAMINOGLYCAN_METABOLISM,-2.272186267,0.391190598,riboflavin
NEUTROPHIL_DEGRANULATION,-2.265787685,0.206184853,riboflavin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.200181648,0.089685828,vinblastine
L1CAM_INTERACTIONS,2.133993382,0.069366383,vinblastine
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.88265541,0.230287049,vinblastine
CHROMATIN_ORGANIZATION,-1.9237975,0.945540329,vinblastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.718138241,0.436167408,vinblastine
DNA_REPAIR,-1.867273595,0.708511146,vinblastine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.851992445,0.528735388,vinblastine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.621517292,0.587161908,vinblastine
CELL_JUNCTION_ORGANIZATION,1.583023671,0.608649137,vinblastine
TCR_SIGNALING,1.580678934,0.5279052,vinblastine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.666931036,0,estriol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.37652216,0,estriol
CELLULAR_RESPONSE_TO_STARVATION,-2.378316316,0,estriol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.438586057,0,estriol
NONSENSE_MEDIATED_DECAY_NMD,-2.439380114,0,estriol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.469856574,0,estriol
EUKARYOTIC_TRANSLATION_INITIATION,-2.484600561,0,estriol
SIGNALING_BY_ROBO_RECEPTORS,-2.448648196,0,estriol
SELENOAMINO_ACID_METABOLISM,-2.502643265,0,estriol
SARS_COV_1_INFECTION,-2.535668981,0,estriol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.733676049,0,sumatriptan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.730082231,0,sumatriptan
NEDDYLATION,1.944111186,0.510275505,sumatriptan
CELL_CYCLE_CHECKPOINTS,1.789576947,0.775517722,sumatriptan
ADAPTIVE_IMMUNE_SYSTEM,1.780934331,0.548588269,sumatriptan
NEURONAL_SYSTEM,-1.816610447,0.350030003,sumatriptan
DEUBIQUITINATION,1.761618294,0.467647291,sumatriptan
FCERI_MEDIATED_NF_KB_ACTIVATION,1.754688833,0.390032366,sumatriptan
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.718125252,0.414283083,sumatriptan
INTERFERON_ALPHA_BETA_SIGNALING,1.703725739,0.387758861,sumatriptan
GPCR_LIGAND_BINDING,-2.835618602,0,dazoxiben
CELLULAR_RESPONSE_TO_STARVATION,2.621640604,0,dazoxiben
SELENOAMINO_ACID_METABOLISM,2.588400645,0,dazoxiben
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.544804245,0,dazoxiben
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.494568838,0.000293117,dazoxiben
EUKARYOTIC_TRANSLATION_ELONGATION,2.479848292,0.000234493,dazoxiben
NONSENSE_MEDIATED_DECAY_NMD,2.386367899,0.000586234,dazoxiben
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.416768541,0.002104173,dazoxiben
INFLUENZA_INFECTION,2.339844683,0.002009944,dazoxiben
EUKARYOTIC_TRANSLATION_INITIATION,2.335525143,0.001758701,dazoxiben
NUCLEOTIDE_EXCISION_REPAIR,-2.263048315,0.033947104,diazoxide
UCH_PROTEINASES,-2.016915636,0.199112822,diazoxide
METABOLISM_OF_STEROIDS,-2.007564336,0.140140609,diazoxide
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.988270073,0.126648812,diazoxide
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.974087418,0.114114496,diazoxide
SIGNALING_BY_NOTCH,-1.891358244,0.171476398,diazoxide
GLUCOSE_METABOLISM,-1.866312953,0.172906404,diazoxide
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.855466282,0.162227988,diazoxide
PROTEIN_FOLDING,-1.853378903,0.146959045,diazoxide
DEATH_RECEPTOR_SIGNALING,1.823240623,0.776330395,diazoxide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.396951424,0.00458573,BRD-K55591206
GPCR_LIGAND_BINDING,2.288346736,0.008598243,BRD-K55591206
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.254337309,0.008025027,BRD-K55591206
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.109958631,0.164053196,BRD-K55591206
EUKARYOTIC_TRANSLATION_ELONGATION,-1.963106019,0.210462981,BRD-K55591206
SIGNALING_BY_GPCR,1.828824379,0.285461682,BRD-K55591206
AUTOPHAGY,1.810375338,0.262533033,BRD-K55591206
SELENOAMINO_ACID_METABOLISM,-1.785195728,0.41516971,BRD-K55591206
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.744556375,0.360361936,BRD-K55591206
UNFOLDED_PROTEIN_RESPONSE_UPR,1.68646324,0.462176056,BRD-K55591206
RESPIRATORY_ELECTRON_TRANSPORT,2.776955612,0,rizatriptan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.497402613,0.000723019,rizatriptan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.335787706,0.00036151,rizatriptan
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.237103548,0.003615096,rizatriptan
COLLAGEN_DEGRADATION,-2.228119543,0.003072831,rizatriptan
PROTEIN_LOCALIZATION,2.337157134,0.015500825,rizatriptan
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.199622612,0.003759699,rizatriptan
ECM_PROTEOGLYCANS,-2.186548039,0.003615096,rizatriptan
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.184331129,0.003201942,rizatriptan
MITOCHONDRIAL_BIOGENESIS,2.224111831,0.023707145,rizatriptan
GPCR_LIGAND_BINDING,-2.764519537,0,tolfenamic-acid
SIGNALING_BY_GPCR,-2.483400912,0,tolfenamic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.442522196,0,tolfenamic-acid
G_ALPHA_S_SIGNALLING_EVENTS,-2.240159799,0.001207538,tolfenamic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.239546029,0.00096603,tolfenamic-acid
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.297913157,0.056938451,tolfenamic-acid
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.124353641,0.003622614,tolfenamic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.080136688,0.005347668,tolfenamic-acid
NEURONAL_SYSTEM,-2.064033652,0.005811276,tolfenamic-acid
INFLUENZA_INFECTION,2.091666187,0.110163525,tolfenamic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.323180301,0.000781326,clenbuterol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.156925307,0.008203926,clenbuterol
COLLAGEN_DEGRADATION,-2.082112917,0.016928737,clenbuterol
MYD88_INDEPENDENT_TLR4_CASCADE,1.895241007,0.4170196,clenbuterol
HIV_LIFE_CYCLE,1.815555657,0.341524673,clenbuterol
FATTY_ACID_METABOLISM,1.793474701,0.262035304,clenbuterol
MITF_M_DEPENDENT_GENE_EXPRESSION,1.749808925,0.243261433,clenbuterol
TCR_SIGNALING,1.732248033,0.215699793,clenbuterol
SENSORY_PERCEPTION,-1.877843443,0.108018361,clenbuterol
MITOCHONDRIAL_TRANSLATION,1.687272503,0.230079779,clenbuterol
CILIUM_ASSEMBLY,2.114674055,0.073555368,amuvatinib
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.898958703,0.273565511,amuvatinib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.837553671,0.306648633,amuvatinib
GPCR_LIGAND_BINDING,-1.848411924,1,amuvatinib
MEMBRANE_TRAFFICKING,1.776289581,0.371303466,amuvatinib
SENSORY_PERCEPTION,-1.782569929,1,amuvatinib
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.732720559,0.405662891,amuvatinib
UB_SPECIFIC_PROCESSING_PROTEASES,1.70509338,0.412111581,amuvatinib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.700242045,0.366913175,amuvatinib
VESICLE_MEDIATED_TRANSPORT,1.667030072,0.404806424,amuvatinib
ADIPOGENESIS,-2.197210467,0.098807686,topotecan
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-2.197098594,0.049403843,topotecan
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-2.130116441,0.04999907,topotecan
INTERFERON_ALPHA_BETA_SIGNALING,2.091458065,0.126269484,topotecan
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.086674127,0.064764025,topotecan
RHOA_GTPASE_CYCLE,-2.030072957,0.078272354,topotecan
CHROMATIN_ORGANIZATION,-2.006544283,0.073808151,topotecan
RRNA_PROCESSING,-2.001097844,0.064284519,topotecan
MITF_M_DEPENDENT_GENE_EXPRESSION,1.956677529,0.11866616,topotecan
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.93164025,0.106107098,topotecan
MITF_M_DEPENDENT_GENE_EXPRESSION,2.366674177,0.009743896,CTS-1027
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.849425346,0.130459942,CTS-1027
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.704361303,0.177916324,CTS-1027
GPCR_LIGAND_BINDING,-1.86107051,0.791064203,CTS-1027
SIGNALING_BY_GPCR,-1.805284546,0.628401627,CTS-1027
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.495433793,0.387861196,CTS-1027
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.778878693,0.524739255,CTS-1027
REGULATION_OF_INSULIN_SECRETION,-1.75614617,0.468952748,CTS-1027
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.707457628,0.545636534,CTS-1027
PI3K_AKT_SIGNALING_IN_CANCER,-1.693627889,0.505457065,CTS-1027
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.643657887,0,dacomitinib
COLLAGEN_DEGRADATION,-2.623919819,0,dacomitinib
ECM_PROTEOGLYCANS,-2.521489571,0.000332802,dacomitinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.452209651,0.000249602,dacomitinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.373814874,0.000998406,dacomitinib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.364743959,0.000998406,dacomitinib
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.307893357,0.001854183,dacomitinib
SIGNALING_BY_MET,-2.238946424,0.003494422,dacomitinib
DEVELOPMENTAL_CELL_LINEAGES,-2.217912529,0.003771757,dacomitinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.171059999,0.006889003,dacomitinib
CELL_CYCLE,-2.958873557,0,linsitinib
DNA_REPAIR,-2.503805757,0,linsitinib
METABOLISM_OF_RNA,-2.608432062,0,linsitinib
CELL_CYCLE_CHECKPOINTS,-2.675746009,0,linsitinib
SYNTHESIS_OF_DNA,-2.740828075,0,linsitinib
DNA_REPLICATION_PRE_INITIATION,-2.513728637,0,linsitinib
INTERFERON_ALPHA_BETA_SIGNALING,2.798904539,0,linsitinib
DNA_REPLICATION,-2.832829487,0,linsitinib
CELL_CYCLE_MITOTIC,-2.927645711,0,linsitinib
S_PHASE,-2.766814878,0,linsitinib
GPCR_LIGAND_BINDING,-2.712532904,0,lorazepam
SIGNALING_BY_GPCR,-2.591580516,0,lorazepam
SENSORY_PERCEPTION,-2.442623331,0.000371007,lorazepam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.304784965,0.00166953,lorazepam
G_ALPHA_I_SIGNALLING_EVENTS,-2.047306691,0.034058409,lorazepam
CILIUM_ASSEMBLY,2.024500922,0.141573708,lorazepam
GASTRULATION,-2.012270684,0.03969771,lorazepam
NEURONAL_SYSTEM,-2.001930556,0.03688866,lorazepam
G_ALPHA_Q_SIGNALLING_EVENTS,-1.970562812,0.041042609,lorazepam
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.922445667,0.054166969,lorazepam
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.625291686,0.003398657,epothilone
MUSCLE_CONTRACTION,-3.152048113,0.290648269,epothilone
CELL_CYCLE_CHECKPOINTS,1.836039156,0.258297931,epothilone
S_PHASE,1.793227918,0.223744918,epothilone
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.784157255,0.178004659,epothilone
TRANSLATION,1.696471326,0.248441825,epothilone
CELL_CYCLE_MITOTIC,1.688028317,0.217230825,epothilone
CELL_CYCLE,1.620894387,0.265823528,epothilone
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.531814276,0.371303275,epothilone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.518533665,0.352705069,epothilone
MUSCLE_CONTRACTION,2.285252481,0.026726058,probenecid
GPCR_LIGAND_BINDING,2.227646926,0.025241277,probenecid
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.19498691,0.025241277,probenecid
SIGNALING_BY_HEDGEHOG,2.176412206,0.022271715,probenecid
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.113602779,0.062196258,probenecid
CARDIAC_CONDUCTION,2.071419464,0.037713437,probenecid
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.068425433,0.047792914,probenecid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.056170151,0.035634744,probenecid
RESPIRATORY_ELECTRON_TRANSPORT,2.035966635,0.038816417,probenecid
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.006825966,0.041573868,probenecid
SENSORY_PERCEPTION,2.204164761,0.020846238,flurbiprofen
GPCR_LIGAND_BINDING,2.164653625,0.016892641,flurbiprofen
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.058337933,0.037858685,flurbiprofen
HIV_LIFE_CYCLE,-2.018782129,0.466874166,flurbiprofen
SIGNALING_BY_GPCR,2.014524247,0.041872185,flurbiprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.951795145,0.055925425,flurbiprofen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.945844895,0.049120446,flurbiprofen
NCAM1_INTERACTIONS,1.934284587,0.046827017,flurbiprofen
TCR_SIGNALING,-1.855815326,0.53160882,flurbiprofen
INNATE_IMMUNE_SYSTEM,-1.851469875,0.360944734,flurbiprofen
KERATINIZATION,-2.480431279,0.000505886,cyclophosphamide
PROGRAMMED_CELL_DEATH,2.253474084,0.0327068,cyclophosphamide
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.257909212,0.010623612,cyclophosphamide
APOPTOSIS,2.112024365,0.069307266,cyclophosphamide
GASTRULATION,2.079157729,0.060741199,cyclophosphamide
DEUBIQUITINATION,2.017084836,0.075537133,cyclophosphamide
RAC1_GTPASE_CYCLE,-2.016888833,0.04502388,cyclophosphamide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.979592185,0.089710079,cyclophosphamide
C_TYPE_LECTIN_RECEPTORS_CLRS,1.962636733,0.08514151,cyclophosphamide
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1.958301993,0.074758399,cyclophosphamide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.193777243,0,tolazamide
SARS_COV_2_INFECTION,-2.488761403,0,tolazamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.705689784,0,tolazamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.763780155,0,tolazamide
SIGNALING_BY_ROBO_RECEPTORS,-2.781099558,0,tolazamide
TRANSLATION,-2.827683495,0,tolazamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.852786796,0,tolazamide
SARS_COV_1_INFECTION,-2.859196247,0,tolazamide
INFLUENZA_INFECTION,-2.888349698,0,tolazamide
SARS_COV_1_HOST_INTERACTIONS,-2.898886706,0,tolazamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.496997883,0.000792219,imipramine
TOLL_LIKE_RECEPTOR_CASCADES,-2.112927241,0.029987738,imipramine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.074840117,0.027845757,imipramine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-1.961770054,0.057833495,imipramine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.954856915,0.049801065,imipramine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.813661823,0.036442058,imipramine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.922807293,0.055477315,imipramine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.917964252,0.048551576,imipramine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.883922928,0.060281473,imipramine
COLLAGEN_FORMATION,1.644779684,0.065358039,imipramine
GPCR_LIGAND_BINDING,2.294492514,0.016827806,calcipotriol
SIGNALING_BY_GPCR,2.232534368,0.016062905,calcipotriol
MUSCLE_CONTRACTION,2.136083938,0.024221841,calcipotriol
CARDIAC_CONDUCTION,1.959899769,0.073812875,calcipotriol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.925100057,0.076948966,calcipotriol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.965624281,0.689970915,calcipotriol
INNATE_IMMUNE_SYSTEM,-1.949195948,0.375383766,calcipotriol
NEUTROPHIL_DEGRANULATION,-1.934107669,0.275234299,calcipotriol
TCR_SIGNALING,-1.912399175,0.232935877,calcipotriol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.860424399,0.252235269,calcipotriol
ADAPTIVE_IMMUNE_SYSTEM,2.701936034,0.002107057,meclizine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.48726712,0.004214114,meclizine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.397725606,0.006321171,meclizine
METABOLISM_OF_RNA,2.375551675,0.005267643,meclizine
SARS_COV_2_HOST_INTERACTIONS,2.302550859,0.009692463,meclizine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.28632442,0.008779405,meclizine
SENSORY_PERCEPTION,-2.206028992,0.013312144,meclizine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.24579575,0.010836294,meclizine
GPCR_LIGAND_BINDING,-2.149813977,0.01358948,meclizine
CELL_CYCLE_CHECKPOINTS,2.155989617,0.019226896,meclizine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.546192962,0.015268039,coumarin
GPCR_LIGAND_BINDING,2.306201768,0.026255423,coumarin
MUSCLE_CONTRACTION,2.279865808,0.015072558,coumarin
SIGNALING_BY_GPCR,2.263072236,0.011669077,coumarin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.101185513,0.03160375,coumarin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.308724377,0.068706175,coumarin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.080035786,0.231395612,coumarin
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.044441853,0.218841891,coumarin
G_ALPHA_Q_SIGNALLING_EVENTS,1.851918048,0.142168254,coumarin
STRIATED_MUSCLE_CONTRACTION,1.728142563,0.248940308,coumarin
SELENOAMINO_ACID_METABOLISM,2.34021029,0.037794131,flufenamic-acid
NONSENSE_MEDIATED_DECAY_NMD,2.240249102,0.030707731,flufenamic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.224655119,0.020471821,flufenamic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.201843635,0.016534932,flufenamic-acid
EUKARYOTIC_TRANSLATION_INITIATION,2.194882225,0.013227946,flufenamic-acid
MITOTIC_METAPHASE_AND_ANAPHASE,2.095492043,0.016534932,flufenamic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.094417646,0.01552259,flufenamic-acid
DNA_REPLICATION,2.055997602,0.018306532,flufenamic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.044420095,0.016272473,flufenamic-acid
TRANSLATION,2.012360123,0.015590079,flufenamic-acid
RRNA_PROCESSING,-2.875463123,0,fostamatinib
METABOLISM_OF_RNA,-2.799962836,0.000815993,fostamatinib
MUSCLE_CONTRACTION,2.503376235,0.001498218,fostamatinib
GPCR_LIGAND_BINDING,2.411177705,0.001123664,fostamatinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.498032259,0.003263974,fostamatinib
SIGNALING_BY_GPCR,2.218178275,0.010237825,fostamatinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.293041183,0.026927785,fostamatinib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.134037824,0.016667679,fostamatinib
CELL_CYCLE,-2.226370468,0.031334149,fostamatinib
CARDIAC_CONDUCTION,2.057834092,0.023522028,fostamatinib
SELENOAMINO_ACID_METABOLISM,2.698880254,0.001821238,thalidomide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.250577607,0.014113876,thalidomide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.201755084,0.089240684,thalidomide
EUKARYOTIC_TRANSLATION_ELONGATION,2.188707346,0.066171663,thalidomide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.141058571,0.068296442,thalidomide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.044600733,0.073060066,thalidomide
DEVELOPMENTAL_CELL_LINEAGES,2.073472995,0.083776968,thalidomide
RAB_REGULATION_OF_TRAFFICKING,-1.948036299,0.125641174,thalidomide
HEMOSTASIS,-1.947604064,0.095061109,thalidomide
SARS_COV_1_HOST_INTERACTIONS,1.918754426,0.168768096,thalidomide
GPCR_LIGAND_BINDING,-3.13402015,0,piribedil
SIGNALING_BY_GPCR,-2.936734597,0,piribedil
INFLUENZA_INFECTION,2.789752201,0,piribedil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.611832654,0,piribedil
G_ALPHA_S_SIGNALLING_EVENTS,-2.606577436,0,piribedil
METABOLISM_OF_RNA,2.629956229,0.001021149,piribedil
RESPIRATORY_ELECTRON_TRANSPORT,2.537456675,0.000680766,piribedil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.506201844,0.001021149,piribedil
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.425324029,0.000313703,piribedil
TRANSLATION,2.443677102,0.001633838,piribedil
METABOLISM_OF_RNA,-2.883840659,0,pyrazolanthrone
GPCR_LIGAND_BINDING,2.609922553,0,pyrazolanthrone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.554293646,0,pyrazolanthrone
SIGNALING_BY_GPCR,2.428299632,0,pyrazolanthrone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.501586978,0.00126249,pyrazolanthrone
G_ALPHA_Q_SIGNALLING_EVENTS,2.231189786,0.001054281,pyrazolanthrone
MRNA_SPLICING,-2.325381825,0.010099917,pyrazolanthrone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.157410201,0.002249134,pyrazolanthrone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.030801532,0.046712116,pyrazolanthrone
CHROMATIN_ORGANIZATION,-1.99581847,0.048479602,pyrazolanthrone
TRANSLATION,3.32256736,0,NU-1025
NONSENSE_MEDIATED_DECAY_NMD,3.316208194,0,NU-1025
EUKARYOTIC_TRANSLATION_ELONGATION,3.121975889,0,NU-1025
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.068860338,0,NU-1025
RRNA_PROCESSING,3.052802243,0,NU-1025
EUKARYOTIC_TRANSLATION_INITIATION,3.045242682,0,NU-1025
SELENOAMINO_ACID_METABOLISM,2.973865039,0,NU-1025
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.746364197,0,NU-1025
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.697022696,0.000499313,NU-1025
METABOLISM_OF_RNA,2.469951142,0.00224691,NU-1025
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.488298069,0.000601781,prazosin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.473898526,0.00030089,prazosin
COLLAGEN_FORMATION,-2.394652563,0.00030089,prazosin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.394652563,0.00030089,prazosin
GPCR_LIGAND_BINDING,-2.225494384,0.004573535,prazosin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.155186725,0.006820184,prazosin
SIGNALING_BY_PDGF,-2.111033865,0.008252996,prazosin
SIGNALING_BY_GPCR,-2.100185025,0.008725824,prazosin
ADAPTIVE_IMMUNE_SYSTEM,2.072458704,0.2009964,prazosin
ECM_PROTEOGLYCANS,-2.054611455,0.012837994,prazosin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.942665289,0,aspirin
DEVELOPMENTAL_CELL_LINEAGES,2.866696326,0,aspirin
GPCR_LIGAND_BINDING,2.795449066,0,aspirin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.715020098,0,aspirin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.569069471,0.000274366,aspirin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.438496268,0.001371831,aspirin
SIGNALING_BY_GPCR,2.328012594,0.00186177,aspirin
COMPLEMENT_CASCADE,2.29903794,0.002143486,aspirin
NEURONAL_SYSTEM,2.278556545,0.001981533,aspirin
MUSCLE_CONTRACTION,2.192669925,0.004595633,aspirin
GPCR_LIGAND_BINDING,2.258146432,0.011421593,enalaprilat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.113507692,0.028173263,enalaprilat
SIGNALING_BY_GPCR,2.107014779,0.020812681,enalaprilat
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.819374918,0.195880325,enalaprilat
DEATH_RECEPTOR_SIGNALING,-2.974876566,1,enalaprilat
SENSORY_PERCEPTION,1.756670433,0.25432081,enalaprilat
NERVOUS_SYSTEM_DEVELOPMENT,1.750300358,0.222721069,enalaprilat
DEUBIQUITINATION,-2.948885257,1,enalaprilat
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.657577258,0.357985366,enalaprilat
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.640633321,0.350071834,enalaprilat
GPCR_LIGAND_BINDING,-2.432464454,0,tipifarnib-P2
INTERFERON_ALPHA_BETA_SIGNALING,2.568886946,0.00388673,tipifarnib-P2
EUKARYOTIC_TRANSLATION_INITIATION,2.474006043,0.001943365,tipifarnib-P2
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.305890204,0.001800708,tipifarnib-P2
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.274312642,0.001200472,tipifarnib-P2
ADAPTIVE_IMMUNE_SYSTEM,2.276287485,0.012955765,tipifarnib-P2
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.161693446,0.005582195,tipifarnib-P2
PHASE_II_CONJUGATION_OF_COMPOUNDS,2.224916755,0.015061077,tipifarnib-P2
COLLAGEN_FORMATION,-2.127476419,0.004921935,tipifarnib-P2
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.127476419,0.004921935,tipifarnib-P2
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.080980463,0.154576867,tolmetin
MITOTIC_G2_G2_M_PHASES,1.969326604,0.166780303,tolmetin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.552638155,0.386945365,tolmetin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.936591212,0.138983586,tolmetin
GPCR_LIGAND_BINDING,1.92305748,0.113136029,tolmetin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.516515524,0.271158645,tolmetin
MUSCLE_CONTRACTION,1.903183674,0.104135994,tolmetin
ORC1_REMOVAL_FROM_CHROMATIN,1.890601369,0.094746128,tolmetin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.47202964,0.263571481,tolmetin
PCP_CE_PATHWAY,1.80610011,0.146295963,tolmetin
MUSCLE_CONTRACTION,2.427806837,0.001754094,calcifediol
G_ALPHA_I_SIGNALLING_EVENTS,2.25332265,0.01403275,calcifediol
STRIATED_MUSCLE_CONTRACTION,2.179721013,0.016663891,calcifediol
GPCR_LIGAND_BINDING,2.046797532,0.032231474,calcifediol
POTASSIUM_CHANNELS,1.959836633,0.054727727,calcifediol
PI3K_AKT_SIGNALING_IN_CANCER,1.956958899,0.046191137,calcifediol
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.860189148,0.082191824,calcifediol
NEURONAL_SYSTEM,1.85107248,0.07619345,calcifediol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.840141763,0.072989792,calcifediol
SIGNALING_BY_GPCR,1.838543197,0.066655565,calcifediol
GPCR_LIGAND_BINDING,3.115590053,0,progesterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.018289098,0,progesterone
SIGNALING_BY_GPCR,2.808969552,0,progesterone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.403875015,0.000549039,progesterone
NEUTROPHIL_DEGRANULATION,-2.630063906,0.005991685,progesterone
INNATE_IMMUNE_SYSTEM,-2.516256911,0.008238567,progesterone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.381025525,0.024466047,progesterone
MEMBRANE_TRAFFICKING,-2.241356572,0.046810039,progesterone
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.219224591,0.045237222,progesterone
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.212206216,0.039195606,progesterone
MUSCLE_CONTRACTION,2.655192735,0.001018043,tadalafil
SIGNALING_BY_GPCR,2.054585711,0.062609635,tadalafil
G_ALPHA_I_SIGNALLING_EVENTS,1.864479282,0.16526229,tadalafil
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.859121368,0.129036931,tadalafil
CARDIAC_CONDUCTION,1.845030277,0.113206365,tadalafil
GPCR_LIGAND_BINDING,1.745366018,0.171540221,tadalafil
ECM_PROTEOGLYCANS,-1.820866191,1,tadalafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.721960257,0.169140548,tadalafil
SIGNALING_BY_VEGF,1.634471699,0.238094772,tadalafil
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.608681892,0.24116304,tadalafil
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.705672486,0,axitinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-2.610380332,0.001081653,axitinib
ADIPOGENESIS,-2.543970376,0.002884409,axitinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.482021888,0.00324496,axitinib
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-2.467707848,0.002595968,axitinib
METABOLISM_OF_STEROIDS,-2.438671036,0.002523858,axitinib
GPCR_LIGAND_BINDING,2.302486012,0.004458347,axitinib
NUCLEOTIDE_EXCISION_REPAIR,-2.412639481,0.003090438,axitinib
METABOLISM_OF_RNA,-2.411352215,0.002704133,axitinib
DISEASES_OF_METABOLISM,-2.386077725,0.002884409,axitinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.147790489,0.022112153,W-7
EUKARYOTIC_TRANSLATION_ELONGATION,2.137820453,0.013267292,W-7
RRNA_PROCESSING,2.132977587,0.008844861,W-7
EUKARYOTIC_TRANSLATION_INITIATION,2.023223623,0.019348134,W-7
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.906466062,0.032725986,W-7
SELENOAMINO_ACID_METABOLISM,1.615782397,0.125302199,W-7
NONSENSE_MEDIATED_DECAY_NMD,1.463793372,0.228702838,W-7
PEROXISOMAL_PROTEIN_IMPORT,-1.869704613,0.800408333,W-7
INTERFERON_SIGNALING,1.399679538,0.274743499,W-7
INFLUENZA_INFECTION,1.38428449,0.263380309,W-7
SIGNALING_BY_GPCR,2.387562468,0.009092034,tropicamide
G_ALPHA_Q_SIGNALLING_EVENTS,2.300168697,0.014206303,tropicamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.15451917,0.037504639,tropicamide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.341493546,0.086107602,tropicamide
GPCR_LIGAND_BINDING,2.074675457,0.05398395,tropicamide
SIGNALING_BY_FGFR,2.065037493,0.047051274,tropicamide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.113398555,0.196041094,tropicamide
NEUTROPHIL_DEGRANULATION,-2.025522495,0.22432563,tropicamide
PEROXISOMAL_PROTEIN_IMPORT,-1.946904113,0.266264769,tropicamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.77192732,0.320304769,tropicamide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.361249074,0.015573113,domperidone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.340049911,0.012166495,domperidone
GASTRULATION,2.10761726,0.119227388,domperidone
GPCR_LIGAND_BINDING,2.03971812,0.09901057,domperidone
INNATE_IMMUNE_SYSTEM,-2.060653889,0.134966983,domperidone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.032836703,0.122881599,domperidone
TCR_SIGNALING,-2.031848937,0.099278598,domperidone
CARDIAC_CONDUCTION,1.827176797,0.299969198,domperidone
MITOTIC_G2_G2_M_PHASES,1.77377683,0.31413825,domperidone
GLYCOSAMINOGLYCAN_METABOLISM,-1.856113132,0.259065231,domperidone
CELL_CYCLE_CHECKPOINTS,-3.003819845,0,regorafenib
GPCR_LIGAND_BINDING,2.844383909,0,regorafenib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.62551635,0,regorafenib
G2_M_CHECKPOINTS,-2.763327454,0.000964419,regorafenib
DNA_REPLICATION,-2.674797906,0.001285892,regorafenib
DNA_REPLICATION_PRE_INITIATION,-2.630839274,0.000964419,regorafenib
METABOLISM_OF_RNA,-2.604807771,0.000771535,regorafenib
SYNTHESIS_OF_DNA,-2.588653375,0.001285892,regorafenib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.420968191,0.00072938,regorafenib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.533531983,0.001377742,regorafenib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.078786037,0.188483844,probucol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.744112117,1,probucol
REGULATION_OF_TP53_ACTIVITY,1.740969339,0.64861303,probucol
ADAPTIVE_IMMUNE_SYSTEM,1.739569994,0.43537039,probucol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.678592588,0.456977362,probucol
DEATH_RECEPTOR_SIGNALING,1.67802408,0.366389627,probucol
FCERI_MEDIATED_NF_KB_ACTIVATION,1.666489076,0.328210579,probucol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.657507698,0.296901143,probucol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.643971663,0.280385801,probucol
RNA_POLYMERASE_II_TRANSCRIPTION,1.62172852,0.280195085,probucol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.801168545,0,gabapentin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.480064445,0,gabapentin
GPCR_LIGAND_BINDING,-2.375574006,0.00063373,gabapentin
ECM_PROTEOGLYCANS,-2.331858045,0.000792162,gabapentin
INTERFERON_ALPHA_BETA_SIGNALING,2.337795266,0.034944556,gabapentin
COLLAGEN_FORMATION,-2.24257776,0.002661665,gabapentin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.204360894,0.003274271,gabapentin
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.135939178,0.085420026,gabapentin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.087631936,0.077654569,gabapentin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.032017097,0.076683887,gabapentin
SIGNALING_BY_NOTCH,-2.180526262,0.083340887,lacosamide
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.007604933,0.233778251,lacosamide
UCH_PROTEINASES,-1.931268039,0.275448695,lacosamide
METABOLISM_OF_RNA,-1.895850535,0.268739047,lacosamide
PROTEIN_FOLDING,-1.875245,0.250022661,lacosamide
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.829456404,0.288632564,lacosamide
DNA_REPLICATION,-1.824707767,0.256278273,lacosamide
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.806679394,0.254083764,lacosamide
CHROMATIN_ORGANIZATION,-1.794463638,0.245314137,lacosamide
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.778976792,0.243807409,lacosamide
INFLUENZA_INFECTION,2.778829102,0,paricalcitol
GPCR_LIGAND_BINDING,-2.539391057,0,paricalcitol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.368087483,0.000683133,paricalcitol
SIGNALING_BY_GPCR,-2.365486648,0.000455422,paricalcitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.360228179,0.000341566,paricalcitol
MITF_M_DEPENDENT_GENE_EXPRESSION,2.226697209,0.039546815,paricalcitol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.14730652,0.00560169,paricalcitol
G_ALPHA_I_SIGNALLING_EVENTS,-2.0956906,0.00831145,paricalcitol
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.111303902,0.06270486,paricalcitol
SARS_COV_2_HOST_INTERACTIONS,2.038066602,0.073215049,paricalcitol
RESPIRATORY_ELECTRON_TRANSPORT,3.16124037,0,procainamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.176660532,0.031370616,procainamide
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.119969829,0.026889099,procainamide
COLLAGEN_FORMATION,-2.084503209,0.025694028,procainamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.987000207,0.115020406,procainamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.019375558,0.037644739,procainamide
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.964865936,0.048938161,procainamide
ECM_PROTEOGLYCANS,-1.899280534,0.07304872,procainamide
MUSCLE_CONTRACTION,1.785754185,0.248463994,procainamide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.879564742,0.076313825,procainamide
METABOLISM_OF_RNA,3.590765243,0,imiquimod
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,3.099517922,0,imiquimod
RESPIRATORY_ELECTRON_TRANSPORT,3.072239686,0,imiquimod
RRNA_PROCESSING,3.070242713,0,imiquimod
KEAP1_NFE2L2_PATHWAY,3.056170851,0,imiquimod
HIV_INFECTION,2.978518661,0,imiquimod
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.877136445,0,imiquimod
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.728384971,0,imiquimod
TRANSLATION,2.620731461,0.00077824,imiquimod
GPCR_LIGAND_BINDING,-2.318101068,0.002388926,imiquimod
ECM_PROTEOGLYCANS,-2.565895882,0,betrixaban
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.467307778,0,betrixaban
FATTY_ACID_METABOLISM,2.599075846,0.001606569,betrixaban
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.250813528,0.002358437,betrixaban
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.219624082,0.002432138,betrixaban
GPCR_LIGAND_BINDING,-2.210519128,0.002299476,betrixaban
PROTEIN_LOCALIZATION,2.065217142,0.058639772,betrixaban
NCAM1_INTERACTIONS,-2.076512417,0.011497381,betrixaban
SIGNALING_BY_GPCR,-2.043241129,0.013266209,betrixaban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.966827168,0.026311314,betrixaban
METABOLISM_OF_RNA,-3.020515601,0,RAF-265
CELL_CYCLE_CHECKPOINTS,-2.670321365,0,RAF-265
RRNA_PROCESSING,-2.528984323,0.000459808,RAF-265
CELL_CYCLE,-2.479133646,0.000689712,RAF-265
MITOTIC_METAPHASE_AND_ANAPHASE,-2.420960071,0.001931194,RAF-265
HIV_INFECTION,-2.324961269,0.003908369,RAF-265
SEPARATION_OF_SISTER_CHROMATIDS,-2.303980121,0.004335334,RAF-265
HIV_LIFE_CYCLE,-2.277625593,0.005517698,RAF-265
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.267500724,0.006130776,RAF-265
G2_M_CHECKPOINTS,-2.252102745,0.005931525,RAF-265
CELL_CYCLE,-3.398915366,0,dabrafenib
RHO_GTPASES_ACTIVATE_FORMINS,-2.470576531,0,dabrafenib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.489360508,0,dabrafenib
DNA_REPAIR,-2.490760326,0,dabrafenib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.494057793,0,dabrafenib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.528023539,0,dabrafenib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.53001326,0,dabrafenib
MITOTIC_PROMETAPHASE,-2.545900994,0,dabrafenib
REGULATION_OF_TP53_ACTIVITY,-2.547778366,0,dabrafenib
HOMOLOGY_DIRECTED_REPAIR,-2.551689017,0,dabrafenib
SEPARATION_OF_SISTER_CHROMATIDS,2.125627644,0.02476362,valproic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.111874126,0.02136859,valproic-acid
GPCR_LIGAND_BINDING,-2.090840787,0.014400572,valproic-acid
HCMV_INFECTION,2.019389736,0.036019811,valproic-acid
MITOTIC_METAPHASE_AND_ANAPHASE,1.971946122,0.031517335,valproic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.844730561,0.050652859,valproic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-1.989238855,0.03251742,valproic-acid
MAPK_FAMILY_SIGNALING_CASCADES,-1.967914911,0.030659282,valproic-acid
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.692386453,0.099954975,valproic-acid
CELL_CYCLE_CHECKPOINTS,1.622348286,0.115188354,valproic-acid
SYNTHESIS_OF_DNA,1.592039208,0.575082508,acamprosate
INTERFERON_GAMMA_SIGNALING,1.519122657,0.421571324,acamprosate
DNA_REPLICATION,1.315705295,0.727294952,acamprosate
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.307917524,0.560666483,acamprosate
DNA_REPLICATION_PRE_INITIATION,1.286885614,0.487183718,acamprosate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.255242748,0.459234812,acamprosate
S_PHASE,1.235075514,0.428361884,acamprosate
INTERFERON_ALPHA_BETA_SIGNALING,1.223915508,0.39371333,acamprosate
SLC_TRANSPORTER_DISORDERS,-1.898713439,1,acamprosate
COPII_MEDIATED_VESICLE_TRANSPORT,-1.812534802,1,acamprosate
GPCR_LIGAND_BINDING,2.441677667,0.007681763,rucaparib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.380600722,0.005974704,rucaparib
SIGNALING_BY_GPCR,2.371013216,0.004552156,rucaparib
MUSCLE_CONTRACTION,2.097296266,0.024325583,rucaparib
REGULATION_OF_INSULIN_SECRETION,2.097196472,0.019460466,rucaparib
G_ALPHA_I_SIGNALLING_EVENTS,1.999715994,0.031296071,rucaparib
EXTRACELLULAR_MATRIX_ORGANIZATION,1.988244051,0.029385792,rucaparib
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-1.983238231,0.309026544,rucaparib
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-1.966251539,0.17612352,rucaparib
AURKA_ACTIVATION_BY_TPX2,-1.917563547,0.188729498,rucaparib
GPCR_LIGAND_BINDING,2.638105275,0,proxymetacaine
SIGNALING_BY_GPCR,2.45577588,0,proxymetacaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.418822032,0.00027713,proxymetacaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.979123258,0.002718934,proxymetacaine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.274348682,0.003741252,proxymetacaine
G_ALPHA_Q_SIGNALLING_EVENTS,2.057116892,0.027103294,proxymetacaine
COLLAGEN_DEGRADATION,2.04812861,0.026050201,proxymetacaine
PEROXISOMAL_PROTEIN_IMPORT,-2.377097468,0.246063568,proxymetacaine
G_ALPHA_I_SIGNALLING_EVENTS,1.987251092,0.036343593,proxymetacaine
SENSORY_PERCEPTION,1.939380214,0.045310722,proxymetacaine
TRANSLATION,3.018751758,0,LY-294002
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.934809738,0,LY-294002
RRNA_PROCESSING,2.833961001,0,LY-294002
SELENOAMINO_ACID_METABOLISM,2.827081939,0,LY-294002
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.796549283,0,LY-294002
EUKARYOTIC_TRANSLATION_INITIATION,2.693036274,0,LY-294002
EUKARYOTIC_TRANSLATION_ELONGATION,2.660960845,0,LY-294002
INFLUENZA_INFECTION,2.60350669,0,LY-294002
RHOA_GTPASE_CYCLE,2.539760325,0.000673984,LY-294002
CELLULAR_RESPONSE_TO_STARVATION,2.397727631,0.003032929,LY-294002
ISG15_ANTIVIRAL_MECHANISM,-2.899104806,0,pizotifen
TRNA_PROCESSING,-2.653703304,0,pizotifen
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.631392893,0,pizotifen
GPCR_LIGAND_BINDING,2.62279023,0,pizotifen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.502207092,0,pizotifen
SIGNALING_BY_GPCR,2.425953692,0.000259007,pizotifen
SARS_COV_2_HOST_INTERACTIONS,-2.245262711,0.021447064,pizotifen
SARS_COV_2_INFECTION,-2.093481728,0.05086018,pizotifen
NEUTROPHIL_DEGRANULATION,-2.067458207,0.050298472,pizotifen
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.021148928,0.061058478,pizotifen
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.672063326,0.001273784,phentermine
CELLULAR_RESPONSE_TO_STARVATION,2.52495276,0.002547568,phentermine
SELENOAMINO_ACID_METABOLISM,2.337967023,0.006793514,phentermine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.281636163,0.006687366,phentermine
EUKARYOTIC_TRANSLATION_ELONGATION,2.275274395,0.005349893,phentermine
NONSENSE_MEDIATED_DECAY_NMD,2.159765062,0.007642704,phentermine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.120020563,0.043545058,phentermine
ECM_PROTEOGLYCANS,-1.943623007,0.15051444,phentermine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.883240419,0.171340337,phentermine
INFLUENZA_INFECTION,1.728786427,0.104268313,phentermine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.135890134,0,tivozanib
TRANSLATION,3.134606274,0,tivozanib
CELLULAR_RESPONSE_TO_STARVATION,2.955952045,0,tivozanib
EUKARYOTIC_TRANSLATION_INITIATION,2.895132256,0,tivozanib
COLLAGEN_FORMATION,-2.680891289,0,tivozanib
COLLAGEN_DEGRADATION,-2.674481003,0,tivozanib
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.669550287,0,tivozanib
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.602496516,0,tivozanib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.521323295,0,tivozanib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.461446931,0.000301011,tivozanib
RESPIRATORY_ELECTRON_TRANSPORT,3.003644353,0,mephenytoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.601910088,0.002434953,mephenytoin
DNA_REPLICATION,2.498509934,0.002434953,mephenytoin
TRANSLATION,2.488919318,0.001826215,mephenytoin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.280980378,0.01412273,mephenytoin
RRNA_PROCESSING,2.240903052,0.011131215,mephenytoin
CELL_CYCLE_CHECKPOINTS,2.241957731,0.012986418,mephenytoin
S_PHASE,2.231027073,0.01095729,mephenytoin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.230313614,0.028314094,mephenytoin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.184422377,0.012661757,mephenytoin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.468226799,0.002459547,citalopram
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.448779276,0.001475728,citalopram
EUKARYOTIC_TRANSLATION_ELONGATION,2.317698055,0.037498592,citalopram
CELLULAR_RESPONSE_TO_STARVATION,2.255493608,0.032450704,citalopram
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.236417479,0.025960563,citalopram
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.181397446,0.026321127,citalopram
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.175283424,0.014593312,citalopram
NONSENSE_MEDIATED_DECAY_NMD,2.076603793,0.047305915,citalopram
SELENOAMINO_ACID_METABOLISM,2.031798828,0.056488263,citalopram
EUKARYOTIC_TRANSLATION_INITIATION,1.991881188,0.067991952,citalopram
GPCR_LIGAND_BINDING,2.638591253,0,ramipril
SIGNALING_BY_GPCR,2.436756972,0,ramipril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.389032425,0,ramipril
MUSCLE_CONTRACTION,2.365838329,0,ramipril
NEURONAL_SYSTEM,2.240506526,0.002257445,ramipril
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.074775119,0.013544671,ramipril
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.962505875,0.028379311,ramipril
ECM_PROTEOGLYCANS,-1.916840935,0.559072536,ramipril
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.854423182,0.429357331,ramipril
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.803960714,0.387848465,ramipril
GPCR_LIGAND_BINDING,-2.088281355,0.056671401,loxoprofen
NONSENSE_MEDIATED_DECAY_NMD,-1.981710128,0.100152045,loxoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.980454029,0.068070821,loxoprofen
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.826843149,0.294117647,loxoprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.945940381,0.080365909,loxoprofen
NEURONAL_SYSTEM,-1.885008458,0.115687826,loxoprofen
EUKARYOTIC_TRANSLATION_INITIATION,-1.870870978,0.108783034,loxoprofen
SIGNALING_BY_GPCR,-1.86337605,0.09910516,loxoprofen
EUKARYOTIC_TRANSLATION_ELONGATION,-1.842090946,0.10686956,loxoprofen
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.560503265,0.554894022,loxoprofen
CELL_CYCLE,-4.022718738,0,palbociclib
MITOTIC_G2_G2_M_PHASES,-2.790972419,0,palbociclib
EXTENSION_OF_TELOMERES,-2.749199375,0,palbociclib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.744829937,0,palbociclib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.720643634,0,palbociclib
G2_M_DNA_DAMAGE_CHECKPOINT,-2.706605008,0,palbociclib
LAGGING_STRAND_SYNTHESIS,-2.688674258,0,palbociclib
HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,-2.653346676,0,palbociclib
G1_S_SPECIFIC_TRANSCRIPTION,-2.648709647,0,palbociclib
REGULATION_OF_TP53_ACTIVITY,-2.635523527,0,palbociclib
MUSCLE_CONTRACTION,3.018302536,0,daunorubicin
METABOLISM_OF_RNA,-2.997988912,0,daunorubicin
STRIATED_MUSCLE_CONTRACTION,2.746238232,0,daunorubicin
M_PHASE,-2.632446788,0,daunorubicin
CELL_CYCLE_MITOTIC,-2.630160003,0,daunorubicin
CELL_CYCLE,-2.530368183,0,daunorubicin
G_ALPHA_S_SIGNALLING_EVENTS,2.430538224,0.001026478,daunorubicin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.413728989,0.000785743,daunorubicin
MITF_M_DEPENDENT_GENE_EXPRESSION,2.360712492,0.001539717,daunorubicin
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.366510037,0.000982179,daunorubicin
SELENOAMINO_ACID_METABOLISM,2.357042976,0.010482563,dipyridamole
CELLULAR_RESPONSE_TO_STARVATION,2.328160514,0.007147202,dipyridamole
GPCR_LIGAND_BINDING,-2.148884678,0.050679634,dipyridamole
TRANSLATION,2.11955719,0.019059205,dipyridamole
SIGNALING_BY_GPCR,-2.063288871,0.065376728,dipyridamole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.054223197,0.047638856,dipyridamole
EUKARYOTIC_TRANSLATION_INITIATION,1.929858233,0.063610097,dipyridamole
TCR_SIGNALING,-1.9774235,0.082607804,dipyridamole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,-1.971219897,0.071154207,dipyridamole
NONSENSE_MEDIATED_DECAY_NMD,1.899455473,0.06499189,dipyridamole
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.174687399,0.046737907,droperidol
MUSCLE_CONTRACTION,2.033023433,0.065857959,droperidol
BIOLOGICAL_OXIDATIONS,2.032693854,0.043905306,droperidol
CELLULAR_SENESCENCE,-1.874795829,1,droperidol
RRNA_PROCESSING,-1.868955779,0.546490615,droperidol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.836445577,0.465024834,droperidol
NEURONAL_SYSTEM,1.729725154,0.213772811,droperidol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.682122091,0.986989278,droperidol
METABOLISM_OF_RNA,-1.645009465,0.992888525,droperidol
EUKARYOTIC_TRANSLATION_INITIATION,-1.613117741,0.98904213,droperidol
METABOLISM_OF_RNA,-4.357517107,0,sunitinib
SEPARATION_OF_SISTER_CHROMATIDS,-3.051799858,0,sunitinib
TRNA_PROCESSING,-3.064574622,0,sunitinib
DNA_REPLICATION_PRE_INITIATION,-3.215253709,0,sunitinib
DNA_REPLICATION,-3.25337459,0,sunitinib
G2_M_CHECKPOINTS,-3.287120521,0,sunitinib
SYNTHESIS_OF_DNA,-3.331948011,0,sunitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.082170438,0,sunitinib
M_PHASE,-3.35161581,0,sunitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-3.462237878,0,sunitinib
MITOTIC_G2_G2_M_PHASES,2.509906556,0.001548249,cisapride
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.460593739,0.002322374,cisapride
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.350339971,0.007741245,cisapride
SYNTHESIS_OF_DNA,2.28051325,0.010063619,cisapride
S_PHASE,2.249690386,0.012385993,cisapride
CELL_CYCLE_MITOTIC,2.229128412,0.01186991,cisapride
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.227398328,0.010395387,cisapride
DNA_REPLICATION,2.206143882,0.010644212,cisapride
PEROXISOMAL_PROTEIN_IMPORT,-2.271642768,0.054894115,cisapride
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.218236756,0.04422026,cisapride
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.539911048,0.00237332,ranitidine
SYNTHESIS_OF_DNA,2.484413244,0.00237332,ranitidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.397932663,0.005537747,ranitidine
DNA_REPLICATION,2.356259947,0.00474664,ranitidine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.34825626,0.003797312,ranitidine
S_PHASE,2.319089883,0.003955534,ranitidine
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,2.171156084,0.009493281,ranitidine
PCP_CE_PATHWAY,2.167860773,0.008306621,ranitidine
CELL_CYCLE_MITOTIC,2.144553823,0.008702174,ranitidine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.08163518,0.013290593,ranitidine
SYNTHESIS_OF_DNA,2.383586573,0.034586879,hesperidin
SELENOAMINO_ACID_METABOLISM,2.359578445,0.019214933,hesperidin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.177464792,0.030743892,hesperidin
EUKARYOTIC_TRANSLATION_INITIATION,2.102810374,0.033626132,hesperidin
EUKARYOTIC_TRANSLATION_ELONGATION,2.090406689,0.024338915,hesperidin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.090406689,0.024338915,hesperidin
DNA_REPLICATION,2.023706443,0.026900906,hesperidin
S_PHASE,1.997539678,0.025940159,hesperidin
TRANSLATION,1.996223171,0.023057919,hesperidin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.934430738,0.02574801,hesperidin
GPCR_LIGAND_BINDING,-2.860118033,0,doxazosin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.828468234,0,doxazosin
SIGNALING_BY_GPCR,-2.579814067,0,doxazosin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.387084197,0.000224245,doxazosin
RRNA_PROCESSING,-2.264699756,0.002870337,doxazosin
G_ALPHA_I_SIGNALLING_EVENTS,-2.001033712,0.03707518,doxazosin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.97766199,0.038954567,doxazosin
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.954425914,0.040700475,doxazosin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.825004886,0.099863792,doxazosin
MAPK_FAMILY_SIGNALING_CASCADES,-1.765266293,0.136610079,doxazosin
GPCR_LIGAND_BINDING,2.783184097,0,miglitol
SIGNALING_BY_GPCR,2.247845206,0.007133349,miglitol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.384115783,0.03690471,miglitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.217366929,0.008259668,miglitol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.191380081,0.008259668,miglitol
SIGNALING_BY_WNT,2.107990871,0.014416874,miglitol
NEURONAL_SYSTEM,2.020319468,0.025279589,miglitol
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-3.20536309,0.299191756,miglitol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.808894733,0.111773683,miglitol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.806761096,0.09939759,miglitol
SENSORY_PERCEPTION,2.183772765,0.023106189,didanosine
GPCR_LIGAND_BINDING,2.161054407,0.016174332,didanosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.007476974,0.049806674,didanosine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.596716543,1,didanosine
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-2.553828959,1,didanosine
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.384844164,1,didanosine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.789328515,1,didanosine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.717426995,1,didanosine
NEUTROPHIL_DEGRANULATION,-1.615423462,1,didanosine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.585222004,1,didanosine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.028793472,0,paroxetine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.578105134,0,paroxetine
SARS_COV_1_INFECTION,-2.579038229,0,paroxetine
RRNA_PROCESSING,-2.582863236,0,paroxetine
SARS_COV_1_HOST_INTERACTIONS,-2.597445056,0,paroxetine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.597488419,0,paroxetine
CELLULAR_RESPONSE_TO_STARVATION,-2.773487241,0,paroxetine
TRANSLATION,-2.724050839,0,paroxetine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.85880533,0,paroxetine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.883391246,0,paroxetine
SENSORY_PERCEPTION,-2.226580704,0.04680684,raclopride
INTEGRATION_OF_ENERGY_METABOLISM,-1.999147907,0.155502722,raclopride
SIGNALING_BY_GPCR,-1.989838359,0.109562676,raclopride
NEURONAL_SYSTEM,-1.919133783,0.131579227,raclopride
OPIOID_SIGNALLING,-1.885046572,0.127522634,raclopride
GPCR_LIGAND_BINDING,-1.88346189,0.10782909,raclopride
G_ALPHA_I_SIGNALLING_EVENTS,-1.801756842,0.154536867,raclopride
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.80127177,0.135999873,raclopride
LEISHMANIA_INFECTION,-1.768575423,0.1480483,raclopride
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.750657064,0.150405978,raclopride
MUSCLE_CONTRACTION,3.836711878,0,noretynodrel
CARDIAC_CONDUCTION,3.510619964,0,noretynodrel
SIGNALING_BY_GPCR,3.319147619,0,noretynodrel
GPCR_LIGAND_BINDING,3.117135776,0,noretynodrel
G_ALPHA_Q_SIGNALLING_EVENTS,2.914711111,0,noretynodrel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.825144576,0,noretynodrel
SENSORY_PERCEPTION,2.542450348,0.00059475,noretynodrel
STRIATED_MUSCLE_CONTRACTION,2.466200546,0.001040812,noretynodrel
G_ALPHA_I_SIGNALLING_EVENTS,2.285309706,0.004047604,noretynodrel
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.206590335,0.107243381,noretynodrel
GPCR_LIGAND_BINDING,2.791976344,0,dicycloverine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.611489336,0,dicycloverine
SIGNALING_BY_GPCR,2.36692397,0.001335641,dicycloverine
SENSORY_PERCEPTION,2.329950452,0.002203808,dicycloverine
VISUAL_PHOTOTRANSDUCTION,2.168875165,0.010578279,dicycloverine
G_ALPHA_I_SIGNALLING_EVENTS,1.896506091,0.08534748,dicycloverine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.097750969,1,dicycloverine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.830620596,0.116544246,dicycloverine
G_ALPHA_Q_SIGNALLING_EVENTS,1.818093065,0.111793179,dicycloverine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.053178378,0.985553726,dicycloverine
INFLUENZA_INFECTION,-2.99385422,0,testosterone
SIGNALING_BY_GPCR,2.90137909,0,testosterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.614574992,0,testosterone
GPCR_LIGAND_BINDING,2.797113796,0,testosterone
G_ALPHA_I_SIGNALLING_EVENTS,2.476689607,0.000328567,testosterone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.842197012,0.001752432,testosterone
CELLULAR_RESPONSE_TO_STARVATION,-2.7869319,0.001168288,testosterone
PROTEIN_LOCALIZATION,-2.626249318,0.004381081,testosterone
EUKARYOTIC_TRANSLATION_INITIATION,-2.592815751,0.005257297,testosterone
SELENOAMINO_ACID_METABOLISM,-2.520951924,0.008762162,testosterone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.910946703,0,alfuzosin
GPCR_LIGAND_BINDING,2.887187651,0,alfuzosin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.678845194,0,alfuzosin
SENSORY_PERCEPTION,2.630456302,0,alfuzosin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.744354456,0.003794449,alfuzosin
NEUTROPHIL_DEGRANULATION,-2.689945181,0.003541486,alfuzosin
INNATE_IMMUNE_SYSTEM,-2.534304463,0.006071119,alfuzosin
VISUAL_PHOTOTRANSDUCTION,2.296391854,0.002055837,alfuzosin
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-2.402678493,0.012142238,alfuzosin
SIGNALING_BY_GPCR,2.196784352,0.004427956,alfuzosin
RESPIRATORY_ELECTRON_TRANSPORT,2.353228109,0.019074153,phenothiazine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.300259973,0.025463548,phenothiazine
MITOCHONDRIAL_TRANSLATION,2.174713443,0.039936509,phenothiazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.052908413,0.169605416,phenothiazine
GASTRULATION,1.90899199,0.189152022,phenothiazine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.882492421,0.168687045,phenothiazine
TRANSLATION,1.838483167,0.172382662,phenothiazine
RRNA_PROCESSING,1.816474811,0.163719817,phenothiazine
DNA_REPLICATION,1.788874166,0.161789694,phenothiazine
TCR_SIGNALING,-1.886773276,0.379528116,phenothiazine
GENE_SILENCING_BY_RNA,-2.184810647,0.094612675,pramipexole
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.03353502,0.116688966,pramipexole
HIV_LIFE_CYCLE,-1.980609654,0.106526864,pramipexole
METABOLISM_OF_RNA,-1.890337873,0.136137127,pramipexole
DNA_REPLICATION_PRE_INITIATION,-1.852841556,0.141708762,pramipexole
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.843281216,0.125799816,pramipexole
HIV_INFECTION,-1.62667136,0.330994184,pramipexole
G2_M_CHECKPOINTS,-1.608728665,0.319580591,pramipexole
TRNA_PROCESSING,-1.599009118,0.298555553,pramipexole
HEMOSTASIS,1.804339546,1,pramipexole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.469223086,0.855766999,colchicine
NONSENSE_MEDIATED_DECAY_NMD,-2.457509822,0.510866966,colchicine
SELENOAMINO_ACID_METABOLISM,-2.435733969,0.452605657,colchicine
EUKARYOTIC_TRANSLATION_INITIATION,-2.428843679,0.370054396,colchicine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.415807267,0.34064713,colchicine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.415133569,0.286120078,colchicine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.389830163,0.312225293,colchicine
CELLULAR_RESPONSE_TO_STARVATION,-2.37604833,0.306779503,colchicine
ONCOGENIC_MAPK_SIGNALING,-2.36121051,0.307384591,colchicine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.354990507,0.288575005,colchicine
METABOLISM_OF_RNA,-5.912130594,0,nintedanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-4.309124655,0,nintedanib
HIV_INFECTION,-3.980605628,0,nintedanib
RRNA_PROCESSING,-3.948880498,0,nintedanib
MRNA_SPLICING,-3.902788399,0,nintedanib
HIV_LIFE_CYCLE,-3.652536993,0,nintedanib
HOST_INTERACTIONS_OF_HIV_FACTORS,-3.027476602,0,nintedanib
TRNA_PROCESSING,-2.969040157,0,nintedanib
DNA_REPLICATION,-2.790847641,0,nintedanib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.753273092,0,nintedanib
DNA_REPLICATION,-3.160425955,0,PLX-4720
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.965053462,0,PLX-4720
EUKARYOTIC_TRANSLATION_ELONGATION,2.521431941,0,PLX-4720
NONSENSE_MEDIATED_DECAY_NMD,2.470363886,0,PLX-4720
SARS_COV_1_HOST_INTERACTIONS,2.461475291,0,PLX-4720
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.445524499,0,PLX-4720
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.421544183,0,PLX-4720
CELL_CYCLE_CHECKPOINTS,-2.623647207,0.001155759,PLX-4720
G2_M_CHECKPOINTS,-2.610660506,0.000866819,PLX-4720
TRNA_PROCESSING,-2.580565077,0.000693456,PLX-4720
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.636807207,0,dienestrol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.582734681,0,dienestrol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.500783344,0,dienestrol
EUKARYOTIC_TRANSLATION_INITIATION,-2.382708214,0,dienestrol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.345337942,0.000204967,dienestrol
SARS_COV_1_HOST_INTERACTIONS,-2.344437257,0.000170805,dienestrol
SELENOAMINO_ACID_METABOLISM,-2.328158471,0.000439214,dienestrol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.321266091,0.000384312,dienestrol
NONSENSE_MEDIATED_DECAY_NMD,-2.268846373,0.000569352,dienestrol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.256379353,0.000652166,dienestrol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.532324758,0.000929118,BMS-927711
COLLAGEN_DEGRADATION,-2.473903706,0.000464559,BMS-927711
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.289305343,0.001858237,BMS-927711
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.280494692,0.001625957,BMS-927711
GPCR_LIGAND_BINDING,-2.265330834,0.001858237,BMS-927711
SIGNALING_BY_GPCR,-2.264894083,0.001548531,BMS-927711
G_ALPHA_Q_SIGNALLING_EVENTS,-2.259608988,0.001460043,BMS-927711
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.227002162,0.001625957,BMS-927711
PROTEIN_LOCALIZATION,2.273650501,0.038205144,BMS-927711
ECM_PROTEOGLYCANS,-2.110865893,0.007536183,BMS-927711
GPCR_LIGAND_BINDING,-2.545054887,0.004463726,radezolid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.257344328,0.027228731,radezolid
CILIUM_ASSEMBLY,2.126090136,0.087684943,radezolid
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.074525259,0.073502694,radezolid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.068338977,0.057805256,radezolid
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.025709768,0.126468668,radezolid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.052470147,0.051243578,radezolid
CELLULAR_RESPONSE_TO_STARVATION,2.015650786,0.091432163,radezolid
DEATH_RECEPTOR_SIGNALING,1.960089489,0.106233681,radezolid
NEURONAL_SYSTEM,-1.977029612,0.078264002,radezolid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.063999335,0.252920631,enzastaurin
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.097997913,0.210124141,enzastaurin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.955182356,0.257526817,enzastaurin
SIGNALING_BY_INTERLEUKINS,1.833183781,0.748645068,enzastaurin
NONSENSE_MEDIATED_DECAY_NMD,1.818401622,0.551126099,enzastaurin
INFLUENZA_INFECTION,1.804223065,0.455618451,enzastaurin
CHROMATIN_ORGANIZATION,1.791467465,0.395712393,enzastaurin
TRANSPORT_OF_SMALL_MOLECULES,-1.850860857,0.325442931,enzastaurin
SIGNALING_BY_ALK_IN_CANCER,1.67204448,0.712995303,enzastaurin
CELLULAR_RESPONSE_TO_STARVATION,1.660296036,0.65367079,enzastaurin
TRANSLATION,3.14908151,0,enalapril
CELLULAR_RESPONSE_TO_STARVATION,2.929097673,0,enalapril
EUKARYOTIC_TRANSLATION_INITIATION,2.601380919,0,enalapril
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.466940295,0,enalapril
ECM_PROTEOGLYCANS,-2.343137508,0,enalapril
COLLAGEN_DEGRADATION,-2.332580244,0,enalapril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.529701782,0.00074252,enalapril
SIGNALING_BY_PDGF,-2.288385587,0.000706189,enalapril
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.259932378,0.000753268,enalapril
NEUTROPHIL_DEGRANULATION,2.331500283,0.003267089,enalapril
EUKARYOTIC_TRANSLATION_ELONGATION,-2.505541302,0,amitriptyline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.420224233,0,amitriptyline
SELENOAMINO_ACID_METABOLISM,-2.419581953,0,amitriptyline
EUKARYOTIC_TRANSLATION_INITIATION,-2.3881122,0.000253887,amitriptyline
NONSENSE_MEDIATED_DECAY_NMD,-2.356368991,0.00040622,amitriptyline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.366730587,0.002238164,amitriptyline
CELLULAR_RESPONSE_TO_STARVATION,-2.291057499,0.000677033,amitriptyline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.278298909,0.000870471,amitriptyline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.189672951,0.001904155,amitriptyline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.147255535,0.002708132,amitriptyline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.162106471,0.008516945,orphenadrine
TRANSLATION,2.067205699,0.106951495,orphenadrine
ECM_PROTEOGLYCANS,-2.036975008,0.025550836,orphenadrine
NEUTROPHIL_DEGRANULATION,1.964115001,0.079490976,orphenadrine
CELL_CYCLE_CHECKPOINTS,1.938703226,0.066483362,orphenadrine
GPCR_LIGAND_BINDING,-2.017725821,0.021576262,orphenadrine
METABOLISM_OF_RNA,1.88174227,0.067928652,orphenadrine
TOLL_LIKE_RECEPTOR_CASCADES,1.848662688,0.066483362,orphenadrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.979867419,0.026189607,orphenadrine
SIGNALING_BY_ROBO_RECEPTORS,1.664133281,0.149828445,orphenadrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.966977512,0,pseudoephedrine
NERVOUS_SYSTEM_DEVELOPMENT,-2.570744854,0,pseudoephedrine
SARS_COV_2_INFECTION,-2.57132549,0,pseudoephedrine
INFECTIOUS_DISEASE,-2.744085163,0,pseudoephedrine
SARS_COV_2_HOST_INTERACTIONS,-2.762436195,0,pseudoephedrine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.784271059,0,pseudoephedrine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.938902992,0,pseudoephedrine
SARS_COV_1_INFECTION,-3.020293392,0,pseudoephedrine
VIRAL_INFECTION_PATHWAYS,-3.023441775,0,pseudoephedrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.108230636,0,pseudoephedrine
DNA_REPAIR,-2.488547142,0,perhexiline
HOMOLOGY_DIRECTED_REPAIR,-2.344809065,0,perhexiline
MUSCLE_CONTRACTION,2.67542797,0.001099845,perhexiline
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.333513804,0.000328653,perhexiline
DISEASES_OF_DNA_REPAIR,-2.318701533,0.00049298,perhexiline
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-2.262648591,0.001183152,perhexiline
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.229217713,0.001643266,perhexiline
G2_M_CHECKPOINTS,-2.201824047,0.001831068,perhexiline
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.200022427,0.001602185,perhexiline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.176533162,0.001862368,perhexiline
EUKARYOTIC_TRANSLATION_ELONGATION,3.751753735,0,pentoxifylline
GPCR_LIGAND_BINDING,-2.510371308,0,pentoxifylline
PROTEIN_LOCALIZATION,2.582249312,0,pentoxifylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.691313835,0,pentoxifylline
RRNA_PROCESSING,2.692084895,0,pentoxifylline
INFLUENZA_INFECTION,3.107491307,0,pentoxifylline
EUKARYOTIC_TRANSLATION_INITIATION,3.17312181,0,pentoxifylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.560954268,0,pentoxifylline
TRANSLATION,3.534020283,0,pentoxifylline
SELENOAMINO_ACID_METABOLISM,3.544445801,0,pentoxifylline
EUKARYOTIC_TRANSLATION_INITIATION,-3.240714821,0,amoxapine
ADAPTIVE_IMMUNE_SYSTEM,-2.593570609,0,amoxapine
SIGNALING_BY_ROBO_RECEPTORS,-2.61014083,0,amoxapine
SARS_COV_1_INFECTION,-2.640648887,0,amoxapine
TCR_SIGNALING,-2.652634161,0,amoxapine
RRNA_PROCESSING,-2.85021394,0,amoxapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.86915597,0,amoxapine
INFLUENZA_INFECTION,-2.89466845,0,amoxapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.034724225,0,amoxapine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.059222719,0,amoxapine
NEUTROPHIL_DEGRANULATION,2.331954548,0.019154758,mebendazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.300151709,0.010945576,mebendazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.982292734,0.085740347,mebendazole
GPCR_LIGAND_BINDING,-2.027545961,0.099345423,mebendazole
METABOLISM_OF_RNA,1.811293112,0.154606263,mebendazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.954501901,0.100133879,mebendazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.750027578,0.181696564,mebendazole
SIGNALING_BY_GPCR,-1.895934065,0.116165812,mebendazole
MAPK6_MAPK4_SIGNALING,1.632210479,0.28458498,mebendazole
G_ALPHA_I_SIGNALLING_EVENTS,-1.854217717,0.130686539,mebendazole
METABOLISM_OF_STEROIDS,2.118330594,0.066586944,loperamide
TRANSLATION,1.869618692,0.171794314,loperamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.895479386,0.335638882,loperamide
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1.64484766,0.466996431,loperamide
GPCR_LIGAND_BINDING,-1.831061843,0.316897625,loperamide
G_ALPHA_Q_SIGNALLING_EVENTS,-1.811833969,0.247895723,loperamide
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.535001014,0.625917269,loperamide
INTERFERON_ALPHA_BETA_SIGNALING,1.485423779,0.654682829,loperamide
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.453493627,0.642342049,loperamide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.750631566,0.335851851,loperamide
NEUTROPHIL_DEGRANULATION,-2.99998832,0,mitotane
GPCR_LIGAND_BINDING,2.786608875,0,mitotane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.616689757,0,mitotane
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.717777803,0.001129574,mitotane
MEMBRANE_TRAFFICKING,-2.702600962,0.000564787,mitotane
VESICLE_MEDIATED_TRANSPORT,-2.702600962,0.000564787,mitotane
SIGNALING_BY_VEGF,-2.639853574,0.000451829,mitotane
SIGNALING_BY_GPCR,2.390286473,0.001068715,mitotane
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-2.425074821,0.002259147,mitotane
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.365120641,0.003227353,mitotane
GPCR_LIGAND_BINDING,2.441068701,0.00144295,BRD-K92073408
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.397122987,0.001803688,BRD-K92073408
SIGNALING_BY_GPCR,2.196817542,0.010822125,BRD-K92073408
PEROXISOMAL_PROTEIN_IMPORT,-2.488349484,0.118162358,BRD-K92073408
MUSCLE_CONTRACTION,2.111129349,0.015331344,BRD-K92073408
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.288665373,0.186332949,BRD-K92073408
PROTEIN_LOCALIZATION,-2.223150698,0.1747187,BRD-K92073408
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.200624746,0.149596575,BRD-K92073408
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.14477856,0.163912399,BRD-K92073408
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.133344785,0.14442066,BRD-K92073408
GPCR_LIGAND_BINDING,2.615368452,0,montelukast
SIGNALING_BY_GPCR,2.504217053,0,montelukast
SENSORY_PERCEPTION,2.373631461,0.00022204,montelukast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.369492538,0.00016653,montelukast
DEUBIQUITINATION,-3.740957237,0.108298138,montelukast
AMINE_LIGAND_BINDING_RECEPTORS,1.988134424,0.031440852,montelukast
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.983157413,0.027754989,montelukast
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.885666118,0.055763739,montelukast
VISUAL_PHOTOTRANSDUCTION,1.879532727,0.051124691,montelukast
DEATH_RECEPTOR_SIGNALING,-3.342838826,1,montelukast
SYNTHESIS_OF_DNA,2.370846923,0.032372884,hydroxyfasudil
NEDDYLATION,2.300757163,0.02856431,hydroxyfasudil
SEPARATION_OF_SISTER_CHROMATIDS,2.220648844,0.036181459,hydroxyfasudil
DNA_REPLICATION,2.205575595,0.029992525,hydroxyfasudil
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.17725935,0.028945167,hydroxyfasudil
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.176627592,0.024120973,hydroxyfasudil
DNA_REPLICATION_PRE_INITIATION,2.146439535,0.025299817,hydroxyfasudil
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.138182385,0.02332752,hydroxyfasudil
MITOTIC_METAPHASE_AND_ANAPHASE,2.095472376,0.027294785,hydroxyfasudil
PCP_CE_PATHWAY,2.089803623,0.025707879,hydroxyfasudil
TRANSLATION,3.516458069,0,fasudil
METABOLISM_OF_RNA,2.34845978,0.007832217,fasudil
HIV_INFECTION,2.023780958,0.034461753,fasudil
HIV_LIFE_CYCLE,1.767923955,0.109651031,fasudil
CELL_CYCLE_CHECKPOINTS,1.681781836,0.139726743,fasudil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.591954471,0.19423897,fasudil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.533717372,0.219302062,fasudil
M_PHASE,1.481224359,0.255721869,fasudil
MITOTIC_PROMETAPHASE,1.477496526,0.230441215,fasudil
CELLULAR_SENESCENCE,-1.761507249,0.848151817,fasudil
GPCR_LIGAND_BINDING,2.228537219,0.018853683,guanfacine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.331985232,0.079832494,guanfacine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.317151105,0.043034704,guanfacine
TCR_SIGNALING,-2.251405068,0.046568955,guanfacine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.063969445,0.053282148,guanfacine
GLYCOSAMINOGLYCAN_METABOLISM,-2.182774444,0.063304673,guanfacine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.11327302,0.082576736,guanfacine
SENSORY_PERCEPTION,1.958754318,0.095088141,guanfacine
VISUAL_PHOTOTRANSDUCTION,1.951249956,0.076029526,guanfacine
INNATE_IMMUNE_SYSTEM,-2.014046956,0.127233038,guanfacine
GPCR_LIGAND_BINDING,2.770392573,0,spironolactone
SIGNALING_BY_GPCR,2.716548554,0,spironolactone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.375981298,0.002597002,spironolactone
COLLAGEN_FORMATION,2.15835545,0.016880512,spironolactone
G_ALPHA_S_SIGNALLING_EVENTS,2.145884411,0.014889477,spironolactone
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,2.125210848,0.014427788,spironolactone
G_ALPHA_I_SIGNALLING_EVENTS,2.115239626,0.01409801,spironolactone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.018710902,0.029432688,spironolactone
MUSCLE_CONTRACTION,1.988922792,0.032606801,spironolactone
SENSORY_PERCEPTION,1.902661891,0.05557584,spironolactone
CDC42_GTPASE_CYCLE,2.141654956,0.08219275,albendazole
MITOCHONDRIAL_BIOGENESIS,1.955476372,0.132696729,albendazole
CELL_JUNCTION_ORGANIZATION,1.857791087,0.16207486,albendazole
NEURONAL_SYSTEM,1.774853803,0.18443855,albendazole
RHO_GTPASE_CYCLE,1.742115196,0.176466844,albendazole
EXTRACELLULAR_MATRIX_ORGANIZATION,1.71069401,0.173628058,albendazole
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.666807046,0.189991158,albendazole
ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,-1.780071844,1,albendazole
INTERFERON_ALPHA_BETA_SIGNALING,-1.761620231,0.848745943,albendazole
CELL_CELL_COMMUNICATION,1.570898418,0.276905393,albendazole
RESPIRATORY_ELECTRON_TRANSPORT,-2.594403891,0.00192019,capecitabine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.535506237,0.000960095,capecitabine
INFLUENZA_INFECTION,-2.531950556,0.000640063,capecitabine
GPCR_LIGAND_BINDING,2.490784668,0.002903416,capecitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.40634343,0.003193757,capecitabine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.427564606,0.004320427,capecitabine
POTASSIUM_CHANNELS,2.239309373,0.005032587,capecitabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.305547322,0.01152114,capecitabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.173154135,0.007113368,capecitabine
METABOLISM_OF_RNA,-2.24504002,0.017281709,capecitabine
MRNA_SPLICING,2.493833304,0.001086268,ifenprodil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.450418752,0.000543134,ifenprodil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.067653954,0.01494912,ifenprodil
SELENOAMINO_ACID_METABOLISM,-2.050373727,0.009467776,ifenprodil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.018068536,0.010298282,ifenprodil
NONSENSE_MEDIATED_DECAY_NMD,-2.01770268,0.007723712,ifenprodil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.994782757,0.008371507,ifenprodil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.993178683,0.007308458,ifenprodil
EUKARYOTIC_TRANSLATION_INITIATION,-1.978835173,0.007403374,ifenprodil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.928562884,0.013827936,ifenprodil
TRANSLATION,2.004747056,0.132850242,hyoscyamine
SYNTHESIS_OF_DNA,1.935917377,0.096618357,hyoscyamine
DNA_REPLICATION,1.848887026,0.116747182,hyoscyamine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.714721112,0.200281804,hyoscyamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.676290619,0.195652174,hyoscyamine
SELENOAMINO_ACID_METABOLISM,1.666592239,0.173778851,hyoscyamine
DNA_REPLICATION_PRE_INITIATION,1.656821195,0.158155049,hyoscyamine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.647254969,0.142411433,hyoscyamine
NONSENSE_MEDIATED_DECAY_NMD,1.643322002,0.128824477,hyoscyamine
KEAP1_NFE2L2_PATHWAY,1.528914945,0.194041868,hyoscyamine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.668687656,0.00876517,sulfacetamide
GPCR_LIGAND_BINDING,2.382913771,0.002971925,sulfacetamide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.385532824,0.036813716,sulfacetamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.150666865,0.023032415,sulfacetamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.121195471,0.020308151,sulfacetamide
GLYCOSAMINOGLYCAN_METABOLISM,-2.253150748,0.060187504,sulfacetamide
SIGNALING_BY_GPCR,2.088948047,0.020803472,sulfacetamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.218992685,0.052152764,sulfacetamide
NEUTROPHIL_DEGRANULATION,-2.184266607,0.053292237,sulfacetamide
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-2.104019532,0.066323123,sulfacetamide
EUKARYOTIC_TRANSLATION_ELONGATION,2.818298865,0,tacrine
EUKARYOTIC_TRANSLATION_INITIATION,2.801916883,0,tacrine
SELENOAMINO_ACID_METABOLISM,2.801570275,0,tacrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.744805019,0,tacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.744206416,0,tacrine
CELLULAR_RESPONSE_TO_STARVATION,2.742338437,0,tacrine
NONSENSE_MEDIATED_DECAY_NMD,2.618680983,0,tacrine
INFLUENZA_INFECTION,2.408914075,0.000480154,tacrine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.334444148,0.000853606,tacrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.327345089,0.000864277,tacrine
TRANSLATION,2.809772353,0.001143917,venlafaxine
CELLULAR_RESPONSE_TO_STARVATION,2.744328221,0.000571958,venlafaxine
RESPIRATORY_ELECTRON_TRANSPORT,2.65340468,0.001143917,venlafaxine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.41499411,0.008656696,venlafaxine
RRNA_PROCESSING,2.454688186,0.002859791,venlafaxine
COLLAGEN_DEGRADATION,-2.386548808,0.006732986,venlafaxine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.339211084,0.007694841,venlafaxine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.264732441,0.011061334,venlafaxine
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.250973088,0.009618551,venlafaxine
COLLAGEN_FORMATION,-2.234780497,0.009137624,venlafaxine
INFLUENZA_INFECTION,3.2490183,0,phenylephrine
CELLULAR_RESPONSE_TO_STARVATION,3.239172969,0,phenylephrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.152332102,0,phenylephrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.985182322,0,phenylephrine
SELENOAMINO_ACID_METABOLISM,2.535206634,0,phenylephrine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.370599169,0.006030242,phenylephrine
EUKARYOTIC_TRANSLATION_ELONGATION,2.438815931,0.001499966,phenylephrine
NONSENSE_MEDIATED_DECAY_NMD,2.431497884,0.001285685,phenylephrine
SARS_COV_2_HOST_INTERACTIONS,2.25422314,0.00309368,phenylephrine
EUKARYOTIC_TRANSLATION_INITIATION,2.243977038,0.002999932,phenylephrine
SELENOAMINO_ACID_METABOLISM,3.372106058,0,vortioxetine
EUKARYOTIC_TRANSLATION_INITIATION,2.7750576,0,vortioxetine
TRANSLATION,2.722762099,0.000664066,vortioxetine
INFLUENZA_INFECTION,2.626600581,0.000498049,vortioxetine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.45871598,0.000398439,vortioxetine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.181794365,0.010387508,vortioxetine
NEUTROPHIL_DEGRANULATION,2.196392674,0.004980493,vortioxetine
SIGNALING_BY_GPCR,-2.140605111,0.009521882,vortioxetine
RESPIRATORY_ELECTRON_TRANSPORT,2.046178228,0.017360576,vortioxetine
RAB_REGULATION_OF_TRAFFICKING,2.044355422,0.015439529,vortioxetine
EUKARYOTIC_TRANSLATION_ELONGATION,3.488780875,0,PD-168393
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.474058,0,PD-168393
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.668102193,0,PD-168393
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.704675863,0,PD-168393
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.981883683,0,PD-168393
EUKARYOTIC_TRANSLATION_INITIATION,3.219824116,0,PD-168393
INFLUENZA_INFECTION,3.235485959,0,PD-168393
RRNA_PROCESSING,3.026670413,0,PD-168393
CELLULAR_RESPONSE_TO_STARVATION,3.295163823,0,PD-168393
TRANSLATION,3.335621659,0,PD-168393
INTERFERON_ALPHA_BETA_SIGNALING,4.293044601,0,gemcitabine
INTERFERON_SIGNALING,3.16409821,0,gemcitabine
INTERFERON_GAMMA_SIGNALING,3.027480213,0,gemcitabine
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.188581987,0.013675525,gemcitabine
ION_CHANNEL_TRANSPORT,2.303308841,0.008259912,gemcitabine
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,2.176831001,0.011824716,gemcitabine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.006030195,0.028692326,gemcitabine
ISG15_ANTIVIRAL_MECHANISM,1.973945179,0.029810208,gemcitabine
RRNA_PROCESSING,-1.993729352,0.078206911,gemcitabine
G2_M_CHECKPOINTS,1.896259185,0.043255854,gemcitabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.098043065,0.04812857,VX-661
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.040956799,0.043796998,VX-661
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.957313101,0.077326569,VX-661
CELLULAR_RESPONSE_TO_STARVATION,1.865177374,0.333962588,VX-661
SELENOAMINO_ACID_METABOLISM,1.808813309,0.222841943,VX-661
ECM_PROTEOGLYCANS,-1.904766992,0.100348068,VX-661
FATTY_ACID_METABOLISM,1.781312448,0.168983468,VX-661
PROTEIN_LOCALIZATION,1.636331439,0.275098679,VX-661
TCR_SIGNALING,1.580843156,0.296962416,VX-661
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.53673197,0.308935416,VX-661
CELLULAR_RESPONSE_TO_STARVATION,2.549898301,0.006945874,ilomastat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.191005774,0.017386374,ilomastat
TRANSLATION,1.996188313,0.093074707,ilomastat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.010391454,0.070003032,ilomastat
GPCR_LIGAND_BINDING,-1.969899874,0.072900761,ilomastat
COLLAGEN_FORMATION,-1.860947196,0.144352657,ilomastat
MITF_M_DEPENDENT_GENE_EXPRESSION,1.73163586,0.290800576,ilomastat
SIGNALING_BY_GPCR,-1.831314358,0.147509656,ilomastat
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.809384283,0.149766834,ilomastat
RAB_REGULATION_OF_TRAFFICKING,1.653128415,0.341042396,ilomastat
MYD88_INDEPENDENT_TLR4_CASCADE,2.858395286,0,BRD-K76022557
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.347314246,0.007051166,BRD-K76022557
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.181322572,0.018019647,BRD-K76022557
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.077785198,0.042713568,BRD-K76022557
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.077692427,0.021775544,BRD-K76022557
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.052472445,0.019542155,BRD-K76022557
TOLL_LIKE_RECEPTOR_CASCADES,1.975861577,0.052296149,BRD-K76022557
MITF_M_DEPENDENT_GENE_EXPRESSION,1.968105561,0.04371723,BRD-K76022557
COLLAGEN_FORMATION,-1.996416583,0.02680067,BRD-K76022557
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.932906617,0.042546064,BRD-K76022557
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.749732902,0,goserelin-acetate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.71004408,0.000722733,goserelin-acetate
CELLULAR_RESPONSE_TO_STARVATION,2.645520274,0.000963644,goserelin-acetate
ECM_PROTEOGLYCANS,-2.234768561,0.009168914,goserelin-acetate
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.176963071,0.013294925,goserelin-acetate
INFLUENZA_INFECTION,2.214128077,0.013370565,goserelin-acetate
NONSENSE_MEDIATED_DECAY_NMD,2.091995609,0.020236531,goserelin-acetate
EUKARYOTIC_TRANSLATION_ELONGATION,2.082169497,0.01782742,goserelin-acetate
SELENOAMINO_ACID_METABOLISM,2.008129531,0.025192416,goserelin-acetate
FATTY_ACID_METABOLISM,1.912180017,0.036317346,goserelin-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.406809297,0.000919091,amonafide
GPCR_LIGAND_BINDING,-2.332107927,0.002297727,amonafide
SIGNALING_BY_GPCR,-2.2318667,0.003982727,amonafide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.17760199,0.00597409,amonafide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.113771471,0.009374726,amonafide
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.028309914,0.02052636,amonafide
RAB_REGULATION_OF_TRAFFICKING,1.929138276,0.268111335,amonafide
G_ALPHA_Q_SIGNALLING_EVENTS,-1.992055604,0.025734541,amonafide
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.988809686,0.023207041,amonafide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.95923905,0.029002419,amonafide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.30005724,0.018646494,nimesulide
ADAPTIVE_IMMUNE_SYSTEM,1.927283879,0.123164997,nimesulide
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.981985817,0.323210376,nimesulide
FATTY_ACID_METABOLISM,1.63456493,0.412512779,nimesulide
INFLUENZA_INFECTION,1.604770115,0.36606011,nimesulide
CELLULAR_RESPONSE_TO_STARVATION,1.601545558,0.297951339,nimesulide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.766301361,1,nimesulide
PROTEIN_LOCALIZATION,1.524593653,0.373911266,nimesulide
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1.508970428,0.347694015,nimesulide
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.48888829,0.336986301,nimesulide
METABOLISM_OF_RNA,2.219431793,0.030953218,febuxostat
HIV_INFECTION,2.05548058,0.067065307,febuxostat
GPCR_LIGAND_BINDING,-2.057433298,0.031486137,febuxostat
HIV_LIFE_CYCLE,1.927665153,0.080822293,febuxostat
SARS_COV_2_HOST_INTERACTIONS,1.782580163,0.137999766,febuxostat
INFECTIOUS_DISEASE,1.677571389,0.198100598,febuxostat
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.619441217,0.224410834,febuxostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.873458587,0.119354425,febuxostat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.578875311,0.229201213,febuxostat
SIGNALING_BY_GPCR,-1.860137673,0.090064995,febuxostat
MITOTIC_METAPHASE_AND_ANAPHASE,2.678303164,0,doxepin
SEPARATION_OF_SISTER_CHROMATIDS,2.567083453,0,doxepin
ORC1_REMOVAL_FROM_CHROMATIN,2.87963003,0,doxepin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.579040762,0,doxepin
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.804444529,0,doxepin
GASTRULATION,2.739445838,0,doxepin
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.734960579,0,doxepin
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.724626748,0,doxepin
SYNTHESIS_OF_DNA,2.562464929,0,doxepin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.64968239,0,doxepin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.007836681,0.26987889,bupropion
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.799915837,0.699543798,bupropion
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.746592772,0.462369702,bupropion
CELL_JUNCTION_ORGANIZATION,-1.697633067,0.406070801,bupropion
NUCLEAR_ENVELOPE_NE_REASSEMBLY,-1.627156187,0.439011647,bupropion
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.564389569,0.471233784,bupropion
EXTRACELLULAR_MATRIX_ORGANIZATION,1.780228343,0.986503727,bupropion
NERVOUS_SYSTEM_DEVELOPMENT,1.776777449,0.672769518,bupropion
CELL_CELL_COMMUNICATION,-1.454270297,0.645241311,bupropion
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.71632457,0.787709009,bupropion
GPCR_LIGAND_BINDING,2.832365822,0,bepridil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.668138187,0,bepridil
SIGNALING_BY_GPCR,2.660753719,0,bepridil
AMINE_LIGAND_BINDING_RECEPTORS,2.245814971,0.006578362,bepridil
G_ALPHA_Q_SIGNALLING_EVENTS,2.150282697,0.012179368,bepridil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.111211934,0.014535048,bepridil
SENSORY_PERCEPTION,2.103363922,0.012780818,bepridil
VISUAL_PHOTOTRANSDUCTION,2.055106283,0.016257953,bepridil
G_ALPHA_I_SIGNALLING_EVENTS,1.962042967,0.031158465,bepridil
NCAM1_INTERACTIONS,1.842144299,0.074053565,bepridil
EUKARYOTIC_TRANSLATION_INITIATION,-3.085085329,0,amodiaquine
RRNA_PROCESSING,-2.681508145,0,amodiaquine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.700825987,0,amodiaquine
SIGNALING_BY_ROBO_RECEPTORS,-2.738505177,0,amodiaquine
INFLUENZA_INFECTION,-2.746600058,0,amodiaquine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.866074358,0,amodiaquine
NONSENSE_MEDIATED_DECAY_NMD,-2.865560685,0,amodiaquine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.939939698,0,amodiaquine
SELENOAMINO_ACID_METABOLISM,-2.95279248,0,amodiaquine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.958584642,0,amodiaquine
MUSCLE_CONTRACTION,2.638086672,0.002302379,H-89
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.350389011,0.012663085,H-89
EXTRACELLULAR_MATRIX_ORGANIZATION,1.964708954,0.068687644,H-89
SIGNALING_BY_GPCR,1.943757267,0.057271681,H-89
GPCR_LIGAND_BINDING,1.891196854,0.061703761,H-89
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.774109088,0.100345357,H-89
CARDIAC_CONDUCTION,1.736365561,0.105416073,H-89
SIGNALING_BY_INTERLEUKINS,1.661122014,0.136128166,H-89
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.655969524,0.123816833,H-89
SIGNALING_BY_INSULIN_RECEPTOR,1.529302846,0.213891021,H-89
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.92913856,0,sonidegib
GPCR_LIGAND_BINDING,2.818231466,0,sonidegib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.632688838,0,sonidegib
G_ALPHA_Q_SIGNALLING_EVENTS,2.621636832,0,sonidegib
SIGNALING_BY_GPCR,2.573407015,0,sonidegib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.18860643,0.00491153,sonidegib
NEUTROPHIL_DEGRANULATION,-2.208901589,0.248984801,sonidegib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.199831067,0.177205399,sonidegib
G_ALPHA_S_SIGNALLING_EVENTS,1.888235065,0.057825914,sonidegib
POTASSIUM_CHANNELS,1.852635826,0.066566517,sonidegib
RESPIRATORY_ELECTRON_TRANSPORT,2.798385985,0,nicotine
GPCR_LIGAND_BINDING,-2.757704614,0,nicotine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.537009556,0,nicotine
SIGNALING_BY_GPCR,-2.4209824,0.000592766,nicotine
INTERFERON_ALPHA_BETA_SIGNALING,2.340663818,0.009361904,nicotine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.24656005,0.016227301,nicotine
NEURONAL_SYSTEM,-2.134644255,0.013114939,nicotine
POTASSIUM_CHANNELS,-2.047053577,0.026318793,nicotine
DNA_DOUBLE_STRAND_BREAK_REPAIR,2.002696585,0.068029839,nicotine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.973221166,0.065158855,nicotine
NEUTROPHIL_DEGRANULATION,-2.225791926,0.045466547,tocainide
MUSCLE_CONTRACTION,2.209386496,0.056307752,tocainide
SARS_COV_2_INFECTION,-2.127677773,0.05466811,tocainide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.058658423,0.074334196,tocainide
SARS_COV_2_HOST_INTERACTIONS,-2.054883037,0.058186355,tocainide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.031072576,0.057157945,tocainide
RHOA_GTPASE_CYCLE,-1.996322953,0.062967559,tocainide
VESICLE_MEDIATED_TRANSPORT,-1.984534926,0.060467415,tocainide
GASTRULATION,1.933628517,0.213536319,tocainide
MEMBRANE_TRAFFICKING,-1.969515752,0.060351428,tocainide
GPCR_LIGAND_BINDING,2.467441487,0.004925682,phenacetin
MUSCLE_CONTRACTION,2.373841935,0.00541825,phenacetin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.270068084,0.009194606,phenacetin
SIGNALING_BY_GPCR,2.18938143,0.014777045,phenacetin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.348529474,0.086903933,phenacetin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.266312221,0.091451231,phenacetin
CARDIAC_CONDUCTION,2.023532814,0.045316272,phenacetin
SENSORY_PERCEPTION,1.928546167,0.077989961,phenacetin
GASTRULATION,1.825403084,0.133556342,phenacetin
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.794609632,0.125769074,phenacetin
PTEN_REGULATION,1.783601251,0.464096656,verapamil
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.647790711,0.452886592,verapamil
MUSCLE_CONTRACTION,1.596770078,0.39085757,verapamil
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.865223151,0.62021668,verapamil
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.564279468,0.349193498,verapamil
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.562398336,0.282942019,verapamil
SEPARATION_OF_SISTER_CHROMATIDS,1.559069936,0.241390048,verapamil
CELL_CYCLE_CHECKPOINTS,1.529625422,0.238614223,verapamil
MITOTIC_METAPHASE_AND_ANAPHASE,1.446585457,0.303232235,verapamil
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.792769572,0.572746591,verapamil
MUSCLE_CONTRACTION,5.416901564,0,mibefradil
TRANSLATION,-2.558431979,0,mibefradil
SARS_COV_1_INFECTION,-2.604773716,0,mibefradil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.634058599,0,mibefradil
SARS_COV_1_HOST_INTERACTIONS,-2.649221403,0,mibefradil
RRNA_PROCESSING,-2.701950023,0,mibefradil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.761437136,0,mibefradil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.808858239,0,mibefradil
INFLUENZA_INFECTION,-2.83275028,0,mibefradil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.84757841,0,mibefradil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.065721853,0.298475746,biotin
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.840228137,0.511507642,biotin
MUSCLE_CONTRACTION,1.719758394,0.503212923,biotin
APOPTOSIS,1.591116642,0.655743581,biotin
ESR_MEDIATED_SIGNALING,1.562784396,0.570261898,biotin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.459409478,0.745142213,biotin
EXTRACELLULAR_MATRIX_ORGANIZATION,1.451969152,0.640075779,biotin
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.419350186,0.632176047,biotin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.413300069,0.570434705,biotin
GLYCOSAMINOGLYCAN_METABOLISM,-2.02291375,1,biotin
GPCR_LIGAND_BINDING,-2.650311662,0,oxybuprocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.508259868,0,oxybuprocaine
SIGNALING_BY_GPCR,-2.392033307,0,oxybuprocaine
INTERFERON_ALPHA_BETA_SIGNALING,2.501022811,0.00642084,oxybuprocaine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.15543661,0.005680295,oxybuprocaine
G_ALPHA_I_SIGNALLING_EVENTS,-2.128456167,0.005998392,oxybuprocaine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.099176613,0.007119303,oxybuprocaine
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.835486055,0.303063658,oxybuprocaine
NEURONAL_SYSTEM,-1.876846124,0.067124858,oxybuprocaine
FATTY_ACID_METABOLISM,1.724707684,0.383966245,oxybuprocaine
DNA_REPLICATION,2.319681493,0.035173015,zolmitriptan
SYNTHESIS_OF_DNA,2.182756428,0.052759523,zolmitriptan
S_PHASE,2.104583751,0.059924397,zolmitriptan
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.074921957,0.054062227,zolmitriptan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.072943682,0.043510323,zolmitriptan
ORC1_REMOVAL_FROM_CHROMATIN,2.027805557,0.045160415,zolmitriptan
DNA_REPLICATION_PRE_INITIATION,1.946004845,0.068298924,zolmitriptan
G2_M_CHECKPOINTS,1.887397239,0.088421053,zolmitriptan
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.972285104,0.544289955,zolmitriptan
GLYCOSAMINOGLYCAN_METABOLISM,-1.946043874,0.331598188,zolmitriptan
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.024866667,0.128015963,benzydamine
PI3K_AKT_SIGNALING_IN_CANCER,1.872923087,0.17813542,benzydamine
MUSCLE_CONTRACTION,1.786397148,0.185180323,benzydamine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.742504348,0.175720024,benzydamine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.733421716,0.146614508,benzydamine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.674224238,0.169882818,benzydamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.496454069,0.360584046,benzydamine
CELL_CELL_COMMUNICATION,-2.890794699,1,benzydamine
DEVELOPMENTAL_CELL_LINEAGES,1.465153517,0.36789493,benzydamine
ADIPOGENESIS,1.421114043,0.40457875,benzydamine
GPCR_LIGAND_BINDING,2.407985615,0.013382378,bisacodyl
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.409319437,0.045269639,bisacodyl
NEURONAL_SYSTEM,2.194831704,0.032978003,bisacodyl
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.130238183,0.03250006,bisacodyl
MUSCLE_CONTRACTION,2.116607782,0.026525785,bisacodyl
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.321691637,0.060188043,bisacodyl
PEROXISOMAL_PROTEIN_IMPORT,-2.287154165,0.051442772,bisacodyl
CARDIAC_CONDUCTION,2.071613456,0.030779469,bisacodyl
G_ALPHA_I_SIGNALLING_EVENTS,1.982024668,0.048909405,bisacodyl
SIGNALING_BY_GPCR,1.975761868,0.044107225,bisacodyl
SIGNALING_BY_GPCR,2.630846091,0,myricetin
NEUTROPHIL_DEGRANULATION,-2.798713279,0.001472347,myricetin
GPCR_LIGAND_BINDING,2.467442157,0.000403635,myricetin
G_ALPHA_I_SIGNALLING_EVENTS,2.250259514,0.004843615,myricetin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.168009789,0.008274509,myricetin
POTASSIUM_CHANNELS,2.13469326,0.010171592,myricetin
MEMBRANE_TRAFFICKING,-2.425175428,0.04932364,myricetin
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.423067385,0.033863992,myricetin
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.351416132,0.042698077,myricetin
INNATE_IMMUNE_SYSTEM,-2.34749482,0.0347474,myricetin
ADAPTIVE_IMMUNE_SYSTEM,2.112215604,0.124472502,pioglitazone
INTERLEUKIN_1_SIGNALING,2.110582664,0.062891369,pioglitazone
INTERLEUKIN_1_FAMILY_SIGNALING,2.041669658,0.077303975,pioglitazone
PHOSPHOLIPID_METABOLISM,-1.920827899,0.338682645,pioglitazone
METABOLISM_OF_RNA,1.869437146,0.21717176,pioglitazone
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.843296407,0.173824757,pioglitazone
KERATINIZATION,1.843296407,0.173824757,pioglitazone
G2_M_CHECKPOINTS,1.732248877,0.329243806,pioglitazone
G_ALPHA_Q_SIGNALLING_EVENTS,1.715556939,0.329688351,pioglitazone
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.679025586,0.377202635,pioglitazone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.437111516,0.117425601,ritanserin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.362270334,0.236195769,ritanserin
MITOTIC_G2_G2_M_PHASES,1.898663564,0.657664942,ritanserin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.286191731,0.356161109,ritanserin
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.261153592,0.320679455,ritanserin
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.178621339,0.390821083,ritanserin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.755284056,0.847833118,ritanserin
HEMOSTASIS,-3.041485074,0.428468985,ritanserin
TRANSPORT_OF_SMALL_MOLECULES,-3.009425765,0.378912052,ritanserin
MEMBRANE_TRAFFICKING,-2.951518647,0.344769631,ritanserin
RESPIRATORY_ELECTRON_TRANSPORT,3.482617555,0,BRD-K98297262
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.440508359,0,BRD-K98297262
CELL_CYCLE_CHECKPOINTS,3.18825555,0,BRD-K98297262
SYNTHESIS_OF_DNA,2.698280165,0,BRD-K98297262
S_PHASE,2.716008102,0,BRD-K98297262
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.780718517,0,BRD-K98297262
TRANSLATION,3.120453513,0,BRD-K98297262
DNA_REPLICATION,2.910605124,0,BRD-K98297262
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.793253746,0,BRD-K98297262
SEPARATION_OF_SISTER_CHROMATIDS,2.521890953,0.000612207,BRD-K98297262
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.03539813,0.167924127,talniflumate
DISEASES_OF_GLYCOSYLATION,-2.376423062,0.720689227,talniflumate
BIOLOGICAL_OXIDATIONS,-2.363065531,0.401058875,talniflumate
EXTRACELLULAR_MATRIX_ORGANIZATION,1.733342321,0.396379045,talniflumate
MUSCLE_CONTRACTION,1.686495399,0.344526504,talniflumate
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.309532244,0.375631961,talniflumate
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.30934822,0.281723971,talniflumate
ADIPOGENESIS,1.661718453,0.296796132,talniflumate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.251299333,0.296512139,talniflumate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.222579581,0.268932517,talniflumate
ECM_PROTEOGLYCANS,-2.032845706,0.147875579,xaliproden
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.766798914,0.880887971,xaliproden
POTASSIUM_CHANNELS,1.593317915,1,xaliproden
NEURONAL_SYSTEM,1.583046183,1,xaliproden
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.751290334,0.655483804,xaliproden
DEVELOPMENTAL_CELL_LINEAGES,1.470712437,1,xaliproden
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.45473946,0.962771306,xaliproden
INFLUENZA_INFECTION,1.438933857,0.832967401,xaliproden
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.354844428,0.993910444,xaliproden
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.346784873,0.882893776,xaliproden
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.661084757,0,estradiol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.483013074,0,estradiol
NONSENSE_MEDIATED_DECAY_NMD,-2.491309883,0,estradiol
EUKARYOTIC_TRANSLATION_INITIATION,-2.506765576,0,estradiol
CELLULAR_RESPONSE_TO_STARVATION,-2.543556237,0,estradiol
SARS_COV_1_HOST_INTERACTIONS,-2.559811773,0,estradiol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.470883145,0,estradiol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.568489772,0,estradiol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.571434051,0,estradiol
SELENOAMINO_ACID_METABOLISM,-2.57190831,0,estradiol
PEROXISOMAL_PROTEIN_IMPORT,-2.436471733,0.002251447,diltiazem
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.234261383,0.078569429,diltiazem
MITOTIC_G2_G2_M_PHASES,2.124703547,0.076653102,diltiazem
REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1.940766874,0.1507511,diltiazem
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.869685116,0.179176625,diltiazem
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.865447362,0.146024159,diltiazem
SYNTHESIS_OF_DNA,1.820383851,0.1507511,diltiazem
DNA_REPLICATION,1.809361267,0.135511733,diltiazem
CELL_CYCLE_MITOTIC,1.781453256,0.138215124,diltiazem
PTEN_REGULATION,1.722017683,0.171617778,diltiazem
CELL_CELL_COMMUNICATION,2.215983585,0.055333327,BRD-K47869605
G_ALPHA_I_SIGNALLING_EVENTS,-2.168635458,0.054585497,BRD-K47869605
PI3K_AKT_SIGNALING_IN_CANCER,2.156352639,0.053403094,BRD-K47869605
MYD88_INDEPENDENT_TLR4_CASCADE,2.057626789,0.080211877,BRD-K47869605
BIOLOGICAL_OXIDATIONS,-2.055569773,0.087497341,BRD-K47869605
GPCR_LIGAND_BINDING,-2.052631428,0.059401865,BRD-K47869605
CELL_JUNCTION_ORGANIZATION,2.041593042,0.068844953,BRD-K47869605
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.971888021,0.094195338,BRD-K47869605
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1.947716722,0.089005157,BRD-K47869605
KERATINIZATION,1.937606898,0.07222286,BRD-K47869605
METABOLISM_OF_RNA,-4.478212224,0,bosutinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.871627527,0,bosutinib
MRNA_SPLICING,-2.882819935,0,bosutinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.88499719,0,bosutinib
SIGNALING_BY_GPCR,2.950647525,0,bosutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.981203776,0,bosutinib
TRNA_PROCESSING,-2.998735086,0,bosutinib
EUKARYOTIC_TRANSLATION_INITIATION,-3.066930996,0,bosutinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.076801878,0,bosutinib
GPCR_LIGAND_BINDING,3.096738606,0,bosutinib
INTERFERON_ALPHA_BETA_SIGNALING,3.20226647,0,cytarabine
IRON_UPTAKE_AND_TRANSPORT,2.683084392,0.000545841,cytarabine
INTERFERON_SIGNALING,2.540838422,0.001455577,cytarabine
METABOLISM_OF_RNA,-2.321311968,0.006786722,cytarabine
INTERFERON_GAMMA_SIGNALING,2.465055607,0.002729206,cytarabine
RRNA_PROCESSING,-2.100779942,0.036842204,cytarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.013979989,0.062373205,cytarabine
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.928085768,0.067684316,cytarabine
MRNA_SPLICING,-1.95347761,0.083379725,cytarabine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.856694985,0.090609648,cytarabine
METABOLISM_OF_RNA,-3.514748602,0,MEK-162
DNA_REPAIR,-2.597213122,0,MEK-162
DNA_STRAND_ELONGATION,-2.624223924,0,MEK-162
ORC1_REMOVAL_FROM_CHROMATIN,-2.669106794,0,MEK-162
G2_M_CHECKPOINTS,-2.712868087,0,MEK-162
MITOTIC_METAPHASE_AND_ANAPHASE,-2.744302492,0,MEK-162
M_PHASE,-2.751504361,0,MEK-162
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.779267432,0,MEK-162
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.789594881,0,MEK-162
EXTENSION_OF_TELOMERES,-2.587546467,0,MEK-162
METABOLISM_OF_RNA,-3.237958795,0,pitavastatin
DNA_REPLICATION,-2.602997217,0.00084207,pitavastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.601646683,0.00056138,pitavastatin
SYNTHESIS_OF_DNA,-2.500510819,0.003368281,pitavastatin
S_PHASE,-2.325880702,0.014820434,pitavastatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.169826645,0.036494094,pitavastatin
CELL_CYCLE,-2.283842205,0.017402783,pitavastatin
MRNA_SPLICING,-2.264488645,0.016600811,pitavastatin
CELL_CYCLE_MITOTIC,-2.252073502,0.01620985,pitavastatin
RRNA_PROCESSING,-2.20897841,0.020583936,pitavastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.097519346,0.08030216,alizapride
GPCR_LIGAND_BINDING,-2.066072417,0.053873601,alizapride
G_ALPHA_Q_SIGNALLING_EVENTS,-2.049025546,0.043031115,alizapride
EUKARYOTIC_TRANSLATION_ELONGATION,-2.037548434,0.038626355,alizapride
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.78212724,0.165661122,alizapride
NONSENSE_MEDIATED_DECAY_NMD,-1.982829925,0.05814283,alizapride
EUKARYOTIC_TRANSLATION_INITIATION,-1.961157244,0.064038431,alizapride
SIGNALING_BY_GPCR,-1.940357522,0.066942669,alizapride
SELENOAMINO_ACID_METABOLISM,-1.918976557,0.072043235,alizapride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.909124495,0.070927928,alizapride
UCH_PROTEINASES,-2.211088118,0.105050108,D-serine
PEROXISOMAL_PROTEIN_IMPORT,2.025586922,0.169128666,D-serine
CILIUM_ASSEMBLY,1.960482264,0.14206808,D-serine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.912330502,0.140940555,D-serine
TCR_SIGNALING,1.909204813,0.108242346,D-serine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.897552687,0.516172136,D-serine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.758912274,0.230962107,D-serine
SIGNALING_BY_NOTCH4,-1.742554382,0.928158774,D-serine
SIGNALING_BY_NOTCH,-1.70155534,0.878984083,D-serine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.676329573,0.315819596,D-serine
GLUCOSE_METABOLISM,-2.487424838,0.009722665,duloxetine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.197597921,0.063197322,duloxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.125361588,0.029833583,duloxetine
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-2.118452104,0.060496582,duloxetine
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.109584563,0.047803103,duloxetine
NUCLEOTIDE_EXCISION_REPAIR,-2.012151968,0.072595898,duloxetine
METABOLISM_OF_RNA,-1.961888259,0.076701024,duloxetine
GPCR_LIGAND_BINDING,2.008462287,0.054514092,duloxetine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.881423162,0.107412299,duloxetine
MRNA_SPLICING,-1.873605411,0.097631761,duloxetine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.356211832,0.0075151,irinotecan
GPCR_LIGAND_BINDING,2.160783859,0.029121014,irinotecan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.06355896,0.047595636,irinotecan
RESPIRATORY_ELECTRON_TRANSPORT,2.031985352,0.045090603,irinotecan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.449483166,0.296799091,irinotecan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.424851957,0.187367772,irinotecan
HEMOSTASIS,-2.402432748,0.150178917,irinotecan
INTERFERON_ALPHA_BETA_SIGNALING,1.957464621,0.066884394,irinotecan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.911839473,0.081726717,irinotecan
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.902579587,0.075419401,irinotecan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.70578318,0,sulpiride
EUKARYOTIC_TRANSLATION_INITIATION,-2.626456581,0,sulpiride
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.592496012,0,sulpiride
NONSENSE_MEDIATED_DECAY_NMD,-2.571752873,0,sulpiride
SELENOAMINO_ACID_METABOLISM,-2.557999258,0,sulpiride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.554543986,0,sulpiride
CELLULAR_RESPONSE_TO_STARVATION,-2.514935607,0,sulpiride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.463969114,0,sulpiride
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.359708791,0.000232633,sulpiride
INFLUENZA_INFECTION,-2.357678872,0.00020937,sulpiride
MUSCLE_CONTRACTION,2.740949421,0,thioridazine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.576109147,0.000688522,thioridazine
KEAP1_NFE2L2_PATHWAY,2.290996298,0.010557338,thioridazine
GPCR_LIGAND_BINDING,-2.134182921,0.067455498,thioridazine
NEDDYLATION,2.030661876,0.059212894,thioridazine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.034730865,0.082029217,thioridazine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.965230648,0.073534152,thioridazine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.945290441,0.072753827,thioridazine
CELLULAR_RESPONSE_TO_STARVATION,1.923744597,0.070622688,thioridazine
SYNTHESIS_OF_DNA,-1.906100592,0.161560082,thioridazine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.622322402,0.002868136,mifepristone
DNA_REPLICATION,2.545631292,0.001434068,mifepristone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.471297845,0.00191209,mifepristone
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.430695611,0.002151102,mifepristone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.373729901,0.004589017,mifepristone
SYNTHESIS_OF_DNA,2.278202706,0.006214294,mifepristone
DNA_REPLICATION_PRE_INITIATION,2.211465399,0.00778494,mifepristone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.133537944,0.012189577,mifepristone
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,2.121765554,0.011791225,mifepristone
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.09291096,0.012906611,mifepristone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.189516258,0.012781982,phenylbutazone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.187402501,0.006817057,phenylbutazone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.171858218,0.005964925,phenylbutazone
SELENOAMINO_ACID_METABOLISM,-2.127204157,0.008947387,phenylbutazone
NONSENSE_MEDIATED_DECAY_NMD,-2.10604841,0.009884733,phenylbutazone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.089794676,0.010509629,phenylbutazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.075686066,0.010955984,phenylbutazone
CELLULAR_RESPONSE_TO_STARVATION,-2.04304759,0.014592762,phenylbutazone
EUKARYOTIC_TRANSLATION_INITIATION,-2.010822525,0.018178818,phenylbutazone
SIGNALING_BY_ROBO_RECEPTORS,-2.005321465,0.017383495,phenylbutazone
SIGNALING_BY_GPCR,3.019421582,0,acitretin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.783189573,0.000356003,acitretin
GPCR_LIGAND_BINDING,2.658798001,0.00047467,acitretin
MUSCLE_CONTRACTION,2.600370984,0.000534004,acitretin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.522313655,0.009668608,acitretin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.470931833,0.011481473,acitretin
G_ALPHA_Q_SIGNALLING_EVENTS,2.224293575,0.007689655,acitretin
STRIATED_MUSCLE_CONTRACTION,2.189829676,0.008781396,acitretin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.404095611,0.034242988,acitretin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.397407309,0.030818689,acitretin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.100850218,0.102698297,BRD-K41170226
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.999862528,0.231749359,BRD-K41170226
MUSCLE_CONTRACTION,1.855990425,0.215788683,BRD-K41170226
RESPIRATORY_ELECTRON_TRANSPORT,1.591576389,0.683432714,BRD-K41170226
GPCR_LIGAND_BINDING,-1.686142063,1,BRD-K41170226
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.683303664,0.912668847,BRD-K41170226
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.656798791,0.827943275,BRD-K41170226
SENSORY_PERCEPTION,-1.645557887,0.72029196,BRD-K41170226
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.415423996,1,BRD-K41170226
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.409191086,0.993239243,BRD-K41170226
DEUBIQUITINATION,-3.5817764,0.018817733,xanthinol
DEATH_RECEPTOR_SIGNALING,-3.521451451,0.036590036,xanthinol
STRIATED_MUSCLE_CONTRACTION,2.003540199,0.221818801,xanthinol
MUSCLE_CONTRACTION,1.953271724,0.184688262,xanthinol
SENSORY_PERCEPTION,1.825125393,0.324369811,xanthinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.82243947,0.246893969,xanthinol
INNATE_IMMUNE_SYSTEM,-2.394944434,1,xanthinol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.250661697,0.861433998,xanthinol
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.158203078,0.707964932,xanthinol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.970758178,0.641719542,xanthinol
G_ALPHA_Q_SIGNALLING_EVENTS,-2.408682717,0.001795963,MK-1775
MITOTIC_G2_G2_M_PHASES,2.390881126,0.016476281,MK-1775
SIGNALING_BY_GPCR,-2.16072427,0.022898534,MK-1775
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.095166878,0.098223985,MK-1775
GPCR_LIGAND_BINDING,-2.052579571,0.046395723,MK-1775
CILIUM_ASSEMBLY,2.025734829,0.108152001,MK-1775
CELLULAR_SENESCENCE,-1.9396274,0.097431019,MK-1775
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.933009064,0.083691898,MK-1775
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.880060562,0.109104781,MK-1775
TRANSLATION,1.810727076,0.294671956,MK-1775
MUSCLE_CONTRACTION,2.711861861,0,thenoyltrifluoroacetone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.563984432,0.001062635,thenoyltrifluoroacetone
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,2.399163206,0.003187904,thenoyltrifluoroacetone
SIGNALING_BY_MET,2.384128457,0.003187904,thenoyltrifluoroacetone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.382417478,0.002550323,thenoyltrifluoroacetone
COLLAGEN_FORMATION,2.340079851,0.003010798,thenoyltrifluoroacetone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.325529549,0.002732489,thenoyltrifluoroacetone
CARDIAC_CONDUCTION,2.216423686,0.007039955,thenoyltrifluoroacetone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.151360649,0.010154065,thenoyltrifluoroacetone
STRIATED_MUSCLE_CONTRACTION,2.150122071,0.009244922,thenoyltrifluoroacetone
GPCR_LIGAND_BINDING,2.907727686,0,thiethylperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.779821562,0,thiethylperazine
G_ALPHA_Q_SIGNALLING_EVENTS,2.610056734,0,thiethylperazine
SIGNALING_BY_GPCR,2.46352812,0,thiethylperazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.303681436,0.001574872,thiethylperazine
DEUBIQUITINATION,-3.7552348,0.0795842,thiethylperazine
SENSORY_PERCEPTION,2.141398947,0.008232286,thiethylperazine
AMINE_LIGAND_BINDING_RECEPTORS,2.112599323,0.008897005,thiethylperazine
DEATH_RECEPTOR_SIGNALING,-3.595058074,0.330997921,thiethylperazine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-3.29938701,0.923056133,thiethylperazine
GPCR_LIGAND_BINDING,2.862554795,0,betaxolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.68599346,0.00042136,betaxolol
G_ALPHA_I_SIGNALLING_EVENTS,2.296693527,0.005056314,betaxolol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.391447028,0.02147115,betaxolol
SIGNALING_BY_GPCR,2.270460533,0.005056314,betaxolol
MUSCLE_CONTRACTION,2.184792195,0.008258646,betaxolol
COPII_MEDIATED_VESICLE_TRANSPORT,-2.276842357,0.049722664,betaxolol
ADAPTIVE_IMMUNE_SYSTEM,-2.240288736,0.048215917,betaxolol
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.161928195,0.060175724,betaxolol
SENSORY_PERCEPTION,2.006354165,0.031742416,betaxolol
GPCR_LIGAND_BINDING,2.634429341,0.000604529,selegiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.548393686,0.000302265,selegiline
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.406545988,0.037499342,selegiline
SENSORY_PERCEPTION,2.275356132,0.002619627,selegiline
SIGNALING_BY_GPCR,2.245997192,0.002871514,selegiline
NEUTROPHIL_DEGRANULATION,-2.317036212,0.036327487,selegiline
GLYCOSAMINOGLYCAN_METABOLISM,-2.171770637,0.071092502,selegiline
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.138537879,0.062108285,selegiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.08659871,0.011606963,selegiline
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.040782171,0.094217096,selegiline
SIGNALING_BY_GPCR,2.526201947,0,benzonatate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.713912143,0.006123255,benzonatate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.288867569,0.006834102,benzonatate
GPCR_LIGAND_BINDING,2.166379087,0.017939518,benzonatate
MUSCLE_CONTRACTION,2.129814583,0.017512387,benzonatate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.515716324,0.096747432,benzonatate
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.458281429,0.142059521,benzonatate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.433399272,0.142671846,benzonatate
G_ALPHA_I_SIGNALLING_EVENTS,1.88455529,0.106441141,benzonatate
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.253330785,0.418830656,benzonatate
METABOLISM_OF_RNA,-3.566766229,0,lapatinib
GPCR_LIGAND_BINDING,3.489176615,0,lapatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.419253854,0,lapatinib
SIGNALING_BY_GPCR,3.180459565,0,lapatinib
RRNA_PROCESSING,-3.107355992,0,lapatinib
NONSENSE_MEDIATED_DECAY_NMD,-2.937957513,0,lapatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.798777608,0,lapatinib
TRANSLATION,-2.75783542,0,lapatinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.732349924,0,lapatinib
SELENOAMINO_ACID_METABOLISM,-2.74472699,0.000367253,lapatinib
SYNTHESIS_OF_DNA,2.434379399,0.006608121,betamethasone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.281438469,0.011564212,betamethasone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.264681455,0.007709475,betamethasone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.255396865,0.005782106,betamethasone
DNA_REPLICATION,2.154851506,0.009251369,betamethasone
EUKARYOTIC_TRANSLATION_ELONGATION,1.990613891,0.021476393,betamethasone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.928294667,0.028497522,betamethasone
EUKARYOTIC_TRANSLATION_INITIATION,1.928294667,0.028497522,betamethasone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.128523112,0.068410958,betamethasone
DNA_REPLICATION_PRE_INITIATION,1.897614402,0.030103662,betamethasone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.442230114,0.012294552,ubenimex
NONSENSE_MEDIATED_DECAY_NMD,2.402047514,0.006147276,ubenimex
TRANSLATION,2.299447862,0.012294552,ubenimex
GPCR_LIGAND_BINDING,-2.203061373,0.010693839,ubenimex
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.179849207,0.005941022,ubenimex
G2_M_CHECKPOINTS,2.192537322,0.022130193,ubenimex
INFLUENZA_INFECTION,2.161864671,0.023113757,ubenimex
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.069670449,0.016832895,ubenimex
NUCLEOTIDE_EXCISION_REPAIR,2.075971281,0.036064018,ubenimex
CELLULAR_RESPONSE_TO_STARVATION,2.071291196,0.031263288,ubenimex
MUSCLE_CONTRACTION,2.762888741,0,PJ-34
SELENOAMINO_ACID_METABOLISM,2.199699084,0.039991474,PJ-34
EUKARYOTIC_TRANSLATION_ELONGATION,2.056180225,0.061741223,PJ-34
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.043316414,0.048936935,PJ-34
CARDIAC_CONDUCTION,1.990887253,0.057671915,PJ-34
EUKARYOTIC_TRANSLATION_INITIATION,1.920938914,0.070511283,PJ-34
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.919604007,0.060738931,PJ-34
SELECTIVE_AUTOPHAGY,1.894225862,0.062092026,PJ-34
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.841538125,0.076007188,PJ-34
NEUREXINS_AND_NEUROLIGINS,1.82670509,0.073668505,PJ-34
MUSCLE_CONTRACTION,2.60164216,0.002987097,quizartinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.153636357,0.028875275,quizartinib
PEPTIDE_HORMONE_METABOLISM,1.985223305,0.073017936,quizartinib
CARDIAC_CONDUCTION,1.933970417,0.078411307,quizartinib
HEMOSTASIS,1.853793169,0.113509701,quizartinib
TCR_SIGNALING,1.820997562,0.118654147,quizartinib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.805462919,0.112087274,quizartinib
L1CAM_INTERACTIONS,1.776061874,0.117492498,quizartinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.805909837,1,quizartinib
INNATE_IMMUNE_SYSTEM,1.750551047,0.12302416,quizartinib
GPCR_LIGAND_BINDING,-2.057898699,0.067218821,nilotinib
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1.954057765,0.342124419,nilotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.953147125,0.092425879,nilotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.915238762,0.097747369,nilotinib
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1.664519034,0.813455401,nilotinib
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.603466671,0.733990332,nilotinib
INTERFERON_GAMMA_SIGNALING,1.594034197,0.579609721,nilotinib
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.574252318,0.511366818,nilotinib
G_ALPHA_S_SIGNALLING_EVENTS,-1.772326203,0.286310167,nilotinib
SENSORY_PERCEPTION,-1.753825391,0.269379426,nilotinib
GPCR_LIGAND_BINDING,2.792977325,0,captopril
SIGNALING_BY_GPCR,2.580622949,0,captopril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.518826692,0,captopril
G_ALPHA_Q_SIGNALLING_EVENTS,2.170113397,0.007796565,captopril
G_ALPHA_I_SIGNALLING_EVENTS,1.947390359,0.060203044,captopril
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.913932104,0.06960412,captopril
SENSORY_PERCEPTION,1.830205724,0.122130049,captopril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.19472335,1,captopril
GLYCOSAMINOGLYCAN_METABOLISM,-2.175334213,1,captopril
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.103101372,1,captopril
GPCR_LIGAND_BINDING,-2.218606638,0.010877935,glipizide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.954574109,0.090649461,glipizide
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.936633588,0.403478225,glipizide
CILIUM_ASSEMBLY,1.928108662,0.212310594,glipizide
RESPIRATORY_ELECTRON_TRANSPORT,1.875809423,0.200270851,glipizide
SIGNALING_BY_GPCR,-1.915232785,0.087748679,glipizide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.886251238,0.0841227,glipizide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.803023111,0.134306242,glipizide
SIGNALING_BY_HEDGEHOG,1.669682707,0.471752379,glipizide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.68679036,0.285727102,glipizide
NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,-2.292396555,0.017335491,azathioprine
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.016598841,0.10834682,azathioprine
RHOA_GTPASE_CYCLE,-1.997295739,0.092455953,azathioprine
NOD1_2_SIGNALING_PATHWAY,-1.954262121,0.091011328,azathioprine
NEUTROPHIL_DEGRANULATION,-1.867682868,0.127849247,azathioprine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.670506601,0.321428898,azathioprine
GLYCOSAMINOGLYCAN_METABOLISM,-1.623228286,0.346090698,azathioprine
ESR_MEDIATED_SIGNALING,-1.576956321,0.386527279,azathioprine
DISEASES_OF_GLYCOSYLATION,-1.567493171,0.362119148,azathioprine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.563404573,0.333058123,azathioprine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.443730141,0.004220794,fulvestrant
SARS_COV_2_HOST_INTERACTIONS,2.26011865,0.013717582,fulvestrant
TRANSLATION,2.233734078,0.013014116,fulvestrant
INFLUENZA_INFECTION,2.128474615,0.023478169,fulvestrant
EUKARYOTIC_TRANSLATION_INITIATION,2.081853519,0.029123482,fulvestrant
HEMOSTASIS,-2.040857777,0.233604504,fulvestrant
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.010734641,0.040273414,fulvestrant
SARS_COV_2_INFECTION,1.957976559,0.052458445,fulvestrant
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.926838676,0.058563523,fulvestrant
CDC42_GTPASE_CYCLE,-1.911538842,0.33254856,fulvestrant
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.19067805,0.029704319,carmustine
KERATINIZATION,-2.142525983,0.028054079,carmustine
ADAPTIVE_IMMUNE_SYSTEM,1.970238825,0.372160464,carmustine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.96210869,0.198738751,carmustine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.958360493,0.137555908,carmustine
C_TYPE_LECTIN_RECEPTORS_CLRS,1.949430338,0.109812654,carmustine
CILIUM_ASSEMBLY,-1.853306884,0.252761755,carmustine
TRANSLATION,1.77817006,0.287854726,carmustine
CLEC7A_DECTIN_1_SIGNALING,1.695027031,0.392414095,carmustine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.688450531,0.34575841,carmustine
MRNA_SPLICING,2.164997324,0.051209904,itraconazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.846965904,0.153629713,itraconazole
NUCLEOTIDE_EXCISION_REPAIR,1.735112713,0.168730069,itraconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.932075826,0.310109483,itraconazole
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.677071942,0.162000563,itraconazole
GPCR_LIGAND_BINDING,-1.895899302,0.238289649,itraconazole
SIGNALING_BY_GPCR,-1.871760849,0.205154228,itraconazole
SELENOAMINO_ACID_METABOLISM,-1.870142618,0.155530369,itraconazole
EUKARYOTIC_TRANSLATION_ELONGATION,-1.85987656,0.13602962,itraconazole
SENSORY_PERCEPTION,-1.844590149,0.130322083,itraconazole
UCH_PROTEINASES,-2.108223698,0.247588768,doxofylline
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.883832152,0.434912487,doxofylline
GASTRULATION,-1.89686086,0.526466227,doxofylline
SIGNALING_BY_NOTCH,-1.872618493,0.42353097,doxofylline
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-1.861255798,0.342135029,doxofylline
CILIUM_ASSEMBLY,1.804829959,0.368296337,doxofylline
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.811792093,0.389884291,doxofylline
MITF_M_DEPENDENT_GENE_EXPRESSION,1.766072923,0.30931023,doxofylline
SYNTHESIS_OF_DNA,-1.789928157,0.368889127,doxofylline
SIGNALING_BY_NOTCH4,-1.753526557,0.40500392,doxofylline
SELENOAMINO_ACID_METABOLISM,3.213751965,0,fomepizole
CELLULAR_RESPONSE_TO_STARVATION,2.901658424,0,fomepizole
TRANSLATION,2.87934234,0,fomepizole
EUKARYOTIC_TRANSLATION_INITIATION,2.858572834,0,fomepizole
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.447368048,0.000927063,fomepizole
COLLAGEN_DEGRADATION,-2.436572595,0.000463531,fomepizole
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.332113322,0.000618042,fomepizole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.377333997,0.001422558,fomepizole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.242826279,0.00162236,fomepizole
RRNA_PROCESSING,2.304190572,0.00237093,fomepizole
GLUCOSE_METABOLISM,-1.93876795,0.27898352,mycophenolate-mofetil
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.93280997,0.150187614,mycophenolate-mofetil
METABOLISM_OF_STEROIDS,1.788770937,0.560434836,mycophenolate-mofetil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.665803739,0.55736396,mycophenolate-mofetil
MUSCLE_CONTRACTION,1.649828335,0.40586742,mycophenolate-mofetil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.804595538,0.317013222,mycophenolate-mofetil
HEMOSTASIS,1.485823184,0.715514065,mycophenolate-mofetil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.471492114,0.614175163,mycophenolate-mofetil
ADAPTIVE_IMMUNE_SYSTEM,1.427830164,0.634903574,mycophenolate-mofetil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.373800701,0.703888606,mycophenolate-mofetil
EUKARYOTIC_TRANSLATION_ELONGATION,3.033107645,0,allopurinol
RRNA_PROCESSING,2.55908353,0,allopurinol
NONSENSE_MEDIATED_DECAY_NMD,2.602354087,0,allopurinol
INFLUENZA_INFECTION,2.636356358,0,allopurinol
SELENOAMINO_ACID_METABOLISM,2.779798799,0,allopurinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.608057937,0,allopurinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.891569877,0,allopurinol
CELLULAR_RESPONSE_TO_STARVATION,2.984440105,0,allopurinol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.998334799,0,allopurinol
GPCR_LIGAND_BINDING,-3.007688932,0,allopurinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.971339612,0,rabeprazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.546328572,0,rabeprazole
TRANSLATION,2.889652191,0.001080082,rabeprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.844549972,0.000720054,rabeprazole
CELLULAR_RESPONSE_TO_STARVATION,2.79757995,0.000540041,rabeprazole
EUKARYOTIC_TRANSLATION_INITIATION,2.78386431,0.000432033,rabeprazole
NONSENSE_MEDIATED_DECAY_NMD,2.773290931,0.000360027,rabeprazole
EUKARYOTIC_TRANSLATION_ELONGATION,2.663305229,0.000308595,rabeprazole
SELENOAMINO_ACID_METABOLISM,2.652606561,0.00027002,rabeprazole
GPCR_LIGAND_BINDING,-2.458962132,0.000285012,rabeprazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.512700695,0,aniracetam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.113564596,0.02337684,aniracetam
INFLUENZA_INFECTION,2.121564188,0.042018427,aniracetam
TCR_SIGNALING,1.990812266,0.068895079,aniracetam
SIGNALING_BY_NOTCH,-2.02658797,0.04090947,aniracetam
CELLULAR_RESPONSE_TO_STARVATION,1.897681203,0.082333405,aniracetam
TRANSLATION,1.753392538,0.128553675,aniracetam
ADAPTIVE_IMMUNE_SYSTEM,1.715217061,0.132111992,aniracetam
INNATE_IMMUNE_SYSTEM,1.694335405,0.128164315,aniracetam
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.640516631,0.146780587,aniracetam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.217488206,0.070866857,alitretinoin
PI3K_AKT_SIGNALING_IN_CANCER,1.938092511,0.311596016,alitretinoin
INFLUENZA_INFECTION,-2.051101466,0.145564355,alitretinoin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.907931067,0.193233572,alitretinoin
SIGNALING_BY_ROBO_RECEPTORS,-2.031941377,0.114919228,alitretinoin
NONSENSE_MEDIATED_DECAY_NMD,-1.996821276,0.116116303,alitretinoin
GPCR_LIGAND_BINDING,1.809246192,0.235256827,alitretinoin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.944198488,0.141542182,alitretinoin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.758527787,0.24250538,alitretinoin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.900045698,0.155619788,alitretinoin
SIGNALING_BY_INTERLEUKINS,2.600009367,0.002829492,methylene-blue
KEAP1_NFE2L2_PATHWAY,2.215278923,0.024050685,methylene-blue
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.173234486,0.023579103,methylene-blue
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.163733434,0.019099073,methylene-blue
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.120139886,0.023201837,methylene-blue
RRNA_PROCESSING,2.033844156,0.033010744,methylene-blue
EUKARYOTIC_TRANSLATION_ELONGATION,2.010561414,0.032337055,methylene-blue
SELENOAMINO_ACID_METABOLISM,1.987382933,0.031831789,methylene-blue
EUKARYOTIC_TRANSLATION_INITIATION,1.93951271,0.033953908,methylene-blue
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.893849926,0.039046994,methylene-blue
TRANSLATION,2.47620368,0.009411027,carbenoxolone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.29916211,0.032938593,carbenoxolone
SELENOAMINO_ACID_METABOLISM,2.297167578,0.021959062,carbenoxolone
EUKARYOTIC_TRANSLATION_ELONGATION,2.240617127,0.022351188,carbenoxolone
NONSENSE_MEDIATED_DECAY_NMD,2.231400187,0.017880951,carbenoxolone
DNA_REPLICATION_PRE_INITIATION,2.229158654,0.014900792,carbenoxolone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.198320079,0.013444324,carbenoxolone
EUKARYOTIC_TRANSLATION_INITIATION,2.189792425,0.011763783,carbenoxolone
PEPTIDE_HORMONE_METABOLISM,-2.299920141,0.020708143,carbenoxolone
BIOLOGICAL_OXIDATIONS,-2.237737521,0.018565922,carbenoxolone
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.796715062,1,amperozide
GASTRULATION,1.754054568,0.947279423,amperozide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.003562052,1,amperozide
MITOTIC_G2_G2_M_PHASES,1.679063266,0.988560956,amperozide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.959799039,1,amperozide
DNA_REPLICATION,1.655368233,0.858348462,amperozide
SYNTHESIS_OF_DNA,1.628862086,0.799192904,amperozide
CELL_CYCLE_MITOTIC,1.609546753,0.728575134,amperozide
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.605587596,0.638420784,amperozide
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.598318104,0.580850926,amperozide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.188194221,0,caffeine
SARS_COV_2_HOST_INTERACTIONS,-2.480682136,0,caffeine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.666477129,0,caffeine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.67753444,0,caffeine
SIGNALING_BY_ROBO_RECEPTORS,-2.735643984,0,caffeine
INFLUENZA_INFECTION,-2.754483208,0,caffeine
SARS_COV_1_INFECTION,-2.84055331,0,caffeine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.896318437,0,caffeine
TRANSLATION,-2.921493575,0,caffeine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.635511573,0,caffeine
GPCR_LIGAND_BINDING,2.816232537,0,dioxybenzone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.574542437,0.000421195,dioxybenzone
SIGNALING_BY_GPCR,2.348717167,0.004211945,dioxybenzone
SENSORY_PERCEPTION,2.028716516,0.043172437,dioxybenzone
G_ALPHA_I_SIGNALLING_EVENTS,1.865723183,0.117092073,dioxybenzone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.168882529,1,dioxybenzone
MUSCLE_CONTRACTION,1.765521167,0.190099121,dioxybenzone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.715349638,0.22335343,dioxybenzone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.04373795,1,dioxybenzone
GLYCOSAMINOGLYCAN_METABOLISM,-1.969984589,1,dioxybenzone
MITOTIC_METAPHASE_AND_ANAPHASE,3.163608042,0,triprolidine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.944974411,0,triprolidine
TRANSLATION,2.933039467,0,triprolidine
CELL_CYCLE_MITOTIC,2.80777243,0,triprolidine
M_PHASE,2.759695467,0,triprolidine
RESPIRATORY_ELECTRON_TRANSPORT,2.752075136,0,triprolidine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.667996547,0,triprolidine
SEPARATION_OF_SISTER_CHROMATIDS,2.661393864,0,triprolidine
CELL_CYCLE_CHECKPOINTS,2.660977006,0,triprolidine
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.561695016,0.000188254,triprolidine
SIGNALING_BY_GPCR,2.606375014,0,loxapine
GPCR_LIGAND_BINDING,2.58750185,0,loxapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.505761685,0,loxapine
SENSORY_PERCEPTION,2.500770348,0,loxapine
G_ALPHA_Q_SIGNALLING_EVENTS,2.082505786,0.022839393,loxapine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.176583346,0.225242086,loxapine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.051702445,0.025424449,loxapine
PROTEIN_LOCALIZATION,-2.147380926,0.136056636,loxapine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.984051933,0.041636847,loxapine
MUSCLE_CONTRACTION,1.969727321,0.040267214,loxapine
MUSCLE_CONTRACTION,2.708962013,0,halcinonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.799231348,0,halcinonide
SIGNALING_BY_GPCR,3.23926771,0,halcinonide
GPCR_LIGAND_BINDING,3.288803222,0,halcinonide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.582285897,0.000193531,halcinonide
EUKARYOTIC_TRANSLATION_INITIATION,-3.41319503,0.003039965,halcinonide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.379181015,0.001935315,halcinonide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.372640724,0.004728835,halcinonide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.376812428,0.007093253,halcinonide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.367807747,0.005066609,halcinonide
SIGNALING_BY_GPCR,3.430410965,0,BRD-K97118047
GPCR_LIGAND_BINDING,3.250011953,0,BRD-K97118047
MUSCLE_CONTRACTION,3.161711811,0.000260178,BRD-K97118047
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.044686968,0.000390266,BRD-K97118047
G_ALPHA_I_SIGNALLING_EVENTS,2.6715722,0.000260178,BRD-K97118047
CARDIAC_CONDUCTION,2.767993153,0.000312213,BRD-K97118047
G_ALPHA_Q_SIGNALLING_EVENTS,2.647365792,0.000334514,BRD-K97118047
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.551878231,0.000390266,BRD-K97118047
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.896458516,0.034343434,BRD-K97118047
KERATINIZATION,1.896458516,0.034343434,BRD-K97118047
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.507101332,0,phenytoin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.481695723,0,phenytoin
SIGNALING_BY_GPCR,-2.436900383,0,phenytoin
COLLAGEN_DEGRADATION,-2.434720874,0,phenytoin
SIGNALING_BY_PDGF,-2.414759492,0,phenytoin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.411497016,0,phenytoin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.326715758,0.000131471,phenytoin
GPCR_LIGAND_BINDING,-2.314554748,0.000230074,phenytoin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.254120067,0.000715786,phenytoin
ECM_PROTEOGLYCANS,-2.214875502,0.001472474,phenytoin
MUSCLE_CONTRACTION,3.021491803,0,cromoglicic-acid
NEURONAL_SYSTEM,2.979377131,0,cromoglicic-acid
STRIATED_MUSCLE_CONTRACTION,2.707178711,0,cromoglicic-acid
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.47191144,0.000405528,cromoglicic-acid
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.354324092,0.000811056,cromoglicic-acid
CARDIAC_CONDUCTION,2.082834101,0.015139718,cromoglicic-acid
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.970743426,0.031978792,cromoglicic-acid
SIGNALING_BY_GPCR,1.845599438,0.073400597,cromoglicic-acid
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.933617824,1,cromoglicic-acid
DEUBIQUITINATION,-1.924168069,0.737147859,cromoglicic-acid
GASTRULATION,2.32894805,0.00979126,BRD-K73589401
FORMATION_OF_PARAXIAL_MESODERM,2.153219737,0.04460463,BRD-K73589401
SEPARATION_OF_SISTER_CHROMATIDS,2.011113182,0.095736766,BRD-K73589401
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.951246496,0.115863245,BRD-K73589401
CELL_CYCLE_CHECKPOINTS,1.942757217,0.100741188,BRD-K73589401
MITOTIC_SPINDLE_CHECKPOINT,1.910047022,0.106978583,BRD-K73589401
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.793198331,0.227219402,BRD-K73589401
MITOTIC_METAPHASE_AND_ANAPHASE,1.779608752,0.2170396,BRD-K73589401
PTEN_REGULATION,1.711917382,0.298572995,BRD-K73589401
SIGNALING_BY_NOTCH4,1.701243497,0.28612238,BRD-K73589401
EUKARYOTIC_TRANSLATION_ELONGATION,-2.727997794,0,ketotifen
INFLUENZA_INFECTION,-2.373336503,0,ketotifen
SIGNALING_BY_ROBO_RECEPTORS,-2.394424304,0,ketotifen
CELLULAR_RESPONSE_TO_STARVATION,-2.408042844,0,ketotifen
RRNA_PROCESSING,-2.424077116,0,ketotifen
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.452099607,0,ketotifen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.47467814,0,ketotifen
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.505955853,0,ketotifen
SARS_COV_1_HOST_INTERACTIONS,-2.347432108,0,ketotifen
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.551636016,0,ketotifen
SENSORY_PERCEPTION,2.816618462,0,brompheniramine
VISUAL_PHOTOTRANSDUCTION,2.732358484,0,brompheniramine
GPCR_LIGAND_BINDING,2.470865479,0.000890278,brompheniramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.197289035,0.01224132,brompheniramine
SIGNALING_BY_GPCR,1.934535772,0.077276113,brompheniramine
NEURONAL_SYSTEM,1.89309844,0.085615049,brompheniramine
REGULATION_OF_INSULIN_SECRETION,1.812244122,0.128200004,brompheniramine
POTASSIUM_CHANNELS,1.752533016,0.170933338,brompheniramine
INTEGRATION_OF_ENERGY_METABOLISM,1.730068744,0.174890128,brompheniramine
G_ALPHA_Q_SIGNALLING_EVENTS,1.690102984,0.206277367,brompheniramine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.409856973,0.002033716,equilin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.401446912,0.001016858,equilin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.333768487,0.001016858,equilin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.24844033,0.002542145,equilin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.212106787,0.002847202,equilin
CELLULAR_RESPONSE_TO_STARVATION,-2.199095791,0.002542145,equilin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.197443732,0.002178981,equilin
SELENOAMINO_ACID_METABOLISM,-2.187164999,0.00228793,equilin
EUKARYOTIC_TRANSLATION_INITIATION,-2.187158618,0.002033716,equilin
NONSENSE_MEDIATED_DECAY_NMD,-2.165661109,0.002745516,equilin
GPCR_LIGAND_BINDING,2.354989563,0.003289147,bromfenac
NEUTROPHIL_DEGRANULATION,-2.337035073,0.076897371,bromfenac
SIGNALING_BY_GPCR,2.055351291,0.0559155,bromfenac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.010728049,0.059204647,bromfenac
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.957344121,0.348061785,bromfenac
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.946507052,0.247555572,bromfenac
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.934261966,0.201349696,bromfenac
INNATE_IMMUNE_SYSTEM,-1.9322119,0.162293925,bromfenac
SARS_COV_1_INFECTION,-1.863216332,0.198651542,bromfenac
NUCLEOTIDE_EXCISION_REPAIR,-1.775079655,0.268562623,bromfenac
MRNA_SPLICING,3.137409105,0,cariporide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.865323841,0.001951143,cariporide
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.948291695,0.093654882,cariporide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.807427576,0.138531179,cariporide
REGULATION_OF_RAS_BY_GAPS,1.440151198,0.648560056,cariporide
HEDGEHOG_ON_STATE,1.425364582,0.577538438,cariporide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.218276245,1,cariporide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.193614687,0.962831298,cariporide
GPCR_LIGAND_BINDING,-2.119102938,0.728411557,cariporide
ABC_TRANSPORTER_DISORDERS,1.338729218,0.777112531,cariporide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.282826436,0,metamizole
MITF_M_DEPENDENT_GENE_EXPRESSION,2.516518871,0.009521194,metamizole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.160096614,0.006993665,metamizole
ECM_PROTEOGLYCANS,-2.159461593,0.004662443,metamizole
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.223007242,0.023802985,metamizole
HIV_LIFE_CYCLE,2.02996334,0.051573133,metamizole
NCAM1_INTERACTIONS,-2.01798856,0.02118669,metamizole
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.902373739,0.072004028,metamizole
GPCR_LIGAND_BINDING,-1.974703378,0.025177192,metamizole
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.963592435,0.023449346,metamizole
GPCR_LIGAND_BINDING,-2.011552675,0.127287271,doramapimod
GASTRULATION,-1.976892637,0.099233827,doramapimod
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.904071079,0.42926671,doramapimod
FATTY_ACID_METABOLISM,1.875938453,0.256367618,doramapimod
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.893762643,0.137057128,doramapimod
PROTEIN_LOCALIZATION,1.741967336,0.343526931,doramapimod
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.616068274,0.502940461,doramapimod
CELL_JUNCTION_ORGANIZATION,-1.788852242,0.263995475,doramapimod
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.572264151,0.500470474,doramapimod
SIGNALING_BY_GPCR,-1.746335532,0.302139786,doramapimod
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.898746172,0.458738469,paclitaxel
GPCR_LIGAND_BINDING,1.817295473,0.390924956,paclitaxel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.808973048,0.271254051,paclitaxel
CHROMATIN_ORGANIZATION,-1.754755574,1,paclitaxel
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.622517569,0.60259287,paclitaxel
INTERLEUKIN_1_FAMILY_SIGNALING,-1.740979088,1,paclitaxel
LEISHMANIA_INFECTION,1.583976034,0.58578908,paclitaxel
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.577971573,0.50295022,paclitaxel
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.699670568,1,paclitaxel
EPH_EPHRIN_SIGNALING,-1.640995285,1,paclitaxel
KERATINIZATION,-2.764849736,0,exemestane
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.629583154,0.000420079,exemestane
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.374246745,0.002800526,exemestane
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.325626127,0.013550019,exemestane
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2.145917542,0.046860483,exemestane
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.167469838,0.016803155,exemestane
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.138791084,0.03274588,exemestane
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.044327641,0.058999042,exemestane
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.008617122,0.061878421,exemestane
KEAP1_NFE2L2_PATHWAY,1.988502845,0.06229245,exemestane
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.241601637,0.009779204,sufentanil
MRNA_SPLICING,2.085569416,0.023225609,sufentanil
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.833661848,0.10023684,sufentanil
EUKARYOTIC_TRANSLATION_ELONGATION,-1.933779003,0.231124353,sufentanil
SELENOAMINO_ACID_METABOLISM,-1.913438599,0.148180533,sufentanil
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.624649263,0.238979296,sufentanil
NONSENSE_MEDIATED_DECAY_NMD,-1.882466266,0.141967512,sufentanil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.859513047,0.133502272,sufentanil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.841897676,0.131032597,sufentanil
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.825991869,0.12581366,sufentanil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.316994818,0.002581383,KD-025
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.314911616,0.001290691,KD-025
COLLAGEN_FORMATION,-2.248477063,0.002868203,KD-025
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.188714522,0.067894434,KD-025
ADAPTIVE_IMMUNE_SYSTEM,2.188643017,0.033947217,KD-025
TCR_SIGNALING,2.125915732,0.033695756,KD-025
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.038667196,0.041868235,KD-025
ECM_PROTEOGLYCANS,-1.964180239,0.0565753,KD-025
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.873334633,0.094750455,KD-025
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.944404771,0.056274139,KD-025
SYNTHESIS_OF_DNA,-1.979386095,0.283525346,zafirlukast
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.951040997,0.166935484,zafirlukast
DNA_REPLICATION,-1.808277363,0.253494624,zafirlukast
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.742781254,0.285512673,zafirlukast
METABOLISM_OF_RNA,-1.726933881,0.249078341,zafirlukast
DEATH_RECEPTOR_SIGNALING,1.89371881,0.44227249,zafirlukast
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.64385676,0.307373272,zafirlukast
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.633949089,0.242785138,zafirlukast
RESPIRATORY_ELECTRON_TRANSPORT,-1.634017558,0.277468729,zafirlukast
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.618455341,0.232885305,zafirlukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.694335145,0,tandutinib
CELL_CYCLE,-2.551469036,0,tandutinib
M_PHASE,-2.545757853,0,tandutinib
GPCR_LIGAND_BINDING,2.464946723,0.000922941,tandutinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.383789806,0.001435686,tandutinib
CELL_CYCLE_MITOTIC,-2.335239461,0.004337127,tandutinib
METABOLISM_OF_RNA,-2.261005542,0.008782681,tandutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.247370971,0.004153236,tandutinib
CHROMATIN_ORGANIZATION,-2.155379998,0.018215931,tandutinib
MITOTIC_PROMETAPHASE,-2.147929483,0.016481081,tandutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.327857488,0.000879002,ALW-II-49-7
GPCR_LIGAND_BINDING,2.300776455,0.000439501,ALW-II-49-7
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.273389217,0.001172003,ALW-II-49-7
G_ALPHA_Q_SIGNALLING_EVENTS,2.24193746,0.002197505,ALW-II-49-7
RRNA_PROCESSING,-2.188915099,0.04967138,ALW-II-49-7
MITOTIC_SPINDLE_CHECKPOINT,-2.118549904,0.037681737,ALW-II-49-7
SIGNALING_BY_GPCR,2.14852101,0.008086818,ALW-II-49-7
CELL_CYCLE_CHECKPOINTS,-2.053989179,0.037110801,ALW-II-49-7
NUCLEOTIDE_EXCISION_REPAIR,-1.799126321,0.122893846,ALW-II-49-7
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.758475694,0.125034854,ALW-II-49-7
NONSENSE_MEDIATED_DECAY_NMD,2.77535335,0,etacrynic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.765563634,0,etacrynic-acid
TRANSLATION,2.671741985,0,etacrynic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.667285563,0,etacrynic-acid
METABOLISM_OF_RNA,2.618530615,0,etacrynic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.815649678,0.000390437,etacrynic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.543773264,0.000320747,etacrynic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.629693763,0.000585655,etacrynic-acid
GPCR_LIGAND_BINDING,-2.605077699,0.000390437,etacrynic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.501483279,0.000824778,etacrynic-acid
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.369321871,0.046366868,tolazoline
ORC1_REMOVAL_FROM_CHROMATIN,2.210160399,0.066447591,tolazoline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.34544753,0.026780863,tolazoline
G2_M_CHECKPOINTS,2.110059129,0.047117383,tolazoline
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.112019735,0.070072005,tolazoline
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.096786895,0.041378727,tolazoline
CELL_CYCLE_CHECKPOINTS,2.07115776,0.04035181,tolazoline
DNA_REPLICATION,2.067913844,0.034230577,tolazoline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.060553358,0.030548633,tolazoline
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.202841462,0.063954301,tolazoline
COLLAGEN_FORMATION,-2.322747484,0.020033934,oxybutynin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.251765797,0.017856333,oxybutynin
SENSORY_PERCEPTION,-2.152181148,0.031357462,oxybutynin
ECM_PROTEOGLYCANS,-2.103615331,0.038543547,oxybutynin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.094944245,0.032576919,oxybutynin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.048153987,0.040067869,oxybutynin
ADAPTIVE_IMMUNE_SYSTEM,1.987107433,0.335102494,oxybutynin
GPCR_LIGAND_BINDING,-1.941616237,0.075407231,oxybutynin
CILIUM_ASSEMBLY,1.897502594,0.335102494,oxybutynin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.897420778,0.223401663,oxybutynin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.896400794,0,BRD-K45330754
NERVOUS_SYSTEM_DEVELOPMENT,-2.508552682,0,BRD-K45330754
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.52671806,0,BRD-K45330754
SARS_COV_1_INFECTION,-2.561249831,0,BRD-K45330754
INFLUENZA_INFECTION,-2.578042347,0,BRD-K45330754
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.650732732,0,BRD-K45330754
CELLULAR_RESPONSE_TO_STARVATION,-2.674613682,0,BRD-K45330754
EUKARYOTIC_TRANSLATION_INITIATION,-2.715858051,0,BRD-K45330754
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.728682125,0,BRD-K45330754
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.7674646,0,BRD-K45330754
EUKARYOTIC_TRANSLATION_ELONGATION,-3.062626574,0,ritonavir
INFECTIOUS_DISEASE,-2.357524048,0,ritonavir
NERVOUS_SYSTEM_DEVELOPMENT,-2.37010531,0,ritonavir
VIRAL_INFECTION_PATHWAYS,-2.425441119,0,ritonavir
SARS_COV_2_HOST_INTERACTIONS,-2.548711595,0,ritonavir
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.608457526,0,ritonavir
TRANSLATION,-2.652614763,0,ritonavir
SIGNALING_BY_ROBO_RECEPTORS,-2.680368119,0,ritonavir
SARS_COV_1_HOST_INTERACTIONS,-2.684967712,0,ritonavir
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.711436538,0,ritonavir
METABOLISM_OF_RNA,3.696417243,0,nifedipine
RESPIRATORY_ELECTRON_TRANSPORT,3.522704148,0,nifedipine
RRNA_PROCESSING,3.46904354,0,nifedipine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.300927868,0,nifedipine
TRANSLATION,3.250492322,0,nifedipine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.983609423,0,nifedipine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.953830805,0,nifedipine
HIV_INFECTION,2.521499674,0,nifedipine
S_PHASE,2.491627719,0.000645856,nifedipine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.452838312,0.00058127,nifedipine
GPCR_LIGAND_BINDING,-2.242550718,0.028277587,moxifloxacin
EUKARYOTIC_TRANSLATION_INITIATION,-2.232716582,0.014580631,moxifloxacin
MITOCHONDRIAL_BIOGENESIS,2.121267019,0.115738967,moxifloxacin
NEDDYLATION,2.090508205,0.075675478,moxifloxacin
RNA_POLYMERASE_II_TRANSCRIPTION,2.07628819,0.056385651,moxifloxacin
KERATINIZATION,-2.07889754,0.046834753,moxifloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.038856182,0.049485777,moxifloxacin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.982362816,0.091255724,moxifloxacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.949474921,0.076879689,moxifloxacin
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.918930847,0.078647038,moxifloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.007405592,0,tubocurarine
GPCR_LIGAND_BINDING,2.862087702,0,tubocurarine
SIGNALING_BY_GPCR,2.753026621,0,tubocurarine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.548062056,0,tubocurarine
G_ALPHA_I_SIGNALLING_EVENTS,2.376494729,0.00048617,tubocurarine
G_ALPHA_Q_SIGNALLING_EVENTS,2.354044387,0.000810284,tubocurarine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.087565552,0.010765202,tubocurarine
SENSORY_PERCEPTION,2.06118622,0.012002332,tubocurarine
G_ALPHA_S_SIGNALLING_EVENTS,2.013976127,0.01546292,tubocurarine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.413355957,1,tubocurarine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.922660412,0,ketorolac
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.326791321,0.005756358,ketorolac
COLLAGEN_DEGRADATION,2.516608284,0.002139068,ketorolac
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,2.44896265,0.002218293,ketorolac
SIGNALING_BY_NTRKS,-2.209026512,0.016117802,ketorolac
ADAPTIVE_IMMUNE_SYSTEM,-2.197008619,0.013047745,ketorolac
TCR_SIGNALING,-2.18529073,0.01093708,ketorolac
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,2.27676745,0.004872321,ketorolac
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.101513581,0.021183398,ketorolac
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.034703381,0.037608206,ketorolac
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.31164625,0.006486034,pentobarbital
SYNTHESIS_OF_DNA,2.161967292,0.017836594,pentobarbital
DNA_REPLICATION,1.934271436,0.061617324,pentobarbital
MRNA_SPLICING,1.85862669,0.067292604,pentobarbital
GABA_RECEPTOR_ACTIVATION,-1.885771029,0.170266565,pentobarbital
DNA_REPLICATION_PRE_INITIATION,1.529260734,0.273062036,pentobarbital
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.810625781,0.213281276,pentobarbital
MYD88_INDEPENDENT_TLR4_CASCADE,1.491420774,0.283763992,pentobarbital
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.364163943,0.433637709,pentobarbital
MITOTIC_SPINDLE_CHECKPOINT,1.336761417,0.428483628,pentobarbital
GPCR_LIGAND_BINDING,2.1496525,0.038683679,desloratadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.142548998,0.020980979,desloratadine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.551773888,0.915017796,desloratadine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-3.532576424,0.528550653,desloratadine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.895676768,0.121951938,desloratadine
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-3.395163315,0.77924911,desloratadine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.833171668,0.154570803,desloratadine
MAPK1_MAPK3_SIGNALING,-3.291231327,0.782880133,desloratadine
MAPK_FAMILY_SIGNALING_CASCADES,-3.174066358,0.705870871,desloratadine
G_ALPHA_Q_SIGNALLING_EVENTS,-3.036369274,0.632113743,desloratadine
METABOLISM_OF_STEROIDS,2.635787564,0.003992599,nortriptyline
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.325357176,0.002684329,nortriptyline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.199163249,0.007158211,nortriptyline
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.222971351,0.026950044,nortriptyline
KEAP1_NFE2L2_PATHWAY,2.132013562,0.024621028,nortriptyline
ECM_PROTEOGLYCANS,-2.060839547,0.023562444,nortriptyline
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.820831304,0.091829779,nortriptyline
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.620660632,0.228775928,nortriptyline
SIGNALING_BY_NTRKS,1.613347083,0.198964521,nortriptyline
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.434693739,0.408100664,nortriptyline
STRIATED_MUSCLE_CONTRACTION,3.159247644,0,amlodipine
MUSCLE_CONTRACTION,3.102290732,0,amlodipine
METABOLISM_OF_RNA,-2.832915727,0,amlodipine
DNA_REPAIR,-2.561212114,0.003257824,amlodipine
CELL_CYCLE,-2.40333414,0.006515647,amlodipine
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.290512318,0.014660206,amlodipine
CELL_CYCLE_CHECKPOINTS,-2.227487025,0.019546942,amlodipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.201910741,0.018461,amlodipine
DEVELOPMENTAL_CELL_LINEAGES,2.164457899,0.012046195,amlodipine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.151934967,0.00993811,amlodipine
NEURONAL_SYSTEM,2.370963752,0.004767275,triamterene
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2.124823657,0.044812385,triamterene
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.974251618,0.091849498,triamterene
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.922246485,0.101542957,triamterene
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.912755576,0.08790855,triamterene
MUSCLE_CONTRACTION,1.796154319,0.16574226,triamterene
BIOLOGICAL_OXIDATIONS,1.786573012,0.150509681,triamterene
DEVELOPMENTAL_CELL_LINEAGES,1.78472598,0.13288779,triamterene
RESPIRATORY_ELECTRON_TRANSPORT,1.783099087,0.119075935,triamterene
CARDIAC_CONDUCTION,1.767938696,0.11927722,triamterene
MUSCLE_CONTRACTION,3.035188903,0,palonosetron
STRIATED_MUSCLE_CONTRACTION,3.00999552,0,palonosetron
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.029250831,0.199113294,palonosetron
SARS_COV_INFECTIONS,-2.014510452,0.108662438,palonosetron
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.966624221,0.039391618,palonosetron
HEMOSTASIS,1.945764998,0.033647007,palonosetron
CARDIAC_CONDUCTION,1.945039684,0.026917606,palonosetron
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.956472002,0.111293,palonosetron
RRNA_PROCESSING,-1.95610031,0.08346975,palonosetron
BIOLOGICAL_OXIDATIONS,1.885935922,0.034905351,palonosetron
MUSCLE_CONTRACTION,2.632592287,0,sulfasalazine
GPCR_LIGAND_BINDING,2.499874598,0,sulfasalazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.333687071,0.000722152,sulfasalazine
STRIATED_MUSCLE_CONTRACTION,2.228317522,0.001489439,sulfasalazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.143439768,0.002383102,sulfasalazine
SIGNALING_BY_GPCR,2.068177004,0.004242643,sulfasalazine
INNATE_IMMUNE_SYSTEM,-2.134453197,0.064291751,sulfasalazine
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.128897413,0.033641032,sulfasalazine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.032681058,0.048343409,sulfasalazine
METABOLISM_OF_RNA,-1.941811445,0.066908275,sulfasalazine
GPCR_LIGAND_BINDING,2.169263758,0.069476422,terfenadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.155709343,0.039623272,terfenadine
STRIATED_MUSCLE_CONTRACTION,2.065603385,0.046317614,terfenadine
MUSCLE_CONTRACTION,2.025531911,0.046950863,terfenadine
SIGNALING_BY_GPCR,1.892365067,0.102043494,terfenadine
G_ALPHA_Q_SIGNALLING_EVENTS,1.75636457,0.216028249,terfenadine
GLYCOSAMINOGLYCAN_METABOLISM,-2.141043945,1,terfenadine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.662905817,0.330788409,terfenadine
PROTEIN_LOCALIZATION,-1.850951125,1,terfenadine
PEROXISOMAL_PROTEIN_IMPORT,-1.839290122,1,terfenadine
METABOLISM_OF_RNA,-3.240154757,0,zosuquidar
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.705471819,0.000982548,zosuquidar
MRNA_SPLICING,-2.424893586,0.009825476,zosuquidar
RRNA_PROCESSING,-2.096128933,0.065339417,zosuquidar
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.047420752,0.073887581,zosuquidar
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.738640967,0.342581603,zosuquidar
UCH_PROTEINASES,-1.732998103,0.302063211,zosuquidar
DNA_REPLICATION,-1.728307663,0.270937506,zosuquidar
SYNTHESIS_OF_DNA,-1.679997239,0.302624667,zosuquidar
PROTEIN_FOLDING,-1.674942692,0.280026072,zosuquidar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.276295877,0.010419273,clozapine
NONSENSE_MEDIATED_DECAY_NMD,-2.205060208,0.013024091,clozapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.204678561,0.008682728,clozapine
SIGNALING_BY_ROBO_RECEPTORS,-2.204613279,0.006512046,clozapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.164398886,0.007501877,clozapine
SELENOAMINO_ACID_METABOLISM,-2.151082725,0.007467146,clozapine
EUKARYOTIC_TRANSLATION_INITIATION,-2.140565745,0.007293491,clozapine
ONCOGENIC_MAPK_SIGNALING,-2.12912913,0.007553973,clozapine
TOLL_LIKE_RECEPTOR_CASCADES,-2.120387952,0.008103879,clozapine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.958570451,0.039962198,clozapine
GPCR_LIGAND_BINDING,2.47057048,0.007557857,flecainide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.351886622,0.054130144,flecainide
NEUTROPHIL_DEGRANULATION,-2.301396523,0.039367378,flecainide
MUSCLE_CONTRACTION,2.167585999,0.031491071,flecainide
NEURONAL_SYSTEM,2.10974381,0.032470794,flecainide
INNATE_IMMUNE_SYSTEM,-2.224234679,0.050029376,flecainide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.215279547,0.039982493,flecainide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.05958839,0.103831458,flecainide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.056338789,0.0885766,flecainide
CELLULAR_RESPONSE_TO_STARVATION,-2.049248427,0.078207514,flecainide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.391354929,0,propylthiouracil
SARS_COV_2_HOST_INTERACTIONS,-2.573514286,0,propylthiouracil
SARS_COV_1_HOST_INTERACTIONS,-2.647058499,0,propylthiouracil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.663846988,0,propylthiouracil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.694272063,0,propylthiouracil
SARS_COV_1_INFECTION,-2.707449743,0,propylthiouracil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.727395197,0,propylthiouracil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.727395197,0,propylthiouracil
SIGNALING_BY_ROBO_RECEPTORS,-2.936628348,0,propylthiouracil
VIRAL_INFECTION_PATHWAYS,-2.565301682,0,propylthiouracil
GPCR_LIGAND_BINDING,2.186241389,0.023262576,SNS-314
SIGNALING_BY_GPCR,2.182735661,0.012018998,SNS-314
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.574993707,0.17030459,SNS-314
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.572816043,0.085152295,SNS-314
DISEASES_OF_GLYCOSYLATION,-2.448310724,0.131933494,SNS-314
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.327465258,0.210515395,SNS-314
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-2.259624643,0.236534152,SNS-314
MUSCLE_CONTRACTION,1.876572846,0.149914381,SNS-314
DISEASES_OF_METABOLISM,-2.210182939,0.236534152,SNS-314
BIOLOGICAL_OXIDATIONS,-2.195658313,0.211303843,SNS-314
EXTRACELLULAR_MATRIX_ORGANIZATION,2.711366319,0,maprotiline
MUSCLE_CONTRACTION,2.279629147,0.015177549,maprotiline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.279386109,0.010118366,maprotiline
BIOLOGICAL_OXIDATIONS,2.093421923,0.02656071,maprotiline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.952330726,0.050302733,maprotiline
INTERFERON_ALPHA_BETA_SIGNALING,1.869070102,0.066492118,maprotiline
SIGNALING_BY_FGFR,1.761365225,0.098189448,maprotiline
SIGNALING_BY_FGFR2,1.709734909,0.113018532,maprotiline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.273118547,0.445308207,maprotiline
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.681329365,0.118288514,maprotiline
GPCR_LIGAND_BINDING,-2.601006464,0,semaxanib
SIGNALING_BY_GPCR,-2.477299647,0,semaxanib
REGULATION_OF_TP53_ACTIVITY,2.632116339,0.001631411,semaxanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.238811258,0.003096178,semaxanib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.392039793,0.011419878,semaxanib
G_ALPHA_S_SIGNALLING_EVENTS,-2.171997349,0.005611823,semaxanib
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.238967482,0.019576933,semaxanib
RNA_POLYMERASE_II_TRANSCRIPTION,2.146130592,0.029365399,semaxanib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.04575324,0.019196306,semaxanib
SENSORY_PERCEPTION,-1.987826839,0.031090791,semaxanib
GPCR_LIGAND_BINDING,-2.800213968,0,pilocarpine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.420200024,0.002181736,pilocarpine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.371458615,0.002908982,pilocarpine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.334720789,0.00272717,pilocarpine
SIGNALING_BY_GPCR,-2.298763794,0.003054431,pilocarpine
REGULATION_OF_TP53_ACTIVITY,2.142160311,0.080939737,pilocarpine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.139394879,0.01102989,pilocarpine
CILIUM_ASSEMBLY,2.080464582,0.066739783,pilocarpine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.055510842,0.059166474,pilocarpine
G_ALPHA_S_SIGNALLING_EVENTS,-2.083096793,0.015687724,pilocarpine
ECM_PROTEOGLYCANS,-2.148976887,0.03188943,clinofibrate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.092445209,0.029231977,clinofibrate
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.086038718,0.02125962,clinofibrate
COLLAGEN_FORMATION,-2.069307806,0.018159259,clinofibrate
ADAPTIVE_IMMUNE_SYSTEM,1.871714645,0.398255122,clinofibrate
SIGNALING_BY_PDGF,-1.900357962,0.080786556,clinofibrate
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.770389045,0.361242564,clinofibrate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.765883166,0.247243886,clinofibrate
GASTRULATION,-1.845360475,0.10747919,clinofibrate
TCR_SIGNALING,1.703530989,0.260198282,clinofibrate
CELLULAR_RESPONSE_TO_STARVATION,2.513520577,0.011626883,chlorpropamide
SELENOAMINO_ACID_METABOLISM,2.325525737,0.011626883,chlorpropamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.164862665,0.017440324,chlorpropamide
TRANSLATION,1.899509686,0.053289879,chlorpropamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.85700137,0.055421475,chlorpropamide
RRNA_PROCESSING,1.841343183,0.050383159,chlorpropamide
SARS_COV_2_HOST_INTERACTIONS,1.828146436,0.045400209,chlorpropamide
INFLUENZA_INFECTION,1.737932581,0.071214657,chlorpropamide
NONSENSE_MEDIATED_DECAY_NMD,1.617358788,0.125311959,chlorpropamide
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.822906137,0.90515687,chlorpropamide
EUKARYOTIC_TRANSLATION_INITIATION,-3.708077059,0,AZD-9291
VIRAL_INFECTION_PATHWAYS,-2.845582692,0,AZD-9291
SARS_COV_1_INFECTION,-2.885533043,0,AZD-9291
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.00706753,0,AZD-9291
SARS_COV_1_HOST_INTERACTIONS,-3.044990454,0,AZD-9291
METABOLISM_OF_RNA,-3.105589932,0,AZD-9291
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.157083402,0,AZD-9291
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.205126712,0,AZD-9291
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.241551572,0,AZD-9291
SIGNALING_BY_ROBO_RECEPTORS,-3.266545121,0,AZD-9291
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.780818558,0.000943237,perphenazine
GPCR_LIGAND_BINDING,2.711663059,0.000471618,perphenazine
SIGNALING_BY_GPCR,2.431185282,0.001572061,perphenazine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.391098059,0.088277561,perphenazine
PEROXISOMAL_PROTEIN_IMPORT,-2.087600703,0.349799836,perphenazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.921268001,0.129695067,perphenazine
NEURONAL_SYSTEM,1.920612534,0.104321996,perphenazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.070157601,0.26446486,perphenazine
TCR_SIGNALING,-2.068408498,0.201107319,perphenazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.062774129,0.166403203,perphenazine
EUKARYOTIC_TRANSLATION_ELONGATION,1.884568109,0.184914691,pindolol
SELENOAMINO_ACID_METABOLISM,1.879401615,0.097352146,pindolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.859282113,0.070702676,pindolol
INFLUENZA_INFECTION,1.818996851,0.068527209,pindolol
EUKARYOTIC_TRANSLATION_INITIATION,1.80413412,0.058955154,pindolol
TRANSLATION,1.721747997,0.083211611,pindolol
CELLULAR_RESPONSE_TO_STARVATION,1.693617535,0.081890792,pindolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.671951491,0.081308077,pindolol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,1.598491466,0.108894207,pindolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.584559796,0.105727694,pindolol
GPCR_LIGAND_BINDING,2.849081636,0,sertraline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.807435997,0,sertraline
SIGNALING_BY_GPCR,2.554843615,0.000326409,sertraline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.251037497,0.005385755,sertraline
PROTEIN_LOCALIZATION,-2.223400291,0.23732064,sertraline
NEUTROPHIL_DEGRANULATION,-2.143578887,0.190061984,sertraline
SENSORY_PERCEPTION,1.908186222,0.105364957,sertraline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.003361647,0.285264203,sertraline
G_ALPHA_I_SIGNALLING_EVENTS,1.853925868,0.13284863,sertraline
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.978464622,0.244769015,sertraline
MUSCLE_CONTRACTION,3.046429471,0,benzthiazide
STRIATED_MUSCLE_CONTRACTION,2.40478512,0.002323486,benzthiazide
GPCR_LIGAND_BINDING,2.393552578,0.001548991,benzthiazide
CARDIAC_CONDUCTION,2.30910143,0.003817156,benzthiazide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.307850588,0.003053725,benzthiazide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.236206724,0.048007681,benzthiazide
EUKARYOTIC_TRANSLATION_INITIATION,-2.21081996,0.033005281,benzthiazide
SELENOAMINO_ACID_METABOLISM,-2.149924504,0.040006401,benzthiazide
CELLULAR_RESPONSE_TO_STARVATION,-2.143993496,0.030904945,benzthiazide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.116792324,0.030244839,benzthiazide
TRANSLATION,4.109723436,0,propentofylline
G2_M_CHECKPOINTS,2.78655975,0,propentofylline
SIGNALING_BY_ROBO_RECEPTORS,2.918069703,0,propentofylline
INFLUENZA_INFECTION,3.105959257,0,propentofylline
NONSENSE_MEDIATED_DECAY_NMD,3.206022443,0,propentofylline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.236779907,0,propentofylline
EUKARYOTIC_TRANSLATION_INITIATION,3.4650113,0,propentofylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.501172745,0,propentofylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.60760366,0,propentofylline
RRNA_PROCESSING,3.621927729,0,propentofylline
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.538399884,0,leflunomide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.436814586,0,leflunomide
ECM_PROTEOGLYCANS,-2.407003651,0,leflunomide
COLLAGEN_FORMATION,-2.343500995,0.000196616,leflunomide
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.316466926,0.000157293,leflunomide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.464818105,0.010280299,leflunomide
COLLAGEN_DEGRADATION,-2.248851634,0.000655387,leflunomide
MITF_M_DEPENDENT_GENE_EXPRESSION,2.288139082,0.014135411,leflunomide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.178821058,0.017133831,leflunomide
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.109160276,0.004606432,leflunomide
GPCR_LIGAND_BINDING,2.988963776,0,ziprasidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.938021284,0,ziprasidone
SIGNALING_BY_GPCR,2.818503248,0,ziprasidone
G_ALPHA_Q_SIGNALLING_EVENTS,2.336898662,0.003315046,ziprasidone
NEURONAL_SYSTEM,2.259569436,0.004925211,ziprasidone
G_ALPHA_I_SIGNALLING_EVENTS,2.077044843,0.015785932,ziprasidone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.073328402,0.013801415,ziprasidone
SENSORY_PERCEPTION,2.049221147,0.014286269,ziprasidone
MUSCLE_CONTRACTION,1.969952967,0.02560829,ziprasidone
EUKARYOTIC_TRANSLATION_ELONGATION,-3.174242436,0.63371638,ziprasidone
METABOLISM_OF_RNA,-3.124297257,0,dactinomycin
GPCR_LIGAND_BINDING,3.086566353,0,dactinomycin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.630647942,0,dactinomycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.727903133,0.00035958,dactinomycin
NEURONAL_SYSTEM,2.673643981,0.00023972,dactinomycin
RNA_POLYMERASE_II_TRANSCRIPTION,-2.456853294,0.000380162,dactinomycin
MUSCLE_CONTRACTION,2.548435736,0.00053937,dactinomycin
SIGNALING_BY_GPCR,2.535585163,0.000431496,dactinomycin
SUMOYLATION,-2.309152005,0.002280973,dactinomycin
SENSORY_PERCEPTION,2.398833586,0.00107874,dactinomycin
MUSCLE_CONTRACTION,2.591428659,0,BRD-K68202742
METABOLISM_OF_RNA,-2.862391609,0.001079522,BRD-K68202742
NEURONAL_SYSTEM,2.562024236,0.000450074,BRD-K68202742
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.7095273,0.001079522,BRD-K68202742
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.487929685,0.004318088,BRD-K68202742
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.351225113,0.005400883,BRD-K68202742
SUMOYLATION,-2.393642543,0.007286773,BRD-K68202742
MRNA_SPLICING,-2.364017116,0.006908941,BRD-K68202742
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.361324116,0.005757451,BRD-K68202742
TRNA_PROCESSING,-2.293800526,0.010024133,BRD-K68202742
DNA_REPLICATION_PRE_INITIATION,2.061280384,0.138969874,phenazopyridine
G2_M_CHECKPOINTS,1.882027302,0.172133139,phenazopyridine
DNA_REPLICATION,1.878619603,0.114755426,phenazopyridine
SELENOAMINO_ACID_METABOLISM,1.811130874,0.116071429,phenazopyridine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.807639126,0.093488824,phenazopyridine
CELL_CYCLE_CHECKPOINTS,1.75993495,0.09633139,phenazopyridine
SYNTHESIS_OF_DNA,1.644688909,0.158822713,phenazopyridine
MITOTIC_METAPHASE_AND_ANAPHASE,1.547566644,0.226615646,phenazopyridine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.540690646,0.208805745,phenazopyridine
TRANSLATION,1.504096229,0.223931001,phenazopyridine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.643704387,0.001116252,diethylcarbamazine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.504821286,0.001116252,diethylcarbamazine
COLLAGEN_FORMATION,-2.504821286,0.001116252,diethylcarbamazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.447210271,0.001534846,diethylcarbamazine
MITOTIC_PROMETAPHASE,2.329227006,0.020293308,diethylcarbamazine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.312805446,0.013268701,diethylcarbamazine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.359017098,0.003237131,diethylcarbamazine
CELL_CYCLE_CHECKPOINTS,2.13938614,0.044749346,diethylcarbamazine
ADAPTIVE_IMMUNE_SYSTEM,2.125772335,0.037854825,diethylcarbamazine
CILIUM_ASSEMBLY,2.116869171,0.032469293,diethylcarbamazine
GPCR_LIGAND_BINDING,2.382578434,0.007030925,ibuprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.32214557,0.004017672,ibuprofen
SIGNALING_BY_GPCR,2.101489603,0.040176717,ibuprofen
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.238772161,0.162088254,ibuprofen
G_ALPHA_Q_SIGNALLING_EVENTS,2.055806793,0.044696598,ibuprofen
INNATE_IMMUNE_SYSTEM,-2.169135112,0.127781231,ibuprofen
NEUTROPHIL_DEGRANULATION,-2.125026831,0.11535115,ibuprofen
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.05585366,0.138222498,ibuprofen
GLYCOSAMINOGLYCAN_METABOLISM,-2.035439894,0.12310752,ibuprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.788878634,0.294495337,ibuprofen
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.635442603,0.243017416,torasemide
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.998642497,0.27568222,torasemide
INTERLEUKIN_1_FAMILY_SIGNALING,1.922764182,0.240756263,torasemide
GASTRULATION,1.856586506,0.267610444,torasemide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.489534211,0.673918341,torasemide
CIRCADIAN_CLOCK,1.838010415,0.230511316,torasemide
PCP_CE_PATHWAY,1.785184689,0.271770513,torasemide
NEUTROPHIL_DEGRANULATION,-3.337452772,0.875362294,torasemide
INTERLEUKIN_1_SIGNALING,1.766985066,0.253640061,torasemide
NEDDYLATION,1.766304195,0.218470177,torasemide
MUSCLE_CONTRACTION,2.822245853,0,calcitriol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.689822327,0,calcitriol
EXTRACELLULAR_MATRIX_ORGANIZATION,2.605498185,0,calcitriol
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.370452191,0.002672328,calcitriol
GLYCOSAMINOGLYCAN_METABOLISM,2.321808716,0.004061939,calcitriol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.083884042,0.022447556,calcitriol
DEVELOPMENTAL_CELL_LINEAGES,2.034813582,0.026875985,calcitriol
INTERFERON_SIGNALING,-2.027587992,0.194119859,calcitriol
SIGNALING_BY_INTERLEUKINS,1.990400784,0.031667087,calcitriol
MEMBRANE_TRAFFICKING,-1.999622396,0.12023842,calcitriol
METABOLISM_OF_RNA,-3.515654898,0,reversine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.754119979,0,reversine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.759991994,0,reversine
VIRAL_INFECTION_PATHWAYS,-2.807117933,0,reversine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.811502635,0,reversine
SARS_COV_1_HOST_INTERACTIONS,-2.830516285,0,reversine
SARS_COV_1_INFECTION,-2.863897386,0,reversine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.893935763,0,reversine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.930287436,0,reversine
SIGNALING_BY_ROBO_RECEPTORS,-2.964616104,0,reversine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.93235897,0.082440598,meclofenamic-acid
RHOA_GTPASE_CYCLE,1.926332237,0.042999592,meclofenamic-acid
O_LINKED_GLYCOSYLATION,-2.016051558,0.200397752,meclofenamic-acid
DISEASES_OF_GLYCOSYLATION,-1.977399916,0.145792015,meclofenamic-acid
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.907921213,0.185553474,meclofenamic-acid
CILIUM_ASSEMBLY,-1.861735033,0.213916648,meclofenamic-acid
ADAPTIVE_IMMUNE_SYSTEM,-1.82091758,0.244718525,meclofenamic-acid
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.817584623,0.210647372,meclofenamic-acid
DISEASES_OF_METABOLISM,-1.734452827,0.342175753,meclofenamic-acid
CDC42_GTPASE_CYCLE,1.39894136,0.448777354,meclofenamic-acid
INTERFERON_ALPHA_BETA_SIGNALING,2.630556631,0,TTNPB
MITF_M_DEPENDENT_GENE_EXPRESSION,2.318311494,0.00623732,TTNPB
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.159484888,0.052394024,TTNPB
GPCR_LIGAND_BINDING,-2.136747698,0.033753843,TTNPB
SELENOAMINO_ACID_METABOLISM,-2.104643501,0.029891463,TTNPB
EUKARYOTIC_TRANSLATION_ELONGATION,-2.062644816,0.035013314,TTNPB
NONSENSE_MEDIATED_DECAY_NMD,-2.053372905,0.02942126,TTNPB
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.025872294,0.032914195,TTNPB
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.021944511,0.029363684,TTNPB
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.99213337,0.034005737,TTNPB
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.081442998,0.068657382,bexarotene
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.931121402,0.374972632,bexarotene
INFLUENZA_INFECTION,1.736817398,0.308523677,bexarotene
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.704623214,0.247977716,bexarotene
ADAPTIVE_IMMUNE_SYSTEM,1.678836351,0.217487465,bexarotene
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.614554647,0.241604457,bexarotene
NEUTROPHIL_DEGRANULATION,1.594519205,0.223933148,bexarotene
INNATE_IMMUNE_SYSTEM,1.572912297,0.213669717,bexarotene
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.727767509,1,bexarotene
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.511336435,0.257682451,bexarotene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.511217508,0,darapladib
MRNA_SPLICING,2.335156004,0,darapladib
SELENOAMINO_ACID_METABOLISM,-2.094348424,0.04299454,darapladib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.090323939,0.021985844,darapladib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.069801261,0.017588675,darapladib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.040018174,0.016611527,darapladib
NONSENSE_MEDIATED_DECAY_NMD,-2.030415192,0.016220667,darapladib
EUKARYOTIC_TRANSLATION_INITIATION,-1.996772859,0.01889154,darapladib
CELLULAR_RESPONSE_TO_STARVATION,-1.970118234,0.022195233,darapladib
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.593879593,0.215178831,darapladib
CELL_CYCLE,-4.045513981,0,trametinib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.927274028,0,trametinib
M_PHASE,-2.91177915,0,trametinib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.910110331,0,trametinib
DISEASES_OF_DNA_REPAIR,-2.889484549,0,trametinib
METABOLISM_OF_NUCLEOTIDES,-2.87263585,0,trametinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.872551594,0,trametinib
REGULATION_OF_TP53_ACTIVITY,-2.869611257,0,trametinib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-2.865025836,0,trametinib
EXTENSION_OF_TELOMERES,-2.83786805,0,trametinib
ECM_PROTEOGLYCANS,-2.255555855,0.010831496,retigabine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.412686096,0.013737516,retigabine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.986922136,0.122592845,retigabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.937696727,0.123085186,retigabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.93081921,0.100437512,retigabine
ADAPTIVE_IMMUNE_SYSTEM,1.839611403,0.239349799,retigabine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.613042759,0.560420206,retigabine
GASTRULATION,-1.730957969,0.442515861,retigabine
SIGNALING_BY_NOTCH,-1.713155253,0.419310201,retigabine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.51968601,0.667854627,retigabine
TCR_SIGNALING,2.256303974,0.03231276,GDC-0199
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.237094193,0.022046589,GDC-0199
MITF_M_DEPENDENT_GENE_EXPRESSION,2.078485869,0.084294158,GDC-0199
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.03868206,0.078674547,GDC-0199
ADAPTIVE_IMMUNE_SYSTEM,2.031634935,0.063571844,GDC-0199
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.052720828,0.075642607,GDC-0199
SENSORY_PERCEPTION,-2.013902383,0.072474994,GDC-0199
GPCR_LIGAND_BINDING,-1.954601036,0.088756526,GDC-0199
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.951549083,0.073437948,GDC-0199
ECM_PROTEOGLYCANS,-1.942679395,0.065886358,GDC-0199
RESPIRATORY_ELECTRON_TRANSPORT,3.158618711,0,liothyronine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.849693526,0,liothyronine
SEPARATION_OF_SISTER_CHROMATIDS,2.592351638,0.000671086,liothyronine
CELL_CYCLE_CHECKPOINTS,2.640965209,0.000894781,liothyronine
MITOTIC_METAPHASE_AND_ANAPHASE,2.547252053,0.00044739,liothyronine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.561315883,0.000536868,liothyronine
TRANSLATION,2.532551731,0.000766955,liothyronine
DNA_REPLICATION,2.490182697,0.001193041,liothyronine
SYNTHESIS_OF_DNA,2.491076807,0.001342171,liothyronine
PCP_CE_PATHWAY,2.415670146,0.001879039,liothyronine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.911179699,0,sirolimus
TRANSLATION,-2.361497642,0,sirolimus
NERVOUS_SYSTEM_DEVELOPMENT,-2.394105233,0,sirolimus
SARS_COV_1_INFECTION,-2.397895447,0,sirolimus
CELLULAR_RESPONSE_TO_STARVATION,-2.546463951,0,sirolimus
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.597095831,0,sirolimus
INFLUENZA_INFECTION,-2.656999357,0,sirolimus
SARS_COV_1_HOST_INTERACTIONS,-2.716971906,0,sirolimus
SIGNALING_BY_ROBO_RECEPTORS,-2.779776238,0,sirolimus
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.763385034,0,sirolimus
MUSCLE_CONTRACTION,3.616520697,0,atomoxetine
CARDIAC_CONDUCTION,1.839319832,0.181260744,atomoxetine
MRNA_SPLICING,1.778683289,0.178951689,atomoxetine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.839078704,0.937625992,atomoxetine
RSV_HOST_INTERACTIONS,-1.76498488,0.848604742,atomoxetine
CELL_CELL_JUNCTION_ORGANIZATION,-1.754514871,0.615407772,atomoxetine
SIGNALING_BY_NTRKS,1.455666747,0.7507312,atomoxetine
CELL_JUNCTION_ORGANIZATION,-1.693648387,0.746278686,atomoxetine
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,-1.68548176,0.634953742,atomoxetine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.680699897,0.548964375,atomoxetine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.729094216,0,iloperidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.755051815,0,iloperidone
SIGNALING_BY_GPCR,3.102178251,0,iloperidone
GPCR_LIGAND_BINDING,2.90412985,0,iloperidone
MUSCLE_CONTRACTION,2.417673578,0.000922942,iloperidone
G_ALPHA_Q_SIGNALLING_EVENTS,2.397528425,0.000984472,iloperidone
G_ALPHA_I_SIGNALLING_EVENTS,2.246525859,0.002973925,iloperidone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.423403353,0.058622574,iloperidone
CARDIAC_CONDUCTION,2.13343504,0.006856142,iloperidone
EUKARYOTIC_TRANSLATION_INITIATION,-3.405929532,0.054804246,iloperidone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.625432719,0,timolol
DNA_REPLICATION_PRE_INITIATION,2.60476073,0,timolol
CELL_CYCLE_MITOTIC,2.557588459,0,timolol
SYNTHESIS_OF_DNA,2.547803702,0,timolol
DNA_REPLICATION,2.455307061,0.001075298,timolol
S_PHASE,2.452972107,0.000896081,timolol
MITOTIC_METAPHASE_AND_ANAPHASE,2.346816113,0.004608419,timolol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.260377249,0.007056641,timolol
MITOTIC_G2_G2_M_PHASES,2.256855758,0.006571264,timolol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.199167734,0.009946504,timolol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.420736377,0.015908202,budesonide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.367791593,0.012196288,budesonide
INNATE_IMMUNE_SYSTEM,-2.206987809,0.038886716,budesonide
NEUTROPHIL_DEGRANULATION,-2.12761753,0.051436519,budesonide
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.092546328,0.04963359,budesonide
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.995426293,0.076965396,budesonide
KERATINIZATION,-1.995426293,0.076965396,budesonide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.891494304,0.136015126,budesonide
MITOTIC_G2_G2_M_PHASES,1.79560962,1,budesonide
TCR_SIGNALING,-1.73158161,0.311682918,budesonide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.052939876,0.200168492,MLN-8054
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.950990394,0.176916596,MLN-8054
CILIUM_ASSEMBLY,1.947937113,0.30731327,MLN-8054
G2_M_CHECKPOINTS,-1.75192857,0.357877001,MLN-8054
RHOA_GTPASE_CYCLE,-1.639511914,0.477169334,MLN-8054
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.606481037,0.45937658,MLN-8054
SYNTHESIS_OF_DNA,-1.533725985,0.559393429,MLN-8054
RHOB_GTPASE_CYCLE,-1.529586274,0.490744975,MLN-8054
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.763865348,0.509756224,MLN-8054
KERATINIZATION,1.763865348,0.509756224,MLN-8054
EXTRACELLULAR_MATRIX_ORGANIZATION,3.296100956,0,gabexate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,3.038402682,0,gabexate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.66242224,0.000645082,gabexate
ORC1_REMOVAL_FROM_CHROMATIN,2.560594637,0.000483812,gabexate
S_PHASE,2.458620255,0.000774098,gabexate
SYNTHESIS_OF_DNA,2.432682526,0.000645082,gabexate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.334953322,0.001658782,gabexate
DNA_REPLICATION,2.139497439,0.009918136,gabexate
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.124908997,0.009461203,gabexate
CIRCADIAN_CLOCK,2.091672047,0.011030903,gabexate
NEUTROPHIL_DEGRANULATION,-2.223116956,0.252928372,vincristine
BIOLOGICAL_OXIDATIONS,-2.184162863,0.16585467,vincristine
SLC_TRANSPORTER_DISORDERS,-2.147065335,0.143049653,vincristine
PROTEIN_LOCALIZATION,-2.111767547,0.131128848,vincristine
GPCR_LIGAND_BINDING,2.002857492,0.178834561,vincristine
GLYCOSAMINOGLYCAN_METABOLISM,-1.992293013,0.199854877,vincristine
DISEASES_OF_GLYCOSYLATION,-1.935355422,0.232196538,vincristine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-1.899095643,0.242266286,vincristine
SENSORY_PERCEPTION,1.877590437,0.264233088,vincristine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-1.856962942,0.254742407,vincristine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.80241032,0,alpelisib
EUKARYOTIC_TRANSLATION_ELONGATION,2.794476476,0,alpelisib
EUKARYOTIC_TRANSLATION_INITIATION,2.749422268,0,alpelisib
SIGNALING_BY_ROBO_RECEPTORS,2.627159545,0,alpelisib
NONSENSE_MEDIATED_DECAY_NMD,2.596459299,0.000149096,alpelisib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.607441582,0.000173946,alpelisib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.565811525,0.000130459,alpelisib
SELENOAMINO_ACID_METABOLISM,2.608035942,0.000208735,alpelisib
DNA_REPLICATION,-2.598037045,0.00130417,alpelisib
CELL_CYCLE_CHECKPOINTS,-2.685841011,0.00260834,alpelisib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.935993848,0,hydroxyurea
EUKARYOTIC_TRANSLATION_ELONGATION,3.788657659,0,hydroxyurea
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.685057869,0,hydroxyurea
SELENOAMINO_ACID_METABOLISM,3.645257044,0,hydroxyurea
NONSENSE_MEDIATED_DECAY_NMD,3.594529494,0,hydroxyurea
CELLULAR_RESPONSE_TO_STARVATION,3.592712287,0,hydroxyurea
EUKARYOTIC_TRANSLATION_INITIATION,3.516001473,0,hydroxyurea
TRANSLATION,3.446595189,0,hydroxyurea
INFLUENZA_INFECTION,3.243676734,0,hydroxyurea
RRNA_PROCESSING,2.90044869,0,hydroxyurea
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.936584101,0,idelalisib
COLLAGEN_FORMATION,-2.513633204,0,idelalisib
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.529875288,0,idelalisib
NONSENSE_MEDIATED_DECAY_NMD,2.573344363,0,idelalisib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.578810918,0,idelalisib
ECM_PROTEOGLYCANS,-2.505641983,0,idelalisib
RESPIRATORY_ELECTRON_TRANSPORT,2.591827065,0,idelalisib
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.599698039,0,idelalisib
COLLAGEN_DEGRADATION,-2.62995846,0,idelalisib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.748199568,0,idelalisib
GPCR_LIGAND_BINDING,-2.403926285,0,milnacipran
SIGNALING_BY_GPCR,-2.29696783,0.00136132,milnacipran
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.281629753,0.000907547,milnacipran
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.084176256,0.006352828,milnacipran
MITF_M_DEPENDENT_GENE_EXPRESSION,2.03503787,0.074342356,milnacipran
FATTY_ACID_METABOLISM,1.874855036,0.101029356,milnacipran
G_ALPHA_I_SIGNALLING_EVENTS,-1.968098597,0.022144144,milnacipran
G_ALPHA_Q_SIGNALLING_EVENTS,-1.959633104,0.021024837,milnacipran
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.823903756,0.090227475,milnacipran
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.915813249,0.029560099,milnacipran
MUSCLE_CONTRACTION,2.482398513,0.002998501,buspirone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.117215403,0.093927218,buspirone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.077148008,0.0701625,buspirone
DNA_REPAIR,-1.913587957,0.201057057,buspirone
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.877393443,0.212184981,buspirone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.730008728,0.547976012,buspirone
SIGNALING_BY_NOTCH,-1.783588437,0.361223711,buspirone
BIOLOGICAL_OXIDATIONS,1.691197384,0.456771614,buspirone
CELL_CELL_COMMUNICATION,1.669884034,0.387931034,buspirone
CELL_JUNCTION_ORGANIZATION,1.653012037,0.335382309,buspirone
RESPIRATORY_ELECTRON_TRANSPORT,2.183308912,0.096297695,BRD-A20239487
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.075364265,0.068432224,BRD-A20239487
GPCR_LIGAND_BINDING,-2.020685504,0.064406799,BRD-A20239487
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.950877963,0.079971775,BRD-A20239487
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.823420284,0.392458529,BRD-A20239487
ECM_PROTEOGLYCANS,-1.889886289,0.108686473,BRD-A20239487
GASTRULATION,-1.873716981,0.104177997,BRD-A20239487
SIGNALING_BY_GPCR,-1.82591693,0.129618682,BRD-A20239487
MYD88_INDEPENDENT_TLR4_CASCADE,1.652423461,0.641378985,BRD-A20239487
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.808376719,0.126053306,BRD-A20239487
GPCR_LIGAND_BINDING,-2.310374035,0,metoprolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.224519978,0.000406966,metoprolol
METABOLISM_OF_RNA,2.286939411,0.023962106,metoprolol
SIGNALING_BY_GPCR,-2.110444872,0.002713109,metoprolol
BIOLOGICAL_OXIDATIONS,2.070758421,0.051917897,metoprolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.039374684,0.006918428,metoprolol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.983948732,0.010743911,metoprolol
HIV_INFECTION,1.889851843,0.091854741,metoprolol
FATTY_ACID_METABOLISM,1.865622802,0.075880004,metoprolol
GLUCOSE_METABOLISM,1.796557744,0.093452215,metoprolol
GPCR_LIGAND_BINDING,2.539129164,0,carbinoxamine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.712296696,0.007667789,carbinoxamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.248142521,0.014437346,carbinoxamine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.461745446,0.022044892,carbinoxamine
SIGNALING_BY_GPCR,2.154503058,0.02440599,carbinoxamine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.261375211,0.070927045,carbinoxamine
TCR_SIGNALING,-2.24362437,0.05966498,carbinoxamine
ADAPTIVE_IMMUNE_SYSTEM,-2.130942418,0.10083142,carbinoxamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.130614515,0.084345675,carbinoxamine
NEUTROPHIL_DEGRANULATION,-2.091376245,0.091191914,carbinoxamine
NEUTROPHIL_DEGRANULATION,-2.342995201,0.08978476,nialamide
INNATE_IMMUNE_SYSTEM,-2.16754694,0.14481413,nialamide
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.983354996,0.31279852,nialamide
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.811933491,1,nialamide
NERVOUS_SYSTEM_DEVELOPMENT,1.804716138,0.635120618,nialamide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.890577043,0.391963578,nialamide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.826932514,0.441007297,nialamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.819566971,0.381987493,nialamide
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.622428139,1,nialamide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.604025084,1,nialamide
TRANSLATION,2.763890189,0,phenethyl-isothiocyanate
CELL_CYCLE_CHECKPOINTS,2.348729631,0.011555369,phenethyl-isothiocyanate
SELENOAMINO_ACID_METABOLISM,2.311766258,0.008666527,phenethyl-isothiocyanate
EUKARYOTIC_TRANSLATION_ELONGATION,2.222706948,0.014444212,phenethyl-isothiocyanate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.195736227,0.012710906,phenethyl-isothiocyanate
EUKARYOTIC_TRANSLATION_INITIATION,2.058697074,0.022629265,phenethyl-isothiocyanate
NONSENSE_MEDIATED_DECAY_NMD,2.024228151,0.023936122,phenethyl-isothiocyanate
S_PHASE,1.929162042,0.035388319,phenethyl-isothiocyanate
RRNA_PROCESSING,1.918614327,0.033703161,phenethyl-isothiocyanate
SEPARATION_OF_SISTER_CHROMATIDS,1.889314104,0.035821645,phenethyl-isothiocyanate
SIGNALING_BY_GPCR,2.838432129,0,dexketoprofen
GPCR_LIGAND_BINDING,2.604847491,0.000680041,dexketoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.570130939,0.000453361,dexketoprofen
MUSCLE_CONTRACTION,2.461083136,0.000850051,dexketoprofen
STRIATED_MUSCLE_CONTRACTION,2.085449011,0.024209453,dexketoprofen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.327967634,0.522073816,dexketoprofen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.01082057,0.037175564,dexketoprofen
G_ALPHA_Q_SIGNALLING_EVENTS,1.969293804,0.041968232,dexketoprofen
G_ALPHA_I_SIGNALLING_EVENTS,1.943042709,0.042757565,dexketoprofen
SENSORY_PERCEPTION,1.92450492,0.04269145,dexketoprofen
MUSCLE_CONTRACTION,3.209865285,0,etodolac
CARDIAC_CONDUCTION,2.236251615,0.010581108,etodolac
ECM_PROTEOGLYCANS,-2.1220044,0.059656801,etodolac
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.07229117,0.050069101,etodolac
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.875835593,0.299349303,etodolac
TRANSPORT_OF_SMALL_MOLECULES,-1.837199845,0.321454278,etodolac
SIGNALING_BY_ROBO_RECEPTORS,-1.728607255,0.634492687,etodolac
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.702378331,0.641488157,etodolac
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.341457077,1,etodolac
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.604509521,1,etodolac
MUSCLE_CONTRACTION,2.876416156,0,gemfibrozil
SIGNALING_BY_GPCR,2.529495614,0.000733006,gemfibrozil
GPCR_LIGAND_BINDING,2.469922379,0.000977341,gemfibrozil
STRIATED_MUSCLE_CONTRACTION,2.424122343,0.00128276,gemfibrozil
G_ALPHA_Q_SIGNALLING_EVENTS,2.23637406,0.006303848,gemfibrozil
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.165524346,0.008307396,gemfibrozil
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.10467657,0.095218688,gemfibrozil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.052536574,0.07834449,gemfibrozil
NEURONAL_SYSTEM,2.064958966,0.016649697,gemfibrozil
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.032143755,0.064282659,gemfibrozil
EUKARYOTIC_TRANSLATION_ELONGATION,2.692324822,0,wortmannin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.583180177,0,wortmannin
NONSENSE_MEDIATED_DECAY_NMD,2.522411215,0.000341969,wortmannin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.519439394,0.000256477,wortmannin
SELENOAMINO_ACID_METABOLISM,2.477136747,0.000205182,wortmannin
CELLULAR_RESPONSE_TO_STARVATION,2.432749558,0.000170985,wortmannin
EUKARYOTIC_TRANSLATION_INITIATION,2.402907027,0.000732791,wortmannin
INFLUENZA_INFECTION,2.390623512,0.000641192,wortmannin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.232491062,0.002507775,wortmannin
CELLULAR_RESPONSES_TO_STIMULI,2.157607688,0.005026948,wortmannin
RESPIRATORY_ELECTRON_TRANSPORT,3.494287038,0,metyrapone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.356550565,0,metyrapone
CELL_CYCLE_MITOTIC,2.592050822,0,metyrapone
SYNTHESIS_OF_DNA,2.717764156,0,metyrapone
CELL_CYCLE_CHECKPOINTS,2.960562909,0,metyrapone
G2_M_CHECKPOINTS,2.76231437,0,metyrapone
DNA_REPLICATION,2.929215195,0,metyrapone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.531633458,0.000230246,metyrapone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.535434594,0.000255829,metyrapone
NEDDYLATION,2.54527119,0.000287808,metyrapone
GPCR_LIGAND_BINDING,2.716979678,0.001713248,ropinirole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.630457506,0.000856624,ropinirole
SIGNALING_BY_GPCR,2.467586609,0.001427707,ropinirole
G_ALPHA_Q_SIGNALLING_EVENTS,2.422333783,0.001713248,ropinirole
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.252013402,0.080997939,ropinirole
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.126302435,0.113059623,ropinirole
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.001776038,0.041117951,ropinirole
COPII_MEDIATED_VESICLE_TRANSPORT,-2.065880431,0.123746852,ropinirole
REGULATION_OF_INSULIN_SECRETION,1.959447035,0.04511553,ropinirole
G_ALPHA_I_SIGNALLING_EVENTS,1.910539424,0.055435809,ropinirole
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.084071151,0.113888208,alimemazine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.975949497,0.347023338,alimemazine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.027007706,0.181407646,alimemazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.023228722,0.132869576,alimemazine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.874043751,0.334074706,alimemazine
NEDDYLATION,1.852240477,0.249189229,alimemazine
DRUG_ADME,1.794436759,0.25077184,alimemazine
RESPIRATORY_ELECTRON_TRANSPORT,1.784818449,0.214084049,alimemazine
INTERLEUKIN_1_SIGNALING,1.753315752,0.210343333,alimemazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.741150269,0.191639754,alimemazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.133356355,0.015133877,dopamine
ONCOGENIC_MAPK_SIGNALING,-1.977025788,0.186894124,dopamine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-1.938857708,0.138921301,dopamine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.886092472,0.159243122,dopamine
TOLL_LIKE_RECEPTOR_CASCADES,-1.869374069,0.137172292,dopamine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.828804482,0.161708392,dopamine
CHROMOSOME_MAINTENANCE,1.457599377,0.412145906,dopamine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.801280434,0.16923746,dopamine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.778015973,0.177613667,dopamine
MRNA_SPLICING,1.362822461,0.428120554,dopamine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.104154539,0.09842935,BRD-A04553218
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.880337192,0.156404746,BRD-A04553218
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,1.991280338,0.151745249,BRD-A04553218
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.982102465,0.106973565,BRD-A04553218
NERVOUS_SYSTEM_DEVELOPMENT,1.95301034,0.107144449,BRD-A04553218
SELENOAMINO_ACID_METABOLISM,1.928159393,0.110733019,BRD-A04553218
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.926926354,0.092790169,BRD-A04553218
EUKARYOTIC_TRANSLATION_ELONGATION,1.900055041,0.099454656,BRD-A04553218
EUKARYOTIC_TRANSLATION_INITIATION,1.875236678,0.107144449,BRD-A04553218
CELLULAR_RESPONSE_TO_STARVATION,1.834438307,0.131353057,BRD-A04553218
GPCR_LIGAND_BINDING,2.600614826,0,procyclidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.451227102,0.000692529,procyclidine
SIGNALING_BY_GPCR,2.407682325,0.000461686,procyclidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.171148906,0.008483477,procyclidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.355333351,0.138152845,procyclidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.042453523,0.023684484,procyclidine
G_ALPHA_I_SIGNALLING_EVENTS,1.924874615,0.058287838,procyclidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.884478689,1,procyclidine
SENSORY_PERCEPTION,1.819674877,0.113772583,procyclidine
G_ALPHA_S_SIGNALLING_EVENTS,1.793833035,0.123270121,procyclidine
RRNA_PROCESSING,2.680013347,0,voapaxar
TRANSLATION,2.674169886,0,voapaxar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.655371323,0,voapaxar
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.61915834,0,voapaxar
INFLUENZA_INFECTION,2.612255195,0,voapaxar
EUKARYOTIC_TRANSLATION_ELONGATION,2.568788504,0,voapaxar
KERATINIZATION,-2.231643739,0.008050144,voapaxar
RESPIRATORY_ELECTRON_TRANSPORT,2.351974112,0.002783941,voapaxar
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.304537115,0.002841939,voapaxar
NONSENSE_MEDIATED_DECAY_NMD,2.258266448,0.002952664,voapaxar
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.516789315,1,BVD-523
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.48584738,0.823867849,BVD-523
GPCR_LIGAND_BINDING,-2.42206831,0.763322497,BVD-523
G_ALPHA_I_SIGNALLING_EVENTS,-2.308184743,0.785875207,BVD-523
SIGNALING_BY_GPCR,-2.300679513,0.637235499,BVD-523
HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,-1.888809956,0.92570201,BVD-523
EUKARYOTIC_TRANSLATION_INITIATION,-1.873610087,0.812492361,BVD-523
MITOCHONDRIAL_TRANSLATION,1.281479941,1,BVD-523
NONSENSE_MEDIATED_DECAY_NMD,-1.852887272,0.735391833,BVD-523
G_ALPHA_Q_SIGNALLING_EVENTS,-1.826333199,0.686065008,BVD-523
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.016897521,0.132191116,relcovaptan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.995161516,0.197309198,relcovaptan
SIGNALING_BY_NOTCH,-1.912499689,0.218842943,relcovaptan
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.877346941,0.192635207,relcovaptan
NEUTROPHIL_DEGRANULATION,1.678115799,0.487019902,relcovaptan
INNATE_IMMUNE_SYSTEM,1.676489511,0.327330383,relcovaptan
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.607502171,0.35234399,relcovaptan
ESR_MEDIATED_SIGNALING,-1.734034362,0.48751397,relcovaptan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.442304426,0.631138036,relcovaptan
HEMOSTASIS,1.428277008,0.561895071,relcovaptan
NUCLEOTIDE_EXCISION_REPAIR,-1.845198417,1,sertindole
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.813984414,0.838268684,sertindole
CILIUM_ASSEMBLY,1.784058372,1,sertindole
METABOLISM_OF_RNA,-1.799788777,0.618914462,sertindole
TCR_SIGNALING,1.748500433,0.665884518,sertindole
DNA_REPLICATION,-1.736967851,0.549317655,sertindole
SYNTHESIS_OF_DNA,-1.736967851,0.549317655,sertindole
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.73237146,0.473713981,sertindole
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.699388573,0.602626107,sertindole
ADAPTIVE_IMMUNE_SYSTEM,1.689719101,0.477780497,sertindole
CELL_CYCLE,-2.617709085,0,BMS-754807
CELL_CYCLE_MITOTIC,-2.58667162,0.001033089,BMS-754807
DNA_REPLICATION,-2.585873564,0.000688726,BMS-754807
DNA_STRAND_ELONGATION,-2.544497137,0.000516545,BMS-754807
SYNTHESIS_OF_DNA,-2.517984062,0.000413236,BMS-754807
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.48829944,0.000344363,BMS-754807
CELL_CYCLE_CHECKPOINTS,-2.418573336,0.000442752,BMS-754807
G2_M_CHECKPOINTS,-2.412911198,0.000387408,BMS-754807
S_PHASE,-2.41112728,0.000344363,BMS-754807
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.409614633,0.000309927,BMS-754807
CELLULAR_RESPONSE_TO_STARVATION,3.192397548,0,yohimbine
TRANSLATION,2.564538895,0,yohimbine
RESPIRATORY_ELECTRON_TRANSPORT,2.606327001,0,yohimbine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.619897693,0,yohimbine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.636473557,0,yohimbine
INFLUENZA_INFECTION,2.740529069,0,yohimbine
EUKARYOTIC_TRANSLATION_INITIATION,2.920138751,0,yohimbine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.003101976,0,yohimbine
RRNA_PROCESSING,3.057811634,0,yohimbine
SIGNALING_BY_ROBO_RECEPTORS,2.963881776,0,yohimbine
TCR_SIGNALING,-2.351498361,0.023116043,GW-3965
STRIATED_MUSCLE_CONTRACTION,2.275569049,0.040887408,GW-3965
INNATE_IMMUNE_SYSTEM,-2.31793653,0.018955155,GW-3965
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.286073741,0.015102481,GW-3965
GPCR_LIGAND_BINDING,2.23678374,0.028394033,GW-3965
MUSCLE_CONTRACTION,2.182943423,0.030665556,GW-3965
PEROXISOMAL_PROTEIN_IMPORT,-2.244608105,0.017799353,GW-3965
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-2.208291962,0.020157189,GW-3965
SENSORY_PERCEPTION,2.048379846,0.063886575,GW-3965
NEUTROPHIL_DEGRANULATION,-2.070395833,0.055940823,GW-3965
RESPIRATORY_ELECTRON_TRANSPORT,3.021595282,0,Y-27632
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.973833707,0,Y-27632
DNA_REPLICATION,2.934027145,0,Y-27632
CELL_CYCLE_CHECKPOINTS,2.875458077,0,Y-27632
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.650412147,0.000250362,Y-27632
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.792238084,0.000500723,Y-27632
SYNTHESIS_OF_DNA,2.744445247,0.000417269,Y-27632
G1_S_DNA_DAMAGE_CHECKPOINTS,2.72015872,0.000357659,Y-27632
CELL_CYCLE,2.717406853,0.000312952,Y-27632
TRANSLATION,2.670254759,0.00027818,Y-27632
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.27207925,0.015625,naltrexone
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.066598065,0.1015625,naltrexone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.04243421,0.084077381,naltrexone
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.029843734,0.069196429,naltrexone
G_ALPHA_S_SIGNALLING_EVENTS,1.996367105,0.223103234,naltrexone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.016778853,0.062276786,naltrexone
RHO_GTPASE_EFFECTORS,-2.007331639,0.056361607,naltrexone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.004541698,0.049107143,naltrexone
MRNA_SPLICING,-1.95128592,0.068080357,naltrexone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.95106986,0.060639881,naltrexone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.249764533,0.002259112,fluoxetine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.103342668,0.013178155,fluoxetine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.033468578,0.301552437,fluoxetine
SIGNALING_BY_ROBO_RECEPTORS,2.027944017,0.156918953,fluoxetine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.990409103,0.155243662,fluoxetine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.944206822,0.17813931,fluoxetine
EUKARYOTIC_TRANSLATION_INITIATION,1.919803615,0.17043297,fluoxetine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.477804963,0.721660878,fluoxetine
HEMOSTASIS,-2.379198035,0.598099985,fluoxetine
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.788446148,0.376568259,fluoxetine
SIGNALING_BY_GPCR,2.774253232,0,flunarizine
GPCR_LIGAND_BINDING,2.714188322,0,flunarizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.390815921,0.000814153,flunarizine
MUSCLE_CONTRACTION,2.25402881,0.00447784,flunarizine
G_ALPHA_Q_SIGNALLING_EVENTS,2.226124543,0.005373408,flunarizine
SENSORY_PERCEPTION,2.204724474,0.005699069,flunarizine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.175159988,0.006745837,flunarizine
NCAM1_INTERACTIONS,2.155410636,0.006818529,flunarizine
NEUTROPHIL_DEGRANULATION,-2.285664152,0.114029641,flunarizine
NEURONAL_SYSTEM,2.056511786,0.01474521,flunarizine
SYNTHESIS_OF_DNA,2.542635435,0,pheniramine
DNA_REPLICATION,2.515701604,0,pheniramine
DNA_REPLICATION_PRE_INITIATION,2.455416979,0.001022809,pheniramine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.364667147,0.003835532,pheniramine
S_PHASE,2.073272346,0.01779687,pheniramine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.023581601,0.019433364,pheniramine
G2_M_CHECKPOINTS,1.765007198,0.075833954,pheniramine
CELL_CYCLE_CHECKPOINTS,1.692387733,0.100107395,pheniramine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.965308586,0.339690971,pheniramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.657002974,0.109099587,pheniramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-4.292287577,0,retinol
NERVOUS_SYSTEM_DEVELOPMENT,-2.813721529,0,retinol
SARS_COV_2_HOST_INTERACTIONS,-2.870670642,0,retinol
SARS_COV_1_INFECTION,-2.897488244,0,retinol
SARS_COV_1_HOST_INTERACTIONS,-3.193692921,0,retinol
CELLULAR_RESPONSES_TO_STIMULI,-3.238175705,0,retinol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.240863884,0,retinol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.375807556,0,retinol
VIRAL_INFECTION_PATHWAYS,-3.383555768,0,retinol
METABOLISM_OF_RNA,-3.385234249,0,retinol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.612024413,0,sitagliptin
TRANSLATION,-2.322206925,0,sitagliptin
INFLUENZA_INFECTION,-2.328936597,0,sitagliptin
SARS_COV_1_INFECTION,-2.346549405,0,sitagliptin
SIGNALING_BY_ROBO_RECEPTORS,-2.394724826,0,sitagliptin
RRNA_PROCESSING,-2.413497681,0,sitagliptin
CELLULAR_RESPONSE_TO_STARVATION,-2.433499841,0,sitagliptin
SARS_COV_1_HOST_INTERACTIONS,-2.447319619,0,sitagliptin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.459266707,0,sitagliptin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.278655264,0,sitagliptin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-4.288116687,0,nefazodone
SARS_COV_INFECTIONS,-2.977064118,0,nefazodone
METABOLISM_OF_RNA,-2.983699266,0,nefazodone
SARS_COV_2_INFECTION,-3.075490805,0,nefazodone
SARS_COV_2_HOST_INTERACTIONS,-3.262242929,0,nefazodone
NERVOUS_SYSTEM_DEVELOPMENT,-3.298849969,0,nefazodone
SARS_COV_1_HOST_INTERACTIONS,-3.319958134,0,nefazodone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.362663966,0,nefazodone
SARS_COV_1_INFECTION,-3.37555887,0,nefazodone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.38582217,0,nefazodone
RESPIRATORY_ELECTRON_TRANSPORT,2.165450755,0.044575756,triclosan
TRANSLATION,1.6158923,0.990907005,triclosan
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.762327007,1,triclosan
PHOSPHOLIPID_METABOLISM,-1.74240711,0.959547797,triclosan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.633498844,1,triclosan
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.40660225,1,triclosan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.34040215,1,triclosan
MUSCLE_CONTRACTION,1.327650527,1,triclosan
NEDDYLATION,1.3235202,1,triclosan
MITOTIC_PROPHASE,1.30140991,1,triclosan
COMPLEMENT_CASCADE,2.735467587,0,flumazenil
ECM_PROTEOGLYCANS,-2.058892384,0.266742024,flumazenil
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.053820924,0.140565299,flumazenil
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.909505061,0.162388897,flumazenil
SIGNALING_BY_NTRKS,1.902906623,0.113546345,flumazenil
NEURONAL_SYSTEM,1.83426616,0.132743482,flumazenil
MUSCLE_CONTRACTION,1.607267704,0.380518727,flumazenil
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.590030416,0.347940242,flumazenil
POTASSIUM_CHANNELS,1.570633651,0.33135967,flumazenil
UNFOLDED_PROTEIN_RESPONSE_UPR,1.525669144,0.363297951,flumazenil
DNA_REPLICATION,2.444498562,0.004239917,pargyline
CELL_CYCLE_CHECKPOINTS,2.268483653,0.008479835,pargyline
DNA_REPLICATION_PRE_INITIATION,2.249560057,0.005653223,pargyline
SYNTHESIS_OF_DNA,2.208366978,0.010599793,pargyline
MITOTIC_METAPHASE_AND_ANAPHASE,2.180727955,0.011871768,pargyline
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.138796265,0.04718427,pargyline
SEPARATION_OF_SISTER_CHROMATIDS,1.901527163,0.048759049,pargyline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.822413294,0.066627271,pargyline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.813897113,0.0614788,pargyline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.048296621,0.053759127,pargyline
INFLUENZA_INFECTION,3.927565036,0,naphazoline
SELENOAMINO_ACID_METABOLISM,3.716525305,0,naphazoline
METABOLISM_OF_RNA,3.61256794,0,naphazoline
EUKARYOTIC_TRANSLATION_ELONGATION,3.464858489,0,naphazoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.410845349,0,naphazoline
CELLULAR_RESPONSE_TO_STARVATION,3.386302714,0,naphazoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.269549786,0,naphazoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.157867307,0,naphazoline
RRNA_PROCESSING,2.950506298,0,naphazoline
NONSENSE_MEDIATED_DECAY_NMD,2.892529918,0,naphazoline
GPCR_LIGAND_BINDING,3.079400377,0,BRD-K25836724
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.896964673,0,BRD-K25836724
SIGNALING_BY_GPCR,2.743370423,0,BRD-K25836724
G_ALPHA_Q_SIGNALLING_EVENTS,2.315558289,0.004490271,BRD-K25836724
SENSORY_PERCEPTION,2.204074929,0.010776651,BRD-K25836724
MUSCLE_CONTRACTION,2.131339442,0.014468651,BRD-K25836724
CARDIAC_CONDUCTION,2.116543027,0.014397377,BRD-K25836724
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.037151436,0.02519541,BRD-K25836724
PROTEIN_LOCALIZATION,-2.125858158,0.411629551,BRD-K25836724
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.090323255,0.264905149,BRD-K25836724
MUSCLE_CONTRACTION,2.724387779,0,ofloxacin
STRIATED_MUSCLE_CONTRACTION,2.528420664,0.000784899,ofloxacin
INTERFERON_ALPHA_BETA_SIGNALING,-2.474909957,0.005140392,ofloxacin
GPCR_LIGAND_BINDING,2.295284297,0.007587359,ofloxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.208797513,0.057829408,ofloxacin
NEURONAL_SYSTEM,2.13747158,0.020014928,ofloxacin
TRANSLATION,-2.196817071,0.044978429,ofloxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.189873085,0.035018919,ofloxacin
CARDIAC_CONDUCTION,2.123880887,0.01852362,ofloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.143386745,0.039323998,ofloxacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.304456194,0.036338493,ruxolitinib
GPCR_LIGAND_BINDING,2.107630727,0.087963775,ruxolitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.034035616,0.102624405,ruxolitinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.00817771,0.086567525,ruxolitinib
SIGNALING_BY_GPCR,1.99805942,0.071208771,ruxolitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.975459749,0.070999333,ruxolitinib
ELASTIC_FIBRE_FORMATION,1.926790126,0.090407214,ruxolitinib
EXTRACELLULAR_MATRIX_ORGANIZATION,1.887420646,0.106214763,ruxolitinib
G_ALPHA_Q_SIGNALLING_EVENTS,1.882599293,0.097126669,ruxolitinib
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.733142917,0.507048746,ruxolitinib
EUKARYOTIC_TRANSLATION_INITIATION,3.081683162,0,PIK-93
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.945626311,0,PIK-93
EUKARYOTIC_TRANSLATION_ELONGATION,2.898382196,0,PIK-93
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.882434766,0,PIK-93
RRNA_PROCESSING,2.858830743,0,PIK-93
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.853591383,0,PIK-93
SIGNALING_BY_ROBO_RECEPTORS,2.812667605,0,PIK-93
NONSENSE_MEDIATED_DECAY_NMD,2.811606556,0,PIK-93
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.790289315,0,PIK-93
SARS_COV_1_HOST_INTERACTIONS,2.727394735,0,PIK-93
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.723644974,0,ibrutinib
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.275202554,0.014380979,ibrutinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.032420209,0.074141935,ibrutinib
SYNTHESIS_OF_DNA,-1.957121367,0.092996996,ibrutinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-1.951547208,0.075548075,ibrutinib
CILIUM_ASSEMBLY,2.037005037,0.16434248,ibrutinib
CELL_CYCLE_CHECKPOINTS,-1.843991246,0.121758953,ibrutinib
PROTEIN_FOLDING,-1.827467472,0.116965294,ibrutinib
MITOCHONDRIAL_TRANSLATION,-1.80996108,0.115766879,ibrutinib
SEPARATION_OF_SISTER_CHROMATIDS,-1.793535495,0.111639005,ibrutinib
GPCR_LIGAND_BINDING,2.665913822,0,veliparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.565039693,0,veliparib
INTERFERON_ALPHA_BETA_SIGNALING,-2.41371559,0.009433797,veliparib
SIGNALING_BY_GPCR,2.16880448,0.010489976,veliparib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.061286005,0.024258069,veliparib
ISG15_ANTIVIRAL_MECHANISM,-1.969889399,0.155657653,veliparib
PEROXISOMAL_PROTEIN_IMPORT,-1.954766994,0.114104023,veliparib
G_ALPHA_Q_SIGNALLING_EVENTS,1.866917338,0.12063472,veliparib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.784198393,0.236855693,veliparib
SIGNALING_BY_ALK_IN_CANCER,-1.659986948,0.390020128,veliparib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.638225615,0.173265583,adapalene
MRNA_SPLICING,1.505904021,0.166574433,adapalene
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.520749071,1,adapalene
GPCR_LIGAND_BINDING,-2.33627868,1,adapalene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.335816868,0.999564941,adapalene
G_ALPHA_I_SIGNALLING_EVENTS,-2.287693408,0.794926166,adapalene
SIGNALING_BY_GPCR,-2.215410133,0.691813334,adapalene
NONSENSE_MEDIATED_DECAY_NMD,-2.190012341,0.59290314,adapalene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.133804388,0.541833752,adapalene
SELENOAMINO_ACID_METABOLISM,-2.115482937,0.483128867,adapalene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.156980763,0.052061955,rotigotine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.152753964,0.026522128,rotigotine
ECM_PROTEOGLYCANS,-2.143378952,0.01866372,rotigotine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.90722899,0.296511763,rotigotine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.744011702,0.352174621,rotigotine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.740528194,0.240848905,rotigotine
ADAPTIVE_IMMUNE_SYSTEM,1.735638092,0.185988877,rotigotine
METABOLISM_OF_STEROIDS,1.6229022,0.273390268,rotigotine
UNFOLDED_PROTEIN_RESPONSE_UPR,1.510944913,0.40676704,rotigotine
GASTRULATION,-1.725731538,0.567524426,rotigotine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.403487112,0.011407019,dapsone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.140314035,0.041825738,dapsone
NEURONAL_SYSTEM,-2.052148203,0.058556033,dapsone
ADAPTIVE_IMMUNE_SYSTEM,1.893819181,0.738521934,dapsone
GPCR_LIGAND_BINDING,-1.909134009,0.127188266,dapsone
TCR_SIGNALING,1.831070289,0.551913267,dapsone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.780412299,0.236505535,dapsone
SARS_COV_2_HOST_INTERACTIONS,1.727538383,0.716542114,dapsone
SENSORY_PERCEPTION,-1.766732252,0.211536837,dapsone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.70067158,0.640931535,dapsone
GPCR_LIGAND_BINDING,3.825376134,0,flupentixol
SIGNALING_BY_GPCR,3.619226546,0,flupentixol
MUSCLE_CONTRACTION,2.790477232,0,flupentixol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.652466772,0,flupentixol
EUKARYOTIC_TRANSLATION_INITIATION,-3.491364121,0.005152436,flupentixol
SELENOAMINO_ACID_METABOLISM,-3.488843191,0.002576218,flupentixol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.468839347,0.003091461,flupentixol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.468404238,0.002318596,flupentixol
CARDIAC_CONDUCTION,2.497579622,0.00113434,flupentixol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.458170847,0.002885364,flupentixol
GPCR_LIGAND_BINDING,2.418282697,0.001950365,orciprenaline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.249749437,0.006826276,orciprenaline
SIGNALING_BY_GPCR,2.021936064,0.039224,orciprenaline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.006779736,0.034618972,orciprenaline
NEURONAL_SYSTEM,2.002877734,0.028735372,orciprenaline
G_ALPHA_Q_SIGNALLING_EVENTS,1.886940158,0.061761547,orciprenaline
POTASSIUM_CHANNELS,1.789229542,0.116743254,orciprenaline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.335841207,1,orciprenaline
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.993606118,1,orciprenaline
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.927592935,1,orciprenaline
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.606157964,0.000749279,fenoterol
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.176596367,0.053356158,fenoterol
MUSCLE_CONTRACTION,2.167808156,0.029596513,fenoterol
HEMOSTASIS,2.119394091,0.028722355,fenoterol
DNA_REPAIR,-2.011471024,0.137280948,fenoterol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.916908428,0.218612036,fenoterol
NEURONAL_SYSTEM,1.814903977,0.154726076,fenoterol
RRNA_PROCESSING,-1.874382829,0.236490054,fenoterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.866198961,0.198529371,fenoterol
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.725939735,0.205602108,fenoterol
METABOLISM_OF_RNA,2.647524494,0,ciglitazone
METABOLISM_OF_STEROIDS,1.794556674,0.205676479,ciglitazone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.764326037,0.170773804,ciglitazone
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.551822522,0.363673411,ciglitazone
MYD88_INDEPENDENT_TLR4_CASCADE,1.545181824,0.299913702,ciglitazone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.511642483,0.292933167,ciglitazone
INNATE_IMMUNE_SYSTEM,1.48951045,0.286878621,ciglitazone
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.474804459,0.268314316,ciglitazone
INTERFERON_ALPHA_BETA_SIGNALING,1.401183543,0.341963116,ciglitazone
TOLL_LIKE_RECEPTOR_CASCADES,1.344558394,0.410605044,ciglitazone
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.479199764,0,repaglinide
EUKARYOTIC_TRANSLATION_ELONGATION,3.015957979,0,repaglinide
EUKARYOTIC_TRANSLATION_INITIATION,3.006216197,0,repaglinide
SELENOAMINO_ACID_METABOLISM,2.980976591,0,repaglinide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.975998752,0,repaglinide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.914952677,0,repaglinide
CELLULAR_RESPONSE_TO_STARVATION,2.805751225,0,repaglinide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.787272752,0,repaglinide
TRANSLATION,2.712483954,0,repaglinide
NONSENSE_MEDIATED_DECAY_NMD,2.711192718,0,repaglinide
METABOLISM_OF_RNA,-3.24469191,0,A-443654
GPCR_LIGAND_BINDING,2.781098895,0,A-443654
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.769727884,0,A-443654
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.616831931,0,A-443654
SIGNALING_BY_GPCR,2.472803932,0.00019321,A-443654
G_ALPHA_Q_SIGNALLING_EVENTS,2.256458215,0.003709627,A-443654
G_ALPHA_I_SIGNALLING_EVENTS,2.231262198,0.003735388,A-443654
NEUTROPHIL_DEGRANULATION,-2.062194175,0.065153353,A-443654
MITOTIC_METAPHASE_AND_ANAPHASE,-2.050574749,0.045245384,A-443654
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.905935443,0.084835095,A-443654
GPCR_LIGAND_BINDING,2.216358827,0.012041212,topiramate
SENSORY_PERCEPTION,2.187473277,0.007329434,topiramate
BIOLOGICAL_OXIDATIONS,-3.624664245,0.411517216,topiramate
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.044342582,0.02163928,topiramate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.022372009,0.020417708,topiramate
DEVELOPMENTAL_CELL_LINEAGES,1.995345182,0.021255357,topiramate
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.558849319,0.411517216,topiramate
DISEASES_OF_METABOLISM,-3.522877142,0.362724347,topiramate
VISUAL_PHOTOTRANSDUCTION,1.958322476,0.025653018,topiramate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-3.504326384,0.306566517,topiramate
TRANSLATION,-2.96367295,0,phenelzine
METABOLISM_OF_RNA,-2.821509477,0,phenelzine
SIGNALING_BY_GPCR,2.599170484,0,phenelzine
GPCR_LIGAND_BINDING,2.580366731,0,phenelzine
G_ALPHA_Q_SIGNALLING_EVENTS,2.33357078,0.001738908,phenelzine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.25126159,0.00309743,phenelzine
RRNA_PROCESSING,-2.290499817,0.017749196,phenelzine
MRNA_SPLICING,-1.934774258,0.114383708,phenelzine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.918127752,0.101367631,phenelzine
G_ALPHA_I_SIGNALLING_EVENTS,1.924663191,0.057514384,phenelzine
STRIATED_MUSCLE_CONTRACTION,2.606036243,0,scopolamine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.759262186,0,scopolamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.528335911,0.000242642,scopolamine
COLLAGEN_FORMATION,2.383481734,0.001091888,scopolamine
GPCR_LIGAND_BINDING,2.355107411,0.001213208,scopolamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.355629149,0.00145585,scopolamine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.240556081,0.069455216,scopolamine
SIGNALING_BY_GPCR,2.225022569,0.004575529,scopolamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.204427446,0.058252762,scopolamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.174500037,0.067214725,scopolamine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.500202115,0.002580041,pyrimethamine
COMPLEMENT_CASCADE,2.462096631,0.001290021,pyrimethamine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.24823587,0.008313466,pyrimethamine
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.947241464,0.079551269,pyrimethamine
SIGNALING_BY_GPCR,1.897573898,0.089269424,pyrimethamine
SIGNALING_BY_NOTCH,-1.867722884,0.690215996,pyrimethamine
GPCR_LIGAND_BINDING,1.862030999,0.095891529,pyrimethamine
BIOLOGICAL_OXIDATIONS,1.856795851,0.085755653,pyrimethamine
NGF_STIMULATED_TRANSCRIPTION,1.830836995,0.089333925,pyrimethamine
CARDIAC_CONDUCTION,1.795797319,0.092451475,pyrimethamine
GPCR_LIGAND_BINDING,2.779201988,0,bethanechol
SIGNALING_BY_GPCR,2.730638187,0,bethanechol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.55146039,0,bethanechol
G_ALPHA_Q_SIGNALLING_EVENTS,2.259370727,0.003290714,bethanechol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.025219891,0.025078702,bethanechol
NEURONAL_SYSTEM,2.003962227,0.024709218,bethanechol
G_ALPHA_S_SIGNALLING_EVENTS,1.985789716,0.024445302,bethanechol
G_ALPHA_I_SIGNALLING_EVENTS,1.929009376,0.033773114,bethanechol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.873356494,0.046339406,bethanechol
NERVOUS_SYSTEM_DEVELOPMENT,1.781193708,0.082094646,bethanechol
GPCR_LIGAND_BINDING,2.367314694,0.006593271,entacapone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.967268479,0.120656855,entacapone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.850020468,0.204391393,entacapone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.103222615,1,entacapone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.756450639,0.305103604,entacapone
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.75433596,1,entacapone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.695859152,1,entacapone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.688157387,1,entacapone
SIGNALING_BY_GPCR,1.631088617,0.562010398,entacapone
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-1.529977499,1,entacapone
CELL_CYCLE,-2.536773471,0.002116956,romidepsin
CELL_CYCLE_MITOTIC,-2.49497151,0.002116956,romidepsin
AUTOPHAGY,2.429081286,0.00527552,romidepsin
S_PHASE,-2.31984164,0.007762171,romidepsin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.307921657,0.006615487,romidepsin
CELL_CYCLE_CHECKPOINTS,-2.284440266,0.006562563,romidepsin
IRON_UPTAKE_AND_TRANSPORT,2.305987974,0.014507681,romidepsin
MITOTIC_SPINDLE_CHECKPOINT,-2.252360605,0.006880106,romidepsin
METABOLISM_OF_RNA,-2.240273157,0.006199656,romidepsin
DEUBIQUITINATION,-2.165334701,0.011246327,romidepsin
METABOLISM_OF_RNA,-2.648217926,0.001939444,amantadine
PROTEIN_FOLDING,-2.287419815,0.0261825,amantadine
MRNA_SPLICING,-2.182971139,0.042021296,amantadine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.167953728,0.033940278,amantadine
GASTRULATION,-2.022340948,0.075250445,amantadine
SIGNALING_BY_NOTCH4,-2.021183993,0.063031945,amantadine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.008590934,0.143642982,amantadine
DNA_REPLICATION,-1.996865839,0.062339286,amantadine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.890459395,0.107639167,amantadine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,-1.886773841,0.098911667,amantadine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.842291367,0.159813084,ketanserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.999098394,0.257669703,ketanserin
SIGNALING_BY_ROBO_RECEPTORS,-1.939606802,0.212812225,ketanserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.919891836,0.17143207,ketanserin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.905433658,0.145786806,ketanserin
G_ALPHA_I_SIGNALLING_EVENTS,-1.880988891,0.150846312,ketanserin
NERVOUS_SYSTEM_DEVELOPMENT,-1.842592874,0.174040063,ketanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.82013307,0.177939633,ketanserin
SIGNALING_BY_GPCR,-1.803655819,0.179821114,ketanserin
RRNA_PROCESSING,-1.788317059,0.180009469,ketanserin
GASTRULATION,2.173132437,0.046157273,modafinil
CELL_CYCLE_MITOTIC,2.065209687,0.05275117,modafinil
CELL_CYCLE_CHECKPOINTS,2.037762219,0.04212767,modafinil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.080534234,0.314667293,modafinil
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.923392981,0.087094379,modafinil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.862846323,0.106381525,modafinil
DEVELOPMENTAL_CELL_LINEAGES,1.813312521,0.125467191,modafinil
CELL_CYCLE,1.778010126,0.13721584,modafinil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.000333163,0.621752242,modafinil
SEPARATION_OF_SISTER_CHROMATIDS,1.754649622,0.137647583,modafinil
EUKARYOTIC_TRANSLATION_INITIATION,2.558568788,0.005271406,homatropine
NEDDYLATION,2.384433174,0.009224961,homatropine
NEUTROPHIL_DEGRANULATION,-2.165860399,0.044623914,homatropine
MUSCLE_CONTRACTION,2.16964308,0.026796315,homatropine
INNATE_IMMUNE_SYSTEM,-1.924341823,0.241333413,homatropine
TRANSLATION,1.831886908,0.172968015,homatropine
INTERFERON_SIGNALING,-1.90921854,0.186691886,homatropine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.864745937,0.204222709,homatropine
MEMBRANE_TRAFFICKING,-1.848806691,0.187784716,homatropine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.716421359,0.271740989,homatropine
METABOLISM_OF_RNA,-4.246316546,0,obatoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.703761949,0,obatoclax
SIGNALING_BY_GPCR,2.773246634,0,obatoclax
CELL_CYCLE_MITOTIC,-2.774315595,0,obatoclax
M_PHASE,-2.816547074,0,obatoclax
GPCR_LIGAND_BINDING,2.954632017,0,obatoclax
CHROMOSOME_MAINTENANCE,-2.97512952,0,obatoclax
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.986437276,0,obatoclax
MRNA_SPLICING,-2.99673875,0,obatoclax
CELL_CYCLE,-3.011235311,0,obatoclax
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.934537313,0.151725526,BRD-K14965640
EXTRACELLULAR_MATRIX_ORGANIZATION,1.797022016,0.167773418,BRD-K14965640
INFLUENZA_INFECTION,1.77085549,0.132273535,BRD-K14965640
NONSENSE_MEDIATED_DECAY_NMD,1.716959375,0.133489285,BRD-K14965640
SYNTHESIS_OF_DNA,1.709753969,0.111459905,BRD-K14965640
DNA_REPLICATION,1.704142284,0.094828454,BRD-K14965640
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.683417769,0.090451756,BRD-K14965640
DNA_REPLICATION_PRE_INITIATION,1.67605818,0.083886709,BRD-K14965640
SELENOAMINO_ACID_METABOLISM,1.657866482,0.083319359,BRD-K14965640
S_PHASE,1.657038069,0.075570983,BRD-K14965640
MUSCLE_CONTRACTION,3.099564661,0,lamotrigine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.955617179,0,lamotrigine
GPCR_LIGAND_BINDING,2.366096893,0.003159593,lamotrigine
INFLUENZA_INFECTION,-2.262504135,0.024857284,lamotrigine
RRNA_PROCESSING,-2.256786136,0.013020482,lamotrigine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.292996704,0.004010252,lamotrigine
SIGNALING_BY_GPCR,2.256080258,0.005103957,lamotrigine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.18892432,0.009235732,lamotrigine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.146292358,0.010832889,lamotrigine
METABOLISM_OF_RNA,-2.070342933,0.06234049,lamotrigine
DNA_REPLICATION,2.616182675,0,tianeptine
RESPIRATORY_ELECTRON_TRANSPORT,3.049187203,0,tianeptine
EUKARYOTIC_TRANSLATION_INITIATION,2.935332136,0,tianeptine
TRANSLATION,2.831097288,0,tianeptine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.531624962,0.000340374,tianeptine
ORC1_REMOVAL_FROM_CHROMATIN,2.553888711,0.000397103,tianeptine
CELL_CYCLE_CHECKPOINTS,2.567780957,0.000476524,tianeptine
RRNA_PROCESSING,2.396935735,0.001588414,tianeptine
G2_M_CHECKPOINTS,2.409055683,0.001786966,tianeptine
MITOTIC_METAPHASE_AND_ANAPHASE,2.388603942,0.001906097,tianeptine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.667746605,0,triflupromazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.659011543,0,triflupromazine
ECM_PROTEOGLYCANS,-2.499085997,0.000505499,triflupromazine
G_ALPHA_Q_SIGNALLING_EVENTS,1.940426208,0.574868138,triflupromazine
TCR_SIGNALING,1.89570998,0.406895064,triflupromazine
MUSCLE_CONTRACTION,1.885133538,0.289859673,triflupromazine
SARS_COV_2_INFECTION,1.879690708,0.225884369,triflupromazine
SARS_COV_2_HOST_INTERACTIONS,1.868385383,0.194533438,triflupromazine
ADAPTIVE_IMMUNE_SYSTEM,1.834908286,0.207389139,triflupromazine
BIOLOGICAL_OXIDATIONS,1.798607342,0.225234653,triflupromazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.520844573,0.006608835,diphenhydramine
MITF_M_DEPENDENT_GENE_EXPRESSION,2.448098618,0.006608835,diphenhydramine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.056203465,0.142824277,diphenhydramine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2.025570905,0.139887016,diphenhydramine
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1.927701594,0.252898102,diphenhydramine
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.924370439,0.216622939,diphenhydramine
UCH_PROTEINASES,1.910747944,0.205188604,diphenhydramine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.895140362,0.202395585,diphenhydramine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.886667686,0.189698054,diphenhydramine
ADAPTIVE_IMMUNE_SYSTEM,1.886005182,0.171389132,diphenhydramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.690665344,0.000857439,ranolazine
MUSCLE_CONTRACTION,2.619491583,0.001286159,ranolazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.49086482,0.001714879,ranolazine
NONSENSE_MEDIATED_DECAY_NMD,2.488519553,0.001286159,ranolazine
ECM_PROTEOGLYCANS,-2.260455476,0.010301313,ranolazine
CELLULAR_RESPONSE_TO_STARVATION,2.33090676,0.003772733,ranolazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.12175689,0.03090394,ranolazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.140895229,0.009860553,ranolazine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.085853845,0.031590694,ranolazine
SELENOAMINO_ACID_METABOLISM,2.09191482,0.011759169,ranolazine
GPCR_LIGAND_BINDING,3.025241614,0,nocodazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.01563071,0,nocodazole
CELLULAR_RESPONSE_TO_STARVATION,-2.85283564,0,nocodazole
SIGNALING_BY_GPCR,2.768939059,0,nocodazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.605018188,0,nocodazole
INFLUENZA_INFECTION,-2.718515889,0.000351293,nocodazole
TRANSLATION,-2.695256105,0.00026347,nocodazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.694067981,0.000210776,nocodazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.687721861,0.000175647,nocodazole
SELENOAMINO_ACID_METABOLISM,-2.580992718,0.000451663,nocodazole
GPCR_LIGAND_BINDING,2.146592641,0.04505656,rescinnamine
PTEN_REGULATION,1.806157753,0.171119064,rescinnamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.734972771,0.169361539,rescinnamine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.911308051,0.773175862,rescinnamine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.668517141,0.181424554,rescinnamine
NEURONAL_SYSTEM,1.625719402,0.177925481,rescinnamine
G_ALPHA_Q_SIGNALLING_EVENTS,1.528970468,0.23950278,rescinnamine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.437309208,0.317176273,rescinnamine
MUSCLE_CONTRACTION,1.399895357,0.330494664,rescinnamine
SIGNALING_BY_GPCR,1.298113392,0.465051874,rescinnamine
HIV_LIFE_CYCLE,-2.321978032,0.02494577,canertinib
DNA_REPLICATION,-2.22463225,0.021827549,canertinib
HIV_INFECTION,-2.208069356,0.016630513,canertinib
SYNTHESIS_OF_DNA,-2.085482122,0.027544288,canertinib
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.904837747,0.062364425,canertinib
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.737581734,0.123689443,canertinib
MITF_M_DEPENDENT_GENE_EXPRESSION,1.928454083,0.343977438,canertinib
NUCLEOTIDE_EXCISION_REPAIR,-1.654540609,0.156801983,canertinib
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-1.584134965,0.192030459,canertinib
SIGNALING_BY_GPCR,1.836075982,0.399722525,canertinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.78529713,0,dorsomorphin
COLLAGEN_DEGRADATION,2.625806937,0,dorsomorphin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.419745977,0.001811184,dorsomorphin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.342638592,0.004414761,dorsomorphin
DEVELOPMENTAL_CELL_LINEAGES,1.968794766,0.052162101,dorsomorphin
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.792027267,0.125424496,dorsomorphin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.774462022,0.118761926,dorsomorphin
CILIUM_ASSEMBLY,-1.828607035,0.769474387,dorsomorphin
SARS_COV_2_HOST_INTERACTIONS,-1.81018072,0.461684632,dorsomorphin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.633708599,0.210040752,dorsomorphin
METABOLISM_OF_RNA,-3.962129406,0,PD-0325901
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.874726885,0,PD-0325901
DNA_REPAIR,-2.858401472,0,PD-0325901
HOMOLOGY_DIRECTED_REPAIR,-2.803921047,0,PD-0325901
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.78242728,0,PD-0325901
TELOMERE_MAINTENANCE,-2.775114996,0,PD-0325901
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.770800369,0,PD-0325901
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.682272521,0,PD-0325901
MITOTIC_SPINDLE_CHECKPOINT,-2.680003692,0,PD-0325901
SEPARATION_OF_SISTER_CHROMATIDS,-2.676136835,0,PD-0325901
CELLULAR_RESPONSE_TO_STARVATION,2.806355262,0,benzylpenicillin
TRANSLATION,2.371715451,0.016573936,benzylpenicillin
ECM_PROTEOGLYCANS,-2.188825141,0.023813801,benzylpenicillin
EUKARYOTIC_TRANSLATION_INITIATION,2.310014619,0.014323155,benzylpenicillin
INFLUENZA_INFECTION,2.155105018,0.020870883,benzylpenicillin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.114006984,0.036196977,benzylpenicillin
G2_M_CHECKPOINTS,2.105050659,0.02357182,benzylpenicillin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.087497876,0.032069251,benzylpenicillin
RAB_REGULATION_OF_TRAFFICKING,2.054164165,0.027418611,benzylpenicillin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.05003085,0.034768149,benzylpenicillin
EXTRACELLULAR_MATRIX_ORGANIZATION,3.469386072,0,anisomycin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.824954347,0,anisomycin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.647073977,0.000180121,anisomycin
ECM_PROTEOGLYCANS,2.661468096,0.000225151,anisomycin
COLLAGEN_FORMATION,2.773835433,0.000300201,anisomycin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.594500468,0.000257315,anisomycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.608770518,0.000300201,anisomycin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.291845662,0.003489835,anisomycin
DEVELOPMENTAL_CELL_LINEAGES,2.220519795,0.005503683,anisomycin
DISEASES_OF_GLYCOSYLATION,-3.086704592,0.089037389,anisomycin
INNATE_IMMUNE_SYSTEM,-2.606686126,0.004893868,terazosin
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.575313326,0.003670401,terazosin
TCR_SIGNALING,-2.427972874,0.014681604,terazosin
GPCR_LIGAND_BINDING,2.195610963,0.023099033,terazosin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.160608027,0.014606742,terazosin
NEUTROPHIL_DEGRANULATION,-2.203618051,0.07707842,terazosin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.062469535,0.148284198,terazosin
DEATH_RECEPTOR_SIGNALING,-2.035568665,0.143145637,terazosin
TOLL_LIKE_RECEPTOR_CASCADES,-1.923639304,0.230710916,terazosin
SIGNALING_BY_ALK_IN_CANCER,-1.846037035,0.290267541,terazosin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.69245482,0.035954622,mexiletine
GPCR_LIGAND_BINDING,2.076194118,0.123863964,mexiletine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.513114172,0.343816071,mexiletine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.457382648,0.367036764,mexiletine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.392673642,0.394939049,mexiletine
SIGNALING_BY_FGFR,1.817517067,0.509783404,mexiletine
SENSORY_PERCEPTION,1.784840549,0.424588414,mexiletine
TRANSPORT_OF_SMALL_MOLECULES,-3.218023227,0.534824999,mexiletine
VESICLE_MEDIATED_TRANSPORT,-3.128113181,0.482578439,mexiletine
MEMBRANE_TRAFFICKING,-3.118467614,0.414922756,mexiletine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.32730715,0.001009191,trapidil
ECM_PROTEOGLYCANS,-2.300666877,0.001009191,trapidil
CELLULAR_RESPONSE_TO_STARVATION,2.495487052,0.005735265,trapidil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.406027111,0.005257327,trapidil
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.225245932,0.003027574,trapidil
MUSCLE_CONTRACTION,2.296704733,0.006053891,trapidil
SELENOAMINO_ACID_METABOLISM,2.286553679,0.004540418,trapidil
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.14480234,0.007316637,trapidil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.187299634,0.008029372,trapidil
INFLUENZA_INFECTION,2.118954687,0.009877401,trapidil
GPCR_LIGAND_BINDING,2.664175153,0.000756333,BRD-K66766661
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.381892473,0.002647167,BRD-K66766661
SIGNALING_BY_GPCR,2.137756097,0.022690004,BRD-K66766661
BIOLOGICAL_OXIDATIONS,-3.296503329,0.579998498,BRD-K66766661
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.236793398,0.573038516,BRD-K66766661
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.888973027,0.137652689,BRD-K66766661
SLC_TRANSPORTER_DISORDERS,-3.192335221,0.577936282,BRD-K66766661
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-3.166915081,0.527411968,BRD-K66766661
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-3.150956082,0.472969442,BRD-K66766661
DISEASES_OF_GLYCOSYLATION,-3.138892342,0.420950021,BRD-K66766661
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.628879891,0,DPPE
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.737296524,0,DPPE
SARS_COV_1_INFECTION,-2.761058546,0,DPPE
STRIATED_MUSCLE_CONTRACTION,2.78118941,0,DPPE
VIRAL_INFECTION_PATHWAYS,-2.868990505,0,DPPE
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.877788472,0,DPPE
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.890198728,0,DPPE
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.949438182,0,DPPE
CELLULAR_RESPONSES_TO_STIMULI,-2.959429019,0,DPPE
SARS_COV_1_HOST_INTERACTIONS,-2.969578024,0,DPPE
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.540163772,0.001874322,fenoldopam
MRNA_SPLICING,2.009270062,0.040297919,fenoldopam
EUKARYOTIC_TRANSLATION_ELONGATION,-2.06455116,0.069645292,fenoldopam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.014407536,0.059627819,fenoldopam
SIGNALING_BY_ROBO_RECEPTORS,-1.998920786,0.04611218,fenoldopam
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.990108337,0.038400315,fenoldopam
SELENOAMINO_ACID_METABOLISM,-1.985681551,0.032246724,fenoldopam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.980693207,0.027667308,fenoldopam
NONSENSE_MEDIATED_DECAY_NMD,-1.974685726,0.024123712,fenoldopam
EUKARYOTIC_TRANSLATION_INITIATION,-1.962005721,0.023851127,fenoldopam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.891722362,0,floxuridine
SIGNALING_BY_GPCR,2.666135623,0,floxuridine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.825356791,0,floxuridine
MITOTIC_SPINDLE_CHECKPOINT,-2.861789687,0,floxuridine
SIGNALING_BY_ROBO_RECEPTORS,-3.034975613,0,floxuridine
RRNA_PROCESSING,-3.177908242,0,floxuridine
GPCR_LIGAND_BINDING,2.613337363,0,floxuridine
METABOLISM_OF_RNA,-3.350530747,0,floxuridine
CELLULAR_RESPONSE_TO_STARVATION,-3.312124067,0,floxuridine
SELENOAMINO_ACID_METABOLISM,-3.496995914,0,floxuridine
GPCR_LIGAND_BINDING,2.288923534,0.01247103,nomifensine
SIGNALING_BY_GPCR,2.171853196,0.020369348,nomifensine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.030838935,0.046004243,nomifensine
G_ALPHA_S_SIGNALLING_EVENTS,1.850191144,0.170437406,nomifensine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.254291794,1,nomifensine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.211039138,1,nomifensine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.188407682,1,nomifensine
GASTRULATION,1.750907577,0.293152338,nomifensine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.982934941,1,nomifensine
G_ALPHA_I_SIGNALLING_EVENTS,1.738658046,0.267018602,nomifensine
SELENOAMINO_ACID_METABOLISM,2.835482188,0,roscovitine
NERVOUS_SYSTEM_DEVELOPMENT,2.403389258,0,roscovitine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.436634872,0,roscovitine
INFLUENZA_INFECTION,2.453062657,0,roscovitine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.497831208,0,roscovitine
SARS_COV_1_HOST_INTERACTIONS,2.637867957,0,roscovitine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.64100515,0,roscovitine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.581678638,0,roscovitine
SIGNALING_BY_ROBO_RECEPTORS,2.683106938,0,roscovitine
CELLULAR_RESPONSE_TO_STARVATION,2.77373882,0,roscovitine
NUCLEOTIDE_EXCISION_REPAIR,-2.088127853,0.300353443,lisinopril
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-1.999433774,0.285406944,lisinopril
PROTEIN_FOLDING,-1.820209278,0.609722233,lisinopril
SYNTHESIS_OF_DNA,-1.793400763,0.544835451,lisinopril
DNA_REPLICATION,-1.788663669,0.447825559,lisinopril
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.775475315,0.406876899,lisinopril
RNA_POLYMERASE_II_TRANSCRIPTION,1.756512337,0.84651944,lisinopril
SIGNALING_BY_NOTCH,-1.746893632,0.412604695,lisinopril
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.733086945,0.387719284,lisinopril
DNA_REPAIR,-1.716651977,0.380384428,lisinopril
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.226452464,0.037616207,rupatadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.96979434,0.112848622,rupatadine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.924262444,0.104071507,rupatadine
INFLUENZA_INFECTION,1.921428274,0.078523833,rupatadine
FATTY_ACID_METABOLISM,1.859366906,0.090655059,rupatadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.825481827,0.09372705,rupatadine
CELLULAR_RESPONSE_TO_STARVATION,1.793852278,0.095652641,rupatadine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.763978873,0.102033962,rupatadine
NONSENSE_MEDIATED_DECAY_NMD,1.761723621,0.092368687,rupatadine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.914493145,0.393867279,rupatadine
METABOLISM_OF_RNA,-3.989791189,0,SB-939
RRNA_PROCESSING,-3.660340164,0,SB-939
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-3.167697701,0,SB-939
DNA_REPLICATION,-2.903645062,0,SB-939
SYNTHESIS_OF_DNA,-2.784402121,0,SB-939
TRNA_PROCESSING,-2.711359915,0,SB-939
DNA_REPLICATION_PRE_INITIATION,-2.617842961,0.000199174,SB-939
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.539759487,0.000174277,SB-939
INTRAFLAGELLAR_TRANSPORT,2.415213931,0.001607607,SB-939
S_PHASE,-2.468432333,0.000774566,SB-939
GPCR_LIGAND_BINDING,-2.283105161,0.002568026,epinephrine
MITF_M_DEPENDENT_GENE_EXPRESSION,2.158716207,0.060626205,epinephrine
GASTRULATION,-2.035308465,0.035952363,epinephrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.020793783,0.028818958,epinephrine
SIGNALING_BY_GPCR,-1.955748473,0.049648501,epinephrine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.932141698,0.051189317,epinephrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.771772872,0.360915376,epinephrine
G_ALPHA_I_SIGNALLING_EVENTS,-1.859745108,0.090879585,epinephrine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.820408181,0.112993141,epinephrine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.58691123,0.667519777,epinephrine
CELLULAR_RESPONSE_TO_STARVATION,2.83241291,0,istaroxime
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.669299389,0.000441329,istaroxime
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.474653009,0.001176876,istaroxime
NONSENSE_MEDIATED_DECAY_NMD,2.211754973,0.005957935,istaroxime
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.162340477,0.036827825,istaroxime
EUKARYOTIC_TRANSLATION_ELONGATION,2.160283385,0.006355131,istaroxime
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.119935943,0.028132367,istaroxime
SELENOAMINO_ACID_METABOLISM,2.125417501,0.007061256,istaroxime
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.09057113,0.027279871,istaroxime
ECM_PROTEOGLYCANS,-2.067997023,0.026853623,istaroxime
MITF_M_DEPENDENT_GENE_EXPRESSION,2.311811353,0.021930799,clofibrate
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.907412907,0.10896866,clofibrate
GPCR_LIGAND_BINDING,-1.957249618,0.240082628,clofibrate
SIGNALING_BY_GPCR,-1.867269068,0.278850835,clofibrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.819782236,0.277138183,clofibrate
GASTRULATION,-1.754045904,0.357087878,clofibrate
DISEASES_OF_GLYCOSYLATION,-1.751888993,0.292209518,clofibrate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.471272944,0.745647181,clofibrate
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.444697262,0.633937171,clofibrate
NEURONAL_SYSTEM,-1.654936161,0.500561381,clofibrate
GPCR_LIGAND_BINDING,-2.471957642,0.00092347,cinnarizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.245617731,0.006464291,cinnarizine
SIGNALING_BY_GPCR,-2.150562529,0.012620759,cinnarizine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.03337734,0.030705383,cinnarizine
INTERFERON_ALPHA_BETA_SIGNALING,1.719280397,1,cinnarizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.750970442,0.29791148,cinnarizine
SENSORY_PERCEPTION,-1.748803489,0.252723006,cinnarizine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.723933955,0.262925152,cinnarizine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.67085005,0.325176937,cinnarizine
DISEASES_OF_DNA_REPAIR,1.539071565,1,cinnarizine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.413823933,0.060824298,BRD-K30697463
DNA_REPAIR,1.791190525,0.921526226,BRD-K30697463
CHROMOSOME_MAINTENANCE,1.772695775,0.517982061,BRD-K30697463
CELL_CYCLE_CHECKPOINTS,1.755880837,0.379050439,BRD-K30697463
DNA_REPLICATION,1.626836256,0.659222519,BRD-K30697463
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.702619884,1,BRD-K30697463
GASTRULATION,1.6070459,0.58158544,BRD-K30697463
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.588612321,1,BRD-K30697463
MITOTIC_METAPHASE_AND_ANAPHASE,1.58051963,0.562753379,BRD-K30697463
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.585516779,0.761751928,BRD-K30697463
METABOLISM_OF_RNA,2.541010114,0,rilmenidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.352501621,0.008859862,rilmenidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.185530588,0.008369884,rilmenidine
MRNA_SPLICING,2.076348808,0.033076819,rilmenidine
BIOLOGICAL_OXIDATIONS,1.981359498,0.03986938,rilmenidine
GPCR_LIGAND_BINDING,-2.040104104,0.025528146,rilmenidine
INFLUENZA_INFECTION,1.918611879,0.044653706,rilmenidine
METABOLISM_OF_STEROIDS,1.597383988,0.191963683,rilmenidine
SIGNALING_BY_GPCR,-1.87128158,0.107971503,rilmenidine
FATTY_ACID_METABOLISM,1.586655265,0.172640745,rilmenidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.44566747,0.002574233,haloperidol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.387933029,0.002896012,haloperidol
GPCR_LIGAND_BINDING,-2.351598533,0.002574233,haloperidol
SIGNALING_BY_GPCR,-2.053346263,0.035073928,haloperidol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.947746614,0.493902109,haloperidol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.935607671,0.071563684,haloperidol
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.877539272,0.429768551,haloperidol
SIGNALING_BY_PDGF,-1.902637518,0.0761544,haloperidol
ADAPTIVE_IMMUNE_SYSTEM,1.849111279,0.348434423,haloperidol
INTERFERON_ALPHA_BETA_SIGNALING,1.81261369,0.322142122,haloperidol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.814956722,0,T-0901317
GPCR_LIGAND_BINDING,2.689697326,0,T-0901317
SIGNALING_BY_GPCR,2.300395991,0.006617938,T-0901317
MUSCLE_CONTRACTION,2.016472878,0.051525371,T-0901317
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.008940402,0.043489304,T-0901317
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.004581966,0.483157993,T-0901317
PEROXISOMAL_PROTEIN_IMPORT,-1.990138936,0.267333687,T-0901317
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.801625983,0.133776881,T-0901317
NEUTROPHIL_DEGRANULATION,-1.88845123,0.375331689,T-0901317
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.862129645,0.334038335,T-0901317
GPCR_LIGAND_BINDING,-2.180523367,0.027043868,fluticasone-propionate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.026358431,0.065677966,fluticasone-propionate
SARS_COV_2_HOST_INTERACTIONS,-1.973451201,0.079521851,fluticasone-propionate
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.953955,0.071956007,fluticasone-propionate
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.785943598,0.612753807,fluticasone-propionate
SIGNALING_BY_GPCR,-1.858386244,0.131742273,fluticasone-propionate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.836072318,0.131033981,fluticasone-propionate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.655026703,0.582233503,fluticasone-propionate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.621618789,0.455848139,fluticasone-propionate
NEDDYLATION,1.569638602,0.449881028,fluticasone-propionate
EUKARYOTIC_TRANSLATION_ELONGATION,3.067529521,0,tetryzoline
EUKARYOTIC_TRANSLATION_INITIATION,3.025269271,0,tetryzoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.784863861,0,tetryzoline
DNA_REPLICATION,2.58144652,0.000527032,tetryzoline
ORC1_REMOVAL_FROM_CHROMATIN,2.488660484,0.004216257,tetryzoline
SYNTHESIS_OF_DNA,2.424575061,0.004918967,tetryzoline
TRANSLATION,2.327434265,0.007529031,tetryzoline
SIGNALING_BY_WNT,2.265791195,0.009750095,tetryzoline
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.262024456,0.008666752,tetryzoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.259453251,0.007800076,tetryzoline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.403948394,0.00536569,physostigmine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.274518539,0.091663865,physostigmine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.263625308,0.073927279,physostigmine
DNA_REPLICATION,1.986528506,0.312853798,physostigmine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.201326918,0.159852837,physostigmine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.187019466,0.149881597,physostigmine
SIGNALING_BY_NOTCH4,1.866076217,0.398229651,physostigmine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.845541319,0.301011957,physostigmine
HEMOSTASIS,-3.161722631,0.163206393,physostigmine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.830282137,0.251830118,physostigmine
DNA_REPLICATION,2.407125573,0.003484885,parachlorophenol
SYNTHESIS_OF_DNA,2.256505131,0.012197099,parachlorophenol
S_PHASE,2.19782723,0.011616284,parachlorophenol
DNA_REPLICATION_PRE_INITIATION,2.188415536,0.008712213,parachlorophenol
SELENOAMINO_ACID_METABOLISM,1.80634342,0.085728179,parachlorophenol
INTERFERON_ALPHA_BETA_SIGNALING,1.794034058,0.076086663,parachlorophenol
EXTRACELLULAR_MATRIX_ORGANIZATION,1.778701579,0.072684751,parachlorophenol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.934434339,0.231677183,parachlorophenol
COPII_MEDIATED_VESICLE_TRANSPORT,-1.880938945,0.196511896,parachlorophenol
EUKARYOTIC_TRANSLATION_ELONGATION,1.561663918,0.208657509,parachlorophenol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.536090124,0,propoxycaine
INFECTIOUS_DISEASE,-2.532733764,0,propoxycaine
SARS_COV_2_INFECTION,-2.552700365,0,propoxycaine
SARS_COV_1_INFECTION,-2.616305587,0,propoxycaine
METABOLISM_OF_RNA,-2.682075172,0,propoxycaine
CELLULAR_RESPONSES_TO_STIMULI,-2.684036769,0,propoxycaine
VIRAL_INFECTION_PATHWAYS,-2.708332122,0,propoxycaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.754836488,0,propoxycaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.851420771,0,propoxycaine
SARS_COV_1_HOST_INTERACTIONS,-2.909578233,0,propoxycaine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.694729158,1,olmesartan
METABOLISM_OF_STEROIDS,1.830438012,1,olmesartan
SEPARATION_OF_SISTER_CHROMATIDS,-1.51466294,1,olmesartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.727971725,1,olmesartan
MITOTIC_METAPHASE_AND_ANAPHASE,-1.404334912,1,olmesartan
RHO_GTPASES_ACTIVATE_FORMINS,-1.356841143,1,olmesartan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.356098224,1,olmesartan
HEDGEHOG_OFF_STATE,-1.355006151,0.919361015,olmesartan
CELL_CYCLE_CHECKPOINTS,-1.345412245,0.821132387,olmesartan
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.616497892,1,olmesartan
SIGNALING_BY_GPCR,2.565591939,0,tranilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.383506342,0.002178563,tranilast
G_ALPHA_I_SIGNALLING_EVENTS,2.344949096,0.001694438,tranilast
GPCR_LIGAND_BINDING,2.323061195,0.001452375,tranilast
NEUTROPHIL_DEGRANULATION,-2.288885511,0.136265399,tranilast
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.132414118,0.189548664,tranilast
SENSORY_PERCEPTION,2.03558781,0.029047506,tranilast
INNATE_IMMUNE_SYSTEM,-2.072782569,0.168875922,tranilast
G_ALPHA_Q_SIGNALLING_EVENTS,1.961570263,0.048775604,tranilast
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.962385657,0.235407211,tranilast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.9977897,0.264074604,vandetanib
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.999464284,0.222111764,vandetanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.924547674,0.208417625,vandetanib
NONSENSE_MEDIATED_DECAY_NMD,1.871305945,0.186707455,vandetanib
ECM_PROTEOGLYCANS,-1.937208845,0.210297308,vandetanib
COLLAGEN_FORMATION,-1.836766255,0.340886423,vandetanib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,1.702970217,0.352888933,vandetanib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,1.700246098,0.287758425,vandetanib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.698505882,0.241377609,vandetanib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.668144724,0.245635058,vandetanib
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-1.962222572,0.730247406,diacerein
CILIUM_ASSEMBLY,1.943171238,0.299984672,diacerein
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.899264568,0.2169532,diacerein
PROTEIN_FOLDING,-1.823084516,0.849960096,diacerein
PHOSPHOLIPID_METABOLISM,-1.790937,0.691229937,diacerein
DEATH_RECEPTOR_SIGNALING,1.784580754,0.311591221,diacerein
G_ALPHA_Q_SIGNALLING_EVENTS,1.78221898,0.237041459,diacerein
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.771862888,0.588919926,diacerein
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.770750433,0.474594307,diacerein
NUCLEOTIDE_EXCISION_REPAIR,-1.718692365,0.537820342,diacerein
GPCR_LIGAND_BINDING,2.42634123,0.00139089,fludarabine
SIGNALING_BY_GPCR,2.320910389,0.002086335,fludarabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.276403437,0.003013594,fludarabine
GLYCOSAMINOGLYCAN_METABOLISM,-2.070216634,0.641190895,fludarabine
G_ALPHA_I_SIGNALLING_EVENTS,1.866260309,0.111097313,fludarabine
DISEASES_OF_GLYCOSYLATION,-1.890632862,0.842045874,fludarabine
FATTY_ACID_METABOLISM,-1.877042671,0.603852469,fludarabine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.860824797,0.488618363,fludarabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.804851719,0.146043416,fludarabine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.814812529,0.496343554,fludarabine
METABOLISM_OF_RNA,-4.271479179,0,ponatinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.464330176,0,ponatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.581168834,0,ponatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.72613975,0,ponatinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.77110436,0,ponatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.776351932,0,ponatinib
GPCR_LIGAND_BINDING,2.904684169,0,ponatinib
SIGNALING_BY_GPCR,2.748407383,0,ponatinib
DNA_REPAIR,-3.096743088,0,ponatinib
CELL_CYCLE_MITOTIC,-3.149852568,0,ponatinib
EUKARYOTIC_TRANSLATION_ELONGATION,3.922251544,0,metoclopramide
CELLULAR_RESPONSE_TO_STARVATION,3.82612521,0,metoclopramide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.75295616,0,metoclopramide
NONSENSE_MEDIATED_DECAY_NMD,3.548320533,0,metoclopramide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.522559112,0,metoclopramide
SELENOAMINO_ACID_METABOLISM,3.52063243,0,metoclopramide
INFLUENZA_INFECTION,3.457852906,0,metoclopramide
SARS_COV_1_HOST_INTERACTIONS,2.496860552,0.00035381,metoclopramide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.661662927,0.000424572,metoclopramide
EUKARYOTIC_TRANSLATION_INITIATION,2.593177267,0.000385975,metoclopramide
CELLULAR_RESPONSE_TO_STARVATION,-3.619128951,0,GW-9662
SARS_COV_2_HOST_INTERACTIONS,-2.662699949,0,GW-9662
INFECTIOUS_DISEASE,-2.554491542,0,GW-9662
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.767656061,0,GW-9662
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.79860138,0,GW-9662
CELLULAR_RESPONSES_TO_STIMULI,-2.803992329,0,GW-9662
VIRAL_INFECTION_PATHWAYS,-2.844519294,0,GW-9662
SARS_COV_1_HOST_INTERACTIONS,-2.851504735,0,GW-9662
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.942406431,0,GW-9662
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.071003861,0,GW-9662
STRIATED_MUSCLE_CONTRACTION,2.169288436,0.043452063,salmeterol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.705494634,0.279585527,salmeterol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.699841921,0.149112281,salmeterol
MUSCLE_CONTRACTION,2.009816583,0.093014572,salmeterol
SIGNALING_BY_GPCR,1.91135697,0.122435239,salmeterol
GPCR_LIGAND_BINDING,1.89899281,0.100482895,salmeterol
NEUTROPHIL_DEGRANULATION,-3.516229109,0.610650293,salmeterol
HEMOSTASIS,-3.303581792,0.861722534,salmeterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.7656283,0.20979199,salmeterol
INNATE_IMMUNE_SYSTEM,-2.955420897,0.919170703,salmeterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.748340165,0,cilostazol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.623154527,0.000348966,cilostazol
COLLAGEN_FORMATION,-2.438182419,0.000348966,cilostazol
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.438182419,0.000348966,cilostazol
ECM_PROTEOGLYCANS,-2.408289495,0.000279173,cilostazol
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.197472252,0.003373339,cilostazol
NEURONAL_SYSTEM,-2.163755774,0.005384048,cilostazol
REGULATION_OF_TP53_ACTIVITY,2.164461828,0.1045096,cilostazol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.144222359,0.063173713,cilostazol
SARS_COV_2_INFECTION,2.012819017,0.106589393,cilostazol
DNA_REPLICATION_PRE_INITIATION,2.558914035,0.000725317,mestranol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.588673524,0.000967089,mestranol
DNA_REPLICATION,2.635262215,0.002901266,mestranol
SYNTHESIS_OF_DNA,2.61065206,0.001450633,mestranol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.497122227,0.00174076,mestranol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.270623132,0.002674937,mestranol
CELL_CYCLE_MITOTIC,2.396641807,0.003384811,mestranol
MITOTIC_G2_G2_M_PHASES,2.375732145,0.003315733,mestranol
S_PHASE,2.299335302,0.003626583,mestranol
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.202166504,0.010637976,mestranol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.515877046,0,betahistine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.499103444,0.000475323,betahistine
ECM_PROTEOGLYCANS,-2.226209188,0.006020756,betahistine
MUSCLE_CONTRACTION,2.271345936,0.028337297,betahistine
COLLAGEN_FORMATION,-2.169275689,0.008318149,betahistine
METABOLISM_OF_STEROIDS,2.036953696,0.059138707,betahistine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.961188839,0.052665769,betahistine
CELLULAR_RESPONSE_TO_STARVATION,1.821291,0.13757963,betahistine
TRANSLATION,1.542374291,0.459249019,betahistine
HEMOSTASIS,1.524779292,0.401650383,betahistine
SIGNALING_BY_GPCR,2.740350864,0,raltitrexed
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.455493233,0.000818887,raltitrexed
GPCR_LIGAND_BINDING,2.433794061,0.000545925,raltitrexed
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.626314047,0.004254673,raltitrexed
G_ALPHA_I_SIGNALLING_EVENTS,2.226821002,0.006141653,raltitrexed
G_ALPHA_Q_SIGNALLING_EVENTS,2.226349955,0.004913322,raltitrexed
PROTEIN_LOCALIZATION,-2.204979903,0.04751051,raltitrexed
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.159329049,0.043019467,raltitrexed
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.062369822,0.058501747,raltitrexed
EXTRACELLULAR_MATRIX_ORGANIZATION,2.060372667,0.024293649,raltitrexed
TRANSLATION,2.90007304,0,BRD-K20152659
RESPIRATORY_ELECTRON_TRANSPORT,2.788075148,0,BRD-K20152659
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.543300789,0.001351504,BRD-K20152659
CELL_CYCLE_CHECKPOINTS,2.476875998,0.002027255,BRD-K20152659
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.445274545,0.001621804,BRD-K20152659
DNA_REPLICATION,2.435579948,0.001689379,BRD-K20152659
G2_M_CHECKPOINTS,2.419084217,0.00144804,BRD-K20152659
SYNTHESIS_OF_DNA,2.408842795,0.001520441,BRD-K20152659
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.347433321,0.001802005,BRD-K20152659
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.338991962,0.00182453,BRD-K20152659
GPCR_LIGAND_BINDING,2.500537739,0,alprenolol
SIGNALING_BY_GPCR,2.310616503,0.00443052,alprenolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.291483515,0.003249048,alprenolol
G_ALPHA_I_SIGNALLING_EVENTS,2.1333476,0.018608184,alprenolol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.572862875,0.246094346,alprenolol
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.531946227,0.215924126,alprenolol
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.460068292,0.286715689,alprenolol
MUSCLE_CONTRACTION,1.904607102,0.113775752,alprenolol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.440931788,0.259404738,alprenolol
G_ALPHA_12_13_SIGNALLING_EVENTS,1.869919585,0.122873087,alprenolol
NONSENSE_MEDIATED_DECAY_NMD,2.826374644,0,BRD-K76674262
CELLULAR_RESPONSE_TO_STARVATION,2.818269741,0,BRD-K76674262
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.560387377,0.00250285,BRD-K76674262
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.483968704,0.003003421,BRD-K76674262
RRNA_PROCESSING,2.328273254,0.004805473,BRD-K76674262
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.108826535,0.015517673,BRD-K76674262
AUTOPHAGY,1.952206446,0.035397457,BRD-K76674262
SIGNALING_BY_NTRKS,1.80836089,0.072269807,BRD-K76674262
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.714487564,0.10461915,BRD-K76674262
RAC2_GTPASE_CYCLE,-1.738801212,1,BRD-K76674262
CELL_CYCLE_CHECKPOINTS,2.200618925,0.06117344,ciprofibrate
SEPARATION_OF_SISTER_CHROMATIDS,1.816780708,0.338868663,ciprofibrate
PI3K_AKT_SIGNALING_IN_CANCER,1.790768792,0.274743872,ciprofibrate
G2_M_CHECKPOINTS,1.753847063,0.253145355,ciprofibrate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.651357979,0.354162023,ciprofibrate
CELL_CELL_COMMUNICATION,-2.874166147,1,ciprofibrate
APOPTOSIS,1.606319001,0.368382165,ciprofibrate
MITOTIC_SPINDLE_CHECKPOINT,1.596392308,0.334614119,ciprofibrate
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.572847153,0.333435495,ciprofibrate
TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1.549616148,0.329656873,ciprofibrate
NEUTROPHIL_DEGRANULATION,-3.017685094,0,ezetimibe
GPCR_LIGAND_BINDING,2.376362162,0.003404244,ezetimibe
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.247907622,0.005957427,ezetimibe
SIGNALING_BY_GPCR,2.175306892,0.010401857,ezetimibe
DISEASES_OF_GLYCOSYLATION,-2.201527101,0.12372725,ezetimibe
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.042741722,0.21775996,ezetimibe
INNATE_IMMUNE_SYSTEM,-2.041375028,0.164144819,ezetimibe
GLYCOSAMINOGLYCAN_METABOLISM,-2.010991398,0.157711002,ezetimibe
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.985477264,0.150672296,ezetimibe
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.926304845,0.061276391,ezetimibe
EUKARYOTIC_TRANSLATION_ELONGATION,3.883174143,0,econazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.799893328,0,econazole
CELLULAR_RESPONSE_TO_STARVATION,3.757167127,0,econazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.742009578,0,econazole
SELENOAMINO_ACID_METABOLISM,3.733372251,0,econazole
NONSENSE_MEDIATED_DECAY_NMD,3.184663781,0,econazole
TRANSLATION,3.154060975,0,econazole
INFLUENZA_INFECTION,3.044132855,0,econazole
EUKARYOTIC_TRANSLATION_INITIATION,3.033158947,0,econazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.631190722,0.000429584,econazole
GPCR_LIGAND_BINDING,-2.623327791,0,dofequidar
SIGNALING_BY_GPCR,-2.452147186,0,dofequidar
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.45193515,0,dofequidar
G_ALPHA_I_SIGNALLING_EVENTS,-2.130057233,0.006262549,dofequidar
NEURONAL_SYSTEM,-2.097712378,0.007793395,dofequidar
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.062978225,0.010205636,dofequidar
G_ALPHA_Q_SIGNALLING_EVENTS,-2.026619744,0.014977102,dofequidar
SENSORY_PERCEPTION,-1.964361167,0.024006439,dofequidar
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.923945942,0.029895297,dofequidar
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.734401449,0.558215452,dofequidar
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.093155062,0,aminosalicylic-acid
GPCR_LIGAND_BINDING,-2.65795999,0,aminosalicylic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.497768531,0.000998831,aminosalicylic-acid
CILIUM_ASSEMBLY,2.257394601,0.044095897,aminosalicylic-acid
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.136348845,0.054174959,aminosalicylic-acid
SIGNALING_BY_GPCR,-2.183412234,0.015918866,aminosalicylic-acid
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,2.109219908,0.045775741,aminosalicylic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.166379896,0.015132286,aminosalicylic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.108239514,0.021974277,aminosalicylic-acid
DEATH_RECEPTOR_SIGNALING,1.998053136,0.084097175,aminosalicylic-acid
GPCR_LIGAND_BINDING,-2.7909052,0,sasapyrine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.52434404,0.002331304,sasapyrine
SIGNALING_BY_GPCR,-2.498703066,0.000309264,sasapyrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.494458893,0.000206176,sasapyrine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.492142856,0.002331304,sasapyrine
INFLUENZA_INFECTION,2.377064054,0.008548116,sasapyrine
REGULATION_OF_TP53_ACTIVITY,2.352889123,0.008159565,sasapyrine
TRANSLATION,2.335573919,0.007926434,sasapyrine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.312557712,0.008936666,sasapyrine
RESPIRATORY_ELECTRON_TRANSPORT,2.226022498,0.011989565,sasapyrine
COLLAGEN_DEGRADATION,-2.589377564,0,carglumic-acid
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.368928896,0.000927159,carglumic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.366423611,0.000618106,carglumic-acid
TRANSLATION,2.700886763,0.004385965,carglumic-acid
GPCR_LIGAND_BINDING,-2.284997699,0.001158949,carglumic-acid
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.250169215,0.001854318,carglumic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.242506553,0.001699792,carglumic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.235798553,0.001589416,carglumic-acid
ECM_PROTEOGLYCANS,-2.214133425,0.001622528,carglumic-acid
SIGNALING_BY_GPCR,-2.173762291,0.002472424,carglumic-acid
DNA_REPLICATION,3.313013731,0,nabumetone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.801886486,0,nabumetone
PROTEASOME_ASSEMBLY,2.771465383,0,nabumetone
CELLULAR_RESPONSE_TO_HYPOXIA,2.764706002,0,nabumetone
INTERLEUKIN_1_FAMILY_SIGNALING,2.763160993,0,nabumetone
SEPARATION_OF_SISTER_CHROMATIDS,2.758417063,0,nabumetone
UCH_PROTEINASES,2.745552855,0,nabumetone
REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,2.74032799,0,nabumetone
SIGNALING_BY_ROBO_RECEPTORS,2.720955498,0,nabumetone
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.718656192,0,nabumetone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.227962046,0.003989935,nicotinamide
GPCR_LIGAND_BINDING,-2.13609044,0.009974838,nicotinamide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.12463777,0.007314881,nicotinamide
SIGNALING_BY_GPCR,-2.008145695,0.024438354,nicotinamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.00147671,0.020548167,nicotinamide
EUKARYOTIC_TRANSLATION_INITIATION,-1.974882586,0.024272106,nicotinamide
NONSENSE_MEDIATED_DECAY_NMD,-1.957268947,0.024937096,nicotinamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.955972036,0.021819959,nicotinamide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.953340821,0.020282171,nicotinamide
TRANSLATION,-1.933399815,0.022044393,nicotinamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.72452986,0,sotalol
EUKARYOTIC_TRANSLATION_ELONGATION,2.668258413,0,sotalol
CELLULAR_RESPONSE_TO_STARVATION,2.590948686,0,sotalol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.577340617,0,sotalol
EUKARYOTIC_TRANSLATION_INITIATION,2.560979628,0,sotalol
NONSENSE_MEDIATED_DECAY_NMD,2.555736267,0,sotalol
SIGNALING_BY_ROBO_RECEPTORS,2.542043477,0,sotalol
SELENOAMINO_ACID_METABOLISM,2.535470292,0,sotalol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.531658319,0,sotalol
RRNA_PROCESSING,2.393574582,0.000100819,sotalol
SELENOAMINO_ACID_METABOLISM,-3.371593007,0,irbesartan
VIRAL_INFECTION_PATHWAYS,-2.734462451,0,irbesartan
CELLULAR_RESPONSES_TO_STIMULI,-2.812995643,0,irbesartan
METABOLISM_OF_RNA,-2.822156426,0,irbesartan
SIGNALING_BY_ROBO_RECEPTORS,-2.837376724,0,irbesartan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.92440903,0,irbesartan
RRNA_PROCESSING,-2.987905702,0,irbesartan
INFECTIOUS_DISEASE,-2.586097073,0,irbesartan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.012642876,0,irbesartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.172172652,0,irbesartan
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.964453356,0.339055418,valsartan
MYD88_INDEPENDENT_TLR4_CASCADE,-1.91565516,0.26521206,valsartan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.675798852,0.434177771,valsartan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.675559166,0.217454971,valsartan
CILIUM_ASSEMBLY,-1.834962705,0.358816317,valsartan
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.829831875,0.278732675,valsartan
DISEASES_OF_GLYCOSYLATION,-1.825150428,0.229434433,valsartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.815461798,0.2081828,valsartan
GPCR_LIGAND_BINDING,-1.803431664,0.197757564,valsartan
RESPIRATORY_ELECTRON_TRANSPORT,1.503326159,0.365353639,valsartan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.564963828,0,riluzole
TRANSLATION,-2.289536895,0,riluzole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.299748903,0,riluzole
INFLUENZA_INFECTION,-2.310506517,0,riluzole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.34304995,0,riluzole
CELLULAR_RESPONSE_TO_STARVATION,-2.405777765,0,riluzole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.33558113,0,riluzole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.476049695,0,riluzole
NONSENSE_MEDIATED_DECAY_NMD,-2.487453078,0,riluzole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.490439717,0,riluzole
INNATE_IMMUNE_SYSTEM,-2.327385003,0.059618589,sibutramine
GPCR_LIGAND_BINDING,2.218961978,0.014374739,sibutramine
NEUTROPHIL_DEGRANULATION,-2.205337376,0.083749923,sibutramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.058898938,0.03773369,sibutramine
G_ALPHA_I_SIGNALLING_EVENTS,2.012986558,0.035936848,sibutramine
SIGNALING_BY_GPCR,1.974704646,0.036685532,sibutramine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.908828978,0.330268057,sibutramine
MUSCLE_CONTRACTION,1.89751044,0.060014536,sibutramine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.782420278,0.462753811,sibutramine
GASTRULATION,1.851870768,0.076166153,sibutramine
RRNA_PROCESSING,-2.00981343,0.136119694,BRD-K48195008
G_ALPHA_Q_SIGNALLING_EVENTS,1.86878384,1,BRD-K48195008
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.489841941,1,BRD-K48195008
MITF_M_DEPENDENT_GENE_EXPRESSION,1.710657771,1,BRD-K48195008
TRANSLATION,-1.343786028,1,BRD-K48195008
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.678014471,1,BRD-K48195008
METABOLISM_OF_STEROIDS,1.646147456,1,BRD-K48195008
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.643395513,0.948531892,BRD-K48195008
SENSORY_PERCEPTION,1.618555505,0.906738724,BRD-K48195008
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.589993403,0.907832039,BRD-K48195008
SIGNALING_BY_GPCR,2.101696735,0.085259428,granisetron
G_ALPHA_Q_SIGNALLING_EVENTS,2.094927369,0.04508912,granisetron
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.121288629,0.309520088,granisetron
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.016270892,0.305221197,granisetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.908319011,0.143192116,granisetron
INNATE_IMMUNE_SYSTEM,-1.917768879,0.372161058,granisetron
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.914763628,0.284647938,granisetron
TCR_SIGNALING,-1.908407388,0.238035686,granisetron
GPCR_LIGAND_BINDING,1.790783513,0.245120855,granisetron
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.81897625,0.318527286,granisetron
EUKARYOTIC_TRANSLATION_ELONGATION,-4.115950076,0,somatostatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.619115905,0,somatostatin
NEURONAL_SYSTEM,2.710300475,0,somatostatin
SARS_COV_INFECTIONS,-2.76887508,0,somatostatin
SARS_COV_2_INFECTION,-2.904688246,0,somatostatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.925670644,0,somatostatin
SARS_COV_2_HOST_INTERACTIONS,-3.077457028,0,somatostatin
SIGNALING_BY_GPCR,3.118442465,0,somatostatin
INFECTIOUS_DISEASE,-3.186808623,0,somatostatin
CELLULAR_RESPONSES_TO_STIMULI,-3.23930773,0,somatostatin
CELL_CYCLE_CHECKPOINTS,-3.184028162,0,R-547
RHO_GTPASE_EFFECTORS,-2.698014849,0,R-547
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.708798149,0,R-547
MITOTIC_PROMETAPHASE,-2.863740031,0,R-547
RHO_GTPASES_ACTIVATE_FORMINS,-2.886801259,0,R-547
MITOTIC_METAPHASE_AND_ANAPHASE,-2.905977807,0,R-547
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.889954183,0,R-547
CELLULAR_RESPONSE_TO_STARVATION,2.955813511,0,R-547
M_PHASE,-3.0346528,0,R-547
MITOTIC_SPINDLE_CHECKPOINT,-3.145289881,0,R-547
CELLULAR_RESPONSE_TO_STARVATION,2.828700486,0,torcitabine
SELENOAMINO_ACID_METABOLISM,2.662256627,0,torcitabine
INFLUENZA_INFECTION,2.610181848,0,torcitabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.504190584,0,torcitabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.484664404,0,torcitabine
EUKARYOTIC_TRANSLATION_ELONGATION,2.403880383,0.000521665,torcitabine
TRANSLATION,2.346064706,0.001117854,torcitabine
NONSENSE_MEDIATED_DECAY_NMD,2.09715657,0.008411855,torcitabine
EUKARYOTIC_TRANSLATION_INITIATION,2.066058487,0.008694424,torcitabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.09665319,0.069658775,torcitabine
ECM_PROTEOGLYCANS,-2.463281047,0,cabozantinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.430696432,0.000551619,cabozantinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.322082888,0.004780699,cabozantinib
COLLAGEN_FORMATION,-2.223352628,0.009377524,cabozantinib
SIGNALING_BY_GPCR,-2.150046259,0.016327924,cabozantinib
GPCR_LIGAND_BINDING,-2.14387064,0.013790477,cabozantinib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.106825715,0.018124627,cabozantinib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.075378786,0.121535948,cabozantinib
SELENOAMINO_ACID_METABOLISM,2.074096121,0.061150163,cabozantinib
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.066037667,0.024960763,cabozantinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.092574884,0.083675144,mefenamic-acid
G2_M_CHECKPOINTS,2.042786782,0.057051234,mefenamic-acid
DNA_REPLICATION,2.028626705,0.04141497,mefenamic-acid
SYNTHESIS_OF_DNA,2.024492475,0.03169513,mefenamic-acid
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.013281988,0.026370348,mefenamic-acid
S_PHASE,1.892907228,0.042682775,mefenamic-acid
DNA_REPLICATION_PRE_INITIATION,1.629786301,0.136560732,mefenamic-acid
CELL_CYCLE_CHECKPOINTS,1.539918417,0.185416511,mefenamic-acid
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1.493675822,0.206511381,mefenamic-acid
TRANSCRIPTION_OF_THE_HIV_GENOME,1.470235804,0.205130882,mefenamic-acid
GPCR_LIGAND_BINDING,2.867258035,0,fluocinonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.622630576,0,fluocinonide
SIGNALING_BY_GPCR,2.514529102,0,fluocinonide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.117143014,0.014901052,fluocinonide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.688331675,0.234833026,fluocinonide
G_ALPHA_Q_SIGNALLING_EVENTS,2.072936124,0.01951874,fluocinonide
POTASSIUM_CHANNELS,2.021326307,0.025981321,fluocinonide
G_ALPHA_S_SIGNALLING_EVENTS,1.805301105,0.126600459,fluocinonide
SENSORY_PERCEPTION,1.802548728,0.113313493,fluocinonide
G_ALPHA_I_SIGNALLING_EVENTS,1.787337032,0.112804055,fluocinonide
SENSORY_PERCEPTION,2.250054712,0.014418634,edrophonium
GPCR_LIGAND_BINDING,2.167733976,0.017811254,edrophonium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.992804357,0.07887841,edrophonium
SIGNALING_BY_GPCR,1.806727028,0.283071713,edrophonium
L1CAM_INTERACTIONS,1.790956299,0.253428698,edrophonium
FATTY_ACID_METABOLISM,-2.162441257,1,edrophonium
NEUTROPHIL_DEGRANULATION,-2.034483553,1,edrophonium
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.803151356,1,edrophonium
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.716904869,1,edrophonium
GLYCOSAMINOGLYCAN_METABOLISM,-1.638039393,1,edrophonium
SIGNALING_BY_GPCR,3.012280392,0,synephrine
GPCR_LIGAND_BINDING,2.923639845,0,synephrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.657975266,0,synephrine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.282277713,0.004008909,synephrine
G_ALPHA_Q_SIGNALLING_EVENTS,2.272218872,0.003385301,synephrine
G_ALPHA_I_SIGNALLING_EVENTS,2.138743787,0.009948033,synephrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.137661613,0.008526885,synephrine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.957862816,0.346682588,synephrine
MUSCLE_CONTRACTION,1.930942386,0.044988864,synephrine
SENSORY_PERCEPTION,1.928004304,0.04088097,synephrine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.231304627,0.01214873,minaprine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.053348613,0.086389894,minaprine
GPCR_LIGAND_BINDING,-2.009289838,0.070998591,minaprine
SARS_COV_2_HOST_INTERACTIONS,-1.987773871,0.056931271,minaprine
TRANSLATION,-1.982680126,0.043194947,minaprine
RESPIRATORY_ELECTRON_TRANSPORT,1.764924547,0.114308504,minaprine
REPRODUCTION,-1.919324839,0.068913318,minaprine
SARS_COV_2_INFECTION,-1.893204205,0.075301536,minaprine
MRNA_SPLICING,1.57947195,0.200269972,minaprine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.838855918,0.111498287,minaprine
GPCR_LIGAND_BINDING,-2.361941001,0.001839226,vardenafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.257186002,0.002758839,vardenafil
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.199951052,0.005211141,vardenafil
BIOLOGICAL_OXIDATIONS,2.108711541,0.118915176,vardenafil
G_ALPHA_Q_SIGNALLING_EVENTS,-2.020841538,0.038623751,vardenafil
MUSCLE_CONTRACTION,1.808286717,0.374841316,vardenafil
SIGNALING_BY_GPCR,-1.861391009,0.124147772,vardenafil
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.720441683,0.317573067,vardenafil
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.401234365,1,vardenafil
SIGNALING_BY_NUCLEAR_RECEPTORS,1.393613141,1,vardenafil
MITF_M_DEPENDENT_GENE_EXPRESSION,2.136495225,0.101103441,benazepril
NEUTROPHIL_DEGRANULATION,2.054559237,0.083165734,benazepril
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.030239698,0.063597326,benazepril
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.930123887,0.081942708,benazepril
SIGNALING_BY_GPCR,-2.000266855,0.184542941,benazepril
KERATINIZATION,1.899961423,0.076969071,benazepril
GPCR_LIGAND_BINDING,-1.959599809,0.137983942,benazepril
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.800883503,0.121758982,benazepril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.740651747,0.143501658,benazepril
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.732233723,0.132086753,benazepril
SYNTHESIS_OF_DNA,3.21369073,0,thioproperazine
RRNA_PROCESSING,2.489955057,0,thioproperazine
DNA_REPLICATION,2.959883782,0,thioproperazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.557874908,0,thioproperazine
SELENOAMINO_ACID_METABOLISM,2.923245563,0,thioproperazine
TRANSLATION,2.87061988,0,thioproperazine
S_PHASE,2.767878615,0,thioproperazine
NONSENSE_MEDIATED_DECAY_NMD,2.718508017,0,thioproperazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.606503693,0,thioproperazine
EUKARYOTIC_TRANSLATION_INITIATION,2.60134145,0,thioproperazine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.377756857,0,toremifene
SARS_COV_2_INFECTION,-2.37026834,0,toremifene
SARS_COV_INFECTIONS,-2.469748116,0,toremifene
VIRAL_INFECTION_PATHWAYS,-2.490257815,0,toremifene
CELLULAR_RESPONSES_TO_STIMULI,-2.591393155,0,toremifene
SARS_COV_2_HOST_INTERACTIONS,-2.604009317,0,toremifene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.741700494,0,toremifene
SARS_COV_1_INFECTION,-2.830981065,0,toremifene
SARS_COV_1_HOST_INTERACTIONS,-2.85023281,0,toremifene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.879224646,0,toremifene
INFLUENZA_INFECTION,3.402423547,0,tacrolimus
CELLULAR_RESPONSES_TO_STIMULI,2.843266618,0,tacrolimus
SIGNALING_BY_ROBO_RECEPTORS,2.920050734,0,tacrolimus
RRNA_PROCESSING,3.00477051,0,tacrolimus
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.191589827,0,tacrolimus
CELLULAR_RESPONSE_TO_STARVATION,3.192286677,0,tacrolimus
SELENOAMINO_ACID_METABOLISM,2.936116371,0,tacrolimus
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.286497249,0,tacrolimus
NONSENSE_MEDIATED_DECAY_NMD,3.310667966,0,tacrolimus
EUKARYOTIC_TRANSLATION_ELONGATION,3.323461246,0,tacrolimus
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.01292089,0.227223178,AR-A014418
PTEN_REGULATION,1.875326113,0.281594438,AR-A014418
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.817371648,0.254814564,AR-A014418
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.650202896,0.463778736,AR-A014418
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.636151841,0.400562002,AR-A014418
GLYCOSAMINOGLYCAN_METABOLISM,-2.453926488,1,AR-A014418
BIOLOGICAL_OXIDATIONS,-2.232035438,1,AR-A014418
CELL_CYCLE_CHECKPOINTS,1.572818155,0.457962905,AR-A014418
MAPK_FAMILY_SIGNALING_CASCADES,1.555818311,0.428246132,AR-A014418
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.528723566,0.42584058,AR-A014418
GPCR_LIGAND_BINDING,2.337004515,0.005389994,acetylcholine
SENSORY_PERCEPTION,2.244708564,0.007411242,acetylcholine
SIGNALING_BY_GPCR,2.117324023,0.020212478,acetylcholine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.042989043,0.02947653,acetylcholine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.985857685,0.038403707,acetylcholine
NEURONAL_SYSTEM,1.940284588,0.045814949,acetylcholine
G_ALPHA_I_SIGNALLING_EVENTS,1.865418927,0.070166172,acetylcholine
POTASSIUM_CHANNELS,1.857188561,0.065522115,acetylcholine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.268205528,1,acetylcholine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.781556399,0.099864611,acetylcholine
GASTRULATION,-2.219271402,0.136445903,mercaptopurine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.123839762,0.143966543,mercaptopurine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.925050273,0.379769091,mercaptopurine
SIGNALING_BY_NOTCH,-2.013242195,0.209861677,mercaptopurine
CELL_JUNCTION_ORGANIZATION,-1.973643466,0.202251505,mercaptopurine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.941542764,0.19918953,mercaptopurine
SIGNALING_BY_WNT,-1.926272674,0.183539436,mercaptopurine
ECM_PROTEOGLYCANS,-1.873444489,0.220093841,mercaptopurine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.797856838,0.305123121,mercaptopurine
ADAPTIVE_IMMUNE_SYSTEM,1.652250809,1,mercaptopurine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.930266067,0,amlexanox
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.430863163,0,amlexanox
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.532418815,0,amlexanox
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.550561889,0,amlexanox
TRANSLATION,-2.568413645,0,amlexanox
SARS_COV_1_HOST_INTERACTIONS,-2.585805979,0,amlexanox
SARS_COV_1_INFECTION,-2.6210832,0,amlexanox
CELLULAR_RESPONSE_TO_STARVATION,-2.623629646,0,amlexanox
SIGNALING_BY_ROBO_RECEPTORS,-2.629148672,0,amlexanox
INFLUENZA_INFECTION,-2.622057054,0,amlexanox
EUKARYOTIC_TRANSLATION_ELONGATION,-3.911498401,0,phenformin
METABOLISM_OF_RNA,-2.479464297,0,phenformin
VIRAL_INFECTION_PATHWAYS,-2.504413821,0,phenformin
MUSCLE_CONTRACTION,2.586089403,0,phenformin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.676849048,0,phenformin
NERVOUS_SYSTEM_DEVELOPMENT,-2.895324255,0,phenformin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.915645199,0,phenformin
SARS_COV_1_INFECTION,-2.943519066,0,phenformin
SARS_COV_1_HOST_INTERACTIONS,-2.987137821,0,phenformin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.034486662,0,phenformin
SIGNALING_BY_GPCR,-2.410206175,0,niacin
GPCR_LIGAND_BINDING,-2.374245604,0,niacin
COLLAGEN_DEGRADATION,-2.239250055,0.003349759,niacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.239189748,0.002512319,niacin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.232019976,0.00219257,niacin
ECM_PROTEOGLYCANS,-2.206248806,0.00258845,niacin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.178321058,0.002740712,niacin
G_ALPHA_I_SIGNALLING_EVENTS,-2.135640598,0.004453657,niacin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.13229486,0.004364838,niacin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.118310744,0.004385139,niacin
INFLUENZA_INFECTION,3.336818165,0,cariprazine
CELLULAR_RESPONSE_TO_STARVATION,2.80067176,0,cariprazine
TRANSLATION,2.742155399,0,cariprazine
GPCR_LIGAND_BINDING,-2.472805609,0.000698009,cariprazine
INTERFERON_ALPHA_BETA_SIGNALING,2.448851273,0.003649849,cariprazine
SIGNALING_BY_GPCR,-2.113267745,0.012913169,cariprazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.147812871,0.020439155,cariprazine
SARS_COV_2_HOST_INTERACTIONS,2.091652607,0.024332327,cariprazine
MITF_M_DEPENDENT_GENE_EXPRESSION,2.087833211,0.02085628,cariprazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.076059209,0.014890861,cariprazine
GPCR_LIGAND_BINDING,-2.682310456,0,varenicline
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.421819494,0.000294126,varenicline
G_ALPHA_S_SIGNALLING_EVENTS,-2.405150496,0.000196084,varenicline
SIGNALING_BY_GPCR,-2.363511873,0.000294126,varenicline
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.339214677,0.000352952,varenicline
ADAPTIVE_IMMUNE_SYSTEM,2.290421826,0.044440526,varenicline
MYD88_INDEPENDENT_TLR4_CASCADE,2.26391066,0.026664315,varenicline
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.234105206,0.022220263,varenicline
TCR_SIGNALING,2.161667308,0.031108368,varenicline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.09912365,0.00921596,varenicline
RRNA_PROCESSING,-2.561110806,0.008899876,etizolam
METABOLISM_OF_RNA,-2.396578921,0.013349815,etizolam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.112101493,0.06289246,etizolam
DNA_REPLICATION,-2.107213234,0.04894932,etizolam
SYNTHESIS_OF_DNA,-1.970658448,0.09861063,etizolam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.84723661,0.176514215,etizolam
MITOTIC_METAPHASE_AND_ANAPHASE,-1.788262942,0.209019954,etizolam
OXIDATIVE_STRESS_INDUCED_SENESCENCE,1.867394995,0.621649774,etizolam
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.763448828,0.210037083,etizolam
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.838037516,0.393993451,etizolam
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.345215785,0.002232974,acrivastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.261796718,0.004465947,acrivastine
INTERFERON_ALPHA_BETA_SIGNALING,2.093239329,0.177189381,acrivastine
NEURONAL_SYSTEM,-2.061164671,0.040193524,acrivastine
TRANSPORT_OF_SMALL_MOLECULES,-2.020409098,0.04447339,acrivastine
SENSORY_PERCEPTION,-1.972715798,0.05493115,acrivastine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.902699528,0.084852996,acrivastine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.896010224,0.076240098,acrivastine
GPCR_LIGAND_BINDING,-1.871772292,0.081503536,acrivastine
DEATH_RECEPTOR_SIGNALING,1.766350234,0.778582154,acrivastine
EUKARYOTIC_TRANSLATION_ELONGATION,3.656192116,0,pasireotide
CELLULAR_RESPONSE_TO_STARVATION,3.505132058,0,pasireotide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.492634647,0,pasireotide
SELENOAMINO_ACID_METABOLISM,3.421269963,0,pasireotide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.393016436,0,pasireotide
NONSENSE_MEDIATED_DECAY_NMD,3.093180397,0,pasireotide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.627950349,0.000134359,pasireotide
EUKARYOTIC_TRANSLATION_INITIATION,2.687777759,0.000149288,pasireotide
TRANSLATION,2.826173081,0.000191942,pasireotide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.702497912,0.000167949,pasireotide
GPCR_LIGAND_BINDING,2.353660665,0.003829139,BRD-K57044355
G_ALPHA_I_SIGNALLING_EVENTS,2.246435843,0.009572847,BRD-K57044355
CELLULAR_RESPONSE_TO_STARVATION,-2.385669587,0.053889585,BRD-K57044355
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.019111009,0.069243594,BRD-K57044355
NEURONAL_SYSTEM,1.970586001,0.08328377,BRD-K57044355
INNATE_IMMUNE_SYSTEM,-2.012710108,0.277868172,BRD-K57044355
TRANSLATION,-1.986256181,0.214809873,BRD-K57044355
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.95848984,0.188052197,BRD-K57044355
SIGNALING_BY_GPCR,1.901203355,0.130382178,BRD-K57044355
FCERI_MEDIATED_NF_KB_ACTIVATION,-1.9132252,0.193553426,BRD-K57044355
SIGNALING_BY_GPCR,2.2596347,0.028592945,ropivacaine
GPCR_LIGAND_BINDING,2.022389719,0.137669734,ropivacaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.961395915,0.142964724,ropivacaine
COLLAGEN_DEGRADATION,1.926872796,0.138199233,ropivacaine
G_ALPHA_S_SIGNALLING_EVENTS,1.888302605,0.145294519,ropivacaine
G_ALPHA_I_SIGNALLING_EVENTS,1.863354869,0.148965712,ropivacaine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.846032174,0.144023722,ropivacaine
MUSCLE_CONTRACTION,1.840684045,0.1294625,ropivacaine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.80065571,0.152378039,ropivacaine
DEVELOPMENTAL_CELL_LINEAGES,1.794291627,0.143070623,ropivacaine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.146071764,0.033216586,alverine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.147551753,0.056786862,alverine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.146750852,0.028393431,alverine
SELENOAMINO_ACID_METABOLISM,-2.122333775,0.02460764,alverine
EUKARYOTIC_TRANSLATION_INITIATION,-2.096937126,0.025317476,alverine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.079550563,0.024418351,alverine
NONSENSE_MEDIATED_DECAY_NMD,-2.053689154,0.02823569,alverine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.016025423,0.036641047,alverine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.995031293,0.038567744,alverine
MITOCHONDRIAL_TRANSLATION,1.736913028,0.198508643,alverine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.968775353,0.310513969,dinoprostone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.956979219,0.159735551,dinoprostone
HOMOLOGY_DIRECTED_REPAIR,1.943618447,0.114949883,dinoprostone
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.883187671,0.123533803,dinoprostone
CELL_CELL_COMMUNICATION,-2.877465411,1,dinoprostone
PTEN_REGULATION,1.664551718,0.320068245,dinoprostone
DNA_REPLICATION,1.617172809,0.347088932,dinoprostone
ADIPOGENESIS,1.575806519,0.359351674,dinoprostone
ECM_PROTEOGLYCANS,1.504667692,0.443564726,dinoprostone
G_ALPHA_Q_SIGNALLING_EVENTS,1.491139296,0.419326556,dinoprostone
RESPIRATORY_ELECTRON_TRANSPORT,2.987292229,0,guaifenesin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.911270018,0,guaifenesin
DNA_REPLICATION,2.58190917,0.004063362,guaifenesin
SYNTHESIS_OF_DNA,2.532282021,0.004876035,guaifenesin
TRANSLATION,2.510360384,0.004876035,guaifenesin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.484714815,0.004063362,guaifenesin
ORC1_REMOVAL_FROM_CHROMATIN,2.466413793,0.004179458,guaifenesin
CELL_CYCLE_CHECKPOINTS,2.384855838,0.006095043,guaifenesin
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.37694734,0.005688707,guaifenesin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.33552756,0.00707025,guaifenesin
RESPIRATORY_ELECTRON_TRANSPORT,2.886617665,0,dipivefrine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.613893525,0.004839599,dipivefrine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.374897019,0.011494048,dipivefrine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.374897019,0.011494048,dipivefrine
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.372911674,0.009679199,dipivefrine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.336539055,0.010082499,dipivefrine
SYNTHESIS_OF_DNA,2.316587978,0.011407627,dipivefrine
DNA_REPLICATION_PRE_INITIATION,2.304373436,0.010889098,dipivefrine
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.294038734,0.010216932,dipivefrine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.276289639,0.010163159,dipivefrine
RESPIRATORY_ELECTRON_TRANSPORT,2.987012188,0,tiaprofenic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.770884952,0.001194115,tiaprofenic-acid
NEDDYLATION,2.704493771,0.000796076,tiaprofenic-acid
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,2.671545259,0.001194115,tiaprofenic-acid
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.588067521,0.002388229,tiaprofenic-acid
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.57424171,0.001990191,tiaprofenic-acid
INTERLEUKIN_1_FAMILY_SIGNALING,2.570538404,0.001705878,tiaprofenic-acid
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,2.535774743,0.002686758,tiaprofenic-acid
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.523144869,0.002653588,tiaprofenic-acid
INTERLEUKIN_1_SIGNALING,2.504767795,0.002388229,tiaprofenic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.821954684,0,mepivacaine
SARS_COV_2_HOST_INTERACTIONS,-2.325223069,0,mepivacaine
SARS_COV_1_INFECTION,-2.360373335,0,mepivacaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.418530009,0,mepivacaine
SARS_COV_1_HOST_INTERACTIONS,-2.455759278,0,mepivacaine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.527803724,0,mepivacaine
SIGNALING_BY_ROBO_RECEPTORS,-2.563107938,0,mepivacaine
CELLULAR_RESPONSE_TO_STARVATION,-2.58301799,0,mepivacaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.594727845,0,mepivacaine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.386478205,0,mepivacaine
SENSORY_PERCEPTION,-1.988001636,0.250444156,tizanidine
ION_CHANNEL_TRANSPORT,-1.973143546,0.136605903,tizanidine
TRANSLATION,1.9466832,0.426172239,tizanidine
EUKARYOTIC_TRANSLATION_ELONGATION,1.924349647,0.260265771,tizanidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.917534716,0.183188391,tizanidine
EUKARYOTIC_TRANSLATION_INITIATION,1.899846658,0.159425746,tizanidine
CELLULAR_RESPONSE_TO_STARVATION,1.865474292,0.169639363,tizanidine
TRANSPORT_OF_SMALL_MOLECULES,-1.774627233,0.322997069,tizanidine
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.841466462,0.170745406,tizanidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.834623905,0.15479666,tizanidine
GLYCOSAMINOGLYCAN_METABOLISM,-3.832060782,0,midazolam
GPCR_LIGAND_BINDING,3.004852839,0,midazolam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.013380248,0,midazolam
SIGNALING_BY_GPCR,2.753011607,0,midazolam
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-3.781697251,0.000956616,midazolam
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.463114297,0.000407387,midazolam
G_ALPHA_I_SIGNALLING_EVENTS,2.351866101,0.000760456,midazolam
G_ALPHA_Q_SIGNALLING_EVENTS,2.308029537,0.001086366,midazolam
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-3.528446317,0.013392626,midazolam
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.348528372,0.040177879,midazolam
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.371344944,0.049875283,vismodegib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.203380469,0.085929705,vismodegib
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.9048809,0.790662651,vismodegib
STIMULI_SENSING_CHANNELS,1.876541207,0.487048193,vismodegib
RAB_REGULATION_OF_TRAFFICKING,1.868700737,0.343674699,vismodegib
MEMBRANE_TRAFFICKING,1.853614232,0.281475904,vismodegib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.821319201,0.282614458,vismodegib
MAPK_FAMILY_SIGNALING_CASCADES,1.810264479,0.254487952,vismodegib
TCR_SIGNALING,1.802688614,0.232409639,vismodegib
SIGNALING_BY_VEGF,1.75026766,0.29064759,vismodegib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.952678176,0,lomustine
INFLUENZA_INFECTION,2.849988773,0,lomustine
TRANSLATION,2.627894732,0.002051507,lomustine
EUKARYOTIC_TRANSLATION_ELONGATION,2.592641627,0.00153863,lomustine
NONSENSE_MEDIATED_DECAY_NMD,2.56103438,0.001230904,lomustine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.498612964,0.001367671,lomustine
EUKARYOTIC_TRANSLATION_INITIATION,2.389722847,0.004103014,lomustine
GPCR_LIGAND_BINDING,-2.230253312,0.008478652,lomustine
RRNA_PROCESSING,2.319013587,0.005128767,lomustine
SELENOAMINO_ACID_METABOLISM,2.30119883,0.004558904,lomustine
GPCR_LIGAND_BINDING,-2.861498195,0,erteberel
EUKARYOTIC_TRANSLATION_INITIATION,2.554962806,0,erteberel
NONSENSE_MEDIATED_DECAY_NMD,2.493703196,0,erteberel
EUKARYOTIC_TRANSLATION_ELONGATION,2.490629815,0,erteberel
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.459207311,0.000338478,erteberel
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.403025531,0.000270783,erteberel
INFLUENZA_INFECTION,2.399279829,0.000225652,erteberel
SELENOAMINO_ACID_METABOLISM,2.39627076,0.000193416,erteberel
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.629474489,0.00169276,erteberel
SIGNALING_BY_GPCR,-2.362067895,0.006771038,erteberel
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.766186847,0,sobetirome
EUKARYOTIC_TRANSLATION_INITIATION,2.650659831,0,sobetirome
EUKARYOTIC_TRANSLATION_ELONGATION,2.602760799,0,sobetirome
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.589917139,0,sobetirome
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.565697867,0,sobetirome
INFLUENZA_INFECTION,2.520111257,0,sobetirome
SELENOAMINO_ACID_METABOLISM,2.502031425,0,sobetirome
CELLULAR_RESPONSE_TO_STARVATION,2.495439894,0,sobetirome
TRANSLATION,2.445796805,0,sobetirome
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.522612506,0.000729933,sobetirome
EUKARYOTIC_TRANSLATION_ELONGATION,-2.918731918,0,levothyroxine
NONSENSE_MEDIATED_DECAY_NMD,-2.884652377,0.000524369,levothyroxine
SELENOAMINO_ACID_METABOLISM,-2.845975779,0.000699159,levothyroxine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.829154319,0.001048739,levothyroxine
EUKARYOTIC_TRANSLATION_INITIATION,-2.80707558,0.001677982,levothyroxine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.713075388,0.015206715,levothyroxine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.712172851,0.013034327,levothyroxine
RRNA_PROCESSING,-2.686165893,0.020057132,levothyroxine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.666005875,0.027034159,levothyroxine
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.814829956,0.069136047,levothyroxine
GPCR_LIGAND_BINDING,2.645904415,0,argatroban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.60277761,0,argatroban
SIGNALING_BY_GPCR,2.334743191,0.004506473,argatroban
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.209462985,0.011730084,argatroban
SENSORY_PERCEPTION,2.148975776,0.013996575,argatroban
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.228237792,0.273760954,argatroban
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.228124598,0.136880477,argatroban
G_ALPHA_Q_SIGNALLING_EVENTS,2.015334212,0.030219879,argatroban
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.967353924,0.380786841,argatroban
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.88821144,0.420780726,argatroban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.744086806,0,alprazolam
GPCR_LIGAND_BINDING,2.696393882,0,alprazolam
G_ALPHA_I_SIGNALLING_EVENTS,2.438145095,0.000446812,alprazolam
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.413007888,0.000335109,alprazolam
INTEGRATION_OF_ENERGY_METABOLISM,1.948400059,0.046647148,alprazolam
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-3.331833878,0.648481642,alprazolam
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,-3.295686999,0.471442175,alprazolam
SENSORY_PERCEPTION,1.879513482,0.069032417,alprazolam
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-3.253514853,0.466800691,alprazolam
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.845634707,1,alprazolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.563961126,0,puromycin
SARS_COV_1_INFECTION,-2.625072058,0,puromycin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.635415696,0,puromycin
VIRAL_INFECTION_PATHWAYS,-2.764994699,0,puromycin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.801955297,0,puromycin
SARS_COV_1_HOST_INTERACTIONS,-2.816718046,0,puromycin
MUSCLE_CONTRACTION,2.943703492,0,puromycin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.974122396,0,puromycin
METABOLISM_OF_RNA,-2.976125531,0,puromycin
SIGNALING_BY_ROBO_RECEPTORS,-3.026742299,0,puromycin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.042899757,0,aliskiren
NONSENSE_MEDIATED_DECAY_NMD,-2.956887591,0,aliskiren
EUKARYOTIC_TRANSLATION_INITIATION,-2.911472515,0,aliskiren
SELENOAMINO_ACID_METABOLISM,-2.900117015,0,aliskiren
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.897457337,0,aliskiren
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.890328787,0,aliskiren
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.848395355,0,aliskiren
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.791535099,0,aliskiren
CELLULAR_RESPONSE_TO_STARVATION,-2.783829674,0,aliskiren
SIGNALING_BY_ROBO_RECEPTORS,-2.756440619,0,aliskiren
MUSCLE_CONTRACTION,2.138183279,0.073900702,methantheline
ORC1_REMOVAL_FROM_CHROMATIN,1.947511777,0.080938864,methantheline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.956131277,0.118768986,methantheline
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.043042679,0.15512361,methantheline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.039897536,0.080544951,methantheline
G2_M_CHECKPOINTS,1.805991808,0.135924506,methantheline
DNA_REPLICATION,1.797091829,0.112962502,methantheline
NONSENSE_MEDIATED_DECAY_NMD,-2.008137139,0.07585715,methantheline
SYNTHESIS_OF_DNA,1.774938877,0.107771857,methantheline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.997110991,0.064776892,methantheline
EXTRACELLULAR_MATRIX_ORGANIZATION,3.691841442,0,finasteride
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,3.149362357,0,finasteride
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.439969485,0.006170935,finasteride
SYNTHESIS_OF_DNA,2.429368735,0.005785251,finasteride
GPCR_LIGAND_BINDING,2.34288428,0.007867942,finasteride
EUKARYOTIC_TRANSLATION_ELONGATION,2.28458023,0.008099352,finasteride
S_PHASE,2.150403785,0.01256226,finasteride
EUKARYOTIC_TRANSLATION_INITIATION,2.107712007,0.013884604,finasteride
DNA_REPLICATION,2.035743506,0.017741438,finasteride
SIGNALING_BY_INTERLEUKINS,2.022866545,0.016430114,finasteride
MAPK6_MAPK4_SIGNALING,2.828261209,0,minoxidil
CELL_CYCLE_CHECKPOINTS,2.538370699,0.005186563,minoxidil
TRANSLATION,2.502964864,0.004322136,minoxidil
G2_M_CHECKPOINTS,2.48707171,0.003241602,minoxidil
RESPIRATORY_ELECTRON_TRANSPORT,2.452969134,0.003111938,minoxidil
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.417897056,0.002593281,minoxidil
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.404208779,0.00296375,minoxidil
MRNA_SPLICING,2.393702139,0.002917442,minoxidil
METABOLISM_OF_RNA,2.388850527,0.002881424,minoxidil
MITOTIC_METAPHASE_AND_ANAPHASE,2.336619187,0.002593281,minoxidil
METABOLISM_OF_RNA,-2.329454437,0.045745089,VX-809
GASTRULATION,-2.184784302,0.0646398,VX-809
UCH_PROTEINASES,-2.098803832,0.080882622,VX-809
SIGNALING_BY_NOTCH4,-2.096368285,0.061656425,VX-809
APOPTOSIS,-2.051264526,0.062451992,VX-809
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.03801003,0.058010077,VX-809
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.963385671,0.087512345,VX-809
DNA_REPLICATION,-1.958539111,0.069391102,VX-809
SYNTHESIS_OF_DNA,-1.958539111,0.069391102,VX-809
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.929380477,0.074186602,VX-809
GPCR_LIGAND_BINDING,-2.81863141,0,pimavanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.587846166,0.000332939,pimavanserin
SIGNALING_BY_GPCR,-2.420648118,0.000443919,pimavanserin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.2941734,0.001664696,pimavanserin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.274480232,0.001598108,pimavanserin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.263148734,0.001442737,pimavanserin
G_ALPHA_S_SIGNALLING_EVENTS,-2.205599853,0.002187886,pimavanserin
CILIUM_ASSEMBLY,2.27067391,0.058045651,pimavanserin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.210345791,0.042497709,pimavanserin
INTERFERON_ALPHA_BETA_SIGNALING,2.160406755,0.034550983,pimavanserin
EUKARYOTIC_TRANSLATION_INITIATION,-2.389566465,0,camptothecin
INFLUENZA_INFECTION,-2.214207346,0.004151023,camptothecin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.186520401,0.00484286,camptothecin
ONCOGENIC_MAPK_SIGNALING,-2.181899529,0.004151023,camptothecin
RRNA_PROCESSING,-2.167440597,0.004566125,camptothecin
CELLULAR_RESPONSE_TO_STARVATION,-2.161651113,0.004323982,camptothecin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.151067512,0.003854521,camptothecin
INTERLEUKIN_12_FAMILY_SIGNALING,-2.11046533,0.005967095,camptothecin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.105635904,0.005650003,camptothecin
TRANSLATION,-2.093695112,0.005811432,camptothecin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.28546362,0.017897092,acetazolamide
INFLUENZA_INFECTION,2.251062944,0.010738255,acetazolamide
MRNA_SPLICING,2.190400904,0.012527964,acetazolamide
CELLULAR_RESPONSE_TO_STARVATION,1.828568226,0.061744966,acetazolamide
G_ALPHA_Q_SIGNALLING_EVENTS,-1.990843233,0.233662804,acetazolamide
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.965273924,0.151500883,acetazolamide
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.610511875,0.159284116,acetazolamide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.859135355,0.268807209,acetazolamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.529001692,0.215063386,acetazolamide
GPCR_LIGAND_BINDING,-1.828987252,0.264057965,acetazolamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.432349695,0,telcagepant
ECM_PROTEOGLYCANS,-2.390841421,0,telcagepant
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.118977837,0.013275026,telcagepant
COLLAGEN_FORMATION,-2.009338521,0.04135681,telcagepant
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.998677779,0.037170071,telcagepant
NEUTROPHIL_DEGRANULATION,1.559283692,1,telcagepant
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.549614849,0.725489435,telcagepant
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.522285226,0.554865906,telcagepant
PROTEIN_LOCALIZATION,1.422023833,0.679099749,telcagepant
TCR_SIGNALING,1.318188147,0.8952078,telcagepant
GPCR_LIGAND_BINDING,2.329215164,0.009508786,fluocinolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.160164489,0.022187168,fluocinolone
SIGNALING_BY_GPCR,2.066786056,0.034442937,fluocinolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.94191099,0.067195424,fluocinolone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.297976203,1,fluocinolone
HIV_LIFE_CYCLE,-1.924789495,1,fluocinolone
TCR_SIGNALING,-1.810983628,1,fluocinolone
GASTRULATION,1.704300914,0.299970515,fluocinolone
NERVOUS_SYSTEM_DEVELOPMENT,1.687587521,0.278079176,fluocinolone
NUCLEOTIDE_EXCISION_REPAIR,-1.641566944,1,fluocinolone
RESPIRATORY_ELECTRON_TRANSPORT,3.583791206,0,icosapent
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.289338082,0,icosapent
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.76847357,0.00026038,icosapent
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.787924287,0.000292927,icosapent
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.814098449,0.000334774,icosapent
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.823424259,0.000468683,icosapent
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.829474276,0.000585854,icosapent
DNA_REPLICATION_PRE_INITIATION,2.823064147,0.00039057,icosapent
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.875114553,0.000781139,icosapent
ORC1_REMOVAL_FROM_CHROMATIN,2.730542899,0.000468683,icosapent
GPCR_LIGAND_BINDING,3.221011573,0,BRD-K18135438
MUSCLE_CONTRACTION,2.611635835,0,BRD-K18135438
SIGNALING_BY_GPCR,2.848644398,0,BRD-K18135438
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.03928647,0,BRD-K18135438
NEURONAL_SYSTEM,2.202485916,0.006966503,BRD-K18135438
G_ALPHA_I_SIGNALLING_EVENTS,2.205401215,0.008229182,BRD-K18135438
CARDIAC_CONDUCTION,2.137791765,0.010449755,BRD-K18135438
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.120907354,0.01077631,BRD-K18135438
STRIATED_MUSCLE_CONTRACTION,2.06580533,0.013425033,BRD-K18135438
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.053347096,0.013323438,BRD-K18135438
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.956255122,0,lypressin
SARS_COV_2_INFECTION,-2.803351315,0,lypressin
SARS_COV_1_INFECTION,-2.803732702,0,lypressin
METABOLISM_OF_RNA,-2.805314811,0,lypressin
INFECTIOUS_DISEASE,-2.888379807,0,lypressin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.899009912,0,lypressin
SARS_COV_2_HOST_INTERACTIONS,-2.91349286,0,lypressin
MUSCLE_CONTRACTION,3.035080047,0,lypressin
VIRAL_INFECTION_PATHWAYS,-3.090918007,0,lypressin
SIGNALING_BY_GPCR,3.111481721,0,lypressin
GPCR_LIGAND_BINDING,2.710723566,0,prilocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.354342633,0.003323428,prilocaine
SIGNALING_BY_GPCR,2.294376652,0.004154285,prilocaine
SENSORY_PERCEPTION,2.123896546,0.017032568,prilocaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.374071097,0.619720875,prilocaine
G_ALPHA_S_SIGNALLING_EVENTS,1.862256554,0.121637462,prilocaine
MUSCLE_CONTRACTION,1.845192157,0.117427787,prilocaine
G_ALPHA_Q_SIGNALLING_EVENTS,1.771999559,0.174954741,prilocaine
G_ALPHA_I_SIGNALLING_EVENTS,1.729021008,0.20574096,prilocaine
VISUAL_PHOTOTRANSDUCTION,1.709339579,0.209006689,prilocaine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.622323015,0.00145433,ORE-1001
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.498544616,0.00145433,ORE-1001
COLLAGEN_FORMATION,-2.336606537,0.003999406,ORE-1001
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.336606537,0.003999406,ORE-1001
GPCR_LIGAND_BINDING,-2.224472899,0.008871411,ORE-1001
ECM_PROTEOGLYCANS,-2.222956161,0.007392842,ORE-1001
INTERFERON_ALPHA_BETA_SIGNALING,1.876717626,0.874504493,ORE-1001
MITF_M_DEPENDENT_GENE_EXPRESSION,1.870023919,0.456863228,ORE-1001
CILIUM_ASSEMBLY,1.869942003,0.304575485,ORE-1001
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.857275259,0.245500431,ORE-1001
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.597068465,0.001269546,dequalinium
EUKARYOTIC_TRANSLATION_ELONGATION,2.5879113,0.000634773,dequalinium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.503415631,0.000846364,dequalinium
SELENOAMINO_ACID_METABOLISM,2.423532656,0.000634773,dequalinium
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.189221254,0.01349579,dequalinium
INFLUENZA_INFECTION,2.236379996,0.00685555,dequalinium
TRANSLATION,2.184718925,0.007617278,dequalinium
CELLULAR_RESPONSE_TO_STARVATION,2.153126054,0.006823812,dequalinium
NONSENSE_MEDIATED_DECAY_NMD,2.155523387,0.007617278,dequalinium
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.123670201,0.01542376,dequalinium
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.162817307,0.030090522,clomethiazole
METABOLISM_OF_RNA,1.922171771,0.19621264,clomethiazole
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.82173994,0.186402008,clomethiazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.00081768,0.078479334,clomethiazole
FATTY_ACID_METABOLISM,1.74067331,0.192942429,clomethiazole
GPCR_LIGAND_BINDING,-1.95569044,0.077801619,clomethiazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.94586491,0.063434073,clomethiazole
HIV_LIFE_CYCLE,1.60814007,0.317210434,clomethiazole
HIV_INFECTION,1.574357401,0.29758917,clomethiazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.534213094,0.297044135,clomethiazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.307184887,0.00101555,perampanel
NONSENSE_MEDIATED_DECAY_NMD,-2.305308989,0.000507775,perampanel
EUKARYOTIC_TRANSLATION_INITIATION,-2.260582027,0.00101555,perampanel
SELENOAMINO_ACID_METABOLISM,-2.246931857,0.000761663,perampanel
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.218974215,0.00081244,perampanel
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.287459217,0.006618458,perampanel
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.195369279,0.001861842,perampanel
CELLULAR_RESPONSE_TO_STARVATION,-2.192289409,0.001740943,perampanel
MRNA_SPLICING,1.882456383,0.044123054,perampanel
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.996345438,0.016700158,perampanel
GPCR_LIGAND_BINDING,-2.543042125,0,aminocaproic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.354463935,0.000896907,aminocaproic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.266656132,0.002591065,aminocaproic-acid
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.209608913,0.004335052,aminocaproic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.065492857,0.016742268,aminocaproic-acid
SIGNALING_BY_GPCR,-2.065275658,0.01395189,aminocaproic-acid
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.070388211,0.276396947,aminocaproic-acid
ADAPTIVE_IMMUNE_SYSTEM,2.047891926,0.16848855,aminocaproic-acid
INTERFERON_ALPHA_BETA_SIGNALING,1.993534869,0.143877863,aminocaproic-acid
TCR_SIGNALING,1.990152273,0.108854962,aminocaproic-acid
GPCR_LIGAND_BINDING,-2.376357424,0.003114542,lonafarnib
SIGNALING_BY_GPCR,-2.290234966,0.006229084,lonafarnib
CELLULAR_RESPONSE_TO_STARVATION,2.418237989,0.011610347,lonafarnib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.0578562,0.052601155,lonafarnib
MITF_M_DEPENDENT_GENE_EXPRESSION,1.89257473,0.183532793,lonafarnib
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.92673783,0.146643022,lonafarnib
INTERFERON_ALPHA_BETA_SIGNALING,1.844500235,0.16790348,lonafarnib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.745501574,0.225731939,lonafarnib
RESPIRATORY_ELECTRON_TRANSPORT,1.740202041,0.186480035,lonafarnib
CILIUM_ASSEMBLY,1.721030724,0.171624745,lonafarnib
SELENOAMINO_ACID_METABOLISM,2.50578599,0.008437304,hexylcaine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.450457827,0.004218652,hexylcaine
EUKARYOTIC_TRANSLATION_ELONGATION,2.388139384,0.004218652,hexylcaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.31945683,0.004218652,hexylcaine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.182136515,0.009281034,hexylcaine
SYNTHESIS_OF_DNA,2.140056567,0.009140412,hexylcaine
EUKARYOTIC_TRANSLATION_INITIATION,2.125915951,0.009039968,hexylcaine
S_PHASE,2.043000688,0.011601293,hexylcaine
DNA_REPLICATION,2.037664764,0.01031226,hexylcaine
RRNA_PROCESSING,2.02216167,0.010968495,hexylcaine
MUSCLE_CONTRACTION,2.919147417,0,BRD-K33396764
CARDIAC_CONDUCTION,2.217050198,0.022720338,BRD-K33396764
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.099344581,0.117496263,BRD-K33396764
SELENOAMINO_ACID_METABOLISM,-2.954431696,0.125888854,BRD-K33396764
EUKARYOTIC_TRANSLATION_ELONGATION,-2.949589936,0.088204478,BRD-K33396764
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.946518727,0.068128086,BRD-K33396764
NEURONAL_SYSTEM,1.830265986,0.158698118,BRD-K33396764
PI3K_AKT_SIGNALING_IN_CANCER,1.821235508,0.126769159,BRD-K33396764
CELLULAR_RESPONSE_TO_STARVATION,-2.87935441,0.113349336,BRD-K33396764
SENSORY_PERCEPTION,1.684560822,0.21171224,BRD-K33396764
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.544455498,0,trimebutine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.421043863,0.001040518,trimebutine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.34311793,0.003468393,trimebutine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.092735098,0.076794393,trimebutine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.020022443,0.0512455,trimebutine
NEURONAL_SYSTEM,1.844645341,0.204066,trimebutine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.789350733,0.181775492,trimebutine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.884591324,0.152123697,trimebutine
COLLAGEN_FORMATION,-1.814464606,0.234983595,trimebutine
SIGNALING_BY_NTRKS,1.621962549,0.356360499,trimebutine
MUSCLE_CONTRACTION,3.130122384,0,lovastatin
GPCR_LIGAND_BINDING,3.036456819,0,lovastatin
CARDIAC_CONDUCTION,2.721561106,0.000717726,lovastatin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.658688387,0.000538294,lovastatin
SIGNALING_BY_GPCR,2.638890585,0.000645953,lovastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.590526631,0.000538294,lovastatin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.341023457,0.007810353,lovastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.333177819,0.004393324,lovastatin
SENSORY_PERCEPTION,2.376127224,0.002614573,lovastatin
METABOLISM_OF_RNA,-2.228044814,0.006101839,lovastatin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-4.02193656,0,HO-013
SARS_COV_1_INFECTION,-2.753977132,0,HO-013
CELLULAR_RESPONSES_TO_STIMULI,-2.888128792,0,HO-013
SARS_COV_1_HOST_INTERACTIONS,-3.021235843,0,HO-013
METABOLISM_OF_RNA,-3.25194031,0,HO-013
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.254550048,0,HO-013
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.285429971,0,HO-013
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.322072009,0,HO-013
SIGNALING_BY_ROBO_RECEPTORS,-3.354122503,0,HO-013
RRNA_PROCESSING,-3.597729007,0,HO-013
MUSCLE_CONTRACTION,3.031355057,0,gavestinel
STRIATED_MUSCLE_CONTRACTION,2.484252705,0.002346416,gavestinel
GPCR_LIGAND_BINDING,2.178037611,0.014469568,gavestinel
CARDIAC_CONDUCTION,2.144886377,0.012611988,gavestinel
SIGNALING_BY_GPCR,2.029043475,0.024168089,gavestinel
REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1.67033543,0.164444681,gavestinel
APOPTOSIS,1.661678603,0.150003047,gavestinel
POTENTIAL_THERAPEUTICS_FOR_SARS,1.601701594,0.179794155,gavestinel
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.539942694,1,gavestinel
G_ALPHA_Q_SIGNALLING_EVENTS,1.565089898,0.19032044,gavestinel
METABOLISM_OF_RNA,1.306057096,1,xylazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.577683262,1,xylazine
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.179865246,1,xylazine
CELL_CYCLE_MITOTIC,1.162291398,1,xylazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.129368928,0.960378079,xylazine
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.071245916,0.957036471,xylazine
HIV_LIFE_CYCLE,1.05667105,0.833619757,xylazine
CELL_CYCLE,0.995119494,0.892877602,xylazine
SARS_COV_INFECTIONS,0.93951884,0.942333397,xylazine
DEUBIQUITINATION,0.92432656,0.875946789,xylazine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.096777073,0,diphenidol
SARS_COV_1_INFECTION,-2.410925683,0,diphenidol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.48245223,0,diphenidol
SIGNALING_BY_ROBO_RECEPTORS,-2.567038342,0,diphenidol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.612203741,0,diphenidol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.620521566,0,diphenidol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.66022923,0,diphenidol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.752649751,0,diphenidol
TRANSLATION,-2.776833214,0,diphenidol
RRNA_PROCESSING,-2.710973516,0,diphenidol
SIGNALING_BY_GPCR,2.616517191,0.000612136,isotretinoin
GPCR_LIGAND_BINDING,2.462135895,0.000306068,isotretinoin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.312729001,0.002040454,isotretinoin
NEURONAL_SYSTEM,2.266921776,0.003213715,isotretinoin
G_ALPHA_Q_SIGNALLING_EVENTS,2.263638651,0.002570972,isotretinoin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.164214471,0.005101136,isotretinoin
POTASSIUM_CHANNELS,1.877464705,0.05885253,isotretinoin
EXTRACELLULAR_MATRIX_ORGANIZATION,1.874084162,0.052720236,isotretinoin
SENSORY_PERCEPTION,1.869506866,0.048698841,isotretinoin
NEUTROPHIL_DEGRANULATION,-2.19312568,1,isotretinoin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.82741602,0,plerixafor
GPCR_LIGAND_BINDING,2.789226412,0,plerixafor
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.424515897,0.023126649,plerixafor
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-2.292807367,0.0239526,plerixafor
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.284657453,0.017069669,plerixafor
ADIPOGENESIS,-2.25104547,0.022300697,plerixafor
METABOLISM_OF_RNA,-2.219983265,0.024448172,plerixafor
IRE1ALPHA_ACTIVATES_CHAPERONES,-2.203693607,0.022300697,plerixafor
VESICLE_MEDIATED_TRANSPORT,-2.198745668,0.020294814,plerixafor
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.190422632,0.019203378,plerixafor
COLLAGEN_DEGRADATION,-2.844188375,0,oxiconazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.835774063,0,oxiconazole
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.820449926,0,oxiconazole
COLLAGEN_FORMATION,-2.694729925,0.002545416,oxiconazole
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.694729925,0.002545416,oxiconazole
PROTEIN_LOCALIZATION,2.244642202,0.022507033,oxiconazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.644756668,0.00571087,oxiconazole
TRANSLATION,2.066062272,0.030947171,oxiconazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.05712636,0.025507971,oxiconazole
NEUTROPHIL_DEGRANULATION,1.859985883,0.07033448,oxiconazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.30078079,0.004115837,primaquine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.275045532,0.003601358,primaquine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.260336512,0.003086878,primaquine
COLLAGEN_DEGRADATION,-2.25143568,0.002829638,primaquine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.222139445,0.002881086,primaquine
CELLULAR_RESPONSE_TO_STARVATION,2.384638443,0.014797169,primaquine
ECM_PROTEOGLYCANS,-2.065754648,0.018178281,primaquine
TRANSLATION,1.96389752,0.10749708,primaquine
SIGNALING_BY_PDGF,-1.925636751,0.064383454,primaquine
L1CAM_INTERACTIONS,-1.921916992,0.059293781,primaquine
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.318049385,0,miconazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.850957251,0,miconazole
GPCR_LIGAND_BINDING,-2.646283766,0,miconazole
EUKARYOTIC_TRANSLATION_ELONGATION,2.516069386,0.006810476,miconazole
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.505436457,0.000634252,miconazole
EUKARYOTIC_TRANSLATION_INITIATION,2.472317755,0.004086285,miconazole
SELENOAMINO_ACID_METABOLISM,2.424317357,0.003632254,miconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.382018298,0.004086285,miconazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.36551699,0.003269028,miconazole
INFLUENZA_INFECTION,2.353538707,0.003178222,miconazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.371819313,0.001782203,mCPP
MITF_M_DEPENDENT_GENE_EXPRESSION,2.29814289,0.03217225,mCPP
ECM_PROTEOGLYCANS,-2.140903236,0.009802118,mCPP
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.132083554,0.007425847,mCPP
COLLAGEN_FORMATION,-2.111949027,0.006906038,mCPP
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.110028663,0.00570305,mCPP
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.124818281,0.03217225,mCPP
NEUTROPHIL_DEGRANULATION,1.996343449,0.039917422,mCPP
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.94615569,0.041108987,mCPP
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.915326015,0.039679109,mCPP
METABOLISM_OF_RNA,-2.73671997,0,almitrine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.546175799,0.005050875,almitrine
MRNA_SPLICING,-2.316414952,0.027611449,almitrine
SYNTHESIS_OF_DNA,-2.176443188,0.047680258,almitrine
DNA_REPLICATION,-2.176443188,0.047680258,almitrine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.155618695,0.045457873,almitrine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-2.106550259,0.051663233,almitrine
CELL_CYCLE_MITOTIC,-2.092689925,0.049498573,almitrine
SEPARATION_OF_SISTER_CHROMATIDS,-2.086237164,0.045345631,almitrine
PROTEIN_FOLDING,-2.059763776,0.050306713,almitrine
TRANSLATION,-2.959559538,0,tofacitinib
METABOLISM_OF_RNA,-2.727582135,0,tofacitinib
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.691930619,0,tofacitinib
MRNA_SPLICING,-2.4689456,0.001622651,tofacitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.349735647,0.002596242,tofacitinib
GPCR_LIGAND_BINDING,2.279202523,0.009487891,tofacitinib
SENSORY_PERCEPTION,2.251305946,0.006325261,tofacitinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.236574852,0.005679279,tofacitinib
NEUTROPHIL_DEGRANULATION,-2.224722472,0.005563376,tofacitinib
SIGNALING_BY_GPCR,2.18900917,0.008433681,tofacitinib
NONSENSE_MEDIATED_DECAY_NMD,2.386233838,0.002628238,molindone
SELENOAMINO_ACID_METABOLISM,2.379508577,0.001314119,molindone
CELLULAR_RESPONSE_TO_STARVATION,2.336877038,0.004380397,molindone
EUKARYOTIC_TRANSLATION_ELONGATION,2.28731627,0.006899126,molindone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.277091796,0.005782124,molindone
ADAPTIVE_IMMUNE_SYSTEM,2.246529354,0.005913536,molindone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.2406777,0.005256477,molindone
INFLUENZA_INFECTION,2.213106694,0.006242066,molindone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.221563114,0.045587778,molindone
EUKARYOTIC_TRANSLATION_INITIATION,2.148305715,0.009344848,molindone
EUKARYOTIC_TRANSLATION_INITIATION,-1.927059961,0.282614181,sphingosine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.827272276,0.258642443,sphingosine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.817898443,0.184203886,sphingosine
SELENOAMINO_ACID_METABOLISM,-1.766582612,0.177580116,sphingosine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.736894726,0.164269493,sphingosine
TRANSLATION,-1.720517295,0.148456556,sphingosine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-1.640406495,0.186907465,sphingosine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.631592973,0.171271764,sphingosine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.829600872,1,sphingosine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.818414061,0.852402746,sphingosine
MITOCHONDRIAL_TRANSLATION,1.893218087,0.194117647,buphenine
TRANSLATION,1.869147915,0.107843137,buphenine
SELENOAMINO_ACID_METABOLISM,1.852163525,0.0821662,buphenine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.818077067,0.080112045,buphenine
DNA_REPLICATION,1.737400762,0.103529412,buphenine
SYNTHESIS_OF_DNA,1.688313825,0.111951447,buphenine
EUKARYOTIC_TRANSLATION_INITIATION,1.678147526,0.102120848,buphenine
DNA_REPLICATION_PRE_INITIATION,1.64684239,0.105147059,buphenine
S_PHASE,1.584485112,0.128042328,buphenine
G2_M_CHECKPOINTS,1.536576349,0.148823529,buphenine
RESPIRATORY_ELECTRON_TRANSPORT,3.374152984,0,oxprenolol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.195168782,0,oxprenolol
NEDDYLATION,3.054999385,0,oxprenolol
DNA_REPLICATION,2.784595744,0,oxprenolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.625560408,0.000881804,oxprenolol
MAPK6_MAPK4_SIGNALING,2.616823181,0.000734837,oxprenolol
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.611780147,0.00062986,oxprenolol
SYNTHESIS_OF_DNA,2.605675829,0.000551128,oxprenolol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.601454377,0.000489891,oxprenolol
ORC1_REMOVAL_FROM_CHROMATIN,2.594799671,0.000440902,oxprenolol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.029680633,0,cholic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.623421025,0,cholic-acid
RRNA_PROCESSING,-2.699217082,0,cholic-acid
INFLUENZA_INFECTION,-2.709415097,0,cholic-acid
TRANSLATION,-2.716866777,0,cholic-acid
SIGNALING_BY_ROBO_RECEPTORS,-2.72140442,0,cholic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.79574078,0,cholic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.815829975,0,cholic-acid
SARS_COV_1_HOST_INTERACTIONS,-2.586223584,0,cholic-acid
CELLULAR_RESPONSE_TO_STARVATION,-2.827359262,0,cholic-acid
ONCOGENIC_MAPK_SIGNALING,-1.822623987,0.968353915,labetalol
TOLL_LIKE_RECEPTOR_CASCADES,-1.796613263,0.580407128,labetalol
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,-1.786956669,0.414374779,labetalol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.715180964,0.492044833,labetalol
CELLULAR_RESPONSE_TO_HEAT_STRESS,-1.667810414,0.502333593,labetalol
INNATE_IMMUNE_SYSTEM,-1.620299409,0.549944327,labetalol
EXTRACELLULAR_MATRIX_ORGANIZATION,1.684077014,1,labetalol
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-1.606560961,0.507348283,labetalol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.603751029,0.449679349,labetalol
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.57543737,0.466423802,labetalol
GPCR_LIGAND_BINDING,2.694535616,0,terbutaline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.573034917,0,terbutaline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.454825288,0.000466884,terbutaline
G_ALPHA_Q_SIGNALLING_EVENTS,2.167915162,0.008929158,terbutaline
SIGNALING_BY_GPCR,2.053867709,0.020729652,terbutaline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.01527969,1,terbutaline
GLYCOSAMINOGLYCAN_METABOLISM,-2.34360418,1,terbutaline
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.886200936,1,terbutaline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.763236443,1,terbutaline
BIOLOGICAL_OXIDATIONS,-1.755564026,1,terbutaline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.905208158,0,ibutilide
SELENOAMINO_ACID_METABOLISM,2.783260176,0.000693347,ibutilide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.726649534,0.000462231,ibutilide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.457534982,0.000943965,ibutilide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.433057453,0.000471982,ibutilide
COLLAGEN_DEGRADATION,-2.406976723,0.000314655,ibutilide
EUKARYOTIC_TRANSLATION_ELONGATION,2.566357864,0.000693347,ibutilide
INFLUENZA_INFECTION,2.532178361,0.001109355,ibutilide
CELLULAR_RESPONSE_TO_STARVATION,2.342255032,0.002311157,ibutilide
NONSENSE_MEDIATED_DECAY_NMD,2.333377422,0.001980992,ibutilide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.330178061,0.005722608,trimetazidine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.281407926,0.002861304,trimetazidine
COLLAGEN_FORMATION,-2.163470768,0.008901834,trimetazidine
GASTRULATION,-1.936195264,0.078924298,trimetazidine
SIGNALING_BY_NOTCH,-1.924712692,0.071532597,trimetazidine
INNATE_IMMUNE_SYSTEM,1.748774122,0.788793987,trimetazidine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.828063544,0.14386,trimetazidine
ADAPTIVE_IMMUNE_SYSTEM,1.658154893,0.634233003,trimetazidine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.657248258,0.425585545,trimetazidine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.623743988,0.374558706,trimetazidine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.361204216,0.025739991,oxibendazole
GENERATION_OF_SECOND_MESSENGER_MOLECULES,-2.273454065,0.036196862,oxibendazole
MITOTIC_G2_G2_M_PHASES,2.152817123,0.100692119,oxibendazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.263422758,0.026008116,oxibendazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.250242467,0.021517024,oxibendazole
INNATE_IMMUNE_SYSTEM,-2.187842385,0.029922739,oxibendazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.18037573,0.026544366,oxibendazole
NEUTROPHIL_DEGRANULATION,-2.174531528,0.023326867,oxibendazole
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,2.029661224,0.139268969,oxibendazole
GPCR_LIGAND_BINDING,1.969375517,0.149076643,oxibendazole
NEUTROPHIL_DEGRANULATION,-2.599715746,0,dofetilide
METABOLISM_OF_RNA,-2.495693151,0.004017857,dofetilide
SIGNALING_BY_GPCR,2.396080296,0.004705103,dofetilide
GPCR_LIGAND_BINDING,2.385773434,0.002352551,dofetilide
GLYCOSAMINOGLYCAN_METABOLISM,-2.418854804,0.008705357,dofetilide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.236633032,0.005685332,dofetilide
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.221912398,0.030636161,dofetilide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.147411231,0.010586481,dofetilide
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.210347242,0.026116071,dofetilide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.185618585,0.028125,dofetilide
CELL_CYCLE_CHECKPOINTS,2.203677704,0.030459945,BRD-K14643723
CELL_CYCLE_MITOTIC,1.926565046,0.154203472,BRD-K14643723
CELL_CYCLE,1.906641832,0.115493959,BRD-K14643723
SYNTHESIS_OF_DNA,1.81467424,0.14468474,BRD-K14643723
G2_M_CHECKPOINTS,1.80273848,0.123362778,BRD-K14643723
MITOTIC_METAPHASE_AND_ANAPHASE,1.732301347,0.150395979,BRD-K14643723
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.708890013,0.148492233,BRD-K14643723
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.680181624,0.147064423,BRD-K14643723
DNA_REPLICATION,1.66527255,0.140031137,BRD-K14643723
PEROXISOMAL_PROTEIN_IMPORT,-1.885566818,0.362716306,BRD-K14643723
GPCR_LIGAND_BINDING,2.350850836,0.001994052,FR-180204
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.231121561,0.005982157,FR-180204
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-2.037424116,0.35950304,FR-180204
NUCLEOTIDE_EXCISION_REPAIR,-1.989466215,0.253578037,FR-180204
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-1.972687683,0.17868157,FR-180204
HIV_LIFE_CYCLE,-1.958680332,0.152467807,FR-180204
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.00851711,0.046749447,FR-180204
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-1.873882152,0.215059854,FR-180204
CELL_CYCLE,-1.865672377,0.187776141,FR-180204
SIGNALING_BY_GPCR,1.95848296,0.056830488,FR-180204
CELLULAR_RESPONSE_TO_STARVATION,2.973572961,0,darifenacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.85668968,0,darifenacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.616981483,0.000387975,darifenacin
SELENOAMINO_ACID_METABOLISM,2.489629472,0.000872943,darifenacin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.225255173,0.014527013,darifenacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.180491571,0.009200442,darifenacin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.1646521,0.007102095,darifenacin
INFLUENZA_INFECTION,2.126540711,0.011406453,darifenacin
EUKARYOTIC_TRANSLATION_ELONGATION,2.116923628,0.009893352,darifenacin
NONSENSE_MEDIATED_DECAY_NMD,2.07546665,0.012636887,darifenacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.688070037,0,hydroflumethiazide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.622959618,0,hydroflumethiazide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.543352528,0,hydroflumethiazide
EUKARYOTIC_TRANSLATION_INITIATION,-2.542125389,0,hydroflumethiazide
SELENOAMINO_ACID_METABOLISM,-2.513262868,0,hydroflumethiazide
TRANSLATION,-2.478129995,0,hydroflumethiazide
NONSENSE_MEDIATED_DECAY_NMD,-2.470140255,0,hydroflumethiazide
INFLUENZA_INFECTION,-2.403351359,0,hydroflumethiazide
CELLULAR_RESPONSE_TO_STARVATION,-2.365436664,0.000113156,hydroflumethiazide
RRNA_PROCESSING,-2.295588167,0.000509201,hydroflumethiazide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.943659011,0,fenofibrate
CELL_CYCLE_CHECKPOINTS,2.767654481,0,fenofibrate
G2_M_CHECKPOINTS,2.463300787,0.00449131,fenofibrate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.37781299,0.005614138,fenofibrate
S_PHASE,2.375536278,0.00449131,fenofibrate
DNA_REPLICATION,2.351584628,0.005239862,fenofibrate
DNA_REPLICATION_PRE_INITIATION,2.348674129,0.00449131,fenofibrate
CELL_CYCLE_MITOTIC,2.323850841,0.003929897,fenofibrate
SYNTHESIS_OF_DNA,2.282780475,0.003493241,fenofibrate
SEPARATION_OF_SISTER_CHROMATIDS,1.882846579,0.033684827,fenofibrate
REGULATION_OF_TP53_ACTIVITY,2.183175507,0.078121041,cerivastatin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.999383744,0.236446351,cerivastatin
ADAPTIVE_IMMUNE_SYSTEM,1.932004615,0.268041972,cerivastatin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.853694663,0.364044052,cerivastatin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.844980713,0.31060926,cerivastatin
RHOA_GTPASE_CYCLE,-1.564556302,1,cerivastatin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.793990107,0.384008318,cerivastatin
DISEASES_OF_GLYCOSYLATION,1.758075222,0.415157533,cerivastatin
INNATE_IMMUNE_SYSTEM,1.757322422,0.364304455,cerivastatin
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.748907626,0.343153907,cerivastatin
STRIATED_MUSCLE_CONTRACTION,2.297020974,0.005726006,BRD-K33211335
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.746889006,0.044256437,BRD-K33211335
MUSCLE_CONTRACTION,2.08507623,0.032720033,BRD-K33211335
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.46052307,0.25495556,BRD-K33211335
GPCR_LIGAND_BINDING,1.957463137,0.079618747,BRD-K33211335
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.86913453,0.135174637,BRD-K33211335
SIGNALING_BY_GPCR,1.815683568,0.171125774,BRD-K33211335
NEUTROPHIL_DEGRANULATION,-1.951331667,1,BRD-K33211335
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.652104941,1,BRD-K33211335
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.739575084,0.254125591,BRD-K33211335
MUSCLE_CONTRACTION,3.05525804,0,telmisartan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.320749205,0.004193671,telmisartan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.275655973,0.004193671,telmisartan
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.199753618,0.00663998,telmisartan
COLLAGEN_FORMATION,-2.193638474,0.005504194,telmisartan
SIGNALING_BY_NTRKS,2.110576666,0.021160524,telmisartan
ECM_PROTEOGLYCANS,-1.933626453,0.101486847,telmisartan
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.777516006,0.133631915,telmisartan
TCR_SIGNALING,1.641300221,0.231611554,telmisartan
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.728094999,0.518267887,telmisartan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.352645601,0.077845312,mephentermine
G_ALPHA_Q_SIGNALLING_EVENTS,2.108846892,0.132744445,mephentermine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.253940985,0.230890706,mephentermine
REGULATION_OF_INSULIN_SECRETION,1.75951348,0.926633553,mephentermine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.135554385,0.617472036,mephentermine
MUSCLE_CONTRACTION,1.721928398,0.784438048,mephentermine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.1240961,0.507128196,mephentermine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.114928367,0.435177966,mephentermine
MITOTIC_G2_G2_M_PHASES,1.695217349,0.70754078,mephentermine
CELL_CYCLE_MITOTIC,1.658258896,0.704705462,mephentermine
SEPARATION_OF_SISTER_CHROMATIDS,1.952496011,0.287247624,moexipril
CELL_CYCLE_CHECKPOINTS,1.862939235,0.238096364,moexipril
EXTRACELLULAR_MATRIX_ORGANIZATION,1.719855461,0.345973805,moexipril
CELL_CELL_COMMUNICATION,-2.950682804,1,moexipril
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.638611951,0.371506927,moexipril
MITOTIC_SPINDLE_CHECKPOINT,1.564353555,0.433807745,moexipril
CELL_JUNCTION_ORGANIZATION,-2.893970588,1,moexipril
DNA_REPLICATION,1.467172183,0.582793513,moexipril
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.443717258,0.555892545,moexipril
SYNTHESIS_OF_DNA,1.433139188,0.512417845,moexipril
DEUBIQUITINATION,-2.459361544,0.321109011,azithromycin
MAPK1_MAPK3_SIGNALING,-2.426601889,0.303087587,azithromycin
MAPK_FAMILY_SIGNALING_CASCADES,-2.335784374,0.466918715,azithromycin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.647013478,0.602409252,azithromycin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.545849347,0.553501446,azithromycin
SIGNALING_BY_GPCR,-2.038261381,0.78720857,azithromycin
INNATE_IMMUNE_SYSTEM,-1.943815367,0.780819156,azithromycin
HEMOSTASIS,-1.886018316,0.755807603,azithromycin
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.430537705,0.657500803,azithromycin
ADAPTIVE_IMMUNE_SYSTEM,-1.837011889,0.721559096,azithromycin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.177194693,0.068909638,diclofenamide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.140524054,0.041708465,diclofenamide
REGULATION_OF_INSULIN_SECRETION,1.790047335,0.202699111,diclofenamide
NEURONAL_SYSTEM,1.744223411,0.192221622,diclofenamide
GPCR_LIGAND_BINDING,1.724970033,0.170702472,diclofenamide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.662185071,0.196855896,diclofenamide
MUSCLE_CONTRACTION,1.544781582,0.30327149,diclofenamide
INTEGRATION_OF_ENERGY_METABOLISM,1.527392605,0.28787908,diclofenamide
SENSORY_PERCEPTION,1.502238586,0.291354786,diclofenamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.527676023,1,diclofenamide
TRANSLATION,2.529802364,0,rasagiline
INFLUENZA_INFECTION,2.505253188,0,rasagiline
NEUTROPHIL_DEGRANULATION,2.401062234,0.001551435,rasagiline
SIGNALING_BY_GPCR,-2.390875115,0.001614328,rasagiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.388272196,0.000807164,rasagiline
GPCR_LIGAND_BINDING,-2.352327949,0.000538109,rasagiline
COLLAGEN_DEGRADATION,-2.349240413,0.000403582,rasagiline
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.278122999,0.001291463,rasagiline
G_ALPHA_Q_SIGNALLING_EVENTS,-2.240654271,0.001499019,rasagiline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.243373023,0.001748856,rasagiline
EUKARYOTIC_TRANSLATION_ELONGATION,3.180511758,0,clofarabine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.805358769,0,clofarabine
SIGNALING_BY_ROBO_RECEPTORS,2.905543106,0,clofarabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.912876323,0,clofarabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.930681848,0,clofarabine
EUKARYOTIC_TRANSLATION_INITIATION,2.946033543,0,clofarabine
CELLULAR_RESPONSES_TO_STIMULI,2.681594855,0,clofarabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.988215811,0,clofarabine
NONSENSE_MEDIATED_DECAY_NMD,3.06488154,0,clofarabine
INFLUENZA_INFECTION,3.084014812,0,clofarabine
GPCR_LIGAND_BINDING,-2.540842619,0,FK-866
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.476906245,0,FK-866
RRNA_PROCESSING,2.675793317,0.004265015,FK-866
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.269040055,0.00068584,FK-866
METABOLISM_OF_RNA,2.401527229,0.00853003,FK-866
SIGNALING_BY_GPCR,-2.162680883,0.002057521,FK-866
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.224320367,0.019903404,FK-866
CELL_CYCLE_CHECKPOINTS,2.219710049,0.014927553,FK-866
S_PHASE,2.167659582,0.013648049,FK-866
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.16754399,0.011373374,FK-866
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.405283557,0.000890351,indacaterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.39750789,0.000445176,indacaterol
ECM_PROTEOGLYCANS,-2.225610815,0.008903512,indacaterol
NEUTROPHIL_DEGRANULATION,1.920189379,0.31979507,indacaterol
INNATE_IMMUNE_SYSTEM,1.911822623,0.169389169,indacaterol
GASTRULATION,-1.926479052,0.092596524,indacaterol
TRNA_PROCESSING,1.684956454,0.413737914,indacaterol
BIOLOGICAL_OXIDATIONS,1.671282552,0.335857836,indacaterol
MUSCLE_CONTRACTION,1.616612934,0.357761608,indacaterol
METABOLISM_OF_STEROIDS,1.583883926,0.306026985,indacaterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.269205971,0.002451602,papaverine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.266994806,0.001225801,papaverine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.680696645,0.174063742,papaverine
SYNTHESIS_OF_DNA,1.668720131,0.137289712,papaverine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.636735239,0.13532843,papaverine
DNA_REPLICATION_PRE_INITIATION,1.56181785,0.179375546,papaverine
DNA_REPLICATION,1.541791968,0.172662826,papaverine
S_PHASE,1.412715083,0.276111675,papaverine
KEAP1_NFE2L2_PATHWAY,1.363928234,0.31952546,papaverine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.032291991,1,papaverine
MUSCLE_CONTRACTION,3.030067378,0,NPI-2358
STRIATED_MUSCLE_CONTRACTION,2.529062783,0,NPI-2358
CARDIAC_CONDUCTION,2.086282668,0.035739143,NPI-2358
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.962784261,0.071672521,NPI-2358
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.872937871,0.106751267,NPI-2358
CELL_CELL_COMMUNICATION,1.804244093,0.140043055,NPI-2358
RAC1_GTPASE_CYCLE,1.706631152,0.213935399,NPI-2358
SIGNALING_BY_GPCR,1.689244031,0.204237549,NPI-2358
SIGNALING_BY_INTERLEUKINS,1.686548639,0.185429177,NPI-2358
TOLL_LIKE_RECEPTOR_CASCADES,1.624711156,0.24030689,NPI-2358
STRIATED_MUSCLE_CONTRACTION,2.432150156,0.000911476,levocabastine
MUSCLE_CONTRACTION,2.352228385,0.002734428,levocabastine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.091496145,1,levocabastine
SIGNALING_BY_WNT,-2.056294268,0.715630764,levocabastine
CARDIAC_CONDUCTION,1.832485723,0.325093098,levocabastine
TRANSCRIPTIONAL_REGULATION_BY_MECP2,1.798963003,0.307623142,levocabastine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.748634639,1,levocabastine
INTEGRATION_OF_ENERGY_METABOLISM,-1.739853114,0.802631579,levocabastine
ION_HOMEOSTASIS,1.727795026,0.427482232,levocabastine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.703378735,0.420646163,levocabastine
SIGNALING_BY_GPCR,2.713538784,0,stiripentol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.672630852,0.000365245,stiripentol
GPCR_LIGAND_BINDING,2.496205574,0.000973986,stiripentol
G_ALPHA_I_SIGNALLING_EVENTS,2.200522052,0.007304895,stiripentol
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.274138002,0.049983424,stiripentol
ADAPTIVE_IMMUNE_SYSTEM,-2.188171923,0.049269375,stiripentol
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.185521467,0.033798315,stiripentol
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.114868535,0.03927269,stiripentol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.103767891,0.03284625,stiripentol
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.093078519,0.029752038,stiripentol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.187407177,0.013182546,brinzolamide
SYNTHESIS_OF_DNA,2.051196067,0.099055354,brinzolamide
DNA_REPLICATION,2.035203591,0.058532709,brinzolamide
PEROXISOMAL_PROTEIN_IMPORT,-2.097391421,0.020549263,brinzolamide
DNA_REPLICATION_PRE_INITIATION,1.929115589,0.085547806,brinzolamide
EUKARYOTIC_TRANSLATION_INITIATION,1.918225377,0.068663371,brinzolamide
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.029963208,0.030242312,brinzolamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.812628809,0.100856361,brinzolamide
SELENOAMINO_ACID_METABOLISM,1.805588781,0.085547806,brinzolamide
S_PHASE,1.761210787,0.090693539,brinzolamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.801896005,1,pipamperone
GPCR_LIGAND_BINDING,1.780917404,0.692037304,pipamperone
STRIATED_MUSCLE_CONTRACTION,1.727154896,0.637096938,pipamperone
G_ALPHA_Q_SIGNALLING_EVENTS,1.715293334,0.517179024,pipamperone
SIGNALING_BY_GPCR,1.676987066,0.523201333,pipamperone
SENSORY_PERCEPTION,1.622641053,0.588319754,pipamperone
CELL_CYCLE_CHECKPOINTS,1.607007472,0.550460207,pipamperone
DNA_REPLICATION,1.598140502,0.506877705,pipamperone
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.594482668,0.457601597,pipamperone
MUSCLE_CONTRACTION,1.592595225,0.415645001,pipamperone
ORC1_REMOVAL_FROM_CHROMATIN,2.367012404,0.037423242,amyleine
SYNTHESIS_OF_DNA,2.3511054,0.023635732,amyleine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.327715994,0.019039895,amyleine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.262132475,0.025112965,amyleine
KEAP1_NFE2L2_PATHWAY,2.193639557,0.020259199,amyleine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.193911809,0.023635732,amyleine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.193911809,0.023635732,amyleine
DNA_REPLICATION,2.166879672,0.021173676,amyleine
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.063364619,0.044426422,amyleine
DNA_REPLICATION_PRE_INITIATION,2.005806489,0.056331827,amyleine
MUSCLE_CONTRACTION,3.068318635,0,dydrogesterone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.328905683,0.037354785,dydrogesterone
CELLULAR_RESPONSE_TO_STARVATION,-2.273537783,0.02873445,dydrogesterone
NONSENSE_MEDIATED_DECAY_NMD,-2.26044629,0.020752658,dydrogesterone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.213160199,0.02681882,dydrogesterone
INFLUENZA_INFECTION,-2.211690886,0.021838182,dydrogesterone
SELENOAMINO_ACID_METABOLISM,-2.204325904,0.0191563,dydrogesterone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.201398637,0.017103839,dydrogesterone
CARDIAC_CONDUCTION,2.011653034,0.078270552,dydrogesterone
EUKARYOTIC_TRANSLATION_INITIATION,-2.130494118,0.029213358,dydrogesterone
EUKARYOTIC_TRANSLATION_INITIATION,-3.695889016,0,androstenedione
EUKARYOTIC_TRANSLATION_ELONGATION,-3.680421041,0,androstenedione
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.679615981,0,androstenedione
CELLULAR_RESPONSE_TO_STARVATION,-3.657967937,0,androstenedione
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.633170865,0,androstenedione
SIGNALING_BY_GPCR,3.13847052,0,androstenedione
GPCR_LIGAND_BINDING,3.168976317,0,androstenedione
MUSCLE_CONTRACTION,2.562990391,0.000167841,androstenedione
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.675193619,0.000223788,androstenedione
INFLUENZA_INFECTION,-3.535722109,0.00021235,androstenedione
GPCR_LIGAND_BINDING,2.306935561,0.009632439,acebutolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.055416236,0.070491937,acebutolol
G_ALPHA_S_SIGNALLING_EVENTS,1.948061279,0.111794666,acebutolol
PEROXISOMAL_PROTEIN_IMPORT,-2.348479673,1,acebutolol
FATTY_ACID_METABOLISM,-2.280216473,1,acebutolol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.995985219,1,acebutolol
GASTRULATION,1.735929702,0.427111085,acebutolol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.835902363,1,acebutolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.803119008,1,acebutolol
PROTEIN_LOCALIZATION,-1.702412644,0.961959313,acebutolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.585652355,0,levomepromazine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.565852503,0,levomepromazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.525051549,0,levomepromazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.485811084,0,levomepromazine
SIGNALING_BY_ROBO_RECEPTORS,-2.460419163,0,levomepromazine
NONSENSE_MEDIATED_DECAY_NMD,-2.447940609,0,levomepromazine
CELLULAR_RESPONSE_TO_STARVATION,-2.437772113,0,levomepromazine
SELENOAMINO_ACID_METABOLISM,-2.381527405,0.000119178,levomepromazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.347432832,0.000423743,levomepromazine
INFLUENZA_INFECTION,-2.289823284,0.000572053,levomepromazine
GPCR_LIGAND_BINDING,3.56031828,0,H-8
SIGNALING_BY_GPCR,3.27972873,0,H-8
MUSCLE_CONTRACTION,3.169303957,0,H-8
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.161109445,0,H-8
CARDIAC_CONDUCTION,2.754977237,0,H-8
EXTRACELLULAR_MATRIX_ORGANIZATION,2.575704585,0,H-8
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.412324256,0.001508487,H-8
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.366972812,0.001799899,H-8
G_ALPHA_Q_SIGNALLING_EVENTS,2.096927756,0.009706123,H-8
G_ALPHA_I_SIGNALLING_EVENTS,1.847963956,0.039069812,H-8
GPCR_LIGAND_BINDING,-2.002091856,0.042502297,letrozole
DISEASES_OF_METABOLISM,1.773476904,0.336926747,letrozole
SIGNALING_BY_GPCR,-1.909817891,0.079126617,letrozole
G_ALPHA_Q_SIGNALLING_EVENTS,-1.901503799,0.058176903,letrozole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.893759363,0.04747597,letrozole
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.692218268,0.271184943,letrozole
G_ALPHA_S_SIGNALLING_EVENTS,-1.88380852,0.043406601,letrozole
EUKARYOTIC_TRANSLATION_ELONGATION,-1.830000155,0.070234293,letrozole
GLYCOSAMINOGLYCAN_METABOLISM,1.50180273,0.493976613,letrozole
POTASSIUM_CHANNELS,-1.793703829,0.084487849,letrozole
GPCR_LIGAND_BINDING,2.641938582,0,mafenide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.462542134,0,mafenide
SIGNALING_BY_GPCR,2.384404806,0.000278228,mafenide
G_ALPHA_Q_SIGNALLING_EVENTS,2.129824771,0.016276337,mafenide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.100998939,0.016359806,mafenide
COLLAGEN_DEGRADATION,1.953518436,0.055367369,mafenide
SENSORY_PERCEPTION,1.896279458,0.074286872,mafenide
DEATH_RECEPTOR_SIGNALING,-3.262317374,1,mafenide
DEUBIQUITINATION,-3.202870267,1,mafenide
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-3.174953738,0.823283082,mafenide
GPCR_LIGAND_BINDING,2.629839397,0.000657544,caffeic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.294802967,0.005917895,caffeic-acid
SIGNALING_BY_GPCR,2.182881928,0.008328889,caffeic-acid
SENSORY_PERCEPTION,2.059425533,0.020548245,caffeic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.823511673,0.129141613,caffeic-acid
VISUAL_PHOTOTRANSDUCTION,1.810794732,0.120111344,caffeic-acid
DISEASES_OF_GLYCOSYLATION,-1.93956159,1,caffeic-acid
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-1.928831694,1,caffeic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.892192108,1,caffeic-acid
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-1.836922435,1,caffeic-acid
MRNA_SPLICING,2.735912478,0.061802575,dalfampridine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.650658646,0.033476395,dalfampridine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.536262419,0.878969957,dalfampridine
DNA_REPLICATION,1.526037647,0.683690987,dalfampridine
DNA_REPLICATION_PRE_INITIATION,1.497215236,0.642746781,dalfampridine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.496383903,0.537339056,dalfampridine
SYNTHESIS_OF_DNA,1.440741202,0.623911711,dalfampridine
ABC_TRANSPORTER_DISORDERS,1.43966079,0.547854077,dalfampridine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.364262632,1,dalfampridine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.391571324,0.606008584,dalfampridine
GPCR_LIGAND_BINDING,-2.401719965,0.003649063,nelarabine
SIGNALING_BY_GPCR,-2.345587066,0.003649063,nelarabine
G2_M_DNA_DAMAGE_CHECKPOINT,2.277011108,0.04379562,nelarabine
G_ALPHA_I_SIGNALLING_EVENTS,-2.200987243,0.010947189,nelarabine
RESPIRATORY_ELECTRON_TRANSPORT,2.036591662,0.154969118,nelarabine
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,2.035829031,0.103874228,nelarabine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.016967729,0.090117911,nelarabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.03040246,0.049809708,nelarabine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.97711964,0.091970803,nelarabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.994629776,0.054881906,nelarabine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.555127478,0.189816765,theobromine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.495652081,1,theobromine
NONSENSE_MEDIATED_DECAY_NMD,-2.478787991,0.707679372,theobromine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.454910792,0.533642667,theobromine
SELENOAMINO_ACID_METABOLISM,-2.427207211,0.450293763,theobromine
EUKARYOTIC_TRANSLATION_INITIATION,-2.406416199,0.385606627,theobromine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.403840636,0.324134626,theobromine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.384294687,0.289062685,theobromine
RRNA_PROCESSING,-2.32265698,0.290279594,theobromine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.299951958,0.26722905,theobromine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.140046408,0.15565359,levamisole
UCH_PROTEINASES,-2.123209508,0.094549908,levamisole
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-1.904453003,0.331460674,levamisole
ADAPTIVE_IMMUNE_SYSTEM,1.779140955,1,levamisole
NUCLEOTIDE_EXCISION_REPAIR,-1.794713931,0.52999404,levamisole
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.741433938,0.718333516,levamisole
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-1.752894239,0.553406399,levamisole
SYNTHESIS_OF_DNA,-1.744139779,0.417894053,levamisole
DNA_REPLICATION,-1.744139779,0.417894053,levamisole
MITF_M_DEPENDENT_GENE_EXPRESSION,1.709825322,0.575357518,levamisole
GLYCOSAMINOGLYCAN_METABOLISM,-3.279910756,0.148237711,memantine
GPCR_LIGAND_BINDING,2.068786856,0.111229251,memantine
SIGNALING_BY_GPCR,1.881739196,0.278922206,memantine
DISEASES_OF_GLYCOSYLATION,-3.12897154,0.567370002,memantine
BIOLOGICAL_OXIDATIONS,-3.093348342,0.515552394,memantine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.057466834,0.494562984,memantine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.761410598,0.448596344,memantine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-2.952316583,0.673760076,memantine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.877478016,0.720199147,memantine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.669401695,0.642539968,memantine
CELLULAR_RESPONSE_TO_STARVATION,4.10962097,0,phentolamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.582372171,0,phentolamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.493742843,0,phentolamine
INFLUENZA_INFECTION,3.338993972,0,phentolamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.328595423,0,phentolamine
SELENOAMINO_ACID_METABOLISM,3.283237263,0,phentolamine
NONSENSE_MEDIATED_DECAY_NMD,3.189067903,0,phentolamine
EUKARYOTIC_TRANSLATION_INITIATION,2.904241877,0,phentolamine
RRNA_PROCESSING,2.478817819,0.000812228,phentolamine
TRANSLATION,2.336981907,0.002193017,phentolamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.755245694,0,flumetasone
GPCR_LIGAND_BINDING,2.783147068,0,flumetasone
INFECTIOUS_DISEASE,-2.804290867,0,flumetasone
CARDIAC_CONDUCTION,2.820623814,0,flumetasone
STRIATED_MUSCLE_CONTRACTION,2.845675473,0,flumetasone
SARS_COV_1_INFECTION,-2.857396953,0,flumetasone
VIRAL_INFECTION_PATHWAYS,-2.88582217,0,flumetasone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.907951938,0,flumetasone
SARS_COV_1_HOST_INTERACTIONS,-2.945720368,0,flumetasone
METABOLISM_OF_RNA,-2.951809654,0,flumetasone
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.988310801,0.204209122,tolterodine
RHO_GTPASE_CYCLE,-1.75881255,0.328193231,tolterodine
O_LINKED_GLYCOSYLATION,1.926567804,0.776038393,tolterodine
FATTY_ACID_METABOLISM,1.807689303,0.839656059,tolterodine
AUTOPHAGY,-1.534338876,0.655638444,tolterodine
RAC1_GTPASE_CYCLE,-1.530307617,0.503229622,tolterodine
APOPTOSIS,1.763662373,0.745281761,tolterodine
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.494564029,0.470578603,tolterodine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.74570402,0.622093355,tolterodine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.741057014,0.509524082,tolterodine
INTERFERON_ALPHA_BETA_SIGNALING,3.595456667,0,midostaurin
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,2.59227927,0.00208267,midostaurin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.501284906,0.002314078,midostaurin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.435915291,0.00416534,midostaurin
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,2.418741083,0.00388765,midostaurin
TNF_SIGNALING,2.354997277,0.006016602,midostaurin
INTERFERON_GAMMA_SIGNALING,2.354579216,0.005157087,midostaurin
EUKARYOTIC_TRANSLATION_ELONGATION,2.328490839,0.00624801,midostaurin
TOLL_LIKE_RECEPTOR_CASCADES,2.320967829,0.005708058,midostaurin
RESPIRATORY_ELECTRON_TRANSPORT,2.313612221,0.005276097,midostaurin
STRIATED_MUSCLE_CONTRACTION,2.762582393,0,ibudilast
MUSCLE_CONTRACTION,2.738626076,0,ibudilast
DNA_REPLICATION,1.96230925,0.081655422,ibudilast
G_ALPHA_Q_SIGNALLING_EVENTS,1.674869524,0.301859319,ibudilast
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.556957713,0.47311828,ibudilast
NEURONAL_SYSTEM,1.518854941,0.47737016,ibudilast
CELL_CYCLE_CHECKPOINTS,1.494506262,0.460942441,ibudilast
SYNTHESIS_OF_DNA,1.468284671,0.461848382,ibudilast
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.373428578,1,ibudilast
SEPARATION_OF_SISTER_CHROMATIDS,1.422041502,0.50636025,ibudilast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.006025053,0,mestinon
TRANSLATION,-2.790263589,0,mestinon
EUKARYOTIC_TRANSLATION_ELONGATION,-2.783756968,0,mestinon
SELENOAMINO_ACID_METABOLISM,-2.783756968,0,mestinon
EUKARYOTIC_TRANSLATION_INITIATION,-2.693678722,0,mestinon
NONSENSE_MEDIATED_DECAY_NMD,-2.662365307,0,mestinon
INFLUENZA_INFECTION,-2.610116268,0,mestinon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.563003161,0,mestinon
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.487015772,0.000502211,mestinon
RRNA_PROCESSING,-2.461658121,0.000270556,mestinon
STRIATED_MUSCLE_CONTRACTION,2.178271141,0.051986372,SR-27897
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.760863687,0.237789334,SR-27897
MUSCLE_CONTRACTION,1.996828048,0.128040509,SR-27897
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.627803782,0.30620985,SR-27897
HEMOSTASIS,-1.708223264,1,SR-27897
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.71970627,0.780437387,SR-27897
NEUTROPHIL_DEGRANULATION,-1.620072457,0.949194453,SR-27897
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.472001754,1,SR-27897
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.653937408,0.916259807,SR-27897
INTERFERON_GAMMA_SIGNALING,-1.448223463,0.925920261,SR-27897
GPCR_LIGAND_BINDING,2.841271313,0,sulindac
SIGNALING_BY_GPCR,2.831783888,0,sulindac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.629135821,0,sulindac
SENSORY_PERCEPTION,2.177470524,0.009341771,sulindac
G_ALPHA_Q_SIGNALLING_EVENTS,2.071058841,0.019838524,sulindac
G_ALPHA_I_SIGNALLING_EVENTS,2.050334558,0.019023242,sulindac
NEURONAL_SYSTEM,1.945801663,0.03707591,sulindac
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.944489043,0.032781122,sulindac
G_ALPHA_S_SIGNALLING_EVENTS,1.934074011,0.031252469,sulindac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.095412013,1,sulindac
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-2.05783007,0.353488508,atorvastatin
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,-1.910084418,0.528041717,atorvastatin
CILIUM_ASSEMBLY,1.847307475,0.486691807,atorvastatin
PROTEIN_FOLDING,-1.830945799,0.593042703,atorvastatin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.825980559,0.460484513,atorvastatin
UCH_PROTEINASES,-1.810916499,0.406657854,atorvastatin
SIGNALING_BY_NOTCH,-1.69749056,0.696752142,atorvastatin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.667780843,0.714071827,atorvastatin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.638883735,0.920096191,atorvastatin
UNFOLDED_PROTEIN_RESPONSE_UPR,-1.642736856,0.725053133,atorvastatin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.506469115,0,dexfenfluramine
EUKARYOTIC_TRANSLATION_ELONGATION,4.415282012,0,dexfenfluramine
CELLULAR_RESPONSE_TO_STARVATION,4.347588312,0,dexfenfluramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.318108418,0,dexfenfluramine
NONSENSE_MEDIATED_DECAY_NMD,4.176066741,0,dexfenfluramine
SELENOAMINO_ACID_METABOLISM,4.165126628,0,dexfenfluramine
TRANSLATION,4.15746546,0,dexfenfluramine
EUKARYOTIC_TRANSLATION_INITIATION,3.860982332,0,dexfenfluramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.842419034,0,dexfenfluramine
INFLUENZA_INFECTION,3.489442536,0,dexfenfluramine
CILIUM_ASSEMBLY,2.19890373,0.027845242,azelastine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.177999354,0.017113222,azelastine
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-2.038269228,0.385946989,azelastine
METABOLISM_OF_RNA,-2.036522723,0.195243771,azelastine
RRNA_PROCESSING,-1.981023299,0.197261794,azelastine
UCH_PROTEINASES,-1.95562922,0.171405869,azelastine
NUCLEOTIDE_EXCISION_REPAIR,-1.884638175,0.208562726,azelastine
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.828905302,0.249478152,azelastine
TCR_SIGNALING,1.836845162,0.200331049,azelastine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.772402215,0.308541374,azelastine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.492864251,1,LY-215490
EUKARYOTIC_TRANSLATION_ELONGATION,-2.46041879,1,LY-215490
NONSENSE_MEDIATED_DECAY_NMD,-2.453259573,0.862129488,LY-215490
EUKARYOTIC_TRANSLATION_INITIATION,-2.424513569,0.683981803,LY-215490
SELENOAMINO_ACID_METABOLISM,-2.399301064,0.573933922,LY-215490
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.39214764,0.485123352,LY-215490
RRNA_PROCESSING,-2.375751596,0.427855328,LY-215490
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.436296623,0.440257527,LY-215490
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.334603268,0.39846284,LY-215490
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.283459094,0.377591186,LY-215490
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.440850143,0,clofazimine
COLLAGEN_DEGRADATION,-2.406956084,0,clofazimine
CELLULAR_RESPONSE_TO_STARVATION,2.665852601,0.001549598,clofazimine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.362310344,0.0008467,clofazimine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.34071272,0.0008467,clofazimine
GPCR_LIGAND_BINDING,-2.338404004,0.00067736,clofazimine
ECM_PROTEOGLYCANS,-2.307007404,0.000564467,clofazimine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.289995727,0.000725743,clofazimine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.241130503,0.001164212,clofazimine
COLLAGEN_FORMATION,-2.177541707,0.002069711,clofazimine
GPCR_LIGAND_BINDING,2.61157678,0,cortisone-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.351660525,0.003055915,cortisone-acetate
SIGNALING_BY_GPCR,2.347224518,0.002037277,cortisone-acetate
POTASSIUM_CHANNELS,2.040296941,0.033997057,cortisone-acetate
NEURONAL_SYSTEM,1.97931952,0.046602707,cortisone-acetate
G_ALPHA_S_SIGNALLING_EVENTS,1.905093077,0.072577986,cortisone-acetate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.168499414,1,cortisone-acetate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.851307507,0.094078532,cortisone-acetate
NERVOUS_SYSTEM_DEVELOPMENT,1.775496703,0.142195554,cortisone-acetate
SENSORY_PERCEPTION,1.771166769,0.130131056,cortisone-acetate
EUKARYOTIC_TRANSLATION_INITIATION,1.950583913,0.182795699,molsidomine
EUKARYOTIC_TRANSLATION_ELONGATION,1.850232295,0.147759857,molsidomine
SELENOAMINO_ACID_METABOLISM,1.816960491,0.114755078,molsidomine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.747101126,0.134050179,molsidomine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.910084587,0.298876141,molsidomine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.88000654,0.204881761,molsidomine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.469937825,0.412508961,molsidomine
SEPARATION_OF_SISTER_CHROMATIDS,1.373852684,0.558542413,molsidomine
RESPIRATORY_ELECTRON_TRANSPORT,1.320380174,0.604966718,molsidomine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.289841301,0.610842294,molsidomine
GPCR_LIGAND_BINDING,2.486024477,0.000782059,niflumic-acid
SIGNALING_BY_GPCR,2.294019058,0.003910293,niflumic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.260548229,0.004170979,niflumic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.958051937,0.065692927,niflumic-acid
SENSORY_PERCEPTION,1.936650311,0.062251869,niflumic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,1.84855977,0.111443358,niflumic-acid
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.784864369,0.154959336,niflumic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.713408511,0.219856239,niflumic-acid
NERVOUS_SYSTEM_DEVELOPMENT,1.667490913,0.262945499,niflumic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.62243633,1,niflumic-acid
MUSCLE_CONTRACTION,2.896390995,0,forskolin
MAPK1_MAPK3_SIGNALING,2.001883559,0.025350432,forskolin
RRNA_PROCESSING,-1.952412369,0.461588121,forskolin
MAPK_FAMILY_SIGNALING_CASCADES,1.766905269,0.07849245,forskolin
VIRAL_INFECTION_PATHWAYS,-1.904569724,0.306410348,forskolin
CHROMATIN_ORGANIZATION,-1.90013482,0.208218763,forskolin
METABOLISM_OF_RNA,-1.837340049,0.239341989,forskolin
CELLULAR_RESPONSES_TO_STIMULI,-1.835929847,0.191736604,forskolin
RHO_GTPASE_EFFECTORS,-1.82343443,0.146723778,forskolin
TRANSLATION,-1.82470151,0.16942432,forskolin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.265973482,0.006331022,estrone
SIGNALING_BY_ROBO_RECEPTORS,-2.259047431,0.004220681,estrone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.248602177,0.002813788,estrone
CELLULAR_RESPONSE_TO_STARVATION,-2.235416472,0.002901718,estrone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.207035945,0.004431715,estrone
NONSENSE_MEDIATED_DECAY_NMD,-2.19729611,0.003868958,estrone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.188736112,0.003466988,estrone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.183202917,0.0035612,estrone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.161247098,0.003751717,estrone
SELENOAMINO_ACID_METABOLISM,-2.157454895,0.003693096,estrone
GPCR_LIGAND_BINDING,2.572109409,0.000678254,eprosartan
SIGNALING_BY_GPCR,2.141624671,0.019330243,eprosartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.120459293,0.016278099,eprosartan
GLYCOSAMINOGLYCAN_METABOLISM,-3.121774089,0.172821403,eprosartan
G_ALPHA_Q_SIGNALLING_EVENTS,1.889725145,0.108690224,eprosartan
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.961269767,0.737371319,eprosartan
SENSORY_PERCEPTION,1.762935913,0.2217891,eprosartan
G_ALPHA_S_SIGNALLING_EVENTS,1.757498495,0.191267664,eprosartan
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-2.864378825,1,eprosartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.7367566,0.191267664,eprosartan
EUKARYOTIC_TRANSLATION_ELONGATION,-3.118482559,0,andarine
SARS_COV_2_HOST_INTERACTIONS,-2.448793925,0,andarine
SARS_COV_1_INFECTION,-2.547122062,0,andarine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.552643624,0,andarine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.567597242,0,andarine
NERVOUS_SYSTEM_DEVELOPMENT,-2.576892131,0,andarine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.700808818,0,andarine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.708182718,0,andarine
SARS_COV_1_HOST_INTERACTIONS,-2.717805692,0,andarine
INFLUENZA_INFECTION,-2.884064546,0,andarine
RESPIRATORY_ELECTRON_TRANSPORT,2.535060273,0.003864433,CS-1657
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.527230543,0.001932217,CS-1657
SYNTHESIS_OF_DNA,2.502454144,0.002576289,CS-1657
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.471419003,0.003381379,CS-1657
DNA_REPLICATION,2.421520151,0.001717526,CS-1657
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.43360848,0.001932217,CS-1657
UCH_PROTEINASES,2.443317946,0.002208248,CS-1657
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.4622632,0.002576289,CS-1657
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.462740792,0.003091547,CS-1657
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.394396013,0.001738995,CS-1657
GPCR_LIGAND_BINDING,3.322556289,0,tripelennamine
SIGNALING_BY_GPCR,2.975199764,0,tripelennamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.953249244,0,tripelennamine
MUSCLE_CONTRACTION,2.41015381,0.000775225,tripelennamine
G_ALPHA_I_SIGNALLING_EVENTS,2.300572222,0.002232647,tripelennamine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.264937993,0.002584083,tripelennamine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.236296282,0.003189496,tripelennamine
PEROXISOMAL_PROTEIN_IMPORT,-2.342495058,0.061584602,tripelennamine
G_ALPHA_Q_SIGNALLING_EVENTS,2.207537212,0.003721079,tripelennamine
NEURONAL_SYSTEM,2.154281916,0.00613289,tripelennamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.603166094,0,AS-604850
EUKARYOTIC_TRANSLATION_INITIATION,-3.579844929,0,AS-604850
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.518536448,0,AS-604850
EUKARYOTIC_TRANSLATION_ELONGATION,-3.509651166,0.000293551,AS-604850
MUSCLE_CONTRACTION,2.780093787,0.000771177,AS-604850
STRIATED_MUSCLE_CONTRACTION,2.494708145,0.001927941,AS-604850
GPCR_LIGAND_BINDING,2.306117197,0.006169412,AS-604850
INFLUENZA_INFECTION,-3.422090317,0.011742051,AS-604850
SELENOAMINO_ACID_METABOLISM,-3.370507378,0.033856246,AS-604850
CELLULAR_RESPONSE_TO_STARVATION,-3.364867117,0.032877742,AS-604850
MUSCLE_CONTRACTION,2.582403078,0.003392886,propofol
MITOCHONDRIAL_TRANSLATION,2.147688392,0.019509092,propofol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.198488437,0.035388229,propofol
EXTRACELLULAR_MATRIX_ORGANIZATION,2.044711614,0.022053756,propofol
EUKARYOTIC_TRANSLATION_INITIATION,-2.164944498,0.025609903,propofol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.157875549,0.018625384,propofol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.106817079,0.020487922,propofol
INFLUENZA_INFECTION,-2.091780984,0.018625384,propofol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.086619153,0.016297211,propofol
SELENOAMINO_ACID_METABOLISM,-2.084768999,0.014368153,propofol
ECM_PROTEOGLYCANS,-2.274688976,0.002331002,furosemide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.106833434,0.012820513,furosemide
GPCR_LIGAND_BINDING,-2.097700818,0.00984201,furosemide
TCR_SIGNALING,2.085402616,0.104452278,furosemide
INNATE_IMMUNE_SYSTEM,2.065773212,0.057448753,furosemide
NEUTROPHIL_DEGRANULATION,2.054759262,0.041780911,furosemide
ADAPTIVE_IMMUNE_SYSTEM,2.044397979,0.033294164,furosemide
HIV_LIFE_CYCLE,2.001040766,0.034991513,furosemide
FATTY_ACID_METABOLISM,1.965791581,0.036993515,furosemide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.981733536,0.027972028,furosemide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.518463019,0,levomequitazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.473115954,0,levomequitazine
GPCR_LIGAND_BINDING,-2.47004992,0,levomequitazine
INTERFERON_ALPHA_BETA_SIGNALING,2.266104064,0.046230175,levomequitazine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.183524984,0.00865794,levomequitazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.167722538,0.008465542,levomequitazine
COLLAGEN_FORMATION,-2.155850922,0.007567681,levomequitazine
SIGNALING_BY_GPCR,-2.120521787,0.009455021,levomequitazine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.01127062,0.023665037,levomequitazine
ECM_PROTEOGLYCANS,-2.001772779,0.023002331,levomequitazine
GPCR_LIGAND_BINDING,2.802857775,0,azacitidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.662854925,0.000357872,azacitidine
SIGNALING_BY_GPCR,2.530572568,0.000238582,azacitidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.450877718,0.000715745,azacitidine
SENSORY_PERCEPTION,2.074856118,0.0137423,azacitidine
G_ALPHA_Q_SIGNALLING_EVENTS,2.018148796,0.017774329,azacitidine
G_ALPHA_I_SIGNALLING_EVENTS,1.92391381,0.0411042,azacitidine
AMINE_LIGAND_BINDING_RECEPTORS,1.878947859,0.051623092,azacitidine
G_ALPHA_S_SIGNALLING_EVENTS,1.85948386,0.052885586,azacitidine
NEURONAL_SYSTEM,1.801337057,0.076441542,azacitidine
DEATH_RECEPTOR_SIGNALING,-3.120291897,0.707690206,chlordiazepoxide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.734482977,1,chlordiazepoxide
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.717459171,1,chlordiazepoxide
CELL_CYCLE_CHECKPOINTS,1.679176608,1,chlordiazepoxide
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-2.94618924,1,chlordiazepoxide
CELL_CELL_COMMUNICATION,-2.887464663,1,chlordiazepoxide
DNA_REPLICATION_PRE_INITIATION,1.619458526,1,chlordiazepoxide
METABOLISM_OF_RNA,1.622116799,1,chlordiazepoxide
DEUBIQUITINATION,-2.832952266,1,chlordiazepoxide
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.602859198,1,chlordiazepoxide
MITF_M_DEPENDENT_GENE_EXPRESSION,2.790854091,0.001802119,flavoxate
INTERFERON_ALPHA_BETA_SIGNALING,2.683589704,0.000901059,flavoxate
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.106895216,0.01742048,flavoxate
SIGNALING_BY_GPCR,-2.088617001,0.078990625,flavoxate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.882099597,0.060370973,flavoxate
GPCR_LIGAND_BINDING,-2.030651118,0.066423935,flavoxate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.895238824,0.146312181,flavoxate
RHOG_GTPASE_CYCLE,1.644446215,0.195349655,flavoxate
INTERFERON_SIGNALING,1.639884795,0.168798441,flavoxate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.607991964,0.170686375,flavoxate
MUSCLE_CONTRACTION,2.910235339,0,hypericin
STRIATED_MUSCLE_CONTRACTION,2.549488041,0.000481713,hypericin
SENSORY_PERCEPTION,2.23477947,0.015414822,hypericin
CARDIAC_CONDUCTION,2.231916326,0.011801973,hypericin
NEURONAL_SYSTEM,2.213644842,0.010790375,hypericin
GPCR_LIGAND_BINDING,2.194069247,0.010918832,hypericin
ION_HOMEOSTASIS,1.940269631,0.057392686,hypericin
GLYCOSAMINOGLYCAN_METABOLISM,-2.249620876,0.541833049,hypericin
SIGNALING_BY_GPCR,1.902644022,0.064669996,hypericin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.882176914,0.064763662,hypericin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.548388391,0.00273224,pantoprazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.186138941,0.002949599,pantoprazole
MRNA_SPLICING,2.291794908,0.006830601,pantoprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.117957458,0.005899199,pantoprazole
GPCR_LIGAND_BINDING,-2.087472678,0.007210132,pantoprazole
SELENOAMINO_ACID_METABOLISM,-2.073106562,0.006144999,pantoprazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.034184203,0.007472319,pantoprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.034018009,0.006226932,pantoprazole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.006683817,0.020491803,pantoprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.01705777,0.007163313,pantoprazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.496978066,0.003396193,cabergoline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.265373136,0.011886674,cabergoline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.09555123,0.032150624,cabergoline
CELLULAR_RESPONSE_TO_STARVATION,2.06618137,0.167829063,cabergoline
GPCR_LIGAND_BINDING,-2.076237405,0.028188399,cabergoline
EUKARYOTIC_TRANSLATION_INITIATION,2.027062596,0.118545925,cabergoline
INFLUENZA_INFECTION,2.01394822,0.08968643,cabergoline
EUKARYOTIC_TRANSLATION_ELONGATION,2.004781107,0.072259735,cabergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.98691162,0.068996393,cabergoline
SELENOAMINO_ACID_METABOLISM,1.978749499,0.060826936,cabergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.219636135,0.036170063,EMD-1214063
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.175313555,0.026122823,EMD-1214063
INFLUENZA_INFECTION,2.113683433,0.027462455,EMD-1214063
CELLULAR_RESPONSE_TO_STARVATION,2.032303496,0.031648805,EMD-1214063
MUSCLE_CONTRACTION,1.945418908,0.043404075,EMD-1214063
RHOG_GTPASE_CYCLE,1.695733538,0.169463442,EMD-1214063
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.659241313,0.178553802,EMD-1214063
EUKARYOTIC_TRANSLATION_ELONGATION,1.624121039,0.186878658,EMD-1214063
NONSENSE_MEDIATED_DECAY_NMD,1.617228592,0.172142706,EMD-1214063
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.567733501,0.1987344,EMD-1214063
RESPIRATORY_ELECTRON_TRANSPORT,3.459386595,0,ethotoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.249056914,0,ethotoin
DNA_REPLICATION,3.109395365,0,ethotoin
TRANSLATION,2.992511333,0,ethotoin
DNA_REPLICATION_PRE_INITIATION,2.821430656,0,ethotoin
SYNTHESIS_OF_DNA,2.890564369,0,ethotoin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.829372968,0,ethotoin
CELL_CYCLE_CHECKPOINTS,2.677386417,0.000296344,ethotoin
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,2.557948586,0.00047415,ethotoin
G2_M_CHECKPOINTS,2.579870165,0.000526833,ethotoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.416636211,0.004545973,vanoxerine
RESPIRATORY_ELECTRON_TRANSPORT,2.360455391,0.004545973,vanoxerine
STRIATED_MUSCLE_CONTRACTION,2.123615537,0.041671423,vanoxerine
MUSCLE_CONTRACTION,1.961889023,0.152005985,vanoxerine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.936960949,0.14683494,vanoxerine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1.872557626,0.199833414,vanoxerine
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1.843471573,0.210413625,vanoxerine
MITOTIC_METAPHASE_AND_ANAPHASE,1.835246468,0.195760979,vanoxerine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.834002301,0.175651361,vanoxerine
SEPARATION_OF_SISTER_CHROMATIDS,1.824091535,0.17081495,vanoxerine
NONSENSE_MEDIATED_DECAY_NMD,-2.621564002,0,eugenol
EUKARYOTIC_TRANSLATION_INITIATION,-2.614617069,0,eugenol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.612096737,0,eugenol
SELENOAMINO_ACID_METABOLISM,-2.520206289,0,eugenol
RRNA_PROCESSING,-2.49511546,0,eugenol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.481443898,0,eugenol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.417683042,0,eugenol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.417640223,0,eugenol
TRANSLATION,-2.378712216,0,eugenol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.363448369,0,eugenol
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.162798348,1,carteolol
RHO_GTPASE_EFFECTORS,1.11654881,1,carteolol
SUMOYLATION,1.101614583,1,carteolol
ESR_MEDIATED_SIGNALING,1.095981729,0.857563247,carteolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.506885773,1,carteolol
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.082160392,0.717357695,carteolol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.736841996,1,carteolol
INTERFERON_SIGNALING,0.895873024,1,carteolol
TRANSLATION,0.876532251,1,carteolol
MITOTIC_PROMETAPHASE,0.873696134,0.887517569,carteolol
GPCR_LIGAND_BINDING,2.285111876,0.011885269,tegaserod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.146721144,0.020056391,tegaserod
GLYCOSAMINOGLYCAN_METABOLISM,-3.460470943,0.093041593,tegaserod
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-3.28077546,0.48728563,tegaserod
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-3.264294151,0.382679545,tegaserod
DISEASES_OF_GLYCOSYLATION,-3.235029899,0.382022472,tegaserod
SIGNALING_BY_GPCR,1.818940041,0.23399123,tegaserod
BIOLOGICAL_OXIDATIONS,-3.208236837,0.38478218,tegaserod
DISEASES_OF_METABOLISM,-3.17398324,0.402391747,tegaserod
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.037958233,0.564106896,tegaserod
GPCR_LIGAND_BINDING,2.929747844,0,mevastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.813147708,0,mevastatin
SIGNALING_BY_GPCR,2.573261827,0,mevastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.332763898,0.000918539,mevastatin
NCAM1_INTERACTIONS,2.213731106,0.003429213,mevastatin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.153470967,0.005409175,mevastatin
DEUBIQUITINATION,-3.712092505,0.19083841,mevastatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.033339355,0.014959067,mevastatin
MUSCLE_CONTRACTION,1.93968124,0.030847608,mevastatin
NEURONAL_SYSTEM,1.929217818,0.029529334,mevastatin
GPCR_LIGAND_BINDING,-2.638793089,0,methyldopa
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.233369115,0.003545811,methyldopa
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.172708376,0.004727748,methyldopa
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.153971511,0.136998689,methyldopa
SIGNALING_BY_GPCR,-2.073083025,0.013377377,methyldopa
REGULATION_OF_TP53_ACTIVITY,2.099995923,0.091332459,methyldopa
MITOTIC_SPINDLE_CHECKPOINT,2.036581989,0.093615771,methyldopa
SARS_COV_2_HOST_INTERACTIONS,2.031596727,0.072495139,methyldopa
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.989527205,0.076719266,methyldopa
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.986912861,0.064693825,methyldopa
CELLULAR_RESPONSE_TO_STARVATION,2.260515586,0.037787606,zaleplon
INFLUENZA_INFECTION,2.009628476,0.089934501,zaleplon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.924459924,0.095224766,zaleplon
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.003346002,0.197163533,zaleplon
ECM_PROTEOGLYCANS,-1.99938659,0.103166965,zaleplon
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.99633422,0.071834775,zaleplon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.887698108,0.088045121,zaleplon
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.911000278,0.11715182,zaleplon
SARS_COV_2_HOST_INTERACTIONS,1.520574957,0.523887365,zaleplon
SELENOAMINO_ACID_METABOLISM,1.511211396,0.456474276,zaleplon
SIGNALING_BY_GPCR,3.140280644,0,iloprost
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.925224039,0,iloprost
GPCR_LIGAND_BINDING,2.922904139,0,iloprost
METABOLISM_OF_RNA,-2.7875866,0,iloprost
G_ALPHA_I_SIGNALLING_EVENTS,2.667797238,0,iloprost
EXTRACELLULAR_MATRIX_ORGANIZATION,2.549089368,0,iloprost
G_ALPHA_Q_SIGNALLING_EVENTS,2.484375209,0.000138027,iloprost
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.457643595,0.000118309,iloprost
COLLAGEN_DEGRADATION,2.401618553,0.00010352,iloprost
MRNA_SPLICING,-2.545419064,0.001995868,iloprost
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.838761389,0.001040545,digoxin
TRANSLATION,-2.789275369,0.000520273,digoxin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.786821586,0.000346848,digoxin
SELENOAMINO_ACID_METABOLISM,-2.754515251,0.000260136,digoxin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.746819118,0.000208109,digoxin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.584474834,0.000921419,digoxin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.695595574,0.000867121,digoxin
NONSENSE_MEDIATED_DECAY_NMD,-2.69439059,0.000743247,digoxin
EUKARYOTIC_TRANSLATION_INITIATION,-2.675953894,0.000780409,digoxin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.664851298,0.000809313,digoxin
GPCR_LIGAND_BINDING,2.423910726,0.000679852,tegafur
SIGNALING_BY_GPCR,2.415633487,0.000339926,tegafur
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.217158921,0.00430573,tegafur
G_ALPHA_Q_SIGNALLING_EVENTS,2.052724485,0.019545748,tegafur
DISEASES_OF_GLYCOSYLATION,-2.143629585,0.485769079,tegafur
TCR_SIGNALING,-2.063116531,0.389577182,tegafur
HIV_LIFE_CYCLE,-2.044597434,0.290178889,tegafur
GLYCOSAMINOGLYCAN_METABOLISM,-2.038681835,0.226050957,tegafur
NEUTROPHIL_DEGRANULATION,-2.004781006,0.220760403,tegafur
SENSORY_PERCEPTION,1.910405568,0.065265801,tegafur
INTERFERON_ALPHA_BETA_SIGNALING,2.577593638,0,erythromycin
ADAPTIVE_IMMUNE_SYSTEM,2.532802067,0,erythromycin
GPCR_LIGAND_BINDING,-2.482422946,0.00059207,erythromycin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.256012404,0.005032598,erythromycin
MITF_M_DEPENDENT_GENE_EXPRESSION,2.262621008,0.014950859,erythromycin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.244145062,0.003749779,erythromycin
SENSORY_PERCEPTION,-2.195446935,0.00488458,erythromycin
SARS_COV_2_HOST_INTERACTIONS,2.160515168,0.028542548,erythromycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.113907801,0.010302023,erythromycin
SIGNALING_BY_GPCR,-2.079021084,0.011545371,erythromycin
GPCR_LIGAND_BINDING,-2.349305362,0.001454996,vicriviroc
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.278004315,0.00363749,vicriviroc
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.157214127,0.09994956,vicriviroc
INTERFERON_ALPHA_BETA_SIGNALING,2.128051735,0.062468475,vicriviroc
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.014463064,0.043164886,vicriviroc
RESPIRATORY_ELECTRON_TRANSPORT,1.957180432,0.136240769,vicriviroc
CILIUM_ASSEMBLY,1.936536573,0.112889458,vicriviroc
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.988952059,0.042013014,vicriviroc
ECM_PROTEOGLYCANS,-1.988539279,0.033610411,vicriviroc
COLLAGEN_FORMATION,-1.980479676,0.026189931,vicriviroc
GPCR_LIGAND_BINDING,-2.821558832,0,pilaralisib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.397053994,0.002128122,pilaralisib
G_ALPHA_S_SIGNALLING_EVENTS,-2.361546535,0.001418748,pilaralisib
SIGNALING_BY_GPCR,-2.339442206,0.001064061,pilaralisib
ECM_PROTEOGLYCANS,-2.286672119,0.001560623,pilaralisib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.256703796,0.001773435,pilaralisib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.250786071,0.001520087,pilaralisib
INTERFERON_ALPHA_BETA_SIGNALING,2.344373367,0.042201761,pilaralisib
NEURONAL_SYSTEM,-2.113995241,0.006650381,pilaralisib
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.06948771,0.009537139,pilaralisib
NONSENSE_MEDIATED_DECAY_NMD,-2.684556929,0,brexpiprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.679637002,0,brexpiprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.651677518,0,brexpiprazole
SELENOAMINO_ACID_METABOLISM,-2.624373614,0,brexpiprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.616472627,0,brexpiprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.57339821,0,brexpiprazole
CELLULAR_RESPONSE_TO_STARVATION,-2.463491076,0,brexpiprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.396212571,0.000128995,brexpiprazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.376993903,0.000114663,brexpiprazole
RRNA_PROCESSING,-2.333851939,0.000103196,brexpiprazole
EUKARYOTIC_TRANSLATION_ELONGATION,3.677546396,0,vilazodone
NEUTROPHIL_DEGRANULATION,2.570990729,0,vilazodone
INFLUENZA_INFECTION,2.634199945,0,vilazodone
SELENOAMINO_ACID_METABOLISM,3.305367829,0,vilazodone
NONSENSE_MEDIATED_DECAY_NMD,3.344127516,0,vilazodone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.374419392,0,vilazodone
COLLAGEN_DEGRADATION,-2.54359998,0,vilazodone
CELLULAR_RESPONSE_TO_STARVATION,3.560124833,0,vilazodone
TRANSLATION,3.568110352,0,vilazodone
EUKARYOTIC_TRANSLATION_INITIATION,3.618521688,0,vilazodone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.218528396,0.006434292,tamsulosin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.112727035,0.011662153,tamsulosin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.005935358,0.026809548,tamsulosin
COLLAGEN_FORMATION,-1.994862471,0.022922164,tamsulosin
HIV_LIFE_CYCLE,1.8537296,0.310467883,tamsulosin
GPCR_LIGAND_BINDING,-1.962477704,0.025576309,tamsulosin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.729956145,0.349276368,tamsulosin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.67302509,0.329203013,tamsulosin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.671240279,0.248909596,tamsulosin
MYD88_INDEPENDENT_TLR4_CASCADE,1.603897624,0.295479778,tamsulosin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.594944452,0.000715501,enoxacin
ECM_PROTEOGLYCANS,-2.57722012,0.00035775,enoxacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.364575853,0.0002385,enoxacin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.203772664,0.003219753,enoxacin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.187161621,0.003720603,enoxacin
COLLAGEN_FORMATION,-2.124096422,0.006678005,enoxacin
GPCR_LIGAND_BINDING,-2.090879439,0.007461649,enoxacin
MITF_M_DEPENDENT_GENE_EXPRESSION,2.025640245,0.193524918,enoxacin
COLLAGEN_DEGRADATION,-2.061828568,0.007959944,enoxacin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.006677952,0.110585668,enoxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.839627046,0,felbamate
INFECTIOUS_DISEASE,-2.531675134,0,felbamate
SARS_COV_2_INFECTION,-2.66957861,0,felbamate
CELLULAR_RESPONSES_TO_STIMULI,-2.677542949,0,felbamate
VIRAL_INFECTION_PATHWAYS,-2.765131753,0,felbamate
SARS_COV_1_INFECTION,-2.925913509,0,felbamate
NERVOUS_SYSTEM_DEVELOPMENT,-2.943709981,0,felbamate
SARS_COV_2_HOST_INTERACTIONS,-2.970120134,0,felbamate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.085408759,0,felbamate
SARS_COV_1_HOST_INTERACTIONS,-3.09809159,0,felbamate
GPCR_LIGAND_BINDING,3.053643971,0,clotrimazole
SIGNALING_BY_GPCR,2.806250226,0,clotrimazole
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.608643698,0,clotrimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.590858695,0.000244949,clotrimazole
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.336350354,0.002755677,clotrimazole
MEMBRANE_TRAFFICKING,-2.307580185,0.01325822,clotrimazole
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.178766567,0.02848062,clotrimazole
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.177898061,0.021360465,clotrimazole
AMINE_LIGAND_BINDING_RECEPTORS,2.129043501,0.012786341,clotrimazole
VESICLE_MEDIATED_TRANSPORT,-2.131655541,0.025632558,clotrimazole
NONSENSE_MEDIATED_DECAY_NMD,-2.162796688,0.01248931,nateglinide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.153354389,0.007285431,nateglinide
SIGNALING_BY_ROBO_RECEPTORS,-2.099664027,0.01248931,nateglinide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.033818892,0.020295129,nateglinide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.022263955,0.019566586,nateglinide
EUKARYOTIC_TRANSLATION_INITIATION,-2.008135207,0.018907428,nateglinide
SELENOAMINO_ACID_METABOLISM,-1.972787056,0.027506219,nateglinide
RRNA_PROCESSING,-1.956721985,0.029662112,nateglinide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.920341642,0.040243333,nateglinide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.912300803,0.040486181,nateglinide
SENSORY_PERCEPTION,2.331353798,0.005424909,flucytosine
GPCR_LIGAND_BINDING,2.234902265,0.007120192,flucytosine
HIV_LIFE_CYCLE,-2.50032315,0.052369077,flucytosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.203344548,0.00632906,flucytosine
SIGNALING_BY_GPCR,2.142579955,0.008137363,flucytosine
SIGNALING_BY_ALK_IN_CANCER,-1.984045968,0.640897756,flucytosine
RRNA_PROCESSING,-1.897751153,0.670822943,flucytosine
HIV_INFECTION,-1.76463799,0.907107232,flucytosine
TRANSLATION,-1.731686792,0.821945137,flucytosine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.773086589,0.216182604,flucytosine
TRANSLATION,2.51831311,0.003088326,resorcinol
RESPIRATORY_ELECTRON_TRANSPORT,2.138827664,0.03551575,resorcinol
MITF_M_DEPENDENT_GENE_EXPRESSION,2.085884015,0.032942145,resorcinol
FATTY_ACID_METABOLISM,1.924809129,0.059450278,resorcinol
GPCR_LIGAND_BINDING,-2.030545857,0.067559976,resorcinol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.82327377,0.088326127,resorcinol
CELL_CYCLE_CHECKPOINTS,1.62838997,0.241404159,resorcinol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.604819002,0.230300891,resorcinol
HIV_LIFE_CYCLE,1.595199939,0.213480544,resorcinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.842360564,0.233741987,resorcinol
METABOLISM_OF_RNA,-2.753361073,0.003010139,glycopyrrolate
MITOTIC_METAPHASE_AND_ANAPHASE,-2.625566082,0.003010139,glycopyrrolate
RHO_GTPASES_ACTIVATE_FORMINS,-2.265115334,0.022074356,glycopyrrolate
SYNTHESIS_OF_DNA,-2.159875686,0.029348859,glycopyrrolate
SEPARATION_OF_SISTER_CHROMATIDS,-2.123033523,0.028295311,glycopyrrolate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,2.097603736,0.057080258,glycopyrrolate
RRNA_PROCESSING,-2.005208339,0.05217575,glycopyrrolate
TELOMERE_MAINTENANCE,-1.991107765,0.048592251,glycopyrrolate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.973766067,0.048162231,glycopyrrolate
DNA_REPLICATION,-1.928073879,0.05317913,glycopyrrolate
METABOLISM_OF_RNA,3.082069333,0,tirofiban
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.790594357,0,tirofiban
INFLUENZA_INFECTION,2.42102608,0.003870968,tirofiban
MRNA_SPLICING,2.40675242,0.002903226,tirofiban
SLC_TRANSPORTER_DISORDERS,2.229258922,0.007741935,tirofiban
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.057637902,0.021935484,tirofiban
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2.008528998,0.024331797,tirofiban
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.003951791,0.024677419,tirofiban
GPCR_LIGAND_BINDING,-2.006348692,0.107885006,tirofiban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.995373988,0.062723841,tirofiban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.829532661,0,diazepam
GPCR_LIGAND_BINDING,2.828354017,0,diazepam
SIGNALING_BY_GPCR,2.645507103,0,diazepam
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.423862899,0,diazepam
G_ALPHA_Q_SIGNALLING_EVENTS,2.04396143,0.0172079,diazepam
SENSORY_PERCEPTION,2.040147996,0.015523946,diazepam
G_ALPHA_I_SIGNALLING_EVENTS,1.917537919,0.044316544,diazepam
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.831027346,0.082191402,diazepam
RHOG_GTPASE_CYCLE,-1.670338112,1,diazepam
VISUAL_PHOTOTRANSDUCTION,1.746523334,0.137873693,diazepam
SELENOAMINO_ACID_METABOLISM,2.432591006,0.008164227,imexon
TRANSLATION,2.307233928,0.007143698,imexon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.302979695,0.005442818,imexon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.297641234,0.004082113,imexon
CELLULAR_RESPONSE_TO_STARVATION,2.165021338,0.01224634,imexon
EUKARYOTIC_TRANSLATION_INITIATION,2.085352726,0.01394722,imexon
INFLUENZA_INFECTION,2.075181177,0.013121078,imexon
NONSENSE_MEDIATED_DECAY_NMD,2.011254193,0.015818189,imexon
ECM_PROTEOGLYCANS,-2.012163815,0.110100978,imexon
EUKARYOTIC_TRANSLATION_ELONGATION,1.899166858,0.029481929,imexon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.523489266,0.003372049,vernakalant
MRNA_SPLICING,2.256065015,0.007306107,vernakalant
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.947574143,0.022855002,vernakalant
RAB_REGULATION_OF_TRAFFICKING,1.913275258,0.020232297,vernakalant
SENSORY_PERCEPTION,-1.920717115,0.302232527,vernakalant
GABA_RECEPTOR_ACTIVATION,-1.905163095,0.188895329,vernakalant
SELENOAMINO_ACID_METABOLISM,-1.896776446,0.134877893,vernakalant
EUKARYOTIC_TRANSLATION_ELONGATION,-1.882253756,0.117562488,vernakalant
NONSENSE_MEDIATED_DECAY_NMD,-1.861938506,0.115126732,vernakalant
G_ALPHA_Q_SIGNALLING_EVENTS,-1.839872451,0.118639523,vernakalant
INFLUENZA_INFECTION,2.840541714,0,sacubitril
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.36711971,0.000917014,sacubitril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.468093165,0.004124879,sacubitril
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.259557787,0.004126565,sacubitril
ECM_PROTEOGLYCANS,-2.242084794,0.003362386,sacubitril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.298842733,0.009349725,sacubitril
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.16104659,0.014024588,sacubitril
SELENOAMINO_ACID_METABOLISM,2.140098905,0.012209641,sacubitril
CELLULAR_RESPONSE_TO_STARVATION,2.122839041,0.011274668,sacubitril
MITF_M_DEPENDENT_GENE_EXPRESSION,2.016719367,0.015556685,sacubitril
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.179853726,0.010611765,talazoparib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.09069615,0.015563922,talazoparib
ECM_PROTEOGLYCANS,-2.074488203,0.01179085,talazoparib
ADAPTIVE_IMMUNE_SYSTEM,2.058044742,0.135821637,talazoparib
GPCR_LIGAND_BINDING,-2.032910795,0.014679609,talazoparib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.978593024,0.124503167,talazoparib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.974279219,0.085517327,talazoparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.992047784,0.018252236,talazoparib
INNATE_IMMUNE_SYSTEM,1.89306295,0.119472736,talazoparib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.952780007,0.024642877,talazoparib
STRIATED_MUSCLE_CONTRACTION,2.174014553,0.049785183,mometasone
MUSCLE_CONTRACTION,1.937818408,0.12873026,mometasone
INSULIN_RECEPTOR_SIGNALLING_CASCADE,1.871210349,0.126596609,mometasone
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.777316665,0.157534545,mometasone
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.898745175,0.832719234,mometasone
APOPTOSIS,1.692538844,0.20824431,mometasone
EXTRACELLULAR_MATRIX_ORGANIZATION,1.64215202,0.219528952,mometasone
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.575177878,0.259898978,mometasone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.45167351,0.426374536,mometasone
PTEN_REGULATION,1.441589177,0.395594648,mometasone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.939256896,0.3029273,donepezil
CHROMATIN_ORGANIZATION,1.840575261,0.484528136,donepezil
GPCR_LIGAND_BINDING,-1.844436943,0.31034771,donepezil
SIGNALING_BY_ROBO_RECEPTORS,-1.831055633,0.2293052,donepezil
MITF_M_DEPENDENT_GENE_EXPRESSION,1.681857991,0.57193591,donepezil
NEUTROPHIL_DEGRANULATION,1.666590572,0.413867783,donepezil
CELLULAR_SENESCENCE,1.614471857,0.41054124,donepezil
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.569198686,0.419557317,donepezil
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.544263745,0.393908527,donepezil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.707048012,0.425582302,donepezil
STRIATED_MUSCLE_CONTRACTION,3.113748722,0,olomoucine
MUSCLE_CONTRACTION,3.036976903,0,olomoucine
PI3K_AKT_SIGNALING_IN_CANCER,2.368083659,0.00306506,olomoucine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.034727166,0.024367226,olomoucine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.855837792,0.065285777,olomoucine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.812869056,0.06957686,olomoucine
CARDIAC_CONDUCTION,1.708535298,0.10929128,olomoucine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.661246849,1,olomoucine
TOLL_LIKE_RECEPTOR_CASCADES,1.571964712,0.193328655,olomoucine
G_ALPHA_Q_SIGNALLING_EVENTS,1.518156007,0.225384074,olomoucine
DEATH_RECEPTOR_SIGNALING,-3.033941316,1,olopatadine
TRANSLATION,1.706750443,1,olopatadine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.704486871,1,olopatadine
CIRCADIAN_CLOCK,1.689887849,0.95840718,olopatadine
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1.68810845,0.729479061,olopatadine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.682900786,0.599593763,olopatadine
NEDDYLATION,1.678263867,0.515004879,olopatadine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.673587155,0.454393646,olopatadine
DNA_REPLICATION_PRE_INITIATION,1.65677209,0.444625326,olopatadine
DEUBIQUITINATION,-2.729400259,1,olopatadine
TCR_SIGNALING,2.132907354,0.162836001,etomidate
G_ALPHA_Q_SIGNALLING_EVENTS,2.018280497,0.192913988,etomidate
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.891344248,0.339155237,etomidate
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.796284242,0.491360224,etomidate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.78281848,0.426070248,etomidate
CILIUM_ASSEMBLY,-1.467722575,1,etomidate
DEVELOPMENTAL_CELL_LINEAGES,-1.416532514,1,etomidate
ADAPTIVE_IMMUNE_SYSTEM,1.720622585,0.524117573,etomidate
MAPK_FAMILY_SIGNALING_CASCADES,1.681397397,0.576519452,etomidate
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.326693147,1,etomidate
CELLULAR_RESPONSE_TO_STARVATION,2.805678527,0,lurasidone
NONSENSE_MEDIATED_DECAY_NMD,2.712803692,0.000658662,lurasidone
G_ALPHA_Q_SIGNALLING_EVENTS,-2.314457795,0.00190221,lurasidone
INFLUENZA_INFECTION,2.349334397,0.002195541,lurasidone
SIGNALING_BY_GPCR,-2.275923844,0.002377763,lurasidone
EUKARYOTIC_TRANSLATION_INITIATION,2.214233296,0.008891942,lurasidone
GPCR_LIGAND_BINDING,-2.143412521,0.010462156,lurasidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.127421435,0.012909782,lurasidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.094882226,0.014742129,lurasidone
TRANSLATION,2.021016769,0.019979425,lurasidone
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.100561533,0.087116536,desvenlafaxine
CELLULAR_RESPONSE_TO_STARVATION,1.990600167,0.087757099,desvenlafaxine
SELENOAMINO_ACID_METABOLISM,1.816971456,0.170816737,desvenlafaxine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.646439497,0.34302136,desvenlafaxine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.782551107,1,desvenlafaxine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.737982323,1,desvenlafaxine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.49701223,0.606484824,desvenlafaxine
NONSENSE_MEDIATED_DECAY_NMD,1.49063663,0.523553299,desvenlafaxine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.401760667,0.675885224,desvenlafaxine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.30055493,0.951716126,desvenlafaxine
ECM_PROTEOGLYCANS,-2.387906725,0,safinamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.254213481,0.00298864,safinamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.011258513,0.049146517,safinamide
MUSCLE_CONTRACTION,1.860119741,0.406577178,safinamide
GASTRULATION,-1.892187174,0.119296529,safinamide
SIGNALING_BY_GPCR,-1.755438301,0.31420564,safinamide
TCR_SIGNALING,1.550702973,1,safinamide
GPCR_LIGAND_BINDING,-1.726108931,0.336387987,safinamide
PROTEIN_LOCALIZATION,1.4520213,1,safinamide
G_ALPHA_I_SIGNALLING_EVENTS,-1.653129587,0.503514609,safinamide
SELENOAMINO_ACID_METABOLISM,2.294647039,0.032105843,isradipine
CELLULAR_RESPONSE_TO_STARVATION,2.165146112,0.038280044,isradipine
TRANSLATION,2.143579258,0.031282617,isradipine
INFLUENZA_INFECTION,2.115442653,0.027166483,isradipine
EUKARYOTIC_TRANSLATION_INITIATION,1.926466625,0.061248071,isradipine
FATTY_ACID_METABOLISM,1.854062874,0.076148475,isradipine
RRNA_PROCESSING,1.837239369,0.06985667,isradipine
METABOLISM_OF_RNA,1.783998114,0.080573319,isradipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.777640196,0.073267181,isradipine
NONSENSE_MEDIATED_DECAY_NMD,1.765434139,0.073349504,isradipine
NEUTROPHIL_DEGRANULATION,2.738676371,0,oxybenzone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.244282291,0.006069067,oxybenzone
GPCR_LIGAND_BINDING,-2.177377278,0.005310434,oxybenzone
SIGNALING_BY_GPCR,-2.137057663,0.008344967,oxybenzone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.114927579,0.007965651,oxybenzone
INNATE_IMMUNE_SYSTEM,1.945429848,0.114921223,oxybenzone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.061622922,0.012745041,oxybenzone
COLLAGEN_DEGRADATION,-2.035898923,0.01378184,oxybenzone
G_ALPHA_Q_SIGNALLING_EVENTS,-2.022554513,0.012788392,oxybenzone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.819290577,0.168551128,oxybenzone
EUKARYOTIC_TRANSLATION_ELONGATION,2.29468557,0.00810835,esmolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.278446902,0.00557449,esmolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.27362296,0.003716327,esmolol
CELLULAR_RESPONSE_TO_STARVATION,2.260990593,0.003294017,esmolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.254537919,0.002837922,esmolol
SELENOAMINO_ACID_METABOLISM,2.224486236,0.004560947,esmolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.181121084,0.007094806,esmolol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.179622641,0.006334648,esmolol
SIGNALING_BY_ROBO_RECEPTORS,2.177228445,0.005630798,esmolol
EUKARYOTIC_TRANSLATION_INITIATION,2.139320651,0.008716476,esmolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.444025117,0.002040668,neostigmine
MRNA_SPLICING,2.411977423,0.001530501,neostigmine
HCMV_INFECTION,1.583866723,0.142846731,neostigmine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.445010525,0.215800598,neostigmine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.423978649,0.190394286,neostigmine
HCMV_EARLY_EVENTS,1.418837057,0.163083352,neostigmine
SELENOAMINO_ACID_METABOLISM,-1.926710578,1,neostigmine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.916451007,1,neostigmine
GPCR_LIGAND_BINDING,-1.904616658,1,neostigmine
SENSORY_PERCEPTION,-1.902045043,0.889837263,neostigmine
RAB_REGULATION_OF_TRAFFICKING,1.635896445,0.216509885,seocalcitol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.536541422,0.763444673,seocalcitol
NONSENSE_MEDIATED_DECAY_NMD,-2.498577843,0.594425927,seocalcitol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.469735155,0.516243923,seocalcitol
SELENOAMINO_ACID_METABOLISM,-2.453022112,0.444129258,seocalcitol
EUKARYOTIC_TRANSLATION_INITIATION,-2.446947636,0.368824906,seocalcitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.445375195,0.309954377,seocalcitol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.413172867,0.319315415,seocalcitol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.368852457,0.327896367,seocalcitol
GPCR_LIGAND_BINDING,-2.329979813,0.321626782,seocalcitol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.461507908,0,acenocoumarol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.371690069,0.001487046,acenocoumarol
ECM_PROTEOGLYCANS,-2.2841395,0.005287275,acenocoumarol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.20140706,0.053683515,acenocoumarol
ADAPTIVE_IMMUNE_SYSTEM,2.108345716,0.045424513,acenocoumarol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.978862687,0.075019271,acenocoumarol
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.909662503,0.080009085,acenocoumarol
COLLAGEN_FORMATION,-1.994256692,0.077326401,acenocoumarol
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.899031959,0.068756194,acenocoumarol
TCR_SIGNALING,1.844346141,0.07295452,acenocoumarol
GPCR_LIGAND_BINDING,-2.87639494,0,BRD-K82225283
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.593106758,0,BRD-K82225283
G_ALPHA_S_SIGNALLING_EVENTS,-2.399780603,0.001374209,BRD-K82225283
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.328203961,0.017838045,BRD-K82225283
EUKARYOTIC_TRANSLATION_ELONGATION,2.307788673,0.010977259,BRD-K82225283
SIGNALING_BY_GPCR,-2.315925054,0.003950851,BRD-K82225283
INFLUENZA_INFECTION,2.225000123,0.016465888,BRD-K82225283
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.243126095,0.00604652,BRD-K82225283
NONSENSE_MEDIATED_DECAY_NMD,2.187267002,0.016465888,BRD-K82225283
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.184466495,0.01317271,BRD-K82225283
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.622737498,0.002447569,dexniguldipine
ONCOGENIC_MAPK_SIGNALING,-2.699307736,0.088158438,dexniguldipine
MRNA_SPLICING,2.012760657,0.02488362,dexniguldipine
SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,-2.676829197,0.062318896,dexniguldipine
GENE_SILENCING_BY_RNA,1.695366894,0.110956472,dexniguldipine
TRNA_PROCESSING,1.689519089,0.086072851,dexniguldipine
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.435429969,0.239861784,dexniguldipine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.43394482,0.201108605,dexniguldipine
CELLULAR_RESPONSE_TO_STARVATION,1.416933357,0.18706422,dexniguldipine
INFLUENZA_INFECTION,1.386027546,0.192644095,dexniguldipine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.356297089,0.016663652,melatonin
TCR_SIGNALING,2.179619899,0.043174007,melatonin
MITF_M_DEPENDENT_GENE_EXPRESSION,2.07297759,0.049990956,melatonin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.032914605,0.145760607,melatonin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.023140415,0.079904911,melatonin
ADAPTIVE_IMMUNE_SYSTEM,1.943608225,0.076880031,melatonin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.938410668,0.063018902,melatonin
GPCR_LIGAND_BINDING,-1.989217476,0.071124151,melatonin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.979791721,0.057513974,melatonin
RESPIRATORY_ELECTRON_TRANSPORT,1.865629322,0.081803382,melatonin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.089232732,0.064341805,parecoxib
GPCR_LIGAND_BINDING,2.003646135,0.08175194,parecoxib
NEUTROPHIL_DEGRANULATION,-1.956232958,0.791736362,parecoxib
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.904886123,0.530255011,parecoxib
NCAM1_INTERACTIONS,1.927351668,0.107993304,parecoxib
MYD88_INDEPENDENT_TLR4_CASCADE,-1.85385077,0.452123133,parecoxib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.804489175,0.450560495,parecoxib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.79333381,0.38086686,parecoxib
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.833623155,0.176750722,parecoxib
INNATE_IMMUNE_SYSTEM,-1.717260078,0.4729583,parecoxib
MUSCLE_CONTRACTION,3.67876196,0,lestaurtinib
GPCR_LIGAND_BINDING,3.513591423,0,lestaurtinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.278488039,0,lestaurtinib
SIGNALING_BY_GPCR,3.118778315,0,lestaurtinib
CARDIAC_CONDUCTION,2.859704209,0,lestaurtinib
SENSORY_PERCEPTION,2.782944478,0,lestaurtinib
CELL_CYCLE,-2.757742622,0,lestaurtinib
METABOLISM_OF_RNA,-2.708514604,0,lestaurtinib
CELL_CYCLE_CHECKPOINTS,-2.551023673,0,lestaurtinib
CELL_CYCLE_MITOTIC,-2.512684446,0,lestaurtinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.872213457,0,disulfiram
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.814113268,0,disulfiram
SELENOAMINO_ACID_METABOLISM,2.732366751,0,disulfiram
EUKARYOTIC_TRANSLATION_INITIATION,2.696560188,0,disulfiram
NONSENSE_MEDIATED_DECAY_NMD,2.685762145,0,disulfiram
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.676541843,0,disulfiram
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.671074005,0,disulfiram
INFLUENZA_INFECTION,2.648350368,0,disulfiram
CELLULAR_RESPONSE_TO_STARVATION,2.479315594,0.000112505,disulfiram
SIGNALING_BY_ROBO_RECEPTORS,2.3713917,0.000303764,disulfiram
INFLUENZA_INFECTION,3.14509792,0,lomitapide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.844253689,0,lomitapide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.705782441,0,lomitapide
SELENOAMINO_ACID_METABOLISM,2.644797798,0,lomitapide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.471170732,0,lomitapide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.411538518,0.000973113,lomitapide
EUKARYOTIC_TRANSLATION_ELONGATION,2.526299751,0.000748263,lomitapide
ECM_PROTEOGLYCANS,-2.241618923,0.005189938,lomitapide
NONSENSE_MEDIATED_DECAY_NMD,2.338433875,0.001247105,lomitapide
CELLULAR_RESPONSE_TO_STARVATION,2.102448907,0.005166578,lomitapide
GPCR_LIGAND_BINDING,-2.813955867,0,dicoumarol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.542592592,0.000300643,dicoumarol
SIGNALING_BY_GPCR,-2.41420873,0.000400857,dicoumarol
G_ALPHA_S_SIGNALLING_EVENTS,-2.271569961,0.001052249,dicoumarol
NEURONAL_SYSTEM,-2.223087101,0.001322828,dicoumarol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.152497882,0.002405141,dicoumarol
RESPIRATORY_ELECTRON_TRANSPORT,2.287893284,0.074487507,dicoumarol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.130792145,0.003006426,dicoumarol
METABOLISM_OF_RNA,2.196827582,0.062516301,dicoumarol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.072033275,0.005186085,dicoumarol
METABOLISM_OF_RNA,-3.373096664,0,BRD-K49668410
NEUTROPHIL_DEGRANULATION,-3.341684783,0,BRD-K49668410
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.10742682,0,BRD-K49668410
MRNA_SPLICING,-3.045088524,0,BRD-K49668410
INNATE_IMMUNE_SYSTEM,-2.629338192,0,BRD-K49668410
GPCR_LIGAND_BINDING,2.454793773,0.000487842,BRD-K49668410
SENSORY_PERCEPTION,2.39900872,0.001219605,BRD-K49668410
SARS_COV_2_INFECTION,-2.40181684,0.005713314,BRD-K49668410
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.387803893,0.005203197,BRD-K49668410
SARS_COV_INFECTIONS,-2.381915336,0.004820609,BRD-K49668410
G_ALPHA_Q_SIGNALLING_EVENTS,1.923774212,0.291111349,diphenoxylate
SIGNALING_BY_GPCR,1.919188665,0.149598888,diphenoxylate
GPCR_LIGAND_BINDING,1.791166131,0.271644026,diphenoxylate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.942092348,1,diphenoxylate
HEMOSTASIS,-2.306555648,1,diphenoxylate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.841815383,1,diphenoxylate
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.553899029,0.964530966,diphenoxylate
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.523442108,0.916102257,diphenoxylate
CILIUM_ASSEMBLY,1.505524995,0.840239598,diphenoxylate
NEUTROPHIL_DEGRANULATION,-1.432312,1,diphenoxylate
STRIATED_MUSCLE_CONTRACTION,2.909471049,0.002353673,PD-407824
MITOTIC_G2_G2_M_PHASES,2.220550179,0.027067235,PD-407824
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.20225902,0.020006217,PD-407824
MITOTIC_PROMETAPHASE,2.17410961,0.017064126,PD-407824
SEPARATION_OF_SISTER_CHROMATIDS,2.151412384,0.016946443,PD-407824
RHO_GTPASES_ACTIVATE_FORMINS,2.145230835,0.015102733,PD-407824
MITOTIC_SPINDLE_CHECKPOINT,2.057000821,0.021855531,PD-407824
MUSCLE_CONTRACTION,1.997505701,0.028685385,PD-407824
POTENTIAL_THERAPEUTICS_FOR_SARS,1.826126227,0.063549161,PD-407824
MITOTIC_METAPHASE_AND_ANAPHASE,1.799064114,0.06707967,PD-407824
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.381944061,0.015461668,candesartan-cilextil
DNA_REPLICATION,1.953480659,0.471592528,candesartan-cilextil
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.886119022,0.378012809,candesartan-cilextil
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.18445979,0.369452479,candesartan-cilextil
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.170924598,0.282921392,candesartan-cilextil
SYNTHESIS_OF_DNA,1.827411381,0.383758932,candesartan-cilextil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.158205995,0.23843519,candesartan-cilextil
MITOTIC_G2_G2_M_PHASES,1.819625455,0.311214129,candesartan-cilextil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.119624063,0.256663683,candesartan-cilextil
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.769639535,0.34550617,candesartan-cilextil
EUKARYOTIC_TRANSLATION_INITIATION,-2.222262497,0.001962884,perindopril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.195764126,0.001472163,perindopril
EUKARYOTIC_TRANSLATION_ELONGATION,-2.183337171,0.000981442,perindopril
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.180137726,0.000981442,perindopril
SELENOAMINO_ACID_METABOLISM,-2.164613437,0.000981442,perindopril
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.16303795,0.000817868,perindopril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.130690878,0.001261854,perindopril
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.110839732,0.002085564,perindopril
NONSENSE_MEDIATED_DECAY_NMD,-2.108142354,0.001853835,perindopril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.105291011,0.001864739,perindopril
GPCR_LIGAND_BINDING,-3.273922361,0,TG-100115
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.77074137,0,TG-100115
SIGNALING_BY_GPCR,-2.768782484,0,TG-100115
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.376264692,0.001264093,TG-100115
CILIUM_ASSEMBLY,2.320695361,0.017926232,TG-100115
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.263960148,0.014938526,TG-100115
DEUBIQUITINATION,2.21062067,0.017926232,TG-100115
HIV_INFECTION,2.131906399,0.022781253,TG-100115
MYD88_INDEPENDENT_TLR4_CASCADE,2.127949778,0.019420084,TG-100115
HCMV_INFECTION,2.125532982,0.016681354,TG-100115
NEUTROPHIL_DEGRANULATION,2.848715081,0,piclamilast
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.366813655,0.005840072,piclamilast
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.093016248,0.020579301,piclamilast
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.966674994,0.030868951,piclamilast
GPCR_LIGAND_BINDING,-2.017709366,0.112229464,piclamilast
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.824600796,0.064073931,piclamilast
G_ALPHA_Q_SIGNALLING_EVENTS,-1.925096353,0.149790132,piclamilast
SIGNALING_BY_GPCR,-1.907241108,0.120375151,piclamilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.904370187,0.095033014,piclamilast
MEMBRANE_TRAFFICKING,1.592062553,0.209408292,piclamilast
NEDDYLATION,2.089499861,0.16080334,hexylresorcinol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.251557169,0.122313337,hexylresorcinol
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.201453785,0.162502004,hexylresorcinol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.179776274,0.155512671,hexylresorcinol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.169025375,0.138039337,hexylresorcinol
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.154998464,0.13611727,hexylresorcinol
TRANSPORT_OF_SMALL_MOLECULES,-2.914639399,0.394897344,hexylresorcinol
MEMBRANE_TRAFFICKING,-2.640530257,0.389904963,hexylresorcinol
VESICLE_MEDIATED_TRANSPORT,-2.599940152,0.350340343,hexylresorcinol
HEMOSTASIS,-2.547501603,0.323159601,hexylresorcinol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.313410908,0.000872224,proguanil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.227141324,0.004797233,proguanil
INTERLEUKIN_1_FAMILY_SIGNALING,2.121629831,0.078976819,proguanil
CELLULAR_RESPONSE_TO_STARVATION,-2.13837921,0.010175949,proguanil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.076860064,0.013737531,proguanil
MUSCLE_CONTRACTION,1.88545378,0.132134293,proguanil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.045729613,0.01587448,proguanil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.012997438,0.019043561,proguanil
NONSENSE_MEDIATED_DECAY_NMD,-2.005227782,0.017444483,proguanil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.004666348,0.015372951,proguanil
DEATH_RECEPTOR_SIGNALING,-3.29887054,0.459774104,pefloxacin
GPCR_LIGAND_BINDING,1.885991071,0.196284259,pefloxacin
SIGNALING_BY_GPCR,1.846143318,0.134457718,pefloxacin
DEUBIQUITINATION,-3.175720086,0.657086068,pefloxacin
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.613478874,1,pefloxacin
INNATE_IMMUNE_SYSTEM,-2.582458354,0.852536598,pefloxacin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.481254053,0.731543412,pefloxacin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.248862075,0.722546483,pefloxacin
DISEASES_OF_GLYCOSYLATION,-2.031984901,0.663734045,pefloxacin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.990018474,0.582163364,pefloxacin
MRNA_SPLICING,2.582419151,0,VP-20629
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.309182349,0.003010321,VP-20629
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.721157645,0.086295872,VP-20629
SELENOAMINO_ACID_METABOLISM,-1.954130296,0.217347364,VP-20629
EUKARYOTIC_TRANSLATION_ELONGATION,-1.931574436,0.136938586,VP-20629
NONSENSE_MEDIATED_DECAY_NMD,-1.883866822,0.171213843,VP-20629
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.509979798,0.226150373,VP-20629
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.8524913,0.182503561,VP-20629
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.846341556,0.154579785,VP-20629
EUKARYOTIC_TRANSLATION_INITIATION,-1.807699362,0.180635478,VP-20629
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.177787657,0.311286969,danazol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.159618797,0.202544055,danazol
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.879468452,0.71543187,danazol
SENSORY_PERCEPTION,1.875647648,0.242668455,danazol
MITOTIC_G2_G2_M_PHASES,1.875818686,0.364002682,danazol
REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1.80545803,0.301449544,danazol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.076748663,0.401491015,danazol
NERVOUS_SYSTEM_DEVELOPMENT,1.760127965,0.318109425,danazol
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.060635973,0.357980014,danazol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.053771669,0.308298614,danazol
MITOTIC_SPINDLE_CHECKPOINT,-2.892924092,0,galantamine
SEPARATION_OF_SISTER_CHROMATIDS,-2.700104591,0,galantamine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.672803309,0,galantamine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.658535822,0,galantamine
GPCR_LIGAND_BINDING,2.638005217,0,galantamine
SIGNALING_BY_GPCR,2.630181551,0,galantamine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.581076086,0.001193792,galantamine
VESICLE_MEDIATED_TRANSPORT,-2.441264749,0.001193792,galantamine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.462706203,0.001326436,galantamine
MEMBRANE_TRAFFICKING,-2.468272162,0.00149224,galantamine
INTRAFLAGELLAR_TRANSPORT,2.905423775,0,PCI-24781
GPCR_LIGAND_BINDING,-2.645415275,0,PCI-24781
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.481583136,0.000497825,PCI-24781
SIGNALING_BY_GPCR,-2.401291262,0.001327534,PCI-24781
G_ALPHA_Q_SIGNALLING_EVENTS,-2.32255856,0.001493476,PCI-24781
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.059661639,0.02349736,PCI-24781
METABOLISM_OF_RNA,-2.005045196,0.033354303,PCI-24781
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.868825969,0.146865509,PCI-24781
ESR_MEDIATED_SIGNALING,-1.964723303,0.046653354,PCI-24781
CILIUM_ASSEMBLY,1.837122447,0.116948461,PCI-24781
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.825896517,0,conivaptan
MRNA_SPLICING,2.634258187,0,conivaptan
INFLUENZA_INFECTION,2.222667326,0.007037386,conivaptan
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.737869684,0.13063148,conivaptan
UCH_PROTEINASES,1.487632788,0.467634307,conivaptan
ABC_TRANSPORTER_DISORDERS,1.45587891,0.454791078,conivaptan
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.45106978,0.400377003,conivaptan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.39971515,1,conivaptan
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1.43809834,0.377049953,conivaptan
GPCR_LIGAND_BINDING,-2.397670668,0.813144974,conivaptan
INFLUENZA_INFECTION,2.317548427,0.013657204,tanaproget
CELLULAR_RESPONSE_TO_STARVATION,2.039930692,0.041540663,tanaproget
SELENOAMINO_ACID_METABOLISM,1.958408058,0.047041481,tanaproget
PROTEIN_LOCALIZATION,1.858754323,0.059181218,tanaproget
GPCR_LIGAND_BINDING,-1.948984779,0.337417916,tanaproget
FATTY_ACID_METABOLISM,1.760269634,0.081943225,tanaproget
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.933395689,0.195115577,tanaproget
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.896323124,0.182238275,tanaproget
BIOLOGICAL_OXIDATIONS,1.577657459,0.190062758,tanaproget
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.780863978,0.361134972,tanaproget
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.7626001,0,indoramin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.700283268,0,indoramin
COLLAGEN_DEGRADATION,-2.451265795,0,indoramin
COLLAGEN_FORMATION,-2.415192141,0,indoramin
ECM_PROTEOGLYCANS,-2.400482557,0,indoramin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.378144629,0,indoramin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.210295743,0.000949343,indoramin
GPCR_LIGAND_BINDING,-2.08386202,0.005710892,indoramin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.018270454,0.150876187,indoramin
MYD88_INDEPENDENT_TLR4_CASCADE,1.968139312,0.095705044,indoramin
ECM_PROTEOGLYCANS,-1.899508619,0.477371065,gestrinone
GASTRULATION,-1.889875325,0.257317103,gestrinone
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.704792267,0.719746225,gestrinone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.824086696,0.302469289,gestrinone
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.725125386,0.504814865,gestrinone
MITF_M_DEPENDENT_GENE_EXPRESSION,1.484185204,1,gestrinone
TCR_SIGNALING,1.411853657,1,gestrinone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.38596563,0.90768535,gestrinone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.324815655,0.95390625,gestrinone
SIGNALING_BY_NOTCH,-1.59107461,1,gestrinone
GPCR_LIGAND_BINDING,2.604145679,0,perospirone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.590183307,0,perospirone
SIGNALING_BY_GPCR,2.571017116,0,perospirone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.27355294,0.003083159,perospirone
DEUBIQUITINATION,-3.63251471,0.204079376,perospirone
DEATH_RECEPTOR_SIGNALING,-3.567332938,0.270797634,perospirone
SENSORY_PERCEPTION,1.952334527,0.04657383,perospirone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.872641138,0.07568852,perospirone
G_ALPHA_Q_SIGNALLING_EVENTS,1.858892777,0.071612187,perospirone
VISUAL_PHOTOTRANSDUCTION,1.854041348,0.065018373,perospirone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.220565214,0.024735354,itopride
TRANSLATION,2.250340595,0.046354964,itopride
BIOLOGICAL_OXIDATIONS,2.120536579,0.073153928,itopride
ECM_PROTEOGLYCANS,-2.097602365,0.045722927,itopride
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.097431735,0.030731804,itopride
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.073506658,0.029045302,itopride
SIGNALING_BY_ROBO_RECEPTORS,2.043872632,0.094158521,itopride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.031530565,0.076051113,itopride
RESPIRATORY_ELECTRON_TRANSPORT,2.027541231,0.061420327,itopride
COLLAGEN_FORMATION,-1.974075955,0.053518312,itopride
G_ALPHA_Q_SIGNALLING_EVENTS,2.108942687,0.095274615,1-benzylimidazole
DEATH_RECEPTOR_SIGNALING,-3.447527806,0.165383408,1-benzylimidazole
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.913440187,0.252227007,1-benzylimidazole
GPCR_LIGAND_BINDING,1.90681047,0.179851729,1-benzylimidazole
SIGNALING_BY_GPCR,1.902147285,0.138649637,1-benzylimidazole
HOMOLOGY_DIRECTED_REPAIR,1.891882325,0.119745148,1-benzylimidazole
SENSORY_PERCEPTION,1.737093803,0.312066151,1-benzylimidazole
GASTRULATION,1.694319062,0.348432878,1-benzylimidazole
DEUBIQUITINATION,-3.082832469,1,1-benzylimidazole
REGULATION_OF_INSULIN_SECRETION,1.649866803,0.398147602,1-benzylimidazole
GPCR_LIGAND_BINDING,-3.026662301,0,riociguat
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.650477945,0.00033943,riociguat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.530268387,0.000905146,riociguat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.461853827,0.00067886,riociguat
TCR_SIGNALING,2.353775081,0.016308233,riociguat
EUKARYOTIC_TRANSLATION_INITIATION,2.347228941,0.008154116,riociguat
EUKARYOTIC_TRANSLATION_ELONGATION,2.327717127,0.006795097,riociguat
CELLULAR_RESPONSE_TO_STARVATION,2.326801765,0.005096323,riociguat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.320410276,0.004620666,riociguat
SELENOAMINO_ACID_METABOLISM,2.303641481,0.004077058,riociguat
SELENOAMINO_ACID_METABOLISM,3.943020319,0,equol
EUKARYOTIC_TRANSLATION_ELONGATION,3.824383097,0,equol
CELLULAR_RESPONSE_TO_STARVATION,3.78890287,0,equol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.72450171,0,equol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.69380866,0,equol
NONSENSE_MEDIATED_DECAY_NMD,3.329624147,0,equol
EUKARYOTIC_TRANSLATION_INITIATION,3.070938845,0,equol
INFLUENZA_INFECTION,3.029836439,0,equol
TRANSLATION,2.944459358,0,equol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.596008681,0,equol
CELLULAR_RESPONSE_TO_STARVATION,3.408272718,0,ripasudil
SELENOAMINO_ACID_METABOLISM,3.305573232,0,ripasudil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.176468247,0,ripasudil
INFLUENZA_INFECTION,2.813002375,0.000416696,ripasudil
EUKARYOTIC_TRANSLATION_INITIATION,2.784406853,0.000333357,ripasudil
TRANSLATION,2.658893461,0.000277797,ripasudil
NEUTROPHIL_DEGRANULATION,2.581216471,0.000714336,ripasudil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.486229918,0.000833392,ripasudil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.26157899,0.004482899,ripasudil
GPCR_LIGAND_BINDING,-2.243418925,0.002689739,ripasudil
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.090807178,0.080961536,moclobemide
EXTRACELLULAR_MATRIX_ORGANIZATION,1.893919185,0.278628266,moclobemide
GPCR_LIGAND_BINDING,-1.640837022,1,moclobemide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.556497213,1,moclobemide
SIGNALING_BY_GPCR,-1.550601231,1,moclobemide
CELL_CELL_COMMUNICATION,-1.443733389,1,moclobemide
PCP_CE_PATHWAY,-1.430463866,1,moclobemide
RAC2_GTPASE_CYCLE,-1.431616509,1,moclobemide
CILIUM_ASSEMBLY,1.57994763,1,moclobemide
SIGNALING_BY_ALK_IN_CANCER,1.579492146,1,moclobemide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.25434304,0.011161126,dichloroacetic-acid
INNATE_IMMUNE_SYSTEM,-2.457446741,0.089769165,dichloroacetic-acid
SENSORY_PERCEPTION,2.171381892,0.013217123,dichloroacetic-acid
GPCR_LIGAND_BINDING,2.159725472,0.009790461,dichloroacetic-acid
HIV_LIFE_CYCLE,-2.055409294,0.583499573,dichloroacetic-acid
VISUAL_PHOTOTRANSDUCTION,1.927759584,0.060945622,dichloroacetic-acid
DEATH_RECEPTOR_SIGNALING,-2.050109033,0.401823881,dichloroacetic-acid
MRNA_SPLICING,-2.038588115,0.319321744,dichloroacetic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.010420759,0.300598461,dichloroacetic-acid
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.998265774,0.269307495,dichloroacetic-acid
MUSCLE_CONTRACTION,2.553751953,0.00395188,IC-261
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.24556058,0.163495301,IC-261
EUKARYOTIC_TRANSLATION_ELONGATION,-2.221728423,0.097050166,IC-261
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.220510002,0.065237041,IC-261
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.205941624,0.056176341,IC-261
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.853687829,0.253908293,IC-261
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.176792228,0.060887905,IC-261
NONSENSE_MEDIATED_DECAY_NMD,-2.173800588,0.051948014,IC-261
MITOCHONDRIAL_TRANSLATION,1.827237899,0.201545882,IC-261
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.811111211,0.166966932,IC-261
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.828361845,0,isocarboxazid
GPCR_LIGAND_BINDING,2.584341882,0.001485327,isocarboxazid
SIGNALING_BY_GPCR,2.255274796,0.010892396,isocarboxazid
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.107297159,0.372761161,isocarboxazid
EXTRACELLULAR_MATRIX_ORGANIZATION,1.88830968,0.118826142,isocarboxazid
MUSCLE_CONTRACTION,1.883698086,0.098031567,isocarboxazid
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.083584771,0.275300696,isocarboxazid
SIGNALING_BY_WNT,-3.062453191,0.253866092,isocarboxazid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.799846167,0.136815099,isocarboxazid
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.043444304,0.254201008,isocarboxazid
MUSCLE_CONTRACTION,4.343016047,0,mianserin
METABOLISM_OF_RNA,-2.548943752,0,mianserin
TRANSLATION,-2.580939968,0,mianserin
RRNA_PROCESSING,-2.599099578,0,mianserin
VIRAL_INFECTION_PATHWAYS,-2.672487312,0,mianserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.710744398,0,mianserin
NEURONAL_SYSTEM,2.713975033,0,mianserin
SIGNALING_BY_GPCR,2.753209581,0,mianserin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.773186129,0,mianserin
CELLULAR_RESPONSE_TO_STARVATION,-2.812994638,0,mianserin
GPCR_LIGAND_BINDING,2.693920589,0,methotrexate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.501366804,0,methotrexate
SIGNALING_BY_GPCR,2.375640993,0.000388307,methotrexate
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.332415693,0.000728075,methotrexate
DEUBIQUITINATION,-3.93401418,0.036215893,methotrexate
G_ALPHA_I_SIGNALLING_EVENTS,1.991447035,0.022948935,methotrexate
DEATH_RECEPTOR_SIGNALING,-3.678793659,0.313871077,methotrexate
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.939034452,0.032714852,methotrexate
G_ALPHA_Q_SIGNALLING_EVENTS,1.891139133,0.044433399,methotrexate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.325879827,1,methotrexate
GPCR_LIGAND_BINDING,2.227794082,0.00683717,mesalazine
AMINE_LIGAND_BINDING_RECEPTORS,2.227228606,0.003418585,mesalazine
NEUTROPHIL_DEGRANULATION,-2.445017034,0.035062089,mesalazine
G_ALPHA_Q_SIGNALLING_EVENTS,2.139271944,0.00843251,mesalazine
SIGNALING_BY_GPCR,2.126640817,0.008204604,mesalazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.097274439,0.008888321,mesalazine
COLLAGEN_DEGRADATION,2.036086271,0.013560387,mesalazine
ESR_MEDIATED_SIGNALING,-2.026853485,0.27027027,mesalazine
SARS_COV_2_HOST_INTERACTIONS,-2.007596504,0.204528853,mesalazine
TRANSLATION,-1.899108254,0.301680058,mesalazine
GPCR_LIGAND_BINDING,2.733258401,0,clobetasol
SIGNALING_BY_GPCR,2.50930231,0,clobetasol
G_ALPHA_Q_SIGNALLING_EVENTS,2.341987241,0.000814369,clobetasol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.307031265,0.001526942,clobetasol
SENSORY_PERCEPTION,1.967961769,0.043487309,clobetasol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.839760012,0.098029679,clobetasol
PEROXISOMAL_PROTEIN_IMPORT,-2.409661704,1,clobetasol
SARS_COV_1_INFECTION,-2.125218563,1,clobetasol
NEURONAL_SYSTEM,1.754765059,0.153217727,clobetasol
G_ALPHA_S_SIGNALLING_EVENTS,1.745711191,0.142769081,clobetasol
GPCR_LIGAND_BINDING,2.512610084,0,AT-7867
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.511170253,0,AT-7867
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.460708469,0,AT-7867
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.262315642,0.153980132,AT-7867
SIGNALING_BY_GPCR,2.089720874,0.019279974,AT-7867
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.087012087,0.209972907,AT-7867
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.001474734,0.229970326,AT-7867
INTERFERON_ALPHA_BETA_SIGNALING,-1.77557126,0.535430912,AT-7867
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.739478441,0.514333634,AT-7867
CELL_CYCLE_CHECKPOINTS,-1.678856859,0.56892659,AT-7867
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.296187285,0.020833333,LY-364947
EUKARYOTIC_TRANSLATION_ELONGATION,2.286249128,0.012152778,LY-364947
SELENOAMINO_ACID_METABOLISM,2.184754434,0.011574074,LY-364947
EUKARYOTIC_TRANSLATION_INITIATION,2.177769862,0.009548611,LY-364947
SYNTHESIS_OF_DNA,2.144734112,0.009027778,LY-364947
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.127201347,0.008101852,LY-364947
DNA_REPLICATION,2.009078196,0.016369048,LY-364947
DNA_REPLICATION_PRE_INITIATION,1.964687636,0.020833333,LY-364947
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.892144942,0.027006173,LY-364947
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.766974566,0.047916667,LY-364947
KEAP1_NFE2L2_PATHWAY,1.983915054,0.216401475,BRD-K60174629
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.944859456,0.143611888,BRD-K60174629
PTEN_REGULATION,1.792447003,0.22339627,BRD-K60174629
MUSCLE_CONTRACTION,1.702886919,0.271813368,BRD-K60174629
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.6827371,0.241845042,BRD-K60174629
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.596607748,0.310612622,BRD-K60174629
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,-2.800156496,1,BRD-K60174629
G2_M_CHECKPOINTS,1.413278426,0.644895131,BRD-K60174629
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.748804711,1,BRD-K60174629
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.392522521,0.621498478,BRD-K60174629
MUSCLE_CONTRACTION,3.269397434,0,PP-1
STRIATED_MUSCLE_CONTRACTION,2.759318262,0,PP-1
COLLAGEN_DEGRADATION,2.533038132,0.00033323,PP-1
CARDIAC_CONDUCTION,2.537889512,0.000416537,PP-1
EXTRACELLULAR_MATRIX_ORGANIZATION,2.546655898,0.000555383,PP-1
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.502491015,0.000416537,PP-1
COLLAGEN_FORMATION,2.26995661,0.003689331,PP-1
DEVELOPMENTAL_CELL_LINEAGES,2.095542599,0.013329195,PP-1
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.071935467,0.013514323,PP-1
SIGNALING_BY_GPCR,1.793531315,0.066562668,PP-1
TRANSLATION,2.637091582,0.004498302,cirazoline
INFLUENZA_INFECTION,2.313306502,0.017993207,cirazoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.290856598,0.013494905,cirazoline
EUKARYOTIC_TRANSLATION_ELONGATION,2.256401624,0.011245754,cirazoline
EUKARYOTIC_TRANSLATION_INITIATION,2.245294407,0.008996603,cirazoline
RRNA_PROCESSING,2.212597378,0.008246886,cirazoline
NONSENSE_MEDIATED_DECAY_NMD,2.146421704,0.010281832,cirazoline
SELENOAMINO_ACID_METABOLISM,2.050564463,0.014057193,cirazoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.871832136,0.041484338,cirazoline
CELL_CYCLE_CHECKPOINTS,1.864098734,0.037785734,cirazoline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.252989532,0.019935871,diphenylpyraline
MRNA_SPLICING,2.13904961,0.028091454,diphenylpyraline
SELENOAMINO_ACID_METABOLISM,-2.121090393,0.038290287,diphenylpyraline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.108866577,0.022495544,diphenylpyraline
EUKARYOTIC_TRANSLATION_INITIATION,-2.088799218,0.018826058,diphenylpyraline
NONSENSE_MEDIATED_DECAY_NMD,-2.082096563,0.014837486,diphenylpyraline
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.847571631,0.088805242,diphenylpyraline
CELLULAR_RESPONSE_TO_STARVATION,-2.017106585,0.024314332,diphenylpyraline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.011305313,0.021219201,diphenylpyraline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.993216022,0.024341683,diphenylpyraline
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.289108371,0.003913056,chlormezanone
COLLAGEN_FORMATION,-2.266600194,0.00244566,chlormezanone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.172412878,0.006847848,chlormezanone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.130167873,0.008804376,chlormezanone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.097069564,0.012326127,chlormezanone
GPCR_LIGAND_BINDING,-2.088250734,0.010760904,chlormezanone
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.085566243,0.009503136,chlormezanone
ECM_PROTEOGLYCANS,-1.996830683,0.02323377,chlormezanone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.944941994,0.035108809,chlormezanone
SIGNALING_BY_GPCR,-1.895938441,0.049011027,chlormezanone
SIGNALING_BY_GPCR,2.47488434,0.001414887,oxcarbazepine
GPCR_LIGAND_BINDING,2.443604968,0.000707443,oxcarbazepine
METABOLISM_OF_RNA,-2.737556267,0.024016011,oxcarbazepine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.271737872,0.003773031,oxcarbazepine
G_ALPHA_Q_SIGNALLING_EVENTS,2.20176985,0.005836407,oxcarbazepine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.563910952,0.047031354,oxcarbazepine
MUSCLE_CONTRACTION,2.137194655,0.008347831,oxcarbazepine
MRNA_SPLICING,-2.499448733,0.055370247,oxcarbazepine
DEUBIQUITINATION,-2.488292917,0.046030687,oxcarbazepine
SENSORY_PERCEPTION,2.098193319,0.009786299,oxcarbazepine
MUSCLE_CONTRACTION,1.936417468,0.296211251,metergoline
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.741634957,0.416762342,metergoline
KEAP1_NFE2L2_PATHWAY,1.701769773,0.33869116,metergoline
ADIPOGENESIS,1.663730456,0.311280138,metergoline
POTENTIAL_THERAPEUTICS_FOR_SARS,1.624324761,0.312399541,metergoline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.587325414,0.306257176,metergoline
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.571655703,0.288092505,metergoline
DNA_REPLICATION,1.518943249,0.338188863,metergoline
SYNTHESIS_OF_DNA,1.411746696,0.50612323,metergoline
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.225388935,1,metergoline
EUKARYOTIC_TRANSLATION_ELONGATION,-3.962221141,0,moxonidine
SARS_COV_INFECTIONS,-2.86375374,0,moxonidine
SARS_COV_2_INFECTION,-2.919955909,0,moxonidine
INFECTIOUS_DISEASE,-2.934804349,0,moxonidine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.095337412,0,moxonidine
SARS_COV_2_HOST_INTERACTIONS,-3.113753177,0,moxonidine
VIRAL_INFECTION_PATHWAYS,-3.134922069,0,moxonidine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.139974448,0,moxonidine
NERVOUS_SYSTEM_DEVELOPMENT,-3.232632853,0,moxonidine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.280037164,0,moxonidine
REGULATION_OF_PTEN_GENE_TRANSCRIPTION,-2.033400946,0.171352777,fingolimod
GPCR_LIGAND_BINDING,-1.927552353,0.264078488,fingolimod
SIGNALING_BY_GPCR,-1.894919447,0.231723903,fingolimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.862012571,0.22666285,fingolimod
PTEN_REGULATION,-1.852080923,0.196513437,fingolimod
RRNA_PROCESSING,-1.850705505,0.165387965,fingolimod
G_ALPHA_12_13_SIGNALLING_EVENTS,-1.839848227,0.155240038,fingolimod
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.825777003,0.1554918,fingolimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.808893886,0.160025659,fingolimod
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.755673405,0.206451504,fingolimod
INTRAFLAGELLAR_TRANSPORT,1.524853346,0.36048644,cobimetinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.457648595,1,cobimetinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.379283606,1,cobimetinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.303190353,1,cobimetinib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.22381287,1,cobimetinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.187533868,1,cobimetinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.16217427,1,cobimetinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.123037766,1,cobimetinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.11758269,0.900118702,cobimetinib
PROGRAMMED_CELL_DEATH,-2.104374701,0.816163073,cobimetinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.32441559,0.006803593,macitentan
GPCR_LIGAND_BINDING,-2.123709708,0.032506054,macitentan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.020306541,0.05795653,macitentan
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.956335731,0.077107384,macitentan
SARS_COV_2_HOST_INTERACTIONS,1.860201711,0.737712386,macitentan
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.832612465,0.432355487,macitentan
G_ALPHA_S_SIGNALLING_EVENTS,-1.910991414,0.091168142,macitentan
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.75021372,0.439514721,macitentan
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.676929578,0.489318089,macitentan
COLLAGEN_FORMATION,-1.817087201,0.157490572,macitentan
MUSCLE_CONTRACTION,3.008024629,0,tolcapone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.51809429,0,tolcapone
RRNA_PROCESSING,-2.521000135,0,tolcapone
EUKARYOTIC_TRANSLATION_INITIATION,-2.544756583,0,tolcapone
SELENOAMINO_ACID_METABOLISM,-2.601399013,0,tolcapone
CELLULAR_RESPONSE_TO_STARVATION,-2.607927171,0,tolcapone
NONSENSE_MEDIATED_DECAY_NMD,-2.630372002,0,tolcapone
GPCR_LIGAND_BINDING,2.615873004,0,tolcapone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.665093068,0,tolcapone
STRIATED_MUSCLE_CONTRACTION,2.667263767,0,tolcapone
CELLULAR_RESPONSE_TO_STARVATION,3.690137424,0,resiquimod
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.579078806,0,resiquimod
INFLUENZA_INFECTION,3.138391934,0,resiquimod
SELENOAMINO_ACID_METABOLISM,3.032425421,0,resiquimod
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.771703591,0,resiquimod
NONSENSE_MEDIATED_DECAY_NMD,2.756375863,0,resiquimod
EUKARYOTIC_TRANSLATION_ELONGATION,2.370016611,0.001307275,resiquimod
RRNA_PROCESSING,2.220225982,0.006005294,resiquimod
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.190983233,0.006609001,resiquimod
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.109414145,0.065424997,resiquimod
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.130502817,0.036843006,pranlukast
GASTRULATION,-2.02936019,0.050322155,pranlukast
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.029045666,0.033548103,pranlukast
ADAPTIVE_IMMUNE_SYSTEM,1.990446229,0.189416615,pranlukast
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.970657112,0.045829105,pranlukast
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.896883769,0.158581352,pranlukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.787580111,0.188437718,pranlukast
METABOLISM_OF_STEROIDS,1.723838853,0.214745581,pranlukast
GPCR_LIGAND_BINDING,-1.794315038,0.198413067,pranlukast
ECM_PROTEOGLYCANS,-1.793007501,0.167740516,pranlukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.078228879,0,doxorubicin
METABOLISM_OF_RNA,-2.895873052,0,doxorubicin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.557759402,0.001301836,doxorubicin
RRNA_PROCESSING,-2.469300678,0.001081176,doxorubicin
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.41087505,0.001081176,doxorubicin
TRANSLATION,-2.295568876,0.003513822,doxorubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.230395518,0.015911325,doxorubicin
GPCR_LIGAND_BINDING,2.205589819,0.015405055,doxorubicin
DNA_REPLICATION,-2.125591688,0.018163754,doxorubicin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.17109281,0.015795606,doxorubicin
GPCR_LIGAND_BINDING,3.739166902,0,remoxipride
SARS_COV_1_INFECTION,-2.737431875,0,remoxipride
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.742754653,0,remoxipride
VIRAL_INFECTION_PATHWAYS,-2.830873488,0,remoxipride
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.923121983,0,remoxipride
SARS_COV_1_HOST_INTERACTIONS,-2.950749764,0,remoxipride
METABOLISM_OF_RNA,-2.999404366,0,remoxipride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.048287015,0,remoxipride
TRANSLATION,-3.145069688,0,remoxipride
SIGNALING_BY_ROBO_RECEPTORS,-3.177491129,0,remoxipride
SIGNALING_BY_GPCR,3.208977005,0,pregnenolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.142419657,0,pregnenolone
GPCR_LIGAND_BINDING,3.108149686,0,pregnenolone
G_ALPHA_Q_SIGNALLING_EVENTS,2.696692604,0,pregnenolone
MUSCLE_CONTRACTION,2.521252685,0.000138646,pregnenolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.42662635,0.000808771,pregnenolone
CARDIAC_CONDUCTION,2.322127193,0.001980663,pregnenolone
NEURONAL_SYSTEM,2.122161367,0.0086654,pregnenolone
G_ALPHA_I_SIGNALLING_EVENTS,2.121510791,0.007779604,pregnenolone
SENSORY_PERCEPTION,2.059572529,0.010814419,pregnenolone
GPCR_LIGAND_BINDING,-3.022999184,0,nepafenac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.787811477,0,nepafenac
SIGNALING_BY_GPCR,-2.736757968,0,nepafenac
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.533274314,0,nepafenac
G_ALPHA_I_SIGNALLING_EVENTS,-2.235529434,0.003950429,nepafenac
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.118829286,0.007955725,nepafenac
G_ALPHA_Q_SIGNALLING_EVENTS,-2.083035223,0.009288211,nepafenac
NEURONAL_SYSTEM,-2.057048869,0.010596203,nepafenac
RESPIRATORY_ELECTRON_TRANSPORT,1.930757223,0.447207694,nepafenac
INTERFERON_ALPHA_BETA_SIGNALING,1.84220832,0.369274106,nepafenac
METABOLISM_OF_RNA,1.689577324,0.13568167,homosalate
VIRAL_INFECTION_PATHWAYS,1.668522611,0.074363992,homosalate
SIGNALING_BY_INTERLEUKINS,1.308242719,0.357469015,homosalate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.661866828,0.454647256,homosalate
SARS_COV_INFECTIONS,1.231175661,0.367253751,homosalate
TRANSLATION,1.204166184,0.32198304,homosalate
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.03405946,0.519243314,homosalate
VESICLE_MEDIATED_TRANSPORT,0.815285106,0.836082378,homosalate
RHO_GTPASE_EFFECTORS,0.801420251,0.752772342,homosalate
NEURONAL_SYSTEM,-1.514332189,1,homosalate
SELENOAMINO_ACID_METABOLISM,2.479897129,0.001262253,tolbutamide
INFLUENZA_INFECTION,2.42864748,0.003155634,tolbutamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.441119869,0.003536428,tolbutamide
EUKARYOTIC_TRANSLATION_INITIATION,2.393825499,0.00378676,tolbutamide
EUKARYOTIC_TRANSLATION_ELONGATION,2.39143573,0.003155634,tolbutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.318916666,0.003281859,tolbutamide
NONSENSE_MEDIATED_DECAY_NMD,2.31648448,0.002945258,tolbutamide
SIGNALING_BY_ROBO_RECEPTORS,2.313336435,0.002524507,tolbutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.299240654,0.002682289,tolbutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.262492512,0.00350626,tolbutamide
TCR_SIGNALING,1.938444445,0.627551459,tropisetron
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.868742955,0.531043948,tropisetron
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.854520999,0.397482942,tropisetron
GPCR_LIGAND_BINDING,1.745607441,0.621740798,tropisetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.742448039,0.508306576,tropisetron
SIGNALING_BY_VEGF,1.724520206,0.476137406,tropisetron
TRANSLATION,-1.353590761,1,tropisetron
COLLAGEN_DEGRADATION,1.667496926,0.572981767,tropisetron
ADAPTIVE_IMMUNE_SYSTEM,1.662403276,0.51298037,tropisetron
O_LINKED_GLYCOSYLATION,1.645013686,0.503478394,tropisetron
EUKARYOTIC_TRANSLATION_ELONGATION,-2.72727103,0,camostat-mesilate
NONSENSE_MEDIATED_DECAY_NMD,-2.712883292,0,camostat-mesilate
SELENOAMINO_ACID_METABOLISM,-2.709812278,0,camostat-mesilate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.643481247,0,camostat-mesilate
EUKARYOTIC_TRANSLATION_INITIATION,-2.585655188,0,camostat-mesilate
CELLULAR_RESPONSE_TO_STARVATION,-2.555847107,0,camostat-mesilate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.516419321,0,camostat-mesilate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.451103736,0,camostat-mesilate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.445024892,0,camostat-mesilate
INFLUENZA_INFECTION,-2.395837694,0,camostat-mesilate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.520575869,0,ciclopirox
EUKARYOTIC_TRANSLATION_ELONGATION,3.421773706,0,ciclopirox
NONSENSE_MEDIATED_DECAY_NMD,3.344120482,0,ciclopirox
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.309350927,0,ciclopirox
EUKARYOTIC_TRANSLATION_INITIATION,3.299333225,0,ciclopirox
INFLUENZA_INFECTION,3.298779715,0,ciclopirox
TRANSLATION,3.204771407,0,ciclopirox
SELENOAMINO_ACID_METABOLISM,3.073646023,0,ciclopirox
CELLULAR_RESPONSE_TO_STARVATION,3.009501235,0,ciclopirox
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.799658706,0,ciclopirox
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.015308739,0.137104921,felbinac
COLLAGEN_FORMATION,-2.001710425,0.082533555,felbinac
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.970391158,0.072160485,felbinac
ADAPTIVE_IMMUNE_SYSTEM,1.840739026,0.441943985,felbinac
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.921113815,0.085239573,felbinac
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.696599779,0.538574824,felbinac
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.660704543,0.440996624,felbinac
TCR_SIGNALING,1.642551493,0.366984033,felbinac
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.476180683,0.653963415,felbinac
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.475751956,0.545680033,felbinac
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.498498423,0.054174925,alosetron
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.440502086,0.034380241,alosetron
GPCR_LIGAND_BINDING,2.207890062,0.028388846,alosetron
INNATE_IMMUNE_SYSTEM,-2.32682269,0.047923972,alosetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.090454692,0.036351572,alosetron
NEUTROPHIL_DEGRANULATION,-2.164644798,0.095327032,alosetron
SIGNALING_BY_GPCR,2.056836226,0.034851348,alosetron
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.068658105,0.12876963,alosetron
NCAM1_INTERACTIONS,2.004884689,0.04067914,alosetron
HEMOSTASIS,-1.955444685,0.182666734,alosetron
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.754869091,0,orlistat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.282237876,0.006104374,orlistat
MUSCLE_CONTRACTION,-2.197678373,0.010358938,orlistat
GPCR_LIGAND_BINDING,-2.1808984,0.010127712,orlistat
CELLULAR_RESPONSE_TO_STARVATION,2.097143105,0.187432785,orlistat
SELENOAMINO_ACID_METABOLISM,2.031891816,0.168228607,orlistat
O_LINKED_GLYCOSYLATION,-2.061584104,0.025527383,orlistat
MRNA_SPLICING,1.9675053,0.177702668,orlistat
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.899044476,0.23198648,orlistat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.897351503,0.187125519,orlistat
GPCR_LIGAND_BINDING,-2.117278837,0.032422829,zonisamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.773797769,0.40202202,zonisamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.943232023,0.122035927,zonisamide
HIV_LIFE_CYCLE,1.739088323,0.253811137,zonisamide
MITF_M_DEPENDENT_GENE_EXPRESSION,1.698894861,0.209347872,zonisamide
HIV_INFECTION,1.645065572,0.208421554,zonisamide
SIGNALING_BY_GPCR,-1.877448608,0.151906959,zonisamide
FATTY_ACID_METABOLISM,1.631388871,0.180076223,zonisamide
NUCLEOTIDE_EXCISION_REPAIR,1.524113702,0.263074317,zonisamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.772516472,0.282799122,zonisamide
STRIATED_MUSCLE_CONTRACTION,2.833397656,0,trimipramine
MUSCLE_CONTRACTION,2.69512978,0,trimipramine
TRANSLATION,-2.688544251,0,trimipramine
EUKARYOTIC_TRANSLATION_INITIATION,-2.646803933,0,trimipramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.561853574,0.000912205,trimipramine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.554015394,0.000684153,trimipramine
METABOLISM_OF_RNA,-2.544972944,0.000547323,trimipramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.460195592,0.000684153,trimipramine
RRNA_PROCESSING,-2.455584802,0.000586417,trimipramine
NEURONAL_SYSTEM,2.514506519,0.000389113,trimipramine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.274523476,0,propranolol
SARS_COV_1_HOST_INTERACTIONS,-2.627482418,0,propranolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.63355599,0,propranolol
SARS_COV_1_INFECTION,-2.645206487,0,propranolol
CELLULAR_RESPONSES_TO_STIMULI,-2.671348295,0,propranolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.694941711,0,propranolol
METABOLISM_OF_RNA,-2.710197625,0,propranolol
TRANSLATION,-2.776040936,0,propranolol
EXTRACELLULAR_MATRIX_ORGANIZATION,2.803724985,0,propranolol
MUSCLE_CONTRACTION,2.834013856,0,propranolol
METABOLISM_OF_RNA,-2.480274648,0.001022347,pralatrexate
RRNA_PROCESSING,-2.462986203,0.000511174,pralatrexate
INTERFERON_ALPHA_BETA_SIGNALING,2.360199959,0.012874335,pralatrexate
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.211267108,0.007497213,pralatrexate
CELLULAR_RESPONSE_TO_STARVATION,2.255522428,0.014253728,pralatrexate
GPCR_LIGAND_BINDING,-2.174970547,0.009967885,pralatrexate
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.921793663,0.105301759,pralatrexate
GASTRULATION,-1.917720306,0.091500072,pralatrexate
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.836487213,0.156637746,pralatrexate
RESPIRATORY_ELECTRON_TRANSPORT,1.83381844,0.1193175,pralatrexate
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-2.530499301,0.412405991,lacidipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.476504628,0.391344878,lacidipine
DRUG_ADME,1.555401175,0.759169364,lacidipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.474563311,0.579153182,lacidipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.308748341,0.570445975,lacidipine
GPCR_LIGAND_BINDING,-2.234076275,0.496650446,lacidipine
G_ALPHA_I_SIGNALLING_EVENTS,-2.233618478,0.397320356,lacidipine
SIGNALING_BY_GPCR,-2.126934909,0.387916324,lacidipine
CILIUM_ASSEMBLY,-1.948259522,0.418003629,lacidipine
RESPIRATORY_ELECTRON_TRANSPORT,1.312528447,0.829288026,lacidipine
CELLULAR_RESPONSE_TO_STARVATION,2.932835582,0,etoricoxib
INFLUENZA_INFECTION,2.63795238,0,etoricoxib
TRANSLATION,2.620905352,0,etoricoxib
RRNA_PROCESSING,2.491014442,0.001505055,etoricoxib
EUKARYOTIC_TRANSLATION_INITIATION,2.338479284,0.002809435,etoricoxib
GPCR_LIGAND_BINDING,-2.20059394,0.011972395,etoricoxib
SIGNALING_BY_GPCR,-2.169515398,0.009834467,etoricoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.145961688,0.00769654,etoricoxib
ECM_PROTEOGLYCANS,-2.132391232,0.007268954,etoricoxib
METABOLISM_OF_RNA,2.141152896,0.010368155,etoricoxib
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.183258548,0.036443043,dexbrompheniramine
GPCR_LIGAND_BINDING,2.048677127,0.045351343,dexbrompheniramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.950071923,0.085573665,dexbrompheniramine
SIGNALING_BY_GPCR,1.916678769,0.091107608,dexbrompheniramine
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.232800353,1,dexbrompheniramine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.19841965,1,dexbrompheniramine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.737159115,1,dexbrompheniramine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.615781239,1,dexbrompheniramine
NEUTROPHIL_DEGRANULATION,-1.535468581,1,dexbrompheniramine
SENSORY_PERCEPTION,1.72325546,0.332036617,dexbrompheniramine
STRIATED_MUSCLE_CONTRACTION,2.313202039,0.020527322,BRD-K71860425
MUSCLE_CONTRACTION,2.070480323,0.052601262,BRD-K71860425
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.87925279,0.103064261,BRD-K71860425
G_ALPHA_Q_SIGNALLING_EVENTS,1.791638349,0.133748331,BRD-K71860425
MAPK1_MAPK3_SIGNALING,1.586670104,0.341523316,BRD-K71860425
MAPK_FAMILY_SIGNALING_CASCADES,1.473949107,0.50826504,BRD-K71860425
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.436766416,1,BRD-K71860425
SIGNALING_BY_INSULIN_RECEPTOR,1.388694634,0.664572042,BRD-K71860425
DNA_REPLICATION,1.375784602,0.618064829,BRD-K71860425
PI3K_AKT_SIGNALING_IN_CANCER,1.362994417,0.583888263,BRD-K71860425
NONSENSE_MEDIATED_DECAY_NMD,-2.457984862,0,BRD-K44408410
EUKARYOTIC_TRANSLATION_ELONGATION,-2.454635913,0,BRD-K44408410
SELENOAMINO_ACID_METABOLISM,-2.419996307,0,BRD-K44408410
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.381939016,0.000255999,BRD-K44408410
EUKARYOTIC_TRANSLATION_INITIATION,-2.349766452,0.000409598,BRD-K44408410
CELLULAR_RESPONSE_TO_STARVATION,-2.311419579,0.000511998,BRD-K44408410
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.268215612,0.000731425,BRD-K44408410
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.213706576,0.001151995,BRD-K44408410
RRNA_PROCESSING,-2.193741811,0.001137773,BRD-K44408410
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.113114168,0.010106051,BRD-K44408410
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-4.295641794,0,VX-702
HIV_LIFE_CYCLE,-2.567867263,0,VX-702
SARS_COV_2_INFECTION,-2.612491161,0,VX-702
G_ALPHA_Q_SIGNALLING_EVENTS,2.746698791,0,VX-702
SARS_COV_2_HOST_INTERACTIONS,-2.765074263,0,VX-702
SARS_COV_1_INFECTION,-2.858379857,0,VX-702
SARS_COV_1_HOST_INTERACTIONS,-2.938139433,0,VX-702
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.053108218,0,VX-702
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.088978217,0,VX-702
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.165677399,0,VX-702
METABOLISM_OF_RNA,-4.254926184,0,VX-745
RRNA_PROCESSING,-3.753174822,0,VX-745
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.378406114,0,VX-745
TRANSLATION,-3.226175745,0,VX-745
CELLULAR_RESPONSE_TO_STARVATION,-3.146678513,0,VX-745
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-3.09935303,0,VX-745
MRNA_SPLICING,-3.017586569,0,VX-745
GPCR_LIGAND_BINDING,2.995595145,0,VX-745
SIGNALING_BY_GPCR,2.985330495,0,VX-745
MITOTIC_METAPHASE_AND_ANAPHASE,-2.983635962,0,VX-745
SELENOAMINO_ACID_METABOLISM,2.415895141,0.006198738,mepyramine
INFLUENZA_INFECTION,2.358548117,0.005423895,mepyramine
MUSCLE_CONTRACTION,2.358373667,0.00361593,mepyramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.314048468,0.003099369,mepyramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.277371402,0.003719243,mepyramine
EUKARYOTIC_TRANSLATION_ELONGATION,2.211134583,0.004907334,mepyramine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.10911163,0.036280288,mepyramine
CELLULAR_RESPONSE_TO_STARVATION,2.059095018,0.010405024,mepyramine
EUKARYOTIC_TRANSLATION_INITIATION,1.946614021,0.02111445,mepyramine
ECM_PROTEOGLYCANS,-2.020829488,0.05162964,mepyramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.580005646,0,pelitinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.54489009,0,pelitinib
INFLUENZA_INFECTION,2.437992352,0.000394554,pelitinib
EUKARYOTIC_TRANSLATION_INITIATION,2.39930513,0.000295916,pelitinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.348488848,0.00094693,pelitinib
CELLULAR_RESPONSE_TO_STARVATION,2.299085481,0.001775494,pelitinib
SELENOAMINO_ACID_METABOLISM,2.284518783,0.00219823,pelitinib
NONSENSE_MEDIATED_DECAY_NMD,2.26253491,0.003550987,pelitinib
SARS_COV_1_HOST_INTERACTIONS,2.250080093,0.003419469,pelitinib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.230705672,0.003550987,pelitinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.647268085,0,SU-11652
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.626449025,0,SU-11652
SELENOAMINO_ACID_METABOLISM,-2.620436305,0,SU-11652
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.588124668,0,SU-11652
EUKARYOTIC_TRANSLATION_INITIATION,-2.573970217,0,SU-11652
NONSENSE_MEDIATED_DECAY_NMD,-2.571603107,0,SU-11652
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.544726405,0,SU-11652
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.474128872,0,SU-11652
SIGNALING_BY_ROBO_RECEPTORS,-2.455376495,0,SU-11652
CELLULAR_RESPONSE_TO_STARVATION,-2.407336812,0,SU-11652
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.989230657,0.209572275,alvimopan
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.617066831,1,alvimopan
CELLULAR_RESPONSE_TO_STARVATION,1.523942579,0.998739869,alvimopan
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.517480398,0.689224924,alvimopan
POTASSIUM_CHANNELS,1.490560716,0.585574362,alvimopan
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.403018376,0.717220838,alvimopan
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.389966776,0.64160724,alvimopan
SIGNALING_BY_ALK_IN_CANCER,1.373259072,0.593051277,alvimopan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.339866302,0.59788928,alvimopan
SIGNALING_BY_NTRKS,1.321528546,0.576885503,alvimopan
SIGNALING_BY_GPCR,2.646925644,0,bromhexine
GPCR_LIGAND_BINDING,2.642862641,0,bromhexine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.653509542,0.004351692,bromhexine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.343014086,0.001771112,bromhexine
SENSORY_PERCEPTION,2.216592197,0.005882623,bromhexine
NEUTROPHIL_DEGRANULATION,-2.303141914,0.033362969,bromhexine
G_ALPHA_Q_SIGNALLING_EVENTS,2.174430861,0.007135052,bromhexine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.265314094,0.031912405,bromhexine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.201352723,0.035538814,bromhexine
PROTEIN_LOCALIZATION,-2.18010439,0.03249263,bromhexine
PROTEIN_LOCALIZATION,2.281153928,0.03740374,cyclizine
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,2.154638903,0.03190319,cyclizine
FATTY_ACID_METABOLISM,2.149419543,0.022735607,cyclizine
GPCR_LIGAND_BINDING,-2.136519977,0.02928148,cyclizine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.131205001,0.015827827,cyclizine
TRANSLATION,2.018267488,0.043454345,cyclizine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.874032324,0.090209021,cyclizine
SIGNALING_BY_GPCR,-1.950934448,0.074126991,cyclizine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.942305152,0.060937135,cyclizine
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.75548449,0.159515952,cyclizine
METABOLISM_OF_NUCLEOTIDES,2.191457305,0.027651343,SN-38
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.021632886,0.115043186,SN-38
GPCR_LIGAND_BINDING,-2.016141835,0.06235534,SN-38
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.72926414,0.187414656,SN-38
NUCLEOTIDE_EXCISION_REPAIR,1.686117648,0.171540737,SN-38
EUKARYOTIC_TRANSLATION_ELONGATION,-1.917422057,0.129222178,SN-38
EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,-1.907135265,0.10827594,SN-38
NONSENSE_MEDIATED_DECAY_NMD,-1.86724815,0.135538275,SN-38
G_ALPHA_Q_SIGNALLING_EVENTS,-1.851199445,0.130511178,SN-38
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.840118065,0.123191503,SN-38
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.598987172,0.001626193,thiomersal
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.328486375,0.000888979,thiomersal
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.303621956,0.000888979,thiomersal
CELLULAR_RESPONSE_TO_STARVATION,2.361153362,0.009757155,thiomersal
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.180715378,0.022224631,thiomersal
NONSENSE_MEDIATED_DECAY_NMD,1.720243541,0.234578274,thiomersal
SELENOAMINO_ACID_METABOLISM,1.688279554,0.22018647,thiomersal
EUKARYOTIC_TRANSLATION_ELONGATION,1.670495088,0.205713356,thiomersal
SIGNALING_BY_NTRKS,1.647855148,0.200486309,thiomersal
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.624740448,0.196362749,thiomersal
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.436232452,0.000942305,diosmin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.426595104,0.000471152,diosmin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.233872287,0.003455118,diosmin
INFLUENZA_INFECTION,1.865818366,0.390903547,diosmin
CELLULAR_RESPONSE_TO_STARVATION,1.840894693,0.228349597,diosmin
SELENOAMINO_ACID_METABOLISM,1.810007208,0.181045537,diosmin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.784970438,0.157716035,diosmin
FATTY_ACID_METABOLISM,1.750154618,0.151975042,diosmin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.654691713,0.213513323,diosmin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.559459817,0.305387636,diosmin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.715905473,0,razoxane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.847103775,0,razoxane
SIGNALING_BY_GPCR,2.92509518,0,razoxane
GPCR_LIGAND_BINDING,3.180520551,0,razoxane
NEURONAL_SYSTEM,2.508455655,0.000494843,razoxane
MUSCLE_CONTRACTION,2.503989098,0.000527832,razoxane
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.305470437,0.003298953,razoxane
EUKARYOTIC_TRANSLATION_INITIATION,-3.488260739,0.034247146,razoxane
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.48086325,0.027139248,razoxane
STRIATED_MUSCLE_CONTRACTION,2.166144071,0.009519836,razoxane
TCR_SIGNALING,2.772715081,0,BRD-K97440753
ADAPTIVE_IMMUNE_SYSTEM,2.63913782,0,BRD-K97440753
DOWNSTREAM_TCR_SIGNALING,2.26250281,0.012893056,BRD-K97440753
TOLL_LIKE_RECEPTOR_CASCADES,2.207491413,0.015823296,BRD-K97440753
INNATE_IMMUNE_SYSTEM,2.182231011,0.016174925,BRD-K97440753
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.114530822,0.018753536,BRD-K97440753
MRNA_SPLICING,2.103067896,0.018586094,BRD-K97440753
MYD88_INDEPENDENT_TLR4_CASCADE,2.091477122,0.018020976,BRD-K97440753
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.051036177,0.019925633,BRD-K97440753
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.037861848,0.021097729,BRD-K97440753
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.063820372,0.165154743,BRD-K28761384
G_ALPHA_Q_SIGNALLING_EVENTS,1.978650652,0.14630556,BRD-K28761384
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.924497479,0.129849925,BRD-K28761384
KEAP1_NFE2L2_PATHWAY,1.862271135,0.140022499,BRD-K28761384
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.607463589,0.481102946,BRD-K28761384
DNA_REPLICATION,1.495145885,0.701010077,BRD-K28761384
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.482807573,0.638307694,BRD-K28761384
CELL_CELL_COMMUNICATION,-2.847491064,1,BRD-K28761384
MITOTIC_SPINDLE_CHECKPOINT,1.472601726,0.589485746,BRD-K28761384
SIGNALING_BY_INSULIN_RECEPTOR,1.459637303,0.56208462,BRD-K28761384
CELLULAR_RESPONSE_TO_STARVATION,2.639131085,0.00226068,ketoprofen
SELENOAMINO_ACID_METABOLISM,2.575097224,0.00226068,ketoprofen
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.435557229,0.00150712,ketoprofen
INFLUENZA_INFECTION,2.429291966,0.00113034,ketoprofen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.230803123,0.00452136,ketoprofen
FATTY_ACID_METABOLISM,2.037342954,0.013564079,ketoprofen
EUKARYOTIC_TRANSLATION_INITIATION,1.976151459,0.022283843,ketoprofen
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.901851422,0.031932102,ketoprofen
EUKARYOTIC_TRANSLATION_ELONGATION,1.897701517,0.02913765,ketoprofen
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.01432643,0.122907208,ketoprofen
PEROXISOMAL_PROTEIN_IMPORT,-2.237121297,0.012259361,doconexent
SELENOAMINO_ACID_METABOLISM,2.01655448,0.138338322,doconexent
TCR_SIGNALING,-2.12674668,0.022475495,doconexent
NONSENSE_MEDIATED_DECAY_NMD,1.951400502,0.101933501,doconexent
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.930971767,0.080090608,doconexent
DNA_REPLICATION_PRE_INITIATION,1.925442387,0.062798317,doconexent
RRNA_PROCESSING,1.90498833,0.056063425,doconexent
EUKARYOTIC_TRANSLATION_ELONGATION,1.886454913,0.052180244,doconexent
TRANSLATION,1.873824701,0.047326268,doconexent
EUKARYOTIC_TRANSLATION_INITIATION,1.812179305,0.059157835,doconexent
GPCR_LIGAND_BINDING,2.844599476,0,OSI-930
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.775836368,0,OSI-930
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.695078329,0,OSI-930
SIGNALING_BY_GPCR,2.615156141,0,OSI-930
METABOLISM_OF_RNA,-2.587460079,0.006834246,OSI-930
G_ALPHA_I_SIGNALLING_EVENTS,2.261796968,0.002551014,OSI-930
RRNA_PROCESSING,-2.405864258,0.012814211,OSI-930
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-2.265332249,0.023350341,OSI-930
NUCLEOTIDE_EXCISION_REPAIR,-2.117525181,0.038015494,OSI-930
CELL_CYCLE_CHECKPOINTS,-2.10949089,0.032120957,OSI-930
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.142969602,0.020084732,baricitinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.094648614,0.0593908,baricitinib
MRNA_SPLICING,2.045450175,0.017887965,baricitinib
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-2.083158251,0.033791317,baricitinib
EUKARYOTIC_TRANSLATION_INITIATION,-2.069584555,0.025940809,baricitinib
GPCR_LIGAND_BINDING,-2.008378873,0.04403111,baricitinib
SELENOAMINO_ACID_METABOLISM,-1.997751336,0.039525601,baricitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.964304215,0.051028302,baricitinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.944673276,0.054709751,baricitinib
NONSENSE_MEDIATED_DECAY_NMD,-1.922609442,0.060030787,baricitinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.870119154,0.327932647,cilastatin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.992321057,0.444297521,cilastatin
NEDDYLATION,-1.754525985,0.270832554,cilastatin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.66835768,0.271356408,cilastatin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.54144197,0.366435921,cilastatin
RESPIRATORY_ELECTRON_TRANSPORT,1.793571348,0.962479339,cilastatin
PI3K_AKT_SIGNALING_IN_CANCER,-1.420614707,0.485088868,cilastatin
BIOLOGICAL_OXIDATIONS,1.706572687,1,cilastatin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.671697102,1,cilastatin
NERVOUS_SYSTEM_DEVELOPMENT,-1.27652922,0.733395697,cilastatin
MUSCLE_CONTRACTION,2.37199361,0.013448853,L-2167
STRIATED_MUSCLE_CONTRACTION,2.038927125,0.084535649,L-2167
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.91715021,0.134488532,L-2167
EXTRACELLULAR_MATRIX_ORGANIZATION,1.834480595,0.171152667,L-2167
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.200966869,1,L-2167
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.714549133,0.279351893,L-2167
PI3K_AKT_SIGNALING_IN_CANCER,1.662557543,0.313486364,L-2167
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.64625286,0.292489685,L-2167
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.990848757,1,L-2167
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.003323548,1,L-2167
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.536637454,0,EX-527
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.206526242,0.004808776,EX-527
INFLUENZA_INFECTION,2.146836922,0.082955525,EX-527
CELLULAR_RESPONSE_TO_STARVATION,2.094911009,0.05159429,EX-527
COLLAGEN_FORMATION,-2.047404242,0.025938248,EX-527
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.94582369,0.076885608,EX-527
MITF_M_DEPENDENT_GENE_EXPRESSION,1.850349261,0.098130316,EX-527
SIGNALING_BY_GPCR,-1.984713538,0.045246214,EX-527
EUKARYOTIC_TRANSLATION_INITIATION,1.829962309,0.089025441,EX-527
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.690576009,0.165911049,EX-527
INFLUENZA_INFECTION,2.238066801,0.017021821,efaproxiral
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.131861745,0.025532732,efaproxiral
MRNA_SPLICING,1.989997084,0.042959834,efaproxiral
G_ALPHA_Q_SIGNALLING_EVENTS,-2.037908618,0.149309427,efaproxiral
CELLULAR_RESPONSE_TO_STARVATION,1.827508574,0.087540795,efaproxiral
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.817687999,0.074896013,efaproxiral
PEPTIDE_HORMONE_METABOLISM,1.741767231,0.089972484,efaproxiral
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.688876348,0.102478311,efaproxiral
HEDGEHOG_ON_STATE,1.671085805,0.101826966,efaproxiral
EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,-1.938478889,0.205185961,efaproxiral
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.543525195,1,PF-02545920
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.421548351,0.453218884,PF-02545920
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.431272778,1,PF-02545920
GPCR_LIGAND_BINDING,-2.417896403,0.831162338,PF-02545920
EUKARYOTIC_TRANSLATION_ELONGATION,-2.347810054,0.712647309,PF-02545920
NONSENSE_MEDIATED_DECAY_NMD,-2.274824761,0.625551738,PF-02545920
G_ALPHA_I_SIGNALLING_EVENTS,-2.269710759,0.524234364,PF-02545920
SELENOAMINO_ACID_METABOLISM,-2.234610775,0.464915058,PF-02545920
EUKARYOTIC_TRANSLATION_INITIATION,-2.216262828,0.41393753,PF-02545920
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.212895714,0.369213245,PF-02545920
MUSCLE_CONTRACTION,2.248911091,0.030960997,carprofen
MITOCHONDRIAL_TRANSLATION,2.028156879,0.03243533,carprofen
CELL_JUNCTION_ORGANIZATION,1.83909494,0.050127329,carprofen
CELLULAR_RESPONSE_TO_STARVATION,-2.000734582,0.141189873,carprofen
EUKARYOTIC_TRANSLATION_INITIATION,-1.996145668,0.072996125,carprofen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.973922482,0.065312322,carprofen
G2_M_CHECKPOINTS,1.724488419,0.074085243,carprofen
EUKARYOTIC_TRANSLATION_ELONGATION,-1.937115958,0.070114699,carprofen
NONSENSE_MEDIATED_DECAY_NMD,-1.916059091,0.070690984,carprofen
DNA_REPLICATION,1.638446008,0.096421391,carprofen
GPCR_LIGAND_BINDING,2.911429104,0,iniparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.850265145,0,iniparib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.558679281,0,iniparib
SIGNALING_BY_GPCR,2.516467392,0,iniparib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.298995978,0.000130622,iniparib
NEURONAL_SYSTEM,2.203210787,0.001850485,iniparib
ISG15_ANTIVIRAL_MECHANISM,-2.271258734,0.041495107,iniparib
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.160872972,0.002519148,iniparib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.158051098,0.002204255,iniparib
CELL_CYCLE,-2.223886844,0.027663405,iniparib
GPCR_LIGAND_BINDING,3.357628326,0,alectinib
SIGNALING_BY_GPCR,3.047428232,0,alectinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.039505237,0,alectinib
METABOLISM_OF_RNA,-2.952928542,0,alectinib
TRANSLATION,-2.889922137,0,alectinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.688332543,0,alectinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.597952612,0,alectinib
RRNA_PROCESSING,-2.698458244,0.000505399,alectinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.56394936,0.000379049,alectinib
SELENOAMINO_ACID_METABOLISM,-2.379806768,0.002729156,alectinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.596754662,0,pentamidine
GPCR_LIGAND_BINDING,-2.587546883,0.000376667,pentamidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.54523897,0.000251112,pentamidine
SIGNALING_BY_GPCR,-2.497644131,0.000188334,pentamidine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.112472745,0.005725345,pentamidine
VISUAL_PHOTOTRANSDUCTION,-2.098224941,0.005775567,pentamidine
SENSORY_PERCEPTION,-2.097608018,0.005058106,pentamidine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.16478564,0.106294344,pentamidine
G_ALPHA_I_SIGNALLING_EVENTS,-2.048366485,0.007062515,pentamidine
NEURONAL_SYSTEM,-1.986025998,0.011634839,pentamidine
EUKARYOTIC_TRANSLATION_INITIATION,3.034722291,0,candesartan
EUKARYOTIC_TRANSLATION_ELONGATION,2.975126044,0,candesartan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.953281353,0,candesartan
CELLULAR_RESPONSE_TO_STARVATION,2.907470922,0,candesartan
SELENOAMINO_ACID_METABOLISM,2.855108844,0,candesartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.849664681,0,candesartan
NONSENSE_MEDIATED_DECAY_NMD,2.799349342,0,candesartan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.785661275,0,candesartan
GPCR_LIGAND_BINDING,-2.727357794,0,candesartan
INFLUENZA_INFECTION,2.652866026,0,candesartan
CELLULAR_RESPONSE_TO_STARVATION,2.805820119,0,amrinone
GPCR_LIGAND_BINDING,-2.763507241,0,amrinone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.498151786,0.000540667,amrinone
SIGNALING_BY_GPCR,-2.471967359,0.000360445,amrinone
RESPIRATORY_ELECTRON_TRANSPORT,2.558045222,0.012402705,amrinone
INFLUENZA_INFECTION,2.55211197,0.00826847,amrinone
TOLL_LIKE_RECEPTOR_CASCADES,2.401933959,0.010335588,amrinone
MYD88_INDEPENDENT_TLR4_CASCADE,2.343151055,0.011024627,amrinone
ADAPTIVE_IMMUNE_SYSTEM,2.276474751,0.011483986,amrinone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.251828584,0.003379168,amrinone
GPCR_LIGAND_BINDING,-2.232855963,0.00995672,E-2012
MITF_M_DEPENDENT_GENE_EXPRESSION,2.215732668,0.040872942,E-2012
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.157767167,0.013275626,E-2012
SIGNALING_BY_GPCR,-2.100408236,0.016041382,E-2012
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.92415916,0.153874607,E-2012
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.992602171,0.03878972,E-2012
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.869241361,0.138647432,E-2012
NEUTROPHIL_DEGRANULATION,1.731765116,0.20376364,E-2012
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.707711939,0.187053819,E-2012
G_ALPHA_Q_SIGNALLING_EVENTS,-1.901428554,0.07318189,E-2012
GPCR_LIGAND_BINDING,-2.670098479,0,dexloxiglumide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.62903124,0,dexloxiglumide
SIGNALING_BY_GPCR,-2.422518101,0,dexloxiglumide
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,-2.163566006,0.005414679,dexloxiglumide
GASTRULATION,-2.127432387,0.007088307,dexloxiglumide
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-2.124222341,0.005906922,dexloxiglumide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.118152776,0.005484999,dexloxiglumide
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,-2.070964539,0.007506714,dexloxiglumide
INTERFERON_ALPHA_BETA_SIGNALING,2.085997207,0.074738796,dexloxiglumide
G_ALPHA_I_SIGNALLING_EVENTS,-2.058048335,0.007875896,dexloxiglumide
NONSENSE_MEDIATED_DECAY_NMD,-2.650452128,0,felodipine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.64629264,0,felodipine
SELENOAMINO_ACID_METABOLISM,-2.618852495,0,felodipine
EUKARYOTIC_TRANSLATION_INITIATION,-2.587846532,0,felodipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.566641942,0,felodipine
CELLULAR_RESPONSE_TO_STARVATION,-2.461393842,0,felodipine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.41801405,0,felodipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.393452135,0,felodipine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.373742213,0,felodipine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.32599847,0,felodipine
SIGNALING_BY_GPCR,2.972892951,0,nicorandil
GPCR_LIGAND_BINDING,2.901204346,0,nicorandil
G_ALPHA_I_SIGNALLING_EVENTS,2.522659368,0,nicorandil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.486655162,0,nicorandil
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.284502618,0.001938196,nicorandil
G_ALPHA_S_SIGNALLING_EVENTS,2.195317534,0.003445682,nicorandil
GLYCOSAMINOGLYCAN_METABOLISM,-3.699010844,0.077342522,nicorandil
G_ALPHA_Q_SIGNALLING_EVENTS,2.132180805,0.005353112,nicorandil
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.028572789,0.013809646,nicorandil
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.984959952,0.018376968,nicorandil
GPCR_LIGAND_BINDING,-2.429889239,0.000890906,pomalidomide
SIGNALING_BY_GPCR,-2.37426274,0.000890906,pomalidomide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.332757857,0.000890906,pomalidomide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.21334612,0.001559085,pomalidomide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.182179181,0.001781811,pomalidomide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.163177591,0.001930296,pomalidomide
METABOLISM_OF_NUCLEOTIDES,2.08518147,0.085059172,pomalidomide
PROTEIN_LOCALIZATION,2.077129704,0.044378698,pomalidomide
NEURONAL_SYSTEM,-2.019337666,0.009799962,pomalidomide
MITF_M_DEPENDENT_GENE_EXPRESSION,1.912803729,0.079511834,pomalidomide
SELENOAMINO_ACID_METABOLISM,-2.91415202,0,latanoprost
EUKARYOTIC_TRANSLATION_ELONGATION,-2.886979023,0,latanoprost
EUKARYOTIC_TRANSLATION_INITIATION,-2.739123694,0,latanoprost
NONSENSE_MEDIATED_DECAY_NMD,-2.689307096,0,latanoprost
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.681807752,0,latanoprost
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.64533856,0,latanoprost
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.603783806,0,latanoprost
CELLULAR_RESPONSE_TO_STARVATION,-2.593270154,0,latanoprost
RRNA_PROCESSING,-2.434591941,8.35E-05,latanoprost
INFLUENZA_INFECTION,-2.476847325,9.11E-05,latanoprost
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.488132013,0,roflumilast
EUKARYOTIC_TRANSLATION_ELONGATION,-2.271327329,0.014194114,roflumilast
NONSENSE_MEDIATED_DECAY_NMD,-2.252357489,0.008110922,roflumilast
SELENOAMINO_ACID_METABOLISM,-2.249233658,0.005407282,roflumilast
MRNA_SPLICING,2.194565179,0.008006804,roflumilast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.196109919,0.00963172,roflumilast
EUKARYOTIC_TRANSLATION_INITIATION,-2.169180271,0.009530334,roflumilast
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.149732605,0.010814563,roflumilast
CELLULAR_RESPONSE_TO_STARVATION,-2.126186943,0.011442194,roflumilast
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.092165131,0.01444758,roflumilast
RRNA_PROCESSING,-2.26612535,0.04978591,amsacrine
METABOLISM_OF_RNA,-2.219856482,0.041488258,amsacrine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.966320563,0.286591919,amsacrine
SIGNALING_BY_NOTCH,-1.826588638,0.470200261,amsacrine
CHROMATIN_ORGANIZATION,-1.782241598,0.473285285,amsacrine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-1.769339622,0.409776336,amsacrine
TRANSLATION,-1.753912858,0.36999016,amsacrine
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-1.74999453,0.326617453,amsacrine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.714408201,0.857489119,amsacrine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.693684859,0.652708014,amsacrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.548843442,1,ampalex
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.48847979,0.632783838,ampalex
MRNA_SPLICING,1.456461427,0.36347405,ampalex
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.420202347,0.993481357,ampalex
GPCR_LIGAND_BINDING,-2.397802458,0.691581444,ampalex
NONSENSE_MEDIATED_DECAY_NMD,-2.333058484,0.573936865,ampalex
EUKARYOTIC_TRANSLATION_ELONGATION,-2.287110907,0.4835218,ampalex
SELENOAMINO_ACID_METABOLISM,-2.280298852,0.40654937,ampalex
G_ALPHA_I_SIGNALLING_EVENTS,-2.259559234,0.358208009,ampalex
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.252700036,0.316272002,ampalex
DEUBIQUITINATION,-3.322423611,0.028866182,BRD-K81538844
SIGNALING_BY_GPCR,2.044855833,0.117935469,BRD-K81538844
SENSORY_PERCEPTION,1.83220418,0.280374889,BRD-K81538844
DEATH_RECEPTOR_SIGNALING,-3.094001918,0.437052041,BRD-K81538844
GPCR_LIGAND_BINDING,1.737518733,0.336004828,BRD-K81538844
INNATE_IMMUNE_SYSTEM,-2.62379318,0.723158004,BRD-K81538844
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.653369235,0.407489298,BRD-K81538844
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.650537512,0.330219314,BRD-K81538844
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.310122641,0.624231192,BRD-K81538844
G_ALPHA_I_SIGNALLING_EVENTS,1.519797989,0.563531275,BRD-K81538844
GPCR_LIGAND_BINDING,-2.6333521,0,resatorvid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.506115012,0.000512789,resatorvid
SIGNALING_BY_GPCR,-2.447726277,0.000341859,resatorvid
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.261110381,0.002820339,resatorvid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.25996517,0.002461387,resatorvid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.237165958,0.002393015,resatorvid
ECM_PROTEOGLYCANS,-2.185416739,0.004248823,resatorvid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.178403261,0.004102312,resatorvid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.111597727,0.007634858,resatorvid
O_LINKED_GLYCOSYLATION,-1.998656937,0.023178061,resatorvid
METABOLISM_OF_RNA,3.460693279,0,enzalutamide
INFLUENZA_INFECTION,3.193634769,0,enzalutamide
TRANSLATION,3.024013139,0,enzalutamide
CELLULAR_RESPONSE_TO_STARVATION,2.829918867,0,enzalutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.64208295,0.001834994,enzalutamide
MRNA_SPLICING,2.520658618,0.002293742,enzalutamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.337805985,0.004587485,enzalutamide
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.317000416,0.004014049,enzalutamide
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.23704092,0.004077764,enzalutamide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.167239121,0.006881227,enzalutamide
NEUTROPHIL_DEGRANULATION,2.620205138,0.002609314,zofenopril-calcium
GPCR_LIGAND_BINDING,-2.275540926,0.006762122,zofenopril-calcium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.199368378,0.007889143,zofenopril-calcium
SIGNALING_BY_GPCR,-2.14721141,0.00976751,zofenopril-calcium
G_ALPHA_I_SIGNALLING_EVENTS,-2.068136663,0.01897151,zofenopril-calcium
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.051800021,0.017882057,zofenopril-calcium
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.890628353,0.23092433,zofenopril-calcium
MITF_M_DEPENDENT_GENE_EXPRESSION,1.867037054,0.177433383,zofenopril-calcium
PROTEIN_LOCALIZATION,1.856551778,0.140250652,zofenopril-calcium
HIV_LIFE_CYCLE,1.782339157,0.161777497,zofenopril-calcium
COLLAGEN_FORMATION,-2.017653154,0.13510928,bazedoxifene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.017497444,0.067996173,bazedoxifene
ADAPTIVE_IMMUNE_SYSTEM,1.759883108,0.925274583,bazedoxifene
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.707599442,0.62166886,bazedoxifene
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.828978988,0.291117816,bazedoxifene
TCR_SIGNALING,1.653172335,0.560947716,bazedoxifene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.610396004,0.519021211,bazedoxifene
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.598322473,0.44066202,bazedoxifene
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.596756056,0.370832704,bazedoxifene
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.559617274,0.381675765,bazedoxifene
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.246952378,0.012031682,rimexolone
STRIATED_MUSCLE_CONTRACTION,2.094826792,0.04254059,rimexolone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.997861045,0.076487121,rimexolone
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.936559606,0.099691078,rimexolone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.857641664,1,rimexolone
TRANSCRIPTIONAL_REGULATION_BY_MECP2,1.859829924,0.157958795,rimexolone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.515678082,1,rimexolone
NEUTROPHIL_DEGRANULATION,-2.82895994,1,rimexolone
HEMOSTASIS,-2.602130401,1,rimexolone
DISEASES_OF_GLYCOSYLATION,-2.005393522,0.968211594,rimexolone
RHO_GTPASE_EFFECTORS,-1.929388111,0.260733826,loteprednol
OPIOID_SIGNALLING,-1.649767154,0.541482489,loteprednol
MITOTIC_METAPHASE_AND_ANAPHASE,-1.586000256,0.486126137,loteprednol
MITOTIC_PROMETAPHASE,-1.570517845,0.395698742,loteprednol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.842736664,1,loteprednol
TCR_SIGNALING,1.826373889,0.833379976,loteprednol
BIOLOGICAL_OXIDATIONS,1.815319406,0.594569441,loteprednol
SEPARATION_OF_SISTER_CHROMATIDS,-1.477577937,0.478408705,loteprednol
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.683849402,1,loteprednol
M_PHASE,-1.349780437,0.702142129,loteprednol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.657067534,0,hexachlorophene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.370413879,0.001809066,hexachlorophene
COLLAGEN_FORMATION,-2.23935163,0.003618132,hexachlorophene
ECM_PROTEOGLYCANS,-2.175369769,0.009497597,hexachlorophene
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.004010975,0.237407513,hexachlorophene
ADAPTIVE_IMMUNE_SYSTEM,1.708079159,0.7040143,hexachlorophene
GPCR_LIGAND_BINDING,-1.804339991,0.239882152,hexachlorophene
GASTRULATION,-1.790531984,0.220555297,hexachlorophene
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.672532477,0.566999858,hexachlorophene
S_PHASE,-1.786605075,0.194603815,hexachlorophene
EUKARYOTIC_TRANSLATION_ELONGATION,3.625503072,0,rivaroxaban
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.884606848,0,rivaroxaban
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.004243135,0,rivaroxaban
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.156456731,0,rivaroxaban
SIGNALING_BY_ROBO_RECEPTORS,3.16078711,0,rivaroxaban
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.207458501,0,rivaroxaban
NONSENSE_MEDIATED_DECAY_NMD,3.320838204,0,rivaroxaban
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.843026682,0,rivaroxaban
RRNA_PROCESSING,3.35978942,0,rivaroxaban
CELLULAR_RESPONSE_TO_STARVATION,3.412164437,0,rivaroxaban
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.16795496,0.017917259,armodafinil
EUKARYOTIC_TRANSLATION_INITIATION,-2.166179161,0.008958629,armodafinil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.091023178,0.062105034,armodafinil
MRNA_SPLICING,2.049238823,0.035955546,armodafinil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.106119685,0.012940242,armodafinil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.067022168,0.01542875,armodafinil
SELENOAMINO_ACID_METABOLISM,-1.991799419,0.029065775,armodafinil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.989049127,0.025382783,armodafinil
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.716101621,0.088254522,armodafinil
NONSENSE_MEDIATED_DECAY_NMD,-1.95415698,0.031852904,armodafinil
GPCR_LIGAND_BINDING,-3.415934082,0,ciprofloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.337404101,0,ciprofloxacin
SIGNALING_BY_GPCR,-3.061454393,0,ciprofloxacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.754857518,0,ciprofloxacin
G_ALPHA_I_SIGNALLING_EVENTS,-2.522850592,0,ciprofloxacin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.32719879,0.000374529,ciprofloxacin
NEURONAL_SYSTEM,-2.255753197,0.001498116,ciprofloxacin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.235096499,0.001404483,ciprofloxacin
CILIUM_ASSEMBLY,2.027491026,0.212515212,ciprofloxacin
INTERFERON_ALPHA_BETA_SIGNALING,1.974797342,0.168662866,ciprofloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.882965837,0,mitiglinide
INFLUENZA_INFECTION,-2.457460175,0,mitiglinide
RRNA_PROCESSING,-2.458293419,0,mitiglinide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.466731863,0,mitiglinide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.572814084,0,mitiglinide
CELLULAR_RESPONSE_TO_STARVATION,-2.670202863,0,mitiglinide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.515743692,0,mitiglinide
EUKARYOTIC_TRANSLATION_INITIATION,-2.758142954,0,mitiglinide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.79334241,0,mitiglinide
SELENOAMINO_ACID_METABOLISM,-2.83806996,0,mitiglinide
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.993128869,0.509725991,mazindol
UCH_PROTEINASES,-1.929819895,0.403859823,mazindol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.872534838,0.407345129,mazindol
PEROXISOMAL_PROTEIN_IMPORT,1.820831694,0.847501352,mazindol
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.755973556,0.658722819,mazindol
CILIUM_ASSEMBLY,1.711574319,0.806890526,mazindol
DEATH_RECEPTOR_SIGNALING,1.69187081,0.608274733,mazindol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.680088196,0.486331294,mazindol
METABOLISM_OF_RNA,-1.662699947,0.917768181,mazindol
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.650679905,0.81752207,mazindol
INFLUENZA_INFECTION,1.915325747,1,alvespimycin
EUKARYOTIC_TRANSLATION_INITIATION,1.888175095,0.631562435,alvespimycin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.855847014,0.524576448,alvespimycin
ION_CHANNEL_TRANSPORT,-1.565412101,1,alvespimycin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.820132547,0.509909015,alvespimycin
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.812788388,0.428841247,alvespimycin
CELLULAR_RESPONSE_TO_STARVATION,1.787012394,0.4248379,alvespimycin
NONSENSE_MEDIATED_DECAY_NMD,1.785198593,0.369027699,alvespimycin
EUKARYOTIC_TRANSLATION_ELONGATION,1.782638083,0.329111326,alvespimycin
SELENOAMINO_ACID_METABOLISM,1.757079956,0.346726626,alvespimycin
ECM_PROTEOGLYCANS,-2.351102006,0.002207226,carbimazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.002582674,0.118638405,carbimazole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.723716902,0.35095377,carbimazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.769836642,0.642302805,carbimazole
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.445128201,0.760399836,carbimazole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.407359241,0.601466226,carbimazole
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.670043957,1,carbimazole
METABOLISM_OF_STEROIDS,1.340241281,0.615688379,carbimazole
ADAPTIVE_IMMUNE_SYSTEM,1.333506665,0.507439651,carbimazole
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,-1.624005138,1,carbimazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.388453942,0,temazepam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.071267455,0.024665956,temazepam
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.900426222,0.26912214,temazepam
INTERLEUKIN_17_SIGNALING,1.833942109,0.201510173,temazepam
METABOLISM_OF_STEROIDS,1.827318588,0.138759198,temazepam
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.720552824,0.190904375,temazepam
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.686302418,0.181624301,temazepam
GASTRULATION,-1.809646951,0.300335166,temazepam
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.605395622,0.235095202,temazepam
ADAPTIVE_IMMUNE_SYSTEM,1.600485926,0.204729791,temazepam
GPCR_LIGAND_BINDING,2.560072852,0.000726853,nitazoxanide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.38985336,0.00109028,nitazoxanide
SIGNALING_BY_GPCR,2.372595772,0.000726853,nitazoxanide
AMINE_LIGAND_BINDING_RECEPTORS,2.276087488,0.001453707,nitazoxanide
POTASSIUM_CHANNELS,2.173744882,0.004361121,nitazoxanide
SUMOYLATION,-2.261109784,0.064112349,nitazoxanide
M_PHASE,-2.178361278,0.055869333,nitazoxanide
NCAM1_INTERACTIONS,2.107572583,0.007631962,nitazoxanide
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.086564315,0.055564036,nitazoxanide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.079429522,0.04533659,nitazoxanide
GPCR_LIGAND_BINDING,-2.567784959,0,otamixaban
SIGNALING_BY_GPCR,-2.372551765,0.001851532,otamixaban
CELLULAR_RESPONSE_TO_STARVATION,2.506277982,0.0118251,otamixaban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.227382712,0.005924902,otamixaban
NONSENSE_MEDIATED_DECAY_NMD,2.19935698,0.04814505,otamixaban
NEURONAL_SYSTEM,-2.126994058,0.015552867,otamixaban
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.124152708,0.013923519,otamixaban
TRANSLATION,2.102221926,0.0608148,otamixaban
INFLUENZA_INFECTION,2.074601648,0.05321295,otamixaban
G_ALPHA_I_SIGNALLING_EVENTS,-2.078792383,0.016416916,otamixaban
GPCR_LIGAND_BINDING,-2.92250123,0,bopindolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.492895201,0,bopindolol
SIGNALING_BY_GPCR,-2.356449571,0.003343606,bopindolol
INTERFERON_ALPHA_BETA_SIGNALING,2.340532903,0.01463332,bopindolol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.220692477,0.024998589,bopindolol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.17015228,0.023169424,bopindolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.04722619,0.050302038,bopindolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.043431219,0.041217185,bopindolol
CELLULAR_RESPONSE_TO_STARVATION,2.021331079,0.039428668,bopindolol
EUKARYOTIC_TRANSLATION_ELONGATION,2.01457703,0.035886476,bopindolol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.242412178,0.008127957,carisoprodol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.205862194,0.009143952,carisoprodol
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.124210238,0.053239133,carisoprodol
ECM_PROTEOGLYCANS,-2.040040096,0.046735754,carisoprodol
SIGNALING_BY_NTRKS,1.907227378,0.114417435,carisoprodol
ADAPTIVE_IMMUNE_SYSTEM,1.529596143,0.606490241,carisoprodol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.723952123,0.540001161,carisoprodol
TCR_SIGNALING,1.45333263,0.673895342,carisoprodol
GASTRULATION,-1.638496248,0.811373334,carisoprodol
GPCR_LIGAND_BINDING,-1.635807641,0.689521708,carisoprodol
CELL_CYCLE_CHECKPOINTS,2.186880041,0.014670349,nilutamide
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.840558263,0.074818778,nilutamide
MITOTIC_PROMETAPHASE,1.778932653,0.065527557,nilutamide
CELL_CYCLE_MITOTIC,1.677108253,0.083620987,nilutamide
MITOTIC_METAPHASE_AND_ANAPHASE,1.61723702,0.096237487,nilutamide
CELL_CYCLE,1.432288701,0.204406858,nilutamide
G_ALPHA_I_SIGNALLING_EVENTS,1.318132072,0.300532571,nilutamide
M_PHASE,1.299407286,0.287538833,nilutamide
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.266233702,0.296993058,nilutamide
NEDDYLATION,1.22761272,0.311598205,nilutamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.650543655,1,histamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.46815232,0.573540658,histamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.469521363,1,histamine
GPCR_LIGAND_BINDING,-2.375004031,1,histamine
G_ALPHA_I_SIGNALLING_EVENTS,-2.30695902,1,histamine
SIGNALING_BY_GPCR,-2.191171735,1,histamine
NONSENSE_MEDIATED_DECAY_NMD,-2.129210927,1,histamine
EUKARYOTIC_TRANSLATION_INITIATION,-2.108629195,1,histamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.1023172,0.913704926,histamine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.099583037,0.813564398,histamine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.964739722,0.148046607,nitrazepam
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.883424297,0.110856155,nitrazepam
SYNTHESIS_OF_DNA,2.01598035,0.505394204,nitrazepam
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,2.013466773,0.259526753,nitrazepam
MYD88_INDEPENDENT_TLR4_CASCADE,-1.73823,0.15734422,nitrazepam
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.916046647,0.371252846,nitrazepam
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.908392605,0.292098937,nitrazepam
EXTRACELLULAR_MATRIX_ORGANIZATION,1.887994968,0.274236772,nitrazepam
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.884644066,0.233258863,nitrazepam
DNA_REPLICATION,1.856398301,0.246617962,nitrazepam
TCR_SIGNALING,2.077038067,0.097666068,BRD-K63750851
ADAPTIVE_IMMUNE_SYSTEM,2.058079242,0.058328346,BRD-K63750851
INNATE_IMMUNE_SYSTEM,2.017044042,0.056519715,BRD-K63750851
SIGNALING_BY_ALK_IN_CANCER,1.908540718,0.09529224,BRD-K63750851
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.939409938,0.343648308,BRD-K63750851
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.845729414,0.121268701,BRD-K63750851
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.760933642,0.164585411,BRD-K63750851
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.744537473,0.155800633,BRD-K63750851
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.700801465,0.180580491,BRD-K63750851
ECM_PROTEOGLYCANS,-1.769259015,0.720682139,BRD-K63750851
UNFOLDED_PROTEIN_RESPONSE_UPR,1.584561091,0.189647114,bupivacaine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.544790587,1,bupivacaine
NONSENSE_MEDIATED_DECAY_NMD,-2.4874282,0.731575806,bupivacaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.470079531,0.52957095,bupivacaine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.462363421,0.406776902,bupivacaine
SELENOAMINO_ACID_METABOLISM,-2.429850924,0.365061516,bupivacaine
EUKARYOTIC_TRANSLATION_INITIATION,-2.42718011,0.306466271,bupivacaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.313346163,0.331914535,bupivacaine
TRANSLATION,-2.309932947,0.291462914,bupivacaine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.255168313,0.279370871,bupivacaine
METABOLISM_OF_RNA,-2.972451195,0,NVP-BGJ398
SIGNALING_BY_GPCR,2.96717318,0,NVP-BGJ398
GPCR_LIGAND_BINDING,2.911880051,0,NVP-BGJ398
RRNA_PROCESSING,-2.860823401,0,NVP-BGJ398
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.784469346,0,NVP-BGJ398
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.494475489,0,NVP-BGJ398
CELL_CYCLE,-2.649167195,0.000507644,NVP-BGJ398
MITOTIC_METAPHASE_AND_ANAPHASE,-2.615619675,0.000380733,NVP-BGJ398
G_ALPHA_Q_SIGNALLING_EVENTS,2.296931402,0.001520804,NVP-BGJ398
TRANSLATION,-2.291091141,0.009442177,NVP-BGJ398
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.669229742,0,suvorexant
ECM_PROTEOGLYCANS,-2.578039666,0,suvorexant
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.316464222,0.001436537,suvorexant
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.101581324,0.090843352,suvorexant
NEUTROPHIL_DEGRANULATION,2.061504094,0.065104402,suvorexant
INNATE_IMMUNE_SYSTEM,2.05116125,0.047440417,suvorexant
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.987397679,0.055263039,suvorexant
MITF_M_DEPENDENT_GENE_EXPRESSION,1.967314602,0.052083522,suvorexant
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.763233004,0.154181355,suvorexant
TCR_SIGNALING,1.669413292,0.220619568,suvorexant
NONSENSE_MEDIATED_DECAY_NMD,-3.118437204,0,amfepramone
SARS_COV_2_HOST_INTERACTIONS,-2.494520165,0,amfepramone
SIGNALING_BY_ROBO_RECEPTORS,-2.673153743,0,amfepramone
SARS_COV_1_INFECTION,-2.682894972,0,amfepramone
TRANSLATION,-2.714504079,0,amfepramone
RRNA_PROCESSING,-2.738414866,0,amfepramone
INFLUENZA_INFECTION,-2.795289675,0,amfepramone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.795573251,0,amfepramone
SARS_COV_1_HOST_INTERACTIONS,-2.813511472,0,amfepramone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.455885809,0,amfepramone
SENSORY_PERCEPTION,-2.074190864,0.047787165,isoniazid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.989853262,0.069074175,isoniazid
GPCR_LIGAND_BINDING,-1.962575606,0.061399267,isoniazid
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.746517076,0.707920476,isoniazid
INFLUENZA_INFECTION,1.56572311,0.944416033,isoniazid
SIGNALING_BY_GPCR,-1.850108494,0.156828788,isoniazid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.537320317,0.730891347,isoniazid
NUCLEOTIDE_EXCISION_REPAIR,1.526168839,0.579492425,isoniazid
G_ALPHA_Q_SIGNALLING_EVENTS,-1.818777187,0.16682065,isoniazid
MRNA_SPLICING,1.433074261,0.764930001,isoniazid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.735487281,0,levosimendan
NONSENSE_MEDIATED_DECAY_NMD,-2.720766887,0,levosimendan
SELENOAMINO_ACID_METABOLISM,-2.699457083,0,levosimendan
EUKARYOTIC_TRANSLATION_INITIATION,-2.639296684,0,levosimendan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.62151104,0,levosimendan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.600562129,0,levosimendan
CELLULAR_RESPONSE_TO_STARVATION,-2.535673446,0,levosimendan
INFLUENZA_INFECTION,-2.497591713,0,levosimendan
TRANSLATION,-2.461146975,0,levosimendan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.444482853,0,levosimendan
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.078555105,0.067677584,lenvatinib
MRNA_SPLICING,2.058503808,0.037940464,lenvatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.960918212,0.050587285,lenvatinib
BACTERIAL_INFECTION_PATHWAYS,1.781343651,0.102541794,lenvatinib
NUCLEOTIDE_EXCISION_REPAIR,1.634546113,0.189497234,lenvatinib
CELLULAR_RESPONSE_TO_STARVATION,1.557778908,0.230035424,lenvatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.359897138,1,lenvatinib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.353600676,0.930101815,lenvatinib
INFLUENZA_INFECTION,1.439551692,0.338387919,lenvatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.256506072,0.727339619,lenvatinib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.222449539,0.074567147,H-7
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.084609064,0.103896891,H-7
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.888448446,0.289855072,H-7
TCR_SIGNALING,1.867269004,0.396697221,H-7
HIV_LIFE_CYCLE,1.786724293,0.531912314,H-7
SARS_COV_INFECTIONS,-1.451404809,1,H-7
EXTRACELLULAR_MATRIX_ORGANIZATION,1.754489522,0.526344634,H-7
NEUTROPHIL_DEGRANULATION,1.738148194,0.485680683,H-7
RHO_GTPASES_ACTIVATE_FORMINS,1.727764595,0.444846293,H-7
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.708670352,0.438330545,H-7
SIGNALING_BY_HEDGEHOG,-1.875429435,0.40895679,aloisine
O_LINKED_GLYCOSYLATION,1.919521793,0.781124224,aloisine
CDC42_GTPASE_CYCLE,-1.597479207,0.830306209,aloisine
RAC1_GTPASE_CYCLE,-1.568238412,0.642121828,aloisine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.508936687,0.630302931,aloisine
RHO_GTPASE_EFFECTORS,-1.434967897,0.699770507,aloisine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.328951167,0.91200577,aloisine
S_PHASE,-1.311179767,0.83522392,aloisine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.28331051,0.819806898,aloisine
SEPARATION_OF_SISTER_CHROMATIDS,-1.273603821,0.758245361,aloisine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.161939123,0.022304179,oxandrolone
GASTRULATION,-1.976719333,0.091893216,oxandrolone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.976256369,0.061856922,oxandrolone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.791299599,0.575760262,oxandrolone
ADAPTIVE_IMMUNE_SYSTEM,1.537167017,1,oxandrolone
SENSORY_PERCEPTION,-1.74149983,0.390769211,oxandrolone
SIGNALING_BY_NOTCH,-1.684745144,0.490691932,oxandrolone
NEURONAL_SYSTEM,-1.633574136,0.585707734,oxandrolone
INNATE_IMMUNE_SYSTEM,1.302632339,1,oxandrolone
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.57549896,0.727116227,oxandrolone
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.871703637,0.317840724,everolimus
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.017915197,0.43580095,everolimus
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.99964335,0.248259643,everolimus
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1.998175432,0.167465084,everolimus
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.916482483,0.241649179,everolimus
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.903396639,0.214081096,everolimus
METABOLISM_OF_RNA,1.875526641,0.219369467,everolimus
DNA_REPAIR,1.864168662,0.203280508,everolimus
HIV_LIFE_CYCLE,1.827476191,0.227326507,everolimus
NUCLEOTIDE_EXCISION_REPAIR,1.791549185,0.2601748,everolimus
EUKARYOTIC_TRANSLATION_ELONGATION,-2.376352354,0.003589087,CP-945598
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.317820619,0.002243179,CP-945598
NONSENSE_MEDIATED_DECAY_NMD,-2.255342686,0.003289996,CP-945598
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.253387504,0.002467497,CP-945598
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.244340903,0.002332906,CP-945598
SELENOAMINO_ACID_METABOLISM,-2.194502292,0.00284136,CP-945598
EUKARYOTIC_TRANSLATION_INITIATION,-2.154754649,0.003973632,CP-945598
SARS_COV_1_INFECTION,-2.142013921,0.003925563,CP-945598
SARS_COV_1_HOST_INTERACTIONS,-2.140922198,0.003589087,CP-945598
RRNA_PROCESSING,-2.110122347,0.005293903,CP-945598
GPCR_LIGAND_BINDING,-2.701747677,0,rilpivirine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.544648672,0,rilpivirine
SIGNALING_BY_GPCR,-2.442706314,0,rilpivirine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.295566526,0.000421754,rilpivirine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.135093687,0.004048842,rilpivirine
G_ALPHA_S_SIGNALLING_EVENTS,-2.10706239,0.004217544,rilpivirine
G_ALPHA_I_SIGNALLING_EVENTS,-2.089992916,0.004458546,rilpivirine
NEURONAL_SYSTEM,-2.034477432,0.008856842,rilpivirine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.030224689,0.008247641,rilpivirine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.026147837,0.008013333,rilpivirine
GPCR_LIGAND_BINDING,2.66617838,0.000898538,fluorouracil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.644740034,0.001347807,fluorouracil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.532002122,0.001797075,fluorouracil
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.384917852,0.003144882,fluorouracil
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.346734673,0.004133273,fluorouracil
MUSCLE_CONTRACTION,2.177051885,0.011381478,fluorouracil
L1CAM_INTERACTIONS,2.136991589,0.012579528,fluorouracil
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.061521576,0.019992464,fluorouracil
SIGNALING_BY_GPCR,1.99284197,0.027355481,fluorouracil
ADIPOGENESIS,-1.946541343,0.546120324,fluorouracil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.005204472,0,suprofen
VIRAL_INFECTION_PATHWAYS,2.564021968,0,suprofen
NERVOUS_SYSTEM_DEVELOPMENT,2.655823931,0,suprofen
SARS_COV_1_HOST_INTERACTIONS,2.836018815,0,suprofen
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.013391871,0,suprofen
TRANSLATION,3.078021092,0,suprofen
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.131860397,0,suprofen
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.280041133,0,suprofen
CELLULAR_RESPONSES_TO_STIMULI,2.545497887,0,suprofen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.560017856,0,suprofen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.381562145,0,TG-100801
SIGNALING_BY_GPCR,-2.508980851,0,TG-100801
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.72924723,0,TG-100801
NONSENSE_MEDIATED_DECAY_NMD,3.038378191,0,TG-100801
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.049149944,0,TG-100801
EUKARYOTIC_TRANSLATION_ELONGATION,3.1710256,0,TG-100801
GPCR_LIGAND_BINDING,-2.746516974,0,TG-100801
CELLULAR_RESPONSE_TO_STARVATION,3.201428719,0,TG-100801
EUKARYOTIC_TRANSLATION_INITIATION,3.211665593,0,TG-100801
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.249072073,0,TG-100801
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.490720441,0.009908405,paracetamol
MRNA_SPLICING,2.458444249,0.007431304,paracetamol
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.223749303,0.018991109,paracetamol
INFLUENZA_INFECTION,1.906071135,0.071835935,paracetamol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.974810528,0.212959896,paracetamol
METABOLISM_OF_RNA,1.717881905,0.151103174,paracetamol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.81060485,0.550898375,paracetamol
SIGNALING_BY_GPCR,-1.781065053,0.473143949,paracetamol
GPCR_LIGAND_BINDING,-1.765681849,0.406067598,paracetamol
EPH_EPHRIN_SIGNALING,1.290405813,1,paracetamol
GPCR_LIGAND_BINDING,-2.577425723,0,berberine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.464846359,0,berberine
SIGNALING_BY_GPCR,-2.447269425,0,berberine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.423907463,0,berberine
PEROXISOMAL_PROTEIN_IMPORT,2.216488128,0.047849203,berberine
NEURONAL_SYSTEM,-2.095813578,0.005684015,berberine
G_ALPHA_I_SIGNALLING_EVENTS,-2.065824592,0.008255355,berberine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.037762267,0.010324028,berberine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.013441725,0.011977032,berberine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.011382354,0.010916918,berberine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.621890502,0,carfilzomib
GPCR_LIGAND_BINDING,-2.501568192,0.001972958,carfilzomib
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.442058823,0.002746891,carfilzomib
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.38385731,0.00183126,carfilzomib
ASPARAGINE_N_LINKED_GLYCOSYLATION,2.340827545,0.003204706,carfilzomib
INTERFERON_ALPHA_BETA_SIGNALING,2.324191213,0.003662521,carfilzomib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.266096723,0.005493781,carfilzomib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.274346002,0.011508921,carfilzomib
SIGNALING_BY_GPCR,-2.197824572,0.019071925,carfilzomib
G_ALPHA_I_SIGNALLING_EVENTS,-2.167690676,0.020058404,carfilzomib
SELENOAMINO_ACID_METABOLISM,-3.455585004,0,KX-2391
NERVOUS_SYSTEM_DEVELOPMENT,-2.512664547,0,KX-2391
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.697061831,0,KX-2391
SARS_COV_1_HOST_INTERACTIONS,-2.794720354,0,KX-2391
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.795827847,0,KX-2391
SIGNALING_BY_ROBO_RECEPTORS,-2.909393404,0,KX-2391
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.923683071,0,KX-2391
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.934953858,0,KX-2391
TRANSLATION,-2.968666048,0,KX-2391
SARS_COV_1_INFECTION,-2.702525093,0,KX-2391
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.435242206,0.007883194,procaine
MUSCLE_CONTRACTION,2.225294754,0.01801873,procaine
ION_CHANNEL_TRANSPORT,1.994937408,0.058185482,procaine
NEURONAL_SYSTEM,1.802851076,0.149780693,procaine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.70532096,0.216675228,procaine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.560189764,0.384211878,procaine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.534107203,0.38161096,procaine
CELLULAR_SENESCENCE,-1.742567074,1,procaine
TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,-1.709702339,1,procaine
BIOLOGICAL_OXIDATIONS,1.418431276,0.581667128,procaine
ECM_PROTEOGLYCANS,-2.250341089,0.008358791,ARN-509
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.21939856,0.006501282,ARN-509
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.054417695,0.030029732,ARN-509
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.077318126,0.122098865,ARN-509
COLLAGEN_FORMATION,-1.973329157,0.050617125,ARN-509
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.907450622,0.153273044,ARN-509
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.769165798,0.229476591,ARN-509
PROTEIN_LOCALIZATION,1.766783335,0.176328946,ARN-509
INNATE_IMMUNE_SYSTEM,1.603087513,0.351748646,ARN-509
GASTRULATION,-1.753764145,0.313733301,ARN-509
PEPTIDE_HORMONE_METABOLISM,2.03116203,0.16369098,solifenacin-succinate
EXTRACELLULAR_MATRIX_ORGANIZATION,2.006814577,0.096420714,solifenacin-succinate
METABOLISM_OF_STEROIDS,1.915588205,0.111743386,solifenacin-succinate
RSV_HOST_INTERACTIONS,-1.875337928,0.987388679,solifenacin-succinate
DEUBIQUITINATION,-1.84077515,0.643210423,solifenacin-succinate
MUSCLE_CONTRACTION,1.625135935,0.393531054,solifenacin-succinate
HCMV_EARLY_EVENTS,1.56578751,0.421111863,solifenacin-succinate
HEMOSTASIS,1.550008621,0.378021521,solifenacin-succinate
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.779117005,0.682854838,solifenacin-succinate
TNF_SIGNALING,-1.755172932,0.609714936,solifenacin-succinate
EUKARYOTIC_TRANSLATION_ELONGATION,2.855294948,0,avanafil
CELLULAR_RESPONSE_TO_STARVATION,2.852018796,0,avanafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.845897103,0,avanafil
EUKARYOTIC_TRANSLATION_INITIATION,2.791208798,0,avanafil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.774050687,0,avanafil
GPCR_LIGAND_BINDING,-2.72791487,0,avanafil
SELENOAMINO_ACID_METABOLISM,2.700449128,0,avanafil
NONSENSE_MEDIATED_DECAY_NMD,2.69007662,0,avanafil
SIGNALING_BY_GPCR,-2.686709043,0,avanafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.476608901,0,avanafil
GPCR_LIGAND_BINDING,-2.890872855,0,tipiracil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.702938459,0,tipiracil
SIGNALING_BY_GPCR,-2.672866162,0,tipiracil
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.37024312,0,tipiracil
G_ALPHA_Q_SIGNALLING_EVENTS,-2.29445755,0.00014879,tipiracil
G_ALPHA_I_SIGNALLING_EVENTS,-2.15861576,0.00161189,tipiracil
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.098971442,0.003826024,tipiracil
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.027707181,0.007997453,tipiracil
SENSORY_PERCEPTION,-2.021831573,0.007522152,tipiracil
G_ALPHA_S_SIGNALLING_EVENTS,-2.015052036,0.007439491,tipiracil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.706595699,0,tioconazole
TRANSLATION,-2.400504471,0,tioconazole
CELLULAR_RESPONSE_TO_STARVATION,-2.463473616,0,tioconazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.548283554,0,tioconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.555335189,0,tioconazole
RRNA_PROCESSING,-2.414411757,0,tioconazole
NONSENSE_MEDIATED_DECAY_NMD,-2.633995125,0,tioconazole
SELENOAMINO_ACID_METABOLISM,-2.642526099,0,tioconazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.697673471,0,tioconazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.618407813,0,tioconazole
NONSENSE_MEDIATED_DECAY_NMD,3.944770545,0,rotundine
SARS_COV_2_HOST_INTERACTIONS,2.612318162,0,rotundine
TRANSLATION,2.756841932,0,rotundine
SARS_COV_1_INFECTION,2.812078732,0,rotundine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.827561639,0,rotundine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.906805212,0,rotundine
SARS_COV_1_HOST_INTERACTIONS,3.013432446,0,rotundine
NERVOUS_SYSTEM_DEVELOPMENT,3.027144599,0,rotundine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.228443869,0,rotundine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.426055944,0,rotundine
NONSENSE_MEDIATED_DECAY_NMD,-2.435370155,0.001027902,adenosine
EUKARYOTIC_TRANSLATION_INITIATION,-2.416485422,0.000513951,adenosine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.407459602,0.000342634,adenosine
SELENOAMINO_ACID_METABOLISM,-2.370677605,0.000513951,adenosine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.329044114,0.002466964,adenosine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.30177564,0.00222712,adenosine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.06560789,0.01340857,adenosine
CELLULAR_RESPONSE_TO_STARVATION,-2.213153199,0.0085169,adenosine
TRANSLATION,-2.208385897,0.007709263,adenosine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.206330108,0.007309523,adenosine
MUSCLE_CONTRACTION,2.7606387,0,tafamidis-meglumine
NEUTROPHIL_DEGRANULATION,1.70434762,0.531042701,tafamidis-meglumine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.871999929,0.917273431,tafamidis-meglumine
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.689814104,0.384746773,tafamidis-meglumine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.86673593,0.482168861,tafamidis-meglumine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.640302291,0.381578947,tafamidis-meglumine
RSV_HOST_INTERACTIONS,-1.830200095,0.423578621,tafamidis-meglumine
HCMV_EARLY_EVENTS,1.629927734,0.325306852,tafamidis-meglumine
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,-1.809017861,0.374113091,tafamidis-meglumine
ION_CHANNEL_TRANSPORT,1.611008943,0.30123138,tafamidis-meglumine
GPCR_LIGAND_BINDING,-2.858902157,0,emedastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.733975938,0,emedastine
SIGNALING_BY_GPCR,-2.588141405,0,emedastine
INTERFERON_ALPHA_BETA_SIGNALING,2.659344125,0.00270636,emedastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.534025266,0.00541272,emedastine
SELENOAMINO_ACID_METABOLISM,2.429040174,0.00631484,emedastine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.287276598,0.001066506,emedastine
G_ALPHA_I_SIGNALLING_EVENTS,-2.231987944,0.001386458,emedastine
INTERFERON_GAMMA_SIGNALING,2.205656167,0.02435724,emedastine
CELLULAR_RESPONSE_TO_STARVATION,2.19890702,0.021109608,emedastine
EUKARYOTIC_TRANSLATION_ELONGATION,3.81331652,0,linagliptin
VIRAL_INFECTION_PATHWAYS,2.566858233,0,linagliptin
NERVOUS_SYSTEM_DEVELOPMENT,2.600339114,0,linagliptin
SARS_COV_1_INFECTION,2.653898074,0,linagliptin
SARS_COV_2_HOST_INTERACTIONS,2.680709056,0,linagliptin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.886828202,0,linagliptin
SARS_COV_1_HOST_INTERACTIONS,2.90893824,0,linagliptin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.96161619,0,linagliptin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.15590262,0,linagliptin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.199837368,0,linagliptin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.804527506,0,umeclidinium
MITF_M_DEPENDENT_GENE_EXPRESSION,2.148601826,0.04694413,umeclidinium
NEUTROPHIL_DEGRANULATION,2.139932866,0.033799774,umeclidinium
GPCR_LIGAND_BINDING,-2.110525229,0.026857474,umeclidinium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.076322756,0.017585251,umeclidinium
HIV_LIFE_CYCLE,2.047970074,0.048821895,umeclidinium
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.987348163,0.053328532,umeclidinium
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.956100551,0.055707034,umeclidinium
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.974931017,0.033678419,umeclidinium
SIGNALING_BY_GPCR,-1.967613901,0.027496937,umeclidinium
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.47952656,0,PS-178990
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.39730652,0,PS-178990
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.394611697,0,PS-178990
ECM_PROTEOGLYCANS,-2.387364882,0,PS-178990
COLLAGEN_FORMATION,-2.35978066,0,PS-178990
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.004653202,0.02475864,PS-178990
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.868163268,0.477240226,PS-178990
GPCR_LIGAND_BINDING,-1.923145845,0.046368782,PS-178990
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.842423816,0.271533232,PS-178990
MITF_M_DEPENDENT_GENE_EXPRESSION,1.764120557,0.285247032,PS-178990
EUKARYOTIC_TRANSLATION_ELONGATION,-2.766946292,0,norfloxacin
NONSENSE_MEDIATED_DECAY_NMD,-2.628727292,0,norfloxacin
SELENOAMINO_ACID_METABOLISM,-2.628425059,0,norfloxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.591197785,0,norfloxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.559668124,0,norfloxacin
EUKARYOTIC_TRANSLATION_INITIATION,-2.553903882,0,norfloxacin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.451267156,0,norfloxacin
CELLULAR_RESPONSE_TO_STARVATION,-2.374701769,0.000115821,norfloxacin
INFLUENZA_INFECTION,-2.331867319,0.000205905,norfloxacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.251901383,0.000505403,norfloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.977777915,0,naringenin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.395122431,0,naringenin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.403283292,0,naringenin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.423120771,0,naringenin
SARS_COV_1_HOST_INTERACTIONS,-2.489238536,0,naringenin
RRNA_PROCESSING,-2.519640247,0,naringenin
SIGNALING_BY_ROBO_RECEPTORS,-2.585213207,0,naringenin
INFLUENZA_INFECTION,-2.650823196,0,naringenin
SARS_COV_1_INFECTION,-2.36413177,0,naringenin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.719851447,0,naringenin
METABOLISM_OF_RNA,2.856603755,0,AMD-11070
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.527059677,0.002181818,AMD-11070
MRNA_SPLICING,2.373181527,0.002424242,AMD-11070
INFLUENZA_INFECTION,1.767769384,0.067636364,AMD-11070
ONCOGENIC_MAPK_SIGNALING,-2.476630113,0.949038674,AMD-11070
HOST_INTERACTIONS_OF_HIV_FACTORS,1.380883306,0.381963636,AMD-11070
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.358770933,0.350787879,AMD-11070
G_ALPHA_Q_SIGNALLING_EVENTS,-1.870549999,1,AMD-11070
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.831874887,1,AMD-11070
GPCR_LIGAND_BINDING,-1.829122881,0.872950276,AMD-11070
MUSCLE_CONTRACTION,3.160764086,0,KPT-330
CELL_CYCLE,-2.285928276,0.011975815,KPT-330
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.209533127,0.013964578,KPT-330
HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,-2.162119931,0.040282287,KPT-330
DISEASES_OF_DNA_REPAIR,-2.147251222,0.030483893,KPT-330
CELL_CYCLE_CHECKPOINTS,-2.135445522,0.025040341,KPT-330
CELL_CYCLE_MITOTIC,-2.113783199,0.025475825,KPT-330
MITOTIC_SPINDLE_CHECKPOINT,-2.104763759,0.023044371,KPT-330
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.077404765,0.02520436,KPT-330
DNA_REPAIR,-2.094705429,0.021463149,KPT-330
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.519667616,0,phenprocoumon
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.500136087,0,phenprocoumon
NONSENSE_MEDIATED_DECAY_NMD,-2.490791291,0,phenprocoumon
EUKARYOTIC_TRANSLATION_ELONGATION,-2.472622137,0,phenprocoumon
EUKARYOTIC_TRANSLATION_INITIATION,-2.458564637,0,phenprocoumon
SELENOAMINO_ACID_METABOLISM,-2.452476684,0,phenprocoumon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.423992673,0,phenprocoumon
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.411000795,0,phenprocoumon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.315104891,0.000224262,phenprocoumon
CELLULAR_RESPONSE_TO_STARVATION,-2.310221774,0.000201836,phenprocoumon
STRIATED_MUSCLE_CONTRACTION,3.225314555,0,travoprost
MUSCLE_CONTRACTION,3.125312222,0,travoprost
CELL_CYCLE_CHECKPOINTS,-2.074849283,0.173541399,travoprost
NEURONAL_SYSTEM,1.96775665,0.080253325,travoprost
TRANSLATION,-1.92128049,0.348091759,travoprost
CHROMOSOME_MAINTENANCE,-1.911064218,0.254930969,travoprost
METABOLISM_OF_RNA,-1.906623208,0.198765439,travoprost
BIOLOGICAL_OXIDATIONS,1.744221245,0.241491028,travoprost
EXTRACELLULAR_MATRIX_ORGANIZATION,1.730187712,0.207229031,travoprost
MITOTIC_SPINDLE_CHECKPOINT,-1.846415586,0.252240405,travoprost
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.127959888,0.037219573,brequinar
GPCR_LIGAND_BINDING,-2.019126941,0.06275393,brequinar
ECM_PROTEOGLYCANS,-1.991763619,0.056550668,brequinar
SIGNALING_BY_GPCR,-1.966312054,0.05366543,brequinar
MITF_M_DEPENDENT_GENE_EXPRESSION,1.882708277,0.401126539,brequinar
GASTRULATION,-1.950027486,0.049164459,brequinar
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.911247716,0.059003121,brequinar
NEUTROPHIL_DEGRANULATION,1.796048593,0.337201991,brequinar
INNATE_IMMUNE_SYSTEM,1.783680182,0.248240328,brequinar
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.731661587,0.245310453,brequinar
GPCR_LIGAND_BINDING,-2.48233896,0.001760097,nafamostat
EUKARYOTIC_TRANSLATION_ELONGATION,2.372479387,0.010080283,nafamostat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.402804363,0.00308017,nafamostat
CELLULAR_RESPONSE_TO_STARVATION,2.342544811,0.005600157,nafamostat
EUKARYOTIC_TRANSLATION_INITIATION,2.324058247,0.00485347,nafamostat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.303209106,0.004200118,nafamostat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.302244982,0.003584101,nafamostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.292680295,0.009973883,nafamostat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.211839489,0.008400236,nafamostat
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.249537459,0.012100667,nafamostat
INFLUENZA_INFECTION,3.083629299,0,diminazene-aceturate
TRANSLATION,2.908087724,0,diminazene-aceturate
CELLULAR_RESPONSE_TO_STARVATION,2.784838296,0,diminazene-aceturate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.763402618,0.000703384,diminazene-aceturate
NONSENSE_MEDIATED_DECAY_NMD,2.750502186,0.000562707,diminazene-aceturate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.557516763,0.000468923,diminazene-aceturate
RRNA_PROCESSING,1.97548216,0.04582044,diminazene-aceturate
ADAPTIVE_IMMUNE_SYSTEM,1.910495713,0.061194404,diminazene-aceturate
METABOLISM_OF_RNA,1.887064991,0.061272558,diminazene-aceturate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.809252285,0.081029831,diminazene-aceturate
GPCR_LIGAND_BINDING,-2.51472568,0,dipraglurant
CELLULAR_RESPONSE_TO_STARVATION,2.575339671,0.006240147,dipraglurant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.263842964,0.000948437,dipraglurant
SIGNALING_BY_GPCR,-2.262919388,0.000632291,dipraglurant
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.258911327,0.000632291,dipraglurant
REGULATION_OF_TP53_ACTIVITY,2.468259248,0.009360221,dipraglurant
NONSENSE_MEDIATED_DECAY_NMD,2.304198354,0.021840515,dipraglurant
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.303556386,0.016380386,dipraglurant
PEROXISOMAL_PROTEIN_IMPORT,2.260796011,0.016224383,dipraglurant
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.259327996,0.013520319,dipraglurant
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.806767788,0.002111464,rimonabant
CELLULAR_RESPONSE_TO_STARVATION,2.79506648,0.001055732,rimonabant
EUKARYOTIC_TRANSLATION_ELONGATION,2.754917468,0.000703821,rimonabant
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.72184618,0.000527866,rimonabant
GPCR_LIGAND_BINDING,-2.38827557,0.001485166,rimonabant
SELENOAMINO_ACID_METABOLISM,2.453534887,0.002533757,rimonabant
SIGNALING_BY_GPCR,-2.30349958,0.00222775,rimonabant
NONSENSE_MEDIATED_DECAY_NMD,2.36910001,0.00457484,rimonabant
EUKARYOTIC_TRANSLATION_INITIATION,2.320934546,0.006032756,rimonabant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.182451524,0.007178304,rimonabant
FATTY_ACID_METABOLISM,1.465813312,1,tiludronate
METABOLISM_OF_STEROIDS,1.424853546,0.892427663,tiludronate
MUSCLE_CONTRACTION,1.368873111,0.768643546,tiludronate
SELENOAMINO_ACID_METABOLISM,-2.294230873,1,tiludronate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.283631643,1,tiludronate
EUKARYOTIC_TRANSLATION_INITIATION,-2.248282733,1,tiludronate
NONSENSE_MEDIATED_DECAY_NMD,-2.197425961,0.715635202,tiludronate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.213052224,0.891788477,tiludronate
INFLUENZA_INFECTION,-2.169697787,0.604545747,tiludronate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.141700527,0.524480414,tiludronate
MUSCLE_CONTRACTION,2.438450113,0.003832641,mecamylamine
ECM_PROTEOGLYCANS,-2.247169252,0.024263585,mecamylamine
TRANSPORT_OF_SMALL_MOLECULES,2.221481985,0.017246886,mecamylamine
NEURONAL_SYSTEM,2.210103,0.012136698,mecamylamine
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,2.204640643,0.009581603,mecamylamine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.057391815,0.023954008,mecamylamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.966187532,0.214328338,mecamylamine
HEMOSTASIS,1.818154656,0.089747684,mecamylamine
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.909198767,0.225786142,mecamylamine
ION_CHANNEL_TRANSPORT,1.78419011,0.090203951,mecamylamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.793552656,0,gimeracil
NERVOUS_SYSTEM_DEVELOPMENT,2.536734117,0,gimeracil
VIRAL_INFECTION_PATHWAYS,2.645094436,0,gimeracil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.747544356,0,gimeracil
TRANSLATION,2.792361199,0,gimeracil
SARS_COV_1_INFECTION,2.826008027,0,gimeracil
SARS_COV_1_HOST_INTERACTIONS,3.007321553,0,gimeracil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.030450116,0,gimeracil
GPCR_LIGAND_BINDING,-3.137850994,0,gimeracil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.215941037,0,gimeracil
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.485909449,0,ifosfamide
CELL_CYCLE_CHECKPOINTS,-2.26491231,0.005546886,ifosfamide
APOPTOSIS,-2.182541196,0.008068198,ifosfamide
PROGRAMMED_CELL_DEATH,-2.118150634,0.01285869,ifosfamide
SEPARATION_OF_SISTER_CHROMATIDS,-2.117097808,0.010690362,ifosfamide
S_PHASE,-2.10889982,0.009580985,ifosfamide
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.056802075,0.013687121,ifosfamide
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-2.034412504,0.015632133,ifosfamide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.030141212,0.014567579,ifosfamide
GASTRULATION,-2.023874614,0.013917641,ifosfamide
GPCR_LIGAND_BINDING,-3.025986382,0,dronedarone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.786037559,0,dronedarone
SIGNALING_BY_GPCR,-2.580053275,0.000257149,dronedarone
G_ALPHA_I_SIGNALLING_EVENTS,-2.285681822,0.00925736,dronedarone
NONSENSE_MEDIATED_DECAY_NMD,2.112456618,0.105595528,dronedarone
NEURONAL_SYSTEM,-2.19324343,0.017588985,dronedarone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.071297616,0.07578032,dronedarone
SELENOAMINO_ACID_METABOLISM,2.059294798,0.055075314,dronedarone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.057270384,0.041617061,dronedarone
EUKARYOTIC_TRANSLATION_ELONGATION,2.054759908,0.033542109,dronedarone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.102065817,0.036635835,urea
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.101978019,0.018317917,urea
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.052033547,0.02442389,urea
SELENOAMINO_ACID_METABOLISM,-2.040589329,0.020298233,urea
EUKARYOTIC_TRANSLATION_INITIATION,-2.020336292,0.021783469,urea
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.006854785,0.021948496,urea
RRNA_PROCESSING,-2.006409242,0.018954447,urea
NONSENSE_MEDIATED_DECAY_NMD,-1.997020851,0.018317917,urea
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.985334631,0.018482944,urea
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.681573843,0.317812269,urea
MRNA_SPLICING,2.632794275,0,butorphanol-(+)-tartrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.263722826,0.00592842,butorphanol-(+)-tartrate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.830937562,0.051818781,butorphanol-(+)-tartrate
G_ALPHA_Q_SIGNALLING_EVENTS,-1.899720384,0.36487185,butorphanol-(+)-tartrate
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.811670509,0.431568855,butorphanol-(+)-tartrate
GPCR_LIGAND_BINDING,-1.777705596,0.390373646,butorphanol-(+)-tartrate
BIOLOGICAL_OXIDATIONS,1.397755196,0.378760155,butorphanol-(+)-tartrate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.752455146,0.378848796,butorphanol-(+)-tartrate
ONCOGENIC_MAPK_SIGNALING,1.3462605,0.389167826,butorphanol-(+)-tartrate
SIGNALING_BY_GPCR,-1.748403219,0.314849097,butorphanol-(+)-tartrate
EUKARYOTIC_TRANSLATION_ELONGATION,3.70423512,0,setiptiline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.779423929,0,setiptiline
SARS_COV_1_HOST_INTERACTIONS,2.800574444,0,setiptiline
TRANSLATION,2.808922341,0,setiptiline
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.926240339,0,setiptiline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.061610681,0,setiptiline
RRNA_PROCESSING,3.076699997,0,setiptiline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.082057778,0,setiptiline
CELLULAR_RESPONSE_TO_STARVATION,3.263821334,0,setiptiline
NERVOUS_SYSTEM_DEVELOPMENT,2.781803298,0,setiptiline
GPCR_LIGAND_BINDING,-2.647948942,0,apixaban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.59450076,0,apixaban
SIGNALING_BY_GPCR,-2.515737366,0,apixaban
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.34516225,0.000175817,apixaban
G_ALPHA_I_SIGNALLING_EVENTS,-2.159179545,0.002531758,apixaban
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.271483287,0.051500099,apixaban
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.20929616,0.037194516,apixaban
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.19666728,0.02575005,apixaban
G_ALPHA_Q_SIGNALLING_EVENTS,-2.108446345,0.003750752,apixaban
CILIUM_ASSEMBLY,2.150549163,0.024319491,apixaban
EUKARYOTIC_TRANSLATION_ELONGATION,3.810799102,0,levalbuterol
SARS_COV_1_HOST_INTERACTIONS,2.561692786,0,levalbuterol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.618842602,0,levalbuterol
CELLULAR_RESPONSES_TO_STIMULI,2.663953976,0,levalbuterol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.702296666,0,levalbuterol
NERVOUS_SYSTEM_DEVELOPMENT,2.936348136,0,levalbuterol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.028809939,0,levalbuterol
SIGNALING_BY_ROBO_RECEPTORS,3.279122261,0,levalbuterol
RRNA_PROCESSING,3.354772472,0,levalbuterol
TRANSLATION,2.797874963,0,levalbuterol
EUKARYOTIC_TRANSLATION_ELONGATION,3.856554504,0,ciclesonide
SARS_COV_1_INFECTION,2.742324173,0,ciclesonide
SARS_COV_1_HOST_INTERACTIONS,3.14396311,0,ciclesonide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.219464299,0,ciclesonide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.256558076,0,ciclesonide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.261861437,0,ciclesonide
INFLUENZA_INFECTION,3.279649842,0,ciclesonide
RRNA_PROCESSING,3.39379994,0,ciclesonide
SIGNALING_BY_ROBO_RECEPTORS,3.432676518,0,ciclesonide
TRANSLATION,2.946691847,0,ciclesonide
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.634156694,0,marimastat
BIOLOGICAL_OXIDATIONS,2.36843758,0.00501248,marimastat
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.259826928,0.004819693,marimastat
KERATINIZATION,2.259826928,0.004819693,marimastat
MUSCLE_CONTRACTION,2.229931722,0.004472675,marimastat
METABOLISM_OF_STEROIDS,1.997035259,0.020435497,marimastat
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.132758647,0.878536267,marimastat
TRANSPORT_OF_SMALL_MOLECULES,1.790339976,0.06125141,marimastat
SIGNALING_BY_MET,-2.996076037,1,marimastat
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.95260815,0.913154906,marimastat
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.278404162,0.000987511,lesinurad
SARS_COV_1_HOST_INTERACTIONS,-2.257162552,0.000493756,lesinurad
NONSENSE_MEDIATED_DECAY_NMD,-2.160394224,0.003950044,lesinurad
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.157274637,0.003209411,lesinurad
EUKARYOTIC_TRANSLATION_ELONGATION,-2.144996109,0.002765031,lesinurad
SARS_COV_1_INFECTION,-2.137452333,0.002468778,lesinurad
SELENOAMINO_ACID_METABOLISM,-2.125538975,0.002680387,lesinurad
RRNA_PROCESSING,-2.124063269,0.002468778,lesinurad
EUKARYOTIC_TRANSLATION_INITIATION,-2.111208286,0.002633363,lesinurad
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.099542358,0.002863782,lesinurad
EUKARYOTIC_TRANSLATION_ELONGATION,3.688127881,0,oxypurinol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.744202117,0,oxypurinol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.820074474,0,oxypurinol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.86402846,0,oxypurinol
RRNA_PROCESSING,2.935464596,0,oxypurinol
SIGNALING_BY_ROBO_RECEPTORS,2.936292219,0,oxypurinol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.062295349,0,oxypurinol
TRANSLATION,2.725161559,0,oxypurinol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.153516024,0,oxypurinol
SELENOAMINO_ACID_METABOLISM,3.438356722,0,oxypurinol
EUKARYOTIC_TRANSLATION_ELONGATION,3.465804975,0,dimethyl-fumarate
SARS_COV_1_HOST_INTERACTIONS,2.520408064,0,dimethyl-fumarate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.555842799,0,dimethyl-fumarate
TRANSLATION,2.594387115,0,dimethyl-fumarate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.607972201,0,dimethyl-fumarate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.862654717,0,dimethyl-fumarate
RRNA_PROCESSING,2.879420047,0,dimethyl-fumarate
SIGNALING_BY_ROBO_RECEPTORS,2.960747657,0,dimethyl-fumarate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.801406551,0,dimethyl-fumarate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.114362093,0,dimethyl-fumarate
GPCR_LIGAND_BINDING,-2.943714091,0,ixabepilone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.698417939,0,ixabepilone
SIGNALING_BY_GPCR,-2.536756891,0,ixabepilone
FATTY_ACID_METABOLISM,2.12898404,0.057536459,ixabepilone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.070361014,0.057043015,ixabepilone
NEURONAL_SYSTEM,-2.062074378,0.048979343,ixabepilone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.053193662,0.044599076,ixabepilone
G_ALPHA_I_SIGNALLING_EVENTS,-1.930261823,0.104102436,ixabepilone
G_ALPHA_Q_SIGNALLING_EVENTS,-1.905744189,0.108710248,ixabepilone
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-1.886570656,0.109108454,ixabepilone
DISEASES_OF_METABOLISM,-2.923907803,0.021363174,miglustat
MRNA_SPLICING,1.697448762,0.204394225,miglustat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.440990394,0.366666667,miglustat
METABOLISM_OF_STEROIDS,1.276948434,0.538376229,miglustat
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.375947429,1,miglustat
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.199973192,0.573477715,miglustat
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.174687316,1,miglustat
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.133834612,1,miglustat
PKR_MEDIATED_SIGNALING,1.043394009,0.837878217,miglustat
EUKARYOTIC_TRANSLATION_ELONGATION,-2.040680818,1,miglustat
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.518514918,0.009305749,eflornithine
TCR_SIGNALING,2.426014393,0.006979312,eflornithine
CELLULAR_RESPONSE_TO_STARVATION,2.402807716,0.005169861,eflornithine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.163798944,0.014840051,eflornithine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.236668707,0.010468968,eflornithine
EUKARYOTIC_TRANSLATION_INITIATION,2.092462115,0.023884756,eflornithine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.042351828,0.043647209,eflornithine
ADAPTIVE_IMMUNE_SYSTEM,1.932403993,0.046528745,eflornithine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.969270288,0.063433944,eflornithine
ECM_PROTEOGLYCANS,-1.957588109,0.051721943,eflornithine
GPCR_LIGAND_BINDING,-2.388676347,0.001349277,triptorelin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.193116399,0.003373192,triptorelin
SIGNALING_BY_GPCR,-2.117366073,0.005621987,triptorelin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.213000515,0.065236819,triptorelin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.075972445,0.006915044,triptorelin
REPRODUCTION,2.08144554,0.080836927,triptorelin
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,2.008812134,0.072800508,triptorelin
SARS_COV_2_HOST_INTERACTIONS,1.988336098,0.060273148,triptorelin
FATTY_ACID_METABOLISM,1.97859524,0.051054902,triptorelin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.971910463,0.017810454,triptorelin
ECM_PROTEOGLYCANS,-2.358697074,0.000973727,epinastine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.194767881,0.054289869,epinastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.104244324,0.027264361,epinastine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.139228692,0.042888997,epinastine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.032236103,0.049660086,epinastine
ADAPTIVE_IMMUNE_SYSTEM,2.012756048,0.062614316,epinastine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.969450664,0.05809016,epinastine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.897739827,0.076222976,epinastine
TCR_SIGNALING,1.89601614,0.064604944,epinastine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.770470572,0.111992244,epinastine
EUKARYOTIC_TRANSLATION_ELONGATION,3.901903313,0,glasdegib
SARS_COV_1_INFECTION,2.505223993,0,glasdegib
CELLULAR_RESPONSES_TO_STIMULI,2.556020421,0,glasdegib
NERVOUS_SYSTEM_DEVELOPMENT,2.839376375,0,glasdegib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.862502076,0,glasdegib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.898561743,0,glasdegib
TRANSLATION,3.008943332,0,glasdegib
SENSORY_PERCEPTION,-3.02986712,0,glasdegib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.162686039,0,glasdegib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.463854519,0,glasdegib
EUKARYOTIC_TRANSLATION_ELONGATION,3.806169511,0,levobunolol
SARS_COV_2_HOST_INTERACTIONS,2.579060179,0,levobunolol
SARS_COV_1_INFECTION,2.593974274,0,levobunolol
NERVOUS_SYSTEM_DEVELOPMENT,2.660055382,0,levobunolol
TRANSLATION,2.80988796,0,levobunolol
SARS_COV_1_HOST_INTERACTIONS,2.914538288,0,levobunolol
RRNA_PROCESSING,3.018264099,0,levobunolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.047128289,0,levobunolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.255376321,0,levobunolol
SIGNALING_BY_ROBO_RECEPTORS,3.287476209,0,levobunolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.309221995,0.010889075,clonazepam
INFLUENZA_INFECTION,2.172067998,0.010889075,clonazepam
MRNA_SPLICING,2.162405556,0.007259383,clonazepam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.926991057,0.321999616,clonazepam
G_ALPHA_Q_SIGNALLING_EVENTS,-1.894926645,0.225880327,clonazepam
GPCR_LIGAND_BINDING,-1.860555602,0.216268398,clonazepam
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.540892041,0.274560249,clonazepam
HOST_INTERACTIONS_OF_HIV_FACTORS,1.50807039,0.258537753,clonazepam
SIGNALING_BY_GPCR,-1.826733029,0.223717643,clonazepam
RAB_REGULATION_OF_TRAFFICKING,1.300253284,0.590343425,clonazepam
INFLUENZA_INFECTION,2.74429124,0.003678244,cyclobenzaprine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.663402031,0.001839122,cyclobenzaprine
MRNA_SPLICING,2.373705213,0.003678244,cyclobenzaprine
CELLULAR_RESPONSE_TO_STARVATION,2.102150787,0.024828148,cyclobenzaprine
GPCR_LIGAND_BINDING,-2.149572184,0.039044875,cyclobenzaprine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.107981737,0.0286606,cyclobenzaprine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.050660222,0.035998821,cyclobenzaprine
NUCLEOTIDE_EXCISION_REPAIR,1.909155424,0.076507477,cyclobenzaprine
SIGNALING_BY_GPCR,-1.980366419,0.056282772,cyclobenzaprine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.6029023,0.328589805,cyclobenzaprine
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-2.77374387,0.022691046,enprofylline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.39360018,1,enprofylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.135355171,1,enprofylline
G_ALPHA_I_SIGNALLING_EVENTS,-2.12511162,0.903942231,enprofylline
GPCR_LIGAND_BINDING,-2.115441309,0.727889308,enprofylline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.374676267,1,enprofylline
SIGNALING_BY_GPCR,-1.997735476,0.666261741,enprofylline
GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1.293268884,1,enprofylline
RSV_HOST_INTERACTIONS,-1.826352495,0.713710927,enprofylline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.774899745,0.697503037,enprofylline
CELL_CYCLE,-3.874829031,0,NVP-TAE226
CELL_CYCLE_CHECKPOINTS,-3.843306831,0,NVP-TAE226
CELL_CYCLE_MITOTIC,-3.605969998,0,NVP-TAE226
GPCR_LIGAND_BINDING,3.264254736,0,NVP-TAE226
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.759882464,0,NVP-TAE226
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.993120358,0,NVP-TAE226
SIGNALING_BY_GPCR,3.066400559,0,NVP-TAE226
METABOLISM_OF_RNA,-3.504887909,0.000672065,NVP-TAE226
MITOTIC_METAPHASE_AND_ANAPHASE,-3.447798164,0.002957084,NVP-TAE226
DNA_REPLICATION,-3.428383319,0.003360323,NVP-TAE226
NONSENSE_MEDIATED_DECAY_NMD,-3.120977997,0,trovafloxacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.571374821,0,trovafloxacin
SARS_COV_1_INFECTION,-2.57777611,0,trovafloxacin
SIGNALING_BY_ROBO_RECEPTORS,-2.649834204,0,trovafloxacin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.691026228,0,trovafloxacin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.723269644,0,trovafloxacin
INFLUENZA_INFECTION,-2.748056291,0,trovafloxacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.751513771,0,trovafloxacin
RRNA_PROCESSING,-2.753984794,0,trovafloxacin
CELLULAR_RESPONSE_TO_STARVATION,-2.857857134,0,trovafloxacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.45140281,0,elacridar
MRNA_SPLICING,1.999239528,0.0311395,elacridar
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.960080393,0.231912032,elacridar
SIGNALING_BY_GPCR,-1.909982478,0.194068646,elacridar
GPCR_LIGAND_BINDING,-1.876878743,0.178219706,elacridar
G_ALPHA_Q_SIGNALLING_EVENTS,-1.873857839,0.139244253,elacridar
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.595872976,0.302992282,elacridar
GENE_SILENCING_BY_RNA,1.550433406,0.291376754,elacridar
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.798030748,0.237540022,elacridar
ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,1.451428019,0.365370138,elacridar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.395733401,0.017319981,arbutin
EUKARYOTIC_TRANSLATION_INITIATION,-2.380553277,0.009678813,arbutin
NONSENSE_MEDIATED_DECAY_NMD,-2.335414749,0.006792149,arbutin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.322973228,0.00636764,arbutin
G_ALPHA_Q_SIGNALLING_EVENTS,2.574110096,0.002537132,arbutin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.293016115,0.006112935,arbutin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.292032256,0.005094112,arbutin
SELENOAMINO_ACID_METABOLISM,-2.233781043,0.005967388,arbutin
INFLUENZA_INFECTION,-2.193660895,0.00636764,arbutin
SIGNALING_BY_ROBO_RECEPTORS,-2.179605966,0.00633934,arbutin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.932338885,0.160926981,asymmetrical-dimethylarginine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.045464949,0.074074074,asymmetrical-dimethylarginine
TRNA_PROCESSING,1.875399989,0.106809943,asymmetrical-dimethylarginine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.761151493,0.12200069,asymmetrical-dimethylarginine
GPCR_LIGAND_BINDING,-1.956001407,0.102339181,asymmetrical-dimethylarginine
RAB_REGULATION_OF_TRAFFICKING,1.653716279,0.153806318,asymmetrical-dimethylarginine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.625124323,0.140134645,asymmetrical-dimethylarginine
SIGNALING_BY_GPCR,-1.82336166,0.289798571,asymmetrical-dimethylarginine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.817077938,0.227339181,asymmetrical-dimethylarginine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.807801709,0.199610136,asymmetrical-dimethylarginine
NEURONAL_SYSTEM,2.361132456,0.004798355,ceritinib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.863659686,0.146749686,ceritinib
G_ALPHA_I_SIGNALLING_EVENTS,1.66753852,0.344948399,ceritinib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.541644932,0.52182109,ceritinib
MUSCLE_CONTRACTION,1.493778633,0.534376785,ceritinib
GPCR_LIGAND_BINDING,1.4461615,0.561674093,ceritinib
CELL_CELL_COMMUNICATION,1.430546505,0.454944019,ceritinib
RNA_POLYMERASE_II_TRANSCRIPTION,1.430636898,0.519821775,ceritinib
SENSORY_PERCEPTION,-1.72919405,1,ceritinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.616826817,1,ceritinib
SELENOAMINO_ACID_METABOLISM,-2.280049897,0.009185205,azelaic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.184716967,0.009644465,azelaic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.172320109,0.007348164,azelaic-acid
NERVOUS_SYSTEM_DEVELOPMENT,-2.118957665,0.008496315,azelaic-acid
NONSENSE_MEDIATED_DECAY_NMD,-2.114442648,0.00716446,azelaic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.108689164,0.006735817,azelaic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.104463212,0.005773557,azelaic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.08285949,0.005740753,azelaic-acid
SIGNALING_BY_ROBO_RECEPTORS,-2.051673945,0.007041991,azelaic-acid
CELLULAR_RESPONSE_TO_STARVATION,-2.042607695,0.006797052,azelaic-acid
TOLL_LIKE_RECEPTOR_CASCADES,2.105719343,0.268249251,ambrisentan
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,2.10315854,0.137956758,ambrisentan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.070175185,0.126642844,ambrisentan
PLATELET_AGGREGATION_PLUG_FORMATION,2.041319169,0.124818019,ambrisentan
SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,2.000893967,0.138832674,ambrisentan
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.997617478,0.120620922,ambrisentan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.978512475,0.123253883,ambrisentan
ONCOGENIC_MAPK_SIGNALING,1.961062514,0.124270571,ambrisentan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.924425511,0.143552887,ambrisentan
CELLULAR_SENESCENCE,1.923070354,0.130183004,ambrisentan
